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General Introduction 
1  Introduction 
1.1  Natural Product Chemistry 
Mankind has known about the benefit of drugs from the crude herbs worldwide for 
thousands of years.[1] In Asia, Traditional Chinese Medicine (TCM) and Ayurveda, Traditional 
Indian Medicine (TIM) remain the most ancient yet living traditions.[2] The earliest and most 
fundamental composition identified in TCM is the Yellow Emperor’s Classic of Internal 
Medicine probably dating back to 2697 B.C.,[3] while Ayurvedic fundamental and applied 
principles were organized and recorded around 1500 B.C.[4] In Africa, the Egyptians in the 
days of pharaohs had developed great skills in the use of herbs, and the earliest medical texts, 
some 4000 years old, described the rich choice of plants.[5] In Europe, there is also a very long 
history of traditional medicine that has respectable historical and scientific dignity.[6] In fact, 
for most of history, herbal medicine was the only medicine. 
Nowadays, herbal medicines are still used and continue to be used for therapies,[7,8] but 
considerable confusion remains about their exact mechanism of action. Herbalists claim that 
secondary metabolites (e.g., alkaloids, quinones, flavonoids, terpenoids, steroids, 
carbohydrates, and others), produced by plants, can work together synergistically so that the 
effect of the whole herb is greater than the summed effects of the individual components and 
the toxicity of the whole herb is lower than that of isolated active ingredients.[9] This contrasts 
with conventional practice, where polypharmacy is generally avoided whenever possible. 
Conventional practitioners believe that the efficacy of herbs used to treat illness has originated 
from the lead compounds (or active principles) contained in herbs in a mixture of other 
compounds. Such compounds must be isolated and purified, and structurally identified, which 
provides the fundamental prerequisites for the subsequent series of validation steps. 
The first example of conventional medicine derived from a plant is morphine (1) (Figure 1). 
From about 800, Papaver somniferum was used not only to treat pain but also to anaesthetize 
patients. Morphine was isolated from this plant source in 1806, and the manufacturing of this 
analgesic drug was realized by E. Merck, Germany in 1826.[10] Two other examples of a 
plant-derived drug were quinine (2) and artemisinin (3), which are used to treat malaria 
widespread in tropical and subtropical regions. The pure active principle quinine (2) was first 
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isolated in 1820s from the bark of the Cinchona tree. Artemisinin (qinghaosu) (3) was 
identified in 1972 as the bioactive principle of Artemisia annua (qinghao plant). Artemether 
(4), a semi-synthetic derivative of 3, is used for the treatment of multi-drug resistant strains of 
Plasmodium falciparum.[11] 
 
Figure 1. Three naturally occurring structures isolated from medicinal plants, morphine (1), quinine 
(2), and artemisinin (3), and one semi-synthetic derivative of 3, artemether (4). 
Given that natural products have historically provided many novel drugs, one would 
assume that they would still play a pivotal role in the drug discovery strategy in 
pharmaceutical company. However, most big pharmaceutical companies have terminated or 
significantly scaled down their natural products operations during the past 15−20 years.[12,13] 
This trend could be explained by two aspects: the great obstacles of natural products research 
and the emergence of combinatorial chemistry in combination with high-throughput screening 
(HTS). In the course of natural products research, considerable research time and increasingly 
expensive purification technologies e.g., preparative HPLC, are needed to eliminate known 
compounds, and accumulate enough quantities of bioactive molecules for further biological 
evaluation. Also, the complex nature of some naturally bioactive structures impeded the 
further lead optimization process. By contrast, combinatorial synthesis can efficiently provide 
large libraries of related compounds for modern HTS.[12,14] Therefore, this rapidly growing 
area provides an enormous potential to accelerate drug discovery and development. 
It is certainly true that biased combinatorial libraries of pure products are particularly easy 
and convenient to screen, while the hope of identifying interesting lead structures is often 
disappointed. By contrast, natural products derived from all sources or related to natural 
products have played and continue to play a dominant role in the discovery of leads for the 
development of drugs for the treatment of human diseases.[15-19] In Figure 2, the number (616, 
52%) of naturally inspired agents (i.e., N, ND, S/NM, S∗, S∗/NM) in the 1184 chemical 
entities from 1981−2006 is much higher than that of merely synthetic drugs (355, 30%) by 
random screening, even though most of work by the pharmaceutical industry was devoted to 
HTS of predominantly combinatorial chemistry.[17] 
1             2                     3                 4 
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Figure 2. All new chemical entities, 01/1981−06/2006, by source (N = 1184) (Figure from Lit.[17]). 
In conclusion, the search for natural products by isolation and their derivatives by partial or 
total synthesis still provides the best solution to the current productivity crisis in drug 
discovery and development. 
1.2  Ancistrocladaceae and Dioncophyllaceae 
The tropical lianas of the Ancistrocladaceae and Dioncophyllaceae families,[20] mainly 
occurring in Africa, Southern, and Southeastern Asia, have been widely used in the traditional 
medicine. Examples are Ancistrocladus tectorius, which has been applied to treat dysentery 
and malaria in Thailand,[21] and Triphyophyllum peltatum (Figure 3), which has been used to 
treat malaria, elephantiasis, and other diseases.[22] 
 
Figure 3. Pictures of A. tectorius (a) and T. peltatum (b) (pictures from AK Bringmann). 
Phytochemical investigations on these plants have revealed that the bioactive principles are 
a                      b      
B: biological peptides  
or proteins, 14% 
N: natural  
products, 5% 
ND: derived from a 
natural product and 
usually a semi-synthetic 
modification, 23% 
S: totally synthetic drug, 
often found by random 
screening, 30% 
S∗: 4% 
S∗/NM: 10% 
S/NM: 10% 
S∗: made by total synthesis, but the pharmacophore was from a natural product 
NM: natural product mimic 
 
V: vaccine,  
4% 
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due to the presence of a variety of C,C- and N,C-coupled naphthylisoquinoline alkaloids, like 
ancistrocladine (5a), dioncophylline A (6), and ancistrocladinium A (7b) (Figure 4). Their 
occurrence is restricted to the two small families, exclusively. 
 
Figure 4. Structures of the naphthylisoquinoline alkaloids ancistrocladine (5a), dioncophylline A (6), 
ancistrocladinium A (7b), and shuangancistrotectorine A (8). 
The crude extracts and many of more than 140 so far isolated alkaloids from the two 
families Ancistrocladaceae and Dioncophyllaceae, as well as their partial- and total-synthetic 
analogs exhibit promising biological activities. This class of biaryls has been described as 
exhibiting strong growth-inhibition activities in vitro against the plasmodial parasites P. 
falciparum[23-29] and P. berghei[30-32] and in vivo against P. berghei,[33] against the pathogens 
of leishmaniasis, Leishmania donovani,[34-37] and of trypanosomasis, Trypanosoma 
cruzi[35,38,39] and T. brucei rhodesiense.[40] Efficacy against HIV-1 and HIV-2,[41-44] the 
tropical water snail Biomphalaria glabrata (the vector of Schistosoma mansoni, which causes 
schistosomiasis),[45-47] and the malarial vector Anopheles stephensi,[48] have also been reported. 
These findings suggest that naphthylisoquinoline alkaloids constitute a class of 
pharmacologically interesting compounds. 
Structurally, the naphthylisoquinoline alkaloids are unique, consisting of a naphthalene ring 
system and an isoquinoline moiety, which are connected by a C,C-biaryl or an iminium-aryl 
axis (i.e., C,C- or N,C-coupled), while naturally occurring dimers like shuangancistrotectorine 
A (8) (Figure 4) contain an additional C,C-biaryl axis between the two monomeric 
portions.[27,40,47] Most of these alkaloids display the phenomenon of atropisomerism, resulting 
6 
5a 
8 
7b 
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from hindered rotation about the biaryl axes. The large structural variety in their constitutions 
stems from the presence of diverse coupling patterns (i.e., 5,1′-, 5,3′-, 5,8′-, 7,1′-, 7,3′-, 7,6′-, 
7,8′-, N,6′-, and N,8′-), in their oxygen substitution patterns, in their absolute configurations at 
C-1 and C-3, and in the unsaturation degree in the isoquinoline moieties. 
Biosynthetically this class of secondary metabolites, with its broad structural variety, 
originates from an acetate-malonate pathway for both, the naphthalene parts and the 
isoquinoline moieties.[49-51] The biosynthesis of the isoquinoline unit can, however, be easily 
blocked by all sorts of chemical, physical or biotic stress. Then, only small quantities of 
naphthylisoquinoline alkaloids are produced, while enhanced quantities of naphthoquinones 
are formed.[52,53] Recently, phytochemical investigation on cell cultures of T. peltatum led to 
the isolation of two highly promising naphthoquinones, dioncoquinones A (9) and B (10), and 
nine further analogs from A. heyneanus.[54,55] Dioncoquinones A (9) and B (10) exhibited 
excellent anti-multiple myeloma properties (especially 10 with EC50 = 11 μM against INA-6) 
without any significant cytotoxicity on normal cells. In particular, these 
effective-concentration ranges of the compounds 9 and 10 (Figure 5) were similar to those of 
melphalan, a well-known DNA-alkylating agent[56] routineously used in standard 
chemotherapeutic regiments for multiple myeloma.[54] 
 
Figure 5. Structures of bioactive dioncoquinones A (9) and B (10). 
Despite the availability of some antimalarial drugs and co-opted chemotherapeutic 
treatments for multiple myeloma, an urgent need is still to discover more powerful drugs to 
overcome resistance of pathogens and to diminish the side effects. Therefore, the main aims 
of this thesis were to search for two classes of new pharmacologically promising structures, 
naphthylisoquinoline alkaloids and naphthoquinones, by isolation from plants and by 
synthesis. 
In detail, the present work is divided into the following nine parts: 
1) Phytochemical investigations on naphthylisoquinoline alkaloids from the stems of the 
dioncoquinone A (9)                         dioncoquinone B (10) 
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Chinese species Ancistrocladus tectorius. 
2) Phytochemical investigations on naphthylisoquinoline alkaloids from the root bark of a 
novel and botanically yet undescribed Congolese Ancistrocladus species. 
3) Semi-synthesis of the dimeric naphthylisoquinoline alkaloid jozimine A2 and its isomers 
from dioncophylline A. 
4) Phytochemical investigations on naphthoquinones from cell cultures of Triphyophyllum 
peltatum. 
5) Phytochemical investigations on Nepenthaceae. 
6) Establishment of a strategy for improved access to dioncoquinones B and C, and synthesis 
of dioncoquinone B analogs for the first SAR studies. 
7) Synthesis of epoxides and SAR studies. 
8) The first total synthesis of a new naturally occurring compound triphoquinone. 
9) Phytochemical investigations on the Streptomyces strain RV-15 derived from a marine 
sponge. 
.
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2  Multiple Myeloma and Naphthoquinones 
Multiple myeloma is the second most common blood cancer after non-Hodgkin’s 
lymphoma, accounting for approximately 10% of blood cancer and 1% of all cancers.[57] The 
incidence of multiple myeloma varies by gender, race, and age. The statistical data indicate an 
evident predominance among males, blacks, and older individuals for multiple myeloma.[58,59] 
Multiple myeloma is characterized by clonal proliferation of malignant plasma cells in the 
bone marrow. The development of multiple myeloma is described in Figure 6. As multipotent 
stem cells in humans, they are able to give rise to all of the blood cell types including myeloid 
(monocytes, macrophages, neutrophils, basophils, eosinophils, erythrocytes, megakaryocytes, 
platelets, and dendritic cells), and lymphoid lineages (T-cells, B-cells, NK-cells). B cells are 
one of the lymphoid lineages. Immature B cells are produced in the bone marrow of humans. 
Subsequently, these immature B cells migrate to the lymph node, where there are called 
transitional B cells, and some of these cells differentiate into mature B cells. Most of these B 
cells will become plasmablasts, and eventually plasma cells, and begin producing large 
volumes of antibodies (immunoglobulin) upon exogenous stimulus. These plasma cells are 
able to go back to bone marrow and reside there as a memory pool. Therefore, plasma cells 
are terminally differentiated B cells, and, in normal subject plasma cells, they play an 
important role in the human immune system.[60] 
 
Figure 6. The development of B cell tumor. 
However, in multiple myeloma, the space in the marrow will be concurred and occupied by 
the abnormal proliferation of cancerous plasma cells resulting in the suppression of other 
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normal blood cells population. As a consequence, the patients will develop anaemia because 
of a deficiency in red cell and platelet production. At the same time, these cancerous plasma 
cells will produce abnormal immunoglobulin called paraprotein, which suppresses production 
of other normal immunoglobulin leading to immunosuppression of the patients and causing 
them to become very susceptible to infection.[60] 
The first successful myeloma treatment with a combination of melphalan (11) (Figure 7) 
and prednisone was introduced in the late 1960s, and was further improved by high-dose 
chemotherapy with hematopoietic stem-cell transplantation 1980s. The most common 
induction regimens used today are co-opted treatment protocols.[61] Treatment with 
thalidomide (12) plus dexamethasone, lenalidomide (13) plus dexamethasone, 13 plus 11 and 
prednisone, or bortezomib (14) plus 11 and prednisone, are superior to monotherapy alone, as 
initial therapy for patients with myeloma.[62,63] 
 
Figure 7. Structures of melphalan (11), thalidomide (12), lenalidomide (13), and bortezomib (14). 
Melphalan (11) belongs to the class of alkylating agents containing nitrogen. It attaches the 
alkyl group to the guanine base of DNA. Thalidomide (12) was introduced into the market 
initially as a sedative and for treatment of morning sickness for pregnant women in the 
1950s,[64] and first tested in humans as a single agent for the treatment of multiple myeloma in 
1999.[65] Lenalidomide (13), formerly called CC-5013, belongs to a class of thalidomide 
analogs, termed immunomodulatory drugs. With the promising results in two large phase-3 
trials, 13 was approved by the FDA in 2006 for the treatment of myeloma in 
patients.[66,67] Bortezomib (14), a boronic acid dipeptide, is the first inhibitor of the 
proteasome pathway that is responsible for the orderly degradation of eukaryotic cellular 
proteins,[68] and was approved by the FDA in 2003. 
11                                 12 
13                                     14 
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One class of compounds of potential value for the treatment of tumor diseases are 
naphthoquinones, which often show pronounced biological activities, such as antibiotic, 
cytotoxic, or allergenic actions, and they may serve the organism producing them as a weapon 
for defense.[69] The mechanism by which quinones cause these effects can be quite 
complex.[70] Quinones can be Michael acceptors; therefore, damage can occur through 
covalent binding with crucial cellular nucleophiles. For example, they react readily with 
sulfur nucleophiles, such as GSH or cysteine residues on proteins, and with nucleophilic 
amino groups on proteins or with DNA. Alternatively, quinones are highly redox-active 
molecules which can undergo enzymatic and nonenzymatic redox cycling with their 
semiquinone radicals, leading to formation of reactive oxygen species (ROS), including 
superoxide, hydrogen peroxide, and ultimately hydroxy radicals. The hydroxy radicals are 
powerful oxidizing agents that may be responsible for damage to essential 
macromolecules.[70] 
Naphthoquinones have been demonstrated to possess a wide range of biological activities 
e.g., against tumor cell lines, malarial parasites, fungi, and bacteria. Table 1 covers the 
representatives of naturally occurring bioactive naphthoquinones (Figure 8) during the past 15 
years. 
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Table 1. Chemical names, origins, and biological activities of naphthoquinones. 
Structure Origin Bioactivity Lit. 
 Antitumoral Activities 
6-methoxydihydrolindbladione (15) Lindbladia tubulina leukemia cells [71] 
chabrolon-naphthoquinone B (16) Nephthea chabrolii breast cancer cells [72,73] 
neomarinone (17) actinomycete colon carcinoma [74] 
rhinacanthin Q (18) Rhinacanthus nasutus a variety of tumor cells [75] 
    
 Antimalarial Activities 
isodiospyrin (19) Diospyros  T. brucei [76-80] 
8'-hydroxyisodiospyrin (20) Diospyros L. donovani 
newbouldiaquinone A (21) Newbouldia laevis P. falciparum [81] 
sterekunthal A (22) Stereospermum  P. falciparum [82] 
naphthoquinone 23 Cordyceps  P. falciparum [83] 
    
 Antibacterial Activities 
alnumycin (24) strain of Streptomyces G-positive bacterial [84] 
juglomycin Z (25) Streptomyces tendae antibacterial [85] 
    
 Antifungal Activities 
cordiaquinone A (26) Cordia curassavica antifungal activities  [86] 
chimaphilin (27) Chimaphila umbellata antifungal activities [87] 
chlorosesamone (28) Sesamum indicum antifungal activities [88,89] 
engelharquinone (29) Engelhardia M. tuberculosis [90] 
malvone A (30) Malva sylvestris V. dahliae [91] 
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Figure 8. Structures of naturally occurring bioactive naphthoquinones (* stereogenic element of 
unknown absolute configuration). 
15 16 
17 18 
19: R = H 
20: R = OH 
 
21 22 
23 24 
25 
26 
27 
28 29 30 
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The methods for synthesizing pharmacologically promising naphthoquinones include 
reactions like oxidative transformations,[92,93] ring-closures by condensation of benzaldehydes 
with succinic acid derivatives,[94-96] [4+2]-cycloadditions,[97-99] annulations of 
ortho-substituted tertiary benzamides,[100-103] annulations of phthalide anions with Michael 
acceptors,[104-106] Friedel-Crafts acylations,[107] syntheses from cyclobutenediones,[108-111] and 
reactions of Fischer-type carbene complexes with alkynes.[112,113] These eight strategies are 
briefly described in the following part. 
Method 1: Oxidative transformations (Scheme 1) 
The most general method for the preparation of naphtho-1,4-quinones 32 is the oxidation of 
varied naphthalenes 31, using oxidative reagents such as metal derivatives with or without 
hydrogen peroxide.[92,93] This strategy has been applied to prepare naphthoquinones in the 
present thesis, as described in the Results and Discussion part. 
Method 2: Condensation of benzaldehydes with succinic acid derivatives (Scheme 1) 
Benzaldehyde (33) is reacted under typical Stobbe condensation conditions with derivatives 
of succinic acid derivatives 34 to provide the monoesters 35, which may undergo an 
intramolecular Friedel-Crafts acylation, affording naphthalenecarboxylates 36 as precursors to 
naphthoquinones.[94-96] This strategy was used to synthesize dioncoquinone B (10) in A. 
Voskobojnik’s diploma thesis.[114] 
Method 3: [4+2]-Cycloaddition reactions (Scheme 1) 
This reaction proceeds between dienes 37 and dienophiles 38 almost exclusively with endo 
selectivity.[97,98] Within this class, the cycloaddition process of the benzyne 40 with the diene 
41 was applied to synthesize dioncoquinone B (10) in M. Moos’ diploma thesis.[99] 
Method 4: Annulation of ortho-substituted tertiary benzamides (Scheme 1) 
Tertiary benzamides 43 are exceptional members of the family of Directed 
ortho-Metalation (DoM) groups, being good coordinating sites for alkyllithium bases but poor 
electrophilic sites in order to avoid attack from the base itself. These benzamides can undergo 
selective ortho-deprotonation by the action of a strong base, giving rise to ortho-metalated 
species. The latter, upon reaction with an electrophilic reagent allyl bromide (44), yield 
ortho-substituted products 45, which are subject to a base-mediated anionic cyclization 
affording naphthol 46 as a synthetic precursor to naphthoquinones.[100-103] In the present thesis, 
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this strategy was used to synthesize dioncoquinone B (10). 
 
Scheme 1. Strategies to synthesize precursors to naphthoquinones, as used for the synthesis of 
dioncoquinone B (10) and its analogs in our group.[115] 
31 32 
33            34                    35                     36 
37                           39          
38 
40       41                      42       
43              44            45                            46 
Method 1: 
Method 2: 
Method 3: 
Method 4: 
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Method 5: Annulation of phthalide anions with Michael acceptors (Scheme 2) 
The phthalide anion 47 reacts with various Michael acceptors 48 via intermediate 49 to 
dinaphthol 50, which undergoes air oxidation to the corresponding naphthoquinones. The 
presence of the X group serves two purposes: Initially, it provides essential stabilization for 
the carbanion, and later, it becomes a good leaving group, allowing aromatization of the 
newly formed ring.[104-106] 
Method 6: Friedel-Crafts acylation (Scheme 2) 
5,8-dihydroxynaphthoquinone (51) is prepared by double Friedel-Crafts acylation of 
1,4-dihydroxybenzene (52) with maleic anhydride (53) in a fused mixture of aluminum 
trichloride and sodium chloride.[107] 
Method 7: Synthesis from cyclobutenediones (Scheme 2) 
Benzocyclobutenedione (54) is easily transformed into phthaloyl metalate 55 by reaction 
with transition-metal complexes such as chlorotris(triphenylphophine)cobalt (I). The 
phthaloyl complexe serves as a precusor to naphthoquinone 31 by reacting with simple or 
functionalized alkynes.[108,109] 
Cyclobutenedione 56 or substituted squaric acid ester is also used to prepare 
naphthoquinone 31 by nucleophilic addition with an aryllithium derivative via intermediate 
57, followed by ring-opening, concomitant cyclization, and oxidation on exposure to 
air.[109-111] 
Method 8: Reaction of Fischer-type carbene complexes with alkynes (Scheme 2) 
The Fischer-type metal carbene 59 can be easily prepared from the addition of an aryl 
organolithium nucleophile 58 to a metal carbonyl, followed by O-alkylation using strong 
alkylating reagents (such as trialkyloxonium salts). Subsequently oxidative demetalation on 
59 is used to generate the corresponding quinones.[112,113] 
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Scheme 2. Alternative potential strategies used to synthesize naphthoquinones (or their precursors). 
In summary, multiple myeloma is a treatable but incurable blood cancer, and there is, thus, 
still an urgent need for new drugs. Naphthoquinones have been found to exhibit diverse 
pharmacological properties, including activities against a variety of tumor cells. To search 
such promosing compounds, some of the numerous synthetic methods for the preparation of 
naphthoquinones were applied in the present thesis. 
 
 
47          48                  49                        50 
52          53                             51  
54                        55                            31  
56                       57                         31  
58               
Method 8: 
Method 7: 
Method 6: 
Method 5: 
59                       31 
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Results and Discussion  
3  Isolation and Characterization of Naphthylisoquinoline Alkaloids from 
the Chinese Ancistrocladus tectorius Species 
3.1  Naphthylisoquinoline Alkaloids from A. tectorius 
The crude extract of the Chinese species Ancistrocladus tectorius is used in traditional 
medicine to treat dysentery and malaria,[21] and has, additionally, been found to exhibit 
antiviral[116] and antitumoral[117] activity, even in vivo. Phytochemically, this plant has so far 
been investigated in several groups, giving rise to a series of structurally divergent monomeric 
naphthylisoquinoline alkaloids with five different coupling types (5,1', 5,8', 7,1', 7,3', and 
7,6'),[117-122] naphthalene-devoid isoquinolines,[120] and five dimeric analogs with a high 
degree of steric hindrance at the central biaryl axes.[27] The large number and structural 
diversity of meanwhile ca. 30 isolated such alkaloids is in accordance with the pronounced 
morphological and genetic variation within the same species, A. tectorius, which is thus, more 
appropriately, addressed as an ‘A. tectorius complex’.[123] 
In this thesis, the isolation, structural elucidation, and pronounced antiplasmodial activities 
of nine new naphthylisoquinoline alkaloids from A. tectorius is described, including six 
5,1'-coupled structures; ancistectorine A1 (60), N-methylancistectorine A1 (61), ancistectorine 
A2 (62a), 5-epi-ancistectorine A2 (62b), 4'-O-demethylancistectorine A2 (63), ancistectorine 
A3 (64), the 7,1'-coupled ancistectorine B1 (65), the 7,8'-linked ancistectorine C1 (66), and the 
5,8'-linked 5-epi-ancistrolikokine D (67) (Figure 9). 
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Figure 9. Nine new naphthylisoquinoline alkaloids, 60−67, isolated from the Chinese A. tectorius, and 
the highly antiplasmodial known dioncophylline C (68). 
Besides the above nine new alkaloids presented, seven known[124-127] compounds, 69−74 
(Figure 10), were isolated for the first time from A. tectorius, together with fourteen other 
known[21,117-121] metabolites, 5, 7, and 75−83 (Figure 11), which had already been previously 
found in this plant. 
 
Figure 10. Seven known naphthylisoquinoline alkaloids, 69−74, isolated from A. tectorius for the first 
time. 
60: R = H 
61: R = Me 
                   62b                  64 
65                     66                     67             68 
62a: R = Me 
63: R = H 
69 71b 70: R = H 
71a: R = Me 
 
72 73: H   Me 74: Me  H 
R1   R2 
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Figure 11. Fourteen further identified known naphthylisoquinoline alkaloids, 5, 7, and 75−83, which 
had already been isolated from A. tectorius before. 
3.2  Results and Discussion 
Recent investigations on the gene sequences of A. tectorius suggested that the species 
possesses a broad morphological and genetic variability and produces a pronounced structural 
diversity of naphthylisoquinoline alkaloids.[123] Among them are the shuangancistrotectorines, 
the very first naphthylisoquinoline dimers that contain three consecutive stereogenic biaryl 
axes due to the presence of a rotationally hindered central axis between the naphthalene 
moieties.[27] These dimers exhibit excellent and specific antiplasmodial activities. For all these 
reasons, it seemed intriguing to further investigate the secondary metabolites of A. tectorius 
from the Chinese island Hainan in more detail. 
The air-dried twigs from this plant were ground and extracted with 95% EtOH at room 
temperature. The crude extract was submitted to liquid-liquid separation, FCPC (fast 
centrifugal partition chromatography), column chromatography on silica gel, and preparative 
R1  R2 
5a:  H  Me 
75a: Me  Me 
76:  H  H 
77:  Me  H 
R1   R2 
5b:  H   Me 
75b:  Me  Me 78 
79                             80                        81 
                 7b: R = Me 
                                                       
 
83: R = H 
82                           7a  
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HPLC, which permitted isolation of nine new monomeric naphthylisoquinoline alkaloids, 
compounds 60−67. 
The molecular formula of compound 60 was C24H27NO4, as evidenced from HRESIMS 
and from the number of signals in the 13C NMR spectra. The coupling pattern of the aromatic 
protons (one triplett, two doublets of doublets, and two singlets) and the high-field shifted 
signal (Figure 12a) of the CH3-2' protons (2.10 ppm) indicated that the axis in the naphthalene 
moiety was located at C-1' or C-3'. The latter could be excluded due to the HMBC long-range 
couplings of H-8' (6.75 ppm), H-3' (6.82 ppm), and CH3-2' to C-1' (Figure 12b). The 
assignment of H-8' in turn was deduced by a NOESY interaction with equatorial H-4 (2.09 
ppm) (Figure 12c) and by the NOESY series {H-8' ↔ H-7' ↔ H-6' ↔ OCH3-5'}. 
Consequently, the biaryl axis in the naphthalene moiety had to be located at C-1'. 
 
 
Figure 12. Selected 1H and 13C NMR data (δ in ppm) (a) for 60; in {}: the values of compound 61 that 
are different from those of 60. All other values of 61 and 60 are nearly identical (± 0.02 ppm in 1H 
NMR and ± 0.4 ppm in 13C NMR). HMBC (single red arrows) (b) and NOESY (double blue arrows) (b, 
c) correlations for evidencing the constitution of 60 and 61 and their relative configurations at the 
biaryl axis and the stereogenic centers. 
The other methoxy group in compound 60, resonating at 3.92 ppm, was assigned to be 
located at C-8, since its protons were observed to interact with both, H-7 (6.61 ppm) and 
CH3-1 (1.72 ppm) in the NOE correlations. Therefore, the biaryl axis had to be located at C-5 
in the isoquinoline moiety, and accordingly the C-4 position was in direct proximity of this 
axis, which was in agreement with the high-field shifts of H-4eq (2.09 ppm) and H-4ax (2.28 
ppm) (Figure 12a). In conclusion, this alkaloid was established to be 5,1'-coupled and to 
possess the constitution 60, with free hydroxy functions at C-6 and C-4'. 
60: R = H 
{61: R = Me} 
60/61 
60/61 
*only for 61 (R = Me) 
a                            b                       c 
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The relative configuration at C-1 versus C-3 in 60 was deduced to be cis from an NOE 
correlation between H-1 (4.68 ppm) and H-3 (3.20 ppm) (Figure 12c). The absolute 
configuration at C-3 was determined as 3S by GC-MSD analysis of the Mosher derivatives of 
(S)-N-methyl-3-aminobutyric acid and (S)-3-aminobutyric acid (both derived from C-3) 
obtained by a ruthenium-mediated oxidative degradation developed by us earlier.[128] Thus, the 
new alkaloid 60 was S-configured at C-3 and, given the relative cis-configuration assigned 
above, R-configured at C-1. 
The configuration at the axis relative to the stereocenters was assigned from NOE 
interactions between equatorial H-4 and H-3 with H-8' (Figure 12c). This indicated that the 
spin systems were all on the same side of the isoquinoline plane, which, given the 
above-assigned 3S-configuration, should be the upper side, so that the stereogenic axis should 
be P-configured, as shown in Fig. 2c. This stereochemical assignment was confirmed by the 
complementary NOE interaction between the axial proton at C-4 and CH3-2', which are both 
on the bottom side of the molecule. The axial P-configuration was further corroborated by the 
CD spectrum [λmax (Δε) = 210 nm (−7.3) and 238 nm (+7.5)], which was in accordance with 
that of the known,[117] likewise 5,1'-coupled and P-configured[118] - and co-occurring - alkaloid 
(+)-ancistrocline (78). The latter had previously been obtained both, by semi-synthesis from 
the naturally occurring 3,4-dihydroisoquinoline alkaloid ancistrocladinine,[118] and by total 
synthesis via a biaryl lactone key intermediate obtained in an intramolecular aryl coupling 
step.[129] The thus established full stereostructure 60, which had not been described previously, 
was named ancistectorine A1, after the name of the plant. The compound is, simultaneously, 
the 4'-O,N-didemethyl analog of (+)-ancistrocline (75). 
Compound 61 was found to possess a molecular formula of C25H29NO4 as deduced by 
HRESIMS, showing 14 additional mass units (corresponding to a CH2 portion) compared to 
60. Its 1H and 13C NMR spectra were very similar to those of 61, and specifically the 2D 
NMR correlations indicated that 61 was also a 5,1'-coupled type alkaloid containing two 
methoxy groups at C-8 and C-5'. A substantial structural difference between 61 and 60 was 
the presence of an additional N-methyl group in the isoquinoline moiety in compound 61, 
which was evidenced by NOE correlations of the N-CH3 protons at 3.01 ppm with the two 
methyl doublets of C-1 and C-3 (Figure 12b). This also explained the distinct differences 
between 60 and 61 in the chemical shifts of C-1 and C-3 and CH3-3 (Figure 12a). 
Oxidative degradation experiments in combination with the same specific NOE 
correlations as for compound 61 (Figure 12c) established 61 to be R-configured at C-1, S at 
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C-3, and P at the biaryl axis. The nearly identical CD curve of 61 as compared to that of 60 
was expectedly in accordance with the axial configuration in 61. Because the new alkaloid 61 
was the N-methyl analog of 60, it was named N-methylancistectorine A1. The compound is, 
simultaneously, the 4'-O-demethyl analog of (+)-ancistrocline (78). 
Two further new alkaloids, 62a and 62b, gave very close but baseline separated peaks on a 
reversed-phase HPLC column. Each compound possessed a molecular formula of 
C25H29NO4, as deduced from HRESIMS. The NMR spectra and specific HMBC correlations 
of 62a and 62b, in particular the signals of CH3-2' protons (2.05/2.08 ppm), H-4ax (2.15/2.06 
ppm), and H-4eq (2.26/2.37 ppm), indicated that they were 5,1'-coupled, like 60 and 61. Their 
sets of signals were found to be very similar to each other, with just slightly different chemical 
shifts, except for the protons and carbons in the region between the biaryl axis and the 
stereogenic center at C-3 (Figure 13) suggesting that 62a and 62b were diastereomers, 
probably atropo-diastereomers. Based on the observed NOE interactions, two methoxy groups, 
resonating at 3.96 and 3.92 ppm in 62a and 3.95 and 3.92 ppm in 62b, were attributed to be at 
C-4' and C-5'. The remaining methoxy group, showing a significant high-field shift (each 3.58 
ppm), should be located at C-6 in the shielding zone of the naphthalene ring, which was 
further confirmed by the NOE correlations between MeO-6 and H-8' (6.79 ppm) and between 
MeO-6 and Me-2' (2.08 ppm) in both compounds (Figure 13), thus leaving the free hydroxy 
group at C-8. 
 
Figure 13. Comparison of selected 1H data and NOE interactions of compounds 62a and 62b indicative 
of the (joint) constitution. The differences of chemical shifts of the other protons in these two 
compounds that are ≤ 0.01 ppm, are not shown. 
The relative configurations of the two methyl groups at C-1 and C-3 in 62a and 62b were 
demonstrated to be trans to each other in both compounds, from NOE correlations between 
CH3-1 and H-3 (Figure 14). Again by oxidative degradation, the absolute configurations were 
determined, here evidencing S, both for C-1 and C-3. This, in combination with specific NOE 
62a                                      62b 
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interactions between H-4eq (2.26 ppm) and H-8', and between H-4ax (2.15 ppm) and Me-2' 
(2.05 ppm), evidenced the biaryl axis to be P-configured in compound 62a while, expectedly, 
compound 62b was M-configured, as demonstrated by a complementary NOE interaction 
between H-4ax (2.06 ppm) and H-8' (6.71 ppm) and an (albeit weak) NOE correlation from 
H-4eq (2.37 ppm) to CH3-2', which was covered by the strong interaction from H-4eq to the 
overlapping signal of H-4ax (Figure 14). 
In agreement with the thus established 1S,3S,P-configuration for 62a and the 
1S,3S,M-configuration for 62b, the equatorial proton at C-4 is upfield shifted for 62a (2.26 
ppm) as compared to the analogous signal in 62b (2.37 ppm) and, vice versa, the axial proton 
at C-4 is upfield shifted for 62b (2.06 ppm) as compared to that of 62a (2.15 ppm), with the 
protons of the higher-shifted signals always being closer to the larger naphthalene portion and 
thus more strongly influenced by its ring-current effect. 
 
Figure 14. Selected NOE interactions indicative of the relative configurations at the biaryl axes and the 
stereogenic centers in 62a and 62b. 
In agreement with the presence of opposite configurations at the biaryl axes in 62a and 
62b, their CD spectra were fully opposite to each other (Figure 15). The CD curve of 62a gave 
a positive Cotton effect at 240 nm and a negative one at 227 nm, nearly identical to that of its 
known[118,130] 6-O-demethyl-8-O-methyl analog ancistrocladine (5a), while 62b showed a 
spectrum fully in accordance with that of its known[118,131,132] 6-O-demethyl-8-O-methyl 
analog hamatine (5b). Compounds 62a and 62b had hitherto not been described in the 
literature; since they had the same 5,1'-coupling type (“A”) as an A1 (60) and its N-methyl 
analog 61, they were named ancistectorine A2 (62a) and 5-epi-ancistectorine A2 (62b). 
62a                                62b 
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Figure 15. Comparison of the CD spectra of 62a and its atropisomer 62b. 
The fifth new alkaloid, 63, was found to have a molecular formula of C24H27NO4, as 
established by HRESIMS and from the number of carbon signals in the 13C NMR spectrum. 
As in the case of compounds 60−62, it had a 5,1'-coupling pattern, as deduced from HMBC 
correlations from H-3', H-8', and CH3-2' to C-1', from H-4 and H-7 to C-5 (Figure 16a). This 
was in agreement with the signals of the CH3-2' protons (2.00 ppm), of H-4ax (2.14 ppm), 
H-4eq (2.26 ppm), and 6-OCH3 (3.58 ppm). 
The two methyl groups of 63 at C-1 and C-3 were trans to each other, as indicated by an 
NOE correlation between CH3-1 and H-3 (Figure 16b). By application of the usual 
degradation procedure, the configurations at both, C-1 and C-3, were determined as S. This, in 
conjunction with the specific NOE correlations between H-4eq and H-8' (6.80 ppm), and 
between H-4ax and CH3-2', demonstrated the biaryl axis to be P-configured. It was further 
confirmed by the nearly identical CD curve of 63 to that of 62a, which also had a 
P-configured axis, while the spectrum of 63 was opposite to that of 62b, which had a 
M-configured one (Figure 16c). 
The comparison of the 1H NMR spectra of compounds 63 and 62a showed that the 
structures differed in the naphthalene portions, for instance, for CH3-2' (2.00/2.05 ppm), H-3' 
(6.77/6.89 ppm), and 5'-OCH3 (4.08/3.92 ppm), as shown in Figure 16a. In contrast to 62a, 
H-3' in 63 did not show a NOESY interaction with any of the methoxy groups. This suggested 
that 63 was the 4'-O-demethylated analog of 62a. It was, thus, named 
4'-O-demethylancistectorine A2. 
62a 
62b 
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Figure 16. Selected 1H NMR data (δ in ppm) for 63 (a); in {}: the values of compound 62a that are 
different from those of 63. All other values of 62a are nearly identical to those of 63 (± 0.02 ppm in 1H 
NMR). HMBC correlations (single red arrows) (a) in 63, NOESY interactions indicative of the relative 
configurations at C-1 and C-3 and at the biaryl axis (b), and comparison of the CD spectra of 63 and its 
analogs 62 (c). 
The molecular formula of the sixth new alkaloid, compound 64, was C24H25NO4, as 
established by HRESIMS. Like compounds 60−63, it was also 5,1'-coupled, as indicated by its 
NMR spectra, in particular by HMBC correlations from H-3', H-8', and CH3-2' to C-1' and 
NOE interactions between H-7 and CH3O-8 (Figure 17). However, different from the 
tetrahydroisoquinoline moiety contained in compounds 60−63, the presence of a 
3,4-dihydroisoquinoline part in compound 64 was suggested from the 1H NMR shift (2.80 
ppm) of CH3-1 and its multiplicity (singlet), from the low-field shifted value (175.6 ppm) 
(Figure 17) of the 13C NMR signal of C-1, and from the absence of an H-1 signal, which 
normally appears at ca. 4.60−4.80 ppm in naphthyltetrahydroisoquinoline alkaloids, like in 
60−63. From the NOE interactions between CH3O-5' and H-6', and between CH3O-8 and 
both, H-7 and CH3-1, the two methoxy groups were attributed to be located at C-5' and C-8, 
leaving the remaining two free hydroxy groups at C-4' and C-6.  
Our oxidative degradation[128] established the absolute configuration at C-3 of 64 to be S, 
and NOE interactions between H-4ax and CH3-2', and between H-4eq and H-8' (not shown, 
similar as for 60, 61, 62a, and 63) indicated the biaryl axis to be P-configured. This 
stereochemical assignment was further confirmed by the mirror-image like CD spectrum of 64 
in comparison to that of the known[124] alkaloid 5'-O-demethylhamatinine, which has an 
M-configured biaryl axis and has previously been isolated from a Congolese Ancistrocladus 
species related to Ancistrocladus congolensis. Because of its 5,1'-coupling type, compound 
64 was henceforth named ancistectorine A3; it is, simultaneously, the 4'-O-demethyl analog 
of the known[133] alkaloid ancistrocladinine. 
63 
63: R = H {62a: R = Me} 
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Figure 17. Selected 1H and 13C NMR data, HMBC (single red arrows), and NOESY (double blue 
arrows) correlations for the constitution of 64. 
The seventh new alkaloid, compound 65, possessed a molecular formula of C25H29NO4 as 
revealed from HRESIMS and a system of three neighboring and two single aromatic protons 
in the 1H NMR spectrum. The high-field shift of the signal of CH3-2' (2.18 ppm) and HMBC 
long-range couplings from the signals of two aromatic protons of H-8' (6.89 ppm), from H-3' 
(6.90 ppm), and from CH3-2' to C-1' (Figure 18a) established the biaryl axis in the 
naphthalene moiety in 65 to be located at C-1', as in 60−64. However, different from the 
upfield shifted signals of H-4 ranging from 2.10 to 2.40 ppm in compounds 60−64, the two 
diastereotopic protons of H-4 in 65 had “normal” chemical shifts (2.86 and 3.15 ppm), i.e., no 
shielding effect from the naphthalene moiety (Figure 18a), indicating the biaryl axis not to be 
linked to C-5, but to C-7 in the isoquinoline part. An additional proof for this connection site 
was the upfield shifted resonance (3.12 ppm) of one of the CH3O signals, which, in turn, was 
deduced to be located at C-8 by a NOESY interaction to CH3-1. Furthermore, a NOESY 
correlation between H-5 and H-4 evidenced C-5 to be devoid of a naphthalene substituent, 
which was confirmed by an HMBC interaction from H-5 to C-4. The other two methoxy 
groups (3.95 and 3.91 ppm) were assigned to be at C-4' and C-5' by the NOESY interactions 
with H-3' and H-6', respectively (Figure 18a). Thus, the alkaloid 65 was established to be of 
the 7,1'-linkage type, with three methoxy groups at C-8, C-4', and C-5', and with a free 
hydroxy group at C-6. 
The relative configuration at C-1 versus C-3 was shown to be trans by a NOESY 
interaction between CH3-1 and H-3 (Figure 18b), in agreement with the absolute 
configuration at these stereogenic centers, which was determined to be 1S, 3S by oxidative 
degradation. A NOESY correlation between CH3-1 and H-8' revealed that these two spin 
systems were on the same side of the isoquinoline plane, which was, in combination with the 
above established absolute configuration at C-1, the “upper” side of the isoquinoline, thus 
64  
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enabling the assignment of the stereoarray at the axis as P-configured (Figure 18b). This axial 
configuration was further corroborated by the resemblance of the CD spectrum of 65 with that 
of the known alkaloid ancistrotectoriline B,[121] in which the biaryl axis is also P-configured. 
Different from the above identified five structures 60−64, which are based on a 5,1'-coupling 
type, compound 65 is 7,1'-coupled and was, thus, named ancistectorine B1. A similar 
compound, ancistrocongoline D, possessing the same constitution and even the same axial 
configuration but opposite configurations at both of the stereogenic centers (i.e., 1R, 3R) had 
previously been found in A. congolensis.[34] 
 
Figure 18. Selected 1H NMR data, HMBC correlations (single red arrows), and NOE interactions 
(double blue arrows) (a) in 65, and NOESY interactions indicative of the relative configurations at C-1 
and C-3 and at the biaryl axis (b). 
The eighth isolated alkaloid, compound 66, corresponded to a molecular formula of 
C26H31NO4 according to HRESIMS. Its 1H NMR spectrum showed two pairs of doublets and 
one singlet representing the aromatic protons, instead of three neighboring and two single 
aromatic protons like in compounds 60−75, suggesting that the coupling site of its biaryl axis 
should be located in the methyl-free portion of the naphthalene part, i.e., at C-6', or C-8', 
which was in agreement with the “normal” chemical shift measured for the signal of CH3-2' 
(2.32 ppm) in the 1H NMR spectrum. A linkage of the isoquinoline to C-6' in the naphthalene 
ring was excluded by a NOESY correlation of H-6' (6.94 ppm) to the 5'-methoxy group (3.96 
ppm) (Figure 19a), and to C-1' or C-3' excluded by HMBC correlations from H-1' and H-6' to 
C-8' and by an NOE interaction between H-3' and the methoxy group at C-4' (3.95 ppm) 
(Figure 19a). Consequently, the biaryl axis in the naphthalene moiety was located at C-8'. 
In the isoquinoline part of compound 66, the biaryl axis had to be at C-7, like in compound 
65, as evidenced, i.a., from the ‘normal’ chemical shift of H-4 (3.02 ppm), and the 
upfield-shifted signal of CH3O-8 (3.15 ppm). The positions of the three methoxy groups at 
65  
65  
a                                     b 
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C-8, C-4', and C-5', and a methyl group at the nitrogen atom were deduced from NOE 
interactions (Figure 19a). Thus, structure 66 was established as one of the relatively rare 
N-methylated 7,8'-coupled naphthylisoquinolines.[134,135] This coupling type had never been 
found in A. tectorius before. 
 
Figure 19. Selected 1H NMR data and HMBC correlations (single red arrows) in 66 (a), and NOE 
interactions (double blue arrows) (b) indicative of the relative configuration of 66. 
By the usual oxidative degradation in combination with NOE experiments, compound 66 
was determined to be 1R- and 3S-configured (Figure 19b).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
In conjunction with this result, the biaryl axis was evidenced to be M-configured by an NOE 
interaction between H-1' and CH3-1 (Figure 19b). The CD spectrum exhibited a positive 
Cotton effect at 216 nm (Δε, +2.0) and a negative one at 236 nm (Δε, −6.3). The curve was, 
thus, opposite to that of its P-configured, and thus atropisomeric, analog 
6-O-demethylancistrobrevine A, which had previously been isolated from the West African 
species A. abbreviatus.[135] Since being 7,8'-linked and, thus, belonging to the third coupling 
type described in this study, compound 66 was named ancistectorine C1. 
The last isolated new alkaloid, 67, possessed a molecular formula of C24H25NO4 according 
to HRESIMS. Like compounds 60−64, the coupling site in the isoquinoline portion of 67 was 
C-5, as revealed from the HMBC correlations from H-4 (2.27 and 2.70 ppm) and H-7 (6.68 
ppm) to C-5. The presence of a 3,4-dihydroisoquinoline part in 67, like in 64, was suggested 
from the 1H NMR shift (2.79 ppm) and the multiplicity (singlet) of the signal of CH3-1, and 
from the low-field shifted value (175.5 ppm) (Figure 20a) of the 13C NMR signal of C-1. The 
coupling position in the naphthalene portion in 67 was assigned at C-8', as indicated from the 
NOE interactions from H-1' (6.53 ppm) and H-6' (6.95 ppm) to C-8' (Figure 20a). The two 
methoxy functions were located at C-5' and C-8, as evidenced from the NOE interactions 
from CH3O-5' (4.12 ppm) to H-6', and from CH3O-8 (4.04 ppm) to H-7 (6.68 ppm) and 
a b 
66  
66  
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CH3-1. 
 
Figure 20. Selected 1H and 13C NMR data, HMBC correlations (single red arrows), and NOE 
interactions (double blue arrow) in 67 (a); and NOESY interactions indicative of the configuration at 
the biaryl axis relative to the stereogenic center (b). 
The absolute configuration at C-3 was identified as S-configured by the usual oxidative 
degradation. The biaryl axis was deduced to be M-configured from the NOE interactions 
between H-4eq and H-7' (7.14 ppm) and between 3-CH3 (3.78 ppm) and H-1' (Figure 20b). 
The comparison of the CD spectra of 67 with those of other two co-occurring compounds 
71a and 64 further corroborated the M-configuration in 67. As expected, the CD curve of 67 
was identical to that of compound 71a, and opposite to that of ancistectorine A3 (64) (Figure 
21). 
The new alkaloid 67 was named 5-epi-ancistrolikokine D since a similar compound, 
ancistrolikokine D, which had previously been found in A. likoko,[136] possessed the same 
constitution as 67 and an opposite axial configuration (P-configured). 
                             
Figure 21. Comparison of CD spectra of 67 with those of the co-occurring alkaloids 64 and 71a. 
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3.3  Conclusion 
The nine new alkaloids described here and those known isolated from A. tectorius show a 
great structural variety of coupling sites (i.e., the location of the biaryl axis), O-methylation 
patterns, and hydroxylation degrees and stereochemical issues, and still, they have one 
structural feature in common: They possess an oxygen at C-6 and are S-configured at C-3, and 
can, thus, all be classified as so-called[60,137] Ancistrocladaceae-type alkaloids. The remarkable 
variability of naphthylisoquinoline alkaloids of A. tectorius is paralleled by a high genetic 
variability of the plant, which had already been proven by a comparative study of the ITS 
sequence in samples of A. tectorius collected from 21 locations.[123] Thus, regarding the 
number of isolated alkaloids, this plant is now even more intensely investigated than the as 
yet best-studied,[41,138] phylogenetically closely related[123] African species A. korupensis. 
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4  Isolation and Characterization of Naphthylisoquinoline Alkaloids from 
a Congolese Ancistrocladus Species 
4.1  Naphthylisoquinoline Alkaloids from an African Ancistrocladus Species 
Besides the rain forests of Southeast Asia, those of Central and West Africa are another 
rewarding source – for probably an even new, botanically undescribed Ancistrocladus species. 
Samples of a supposed probably new species were collected by Prof. V. Mudogo in the region 
of the town Ikela in the Democratic Republic of Congo, in July 2006. A voucher specimen 
(No. 108) has been deposited at Herb. Bringmann, University of Würzburg. 
From the phytochemically and phytogenetically as yet uninvestigated Congolese 
Ancistrocladus species, the isolation of the new monomeric 6-O-demethylancistrobrevine C 
(84) and the unprecedented dimeric naphthylisoquinoline alkaloid jozimine A2 (85) is 
described. Additionally, four well-known[22,130,131,135,139-141] compounds, ancistrocladine (5a), 
hamatine (5b), dioncophylline A (6), and ancistrobrevine C (86) (Figure 22) were isolated. 
 
Figure 22. Structures of the naturally occurring new monomer 6-O-demethylancistrobrevine C (84), 
the dimer jozimine A2 (85), and the known ancistrocladine (5a), hamatine (5b), dioncophylline A (6), 
and ancistrobrevine C (86). 
85     
84 
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4.2  Results and Discussion 
The root bark of the plant was extracted with CH3OH/CH2Cl2 (v/v 1:1). The crude extract 
was subjected to ion-exchange column chromatography for removal of non-alkaloids. From 
the fractions containing alkaloids six naphthylisoquinolines were isolated by preparative 
HPLC. 
Compound 84 possessed a molecular formula of C24H25NO4 as demonstrated by HRESIMS. 
The NMR signals of the alkaloid 84 for 1-CH3 (δ 2.76 ppm, s), 3-CH3 (δ 1.50 ppm, d, J = 6.8 
Hz) and C-1 (δ 176.0 ppm) (Figure 23a) indicated the presence of a 3,4-dihydroisoquinoline. 
The linkage of the biaryl axis of the isoquinoline part at C-5 in 84 was be ruled out by the 
NOESY correlation of H-5 to H-4 and the HMBC interaction of H-5 to C-4 (Figure 23b). 
Thus, the coupling site in the isoquinoline moiety had to be located at C-7, which was in 
agreement with the typical signals of the two protons at C-4 (δ 2.91 ppm, dd, J = 18.0, 11.2 
Hz, Hax-4; 3.12 ppm, dd, J = 17.0, 5.1Hz, Heq-4). 
The HMBC long-range couplings between H-8', H-3', and CH3-2' to C-1' (Figure 23b) 
established the biaryl axis of compound 84 in the naphthalene moiety to be located at C-1'. 
The two methoxy groups were attributed to be at C-4' (δ 3.99 ppm) and C-5' (δ 3.93 ppm), as 
revealed by the NOE interactions to H-3', and H-6', respectively. 
 
Figure 23. Selected NMR data of 6-O-demethylancistrobrevine C (84). a) Selective 1H and 13C NMR 
shifts (δ in ppm). b) ROESY (blue double arrows) and HMBC interactions (red single arrows) 
indicative of the constitution. 
The 1H NMR spectrum of compound 84 clearly showed a doubling for almost all peaks in 
parallel with the 13C NMR displaying “doubled peaks” with a very small difference in 
chemical shifts (≤ 0.05 ppm). Evidently the doubled signals of CH3-2' were of different 
intensity with an integration ratio of 1.7 : 1. This information suggested the presence of an 
inseparable diastereomeric mixture of the epimer at C-3 or the epimer at C-7. 
a                                       b                          
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The oxidative degradation experiment[128] gave a 4.3 : 1 mixture of 3-R- and 
3-S-aminobutyric acid derivatives, which evidenced the presence of the two epimers at C-3. 
Although this was not in a good agreement with the ratio of the two products as determined 
by 1H NMR spectroscopy (1.7 : 1), C-3 in the main alkaloid, 84, was presumably determined 
to be R-configured. 
The CD spectrum of 84 was nearly identical to that of ancistrocladisine (structure not 
shown.),[142] which suggested the biaryl axis in 84 (for the major compound) to be 
P-configured. These results could not make a conclusion that 84 was a mixture of 
diastereomers with epimerization at C-3 or a mixture of 7,1'-atropoisomers, thus, the isomers 
should have to be resolved. But the major compound, 84, was unambiguously the 
6-O-demethylated analog of ancistrobrevine C (86), hence, name 
6-O-demethylancistrobrevine C. 
In the course of the phytochemical investigation of the plant, LC-MS data hinted at the 
presence of a dimeric alkaloid. In detail, the combination of a monoprotonated mass at m/z 
725.4 [M+1]+ and a doubly protonated one at m/z 363.2 [M+2]2+, observed within the very 
same peak, suggested the existence of a Dioncophyllaceae-type dimer, i.e., lacking an oxygen 
function at C6,[143] which was first discovered by G. Bauckmann. Subsequently, the further 
isolation and structural chracterization of the dimer was done in this thesis. It was found to 
have the molecular formular C46H48N2O6, as deduced from HRESIMS (725.3581 [M+1]+, 
calcd 725.3585) and MALDI-TOF-MS (725.358 [M+1]+). The 1H and 13C NMR data showed 
only a half set of signals, indicating that the dimer was symmetric, leaving open whether it 
was C2-symmetric (i.e., with two homomorphous halves) or CS-symmetric (i.e., with two 
enantiomorphous molecular portions). The latter, an achiral meso-structure, was excluded by 
its optical activity ([α] 20D  = −29.8). 
The 1H NMR spectrum showed five aromatic protons, a two-proton spin system with 
signals at δ 6.89 ppm (d, J = 7.8 Hz, H-5) and δ 7.00 ppm (d, J = 7.8 Hz, H-6) and a 
three-proton spin system with signals at δ 7.01 ppm (d, J = 8.6 Hz, H-6'), δ 7.25 ppm (dd, J = 
8.6, 7.8 Hz, H-7'), and δ 6.92 ppm (d, J = 7.8 Hz, H-8') (Figure 24a), which suggested a 
Dioncophyllaceae-type dimer with 7,1'-, 7,3'-, 5,1'-, or 5,3'-linked monomers. The coupling 
position in the isoquinoline moiety, located at C-7 (δ 125.9 ppm) could be deduced by the 
ROESY series [H-4 ↔ H-5 ↔ H-6] (Figure 24b) and by the HMBC interactions between C-7 
and the 8-OH group (δ 7.44 ppm) and between C-7 and H-5. The connection position at C-1' 
in the naphthalene part was indicated by the ROESY signal of H-8' to the 8-OH group and the 
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HMBC correlations of C-1' (δ 126.3 ppm) to the 2'-CH3 protons (s, δ 1.84 ppm), H-8', and 
H-6 (Figure 24b). 
 
Figure 24. Selected NMR data of jozimine A2 (85) in [D4]methanol (OH signals measured in 
[D6]acetone). a) 1H and 13C NMR shifts (δ in ppm). b) ROESY (blue double arrows) and HMBC 
interactions (red single arrows) indicative of the constitution (including the position of the central axis 
and the outer ones). 
The position of the 5'-OCH3 group at δ = 4.12 ppm was assigned by its ROESY 
correlations to the neighboring hydroxy function 4'-OH (δ = 9.68 ppm) in [D6]acetone and 
H-6'. The extremely upfield shifted proton signal at δ = 1.84 ppm (s, 2'-CH3) as compared to 
cases where the methyl group is next to one biaryl axis (ca. 2.15 ppm)[124] or not neighbored 
by an aryl substitution (ca. 2.37 ppm)[34] indicated that this methyl group was doubly shielded, 
by even two aryl substituents. This was in agreement with the assumption that the two 
monomeric halves of the dimer were 3',3''-coupled, which was further approved by the 
ROESY signal between the 2'-CH3 group and the 4''-OH function obtained in [D6]acetone. 
The shifts of the proton signals at δ = 1.70 ppm (d, J = 6.7 Hz, 1-CH3) and δ = 1.54 ppm (d, 
J = 6.4 Hz, 3-CH3) were assigned to the methyl groups in a 
1,3-dimethyltetrahydroisoquinoline and the position of the 8-OH group was confirmed by its 
ROESY correlation to the 1-CH3 group. 
The relative configuration of the stereocenters at C-1 and C-3 was determined to be trans 
by the ROESY correlation between the 1-CH3 (d, δ = 4.88 ppm) group and H-3 (m, δ = 3.90 
a                                   b                          
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ppm) (Figure 25). From the coupling constants of the protons at C-4 (H4eq, dd, δ = 3.23 ppm, 
J = 17.7, 4.7 Hz; H4ax, dd, δ = 2.96, J = 17.7, 11.8 Hz) with H-3, H-3 was evidenced to be 
axial, and, thus, the 1-CH3 group also had to be axial and hence H-1 was equatorial. The 
absolute configurations at C-1 and C-3 were determined by oxidative degradation,[125,128] 
which resulted in D-alanine and (R)-3-aminobutyric acid derivatives detected by GC-MSD 
analysis. Thus the new dimer 85 was R-configured both, at C-1 and C-3. 
The “outer” axes of the dimer, i.e., the linkages between the naphthalene and isoquinoline 
portions, were assigned to be P-configured by the ROESY correlations between 1-CH3 and 
2'-CH3, and between H1 (q, δ = 4.88 ppm) and H8' (Figure 24) obtained in a low-temperature 
NMR experiment. 
 
Figure 25. ROESY interactions defining the relative configurations at centers versus axes among the 
stereogenic axes in the monomeric halves. 
The structural elucidation of two monomeric halves of the dimer was fully established by 
NMR experiments but still leaving the configurational situation at the central axis unresolved. 
The central axis, being flanked by four ortho substituents, like in the case of the 
shuangancistrotectorine A (8) (Figure 28), was rotationally hindered, too. The structural 
similarity of the inner part of new dimer with that of 7 made it possible to assign the absolute 
configuration at the central axis in jozimine A2 (85) by comparison of its CD spectrum with 
that of 8. This is based on the assumption that the CD behavior of the compounds, despite 
their different configurations at C-1 and C-3 and divergent substitution patterns at C-6 and 
C-8, is dominated by the orientation of the naphthyl portions (as the main chromophores) to 
each other, i.e., by the configuration at the central axis. 
Indeed, the CD spectrum of the dimer 85 was virtually identical with that of 8, giving 
nearly the same curve (Figure 25), evidencing that the central axis in 85 should have the same 
M-configuration like in 8, so that 85 should be 1R,3R,7P,3'M,7'''P,3'''R,1'''R-configured, as 
shown in Figure 26. 
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Figure 26. Assignment of the absolute configuration at the central axis of jozimine A2 (85) by 
comparison of its CD spectrum (solid line, red) with that of shuangancistrotectorine A (8) (dotted line, 
black). 
  The structure of jozimine A2 (85) thus established was subsequently verified in all details 
of its constitution and relative configuration by an X-ray diffraction analysis (Figure 27). 
Suitable single crystals were obtained by slow (over one week) recrystallization from 
acetone/cyclohexane at room temperature. Even though the data set appeared to be of 
adequate quality, weak scattering and the presence of at least five highly disordered acetone 
solvent molecules within the crystal lattice significantly hampered a reasonable structure 
refinement. Consequently, the results deduced form X-ray crystallography can only serve to 
validate the molecular composition and the relative configuration of 85 in the solid state. 
However, the structural characterization of 85 is unique given the fact that no X-ray 
diffraction data of any dimeric naphthylisoquinoline alkaloid has been reported so far. 
 
Figure 27. Molecular structure of jozimine A2 (85) in the solid state. Hydrogen atoms (except for those 
attached to nitrogen) have been omitted for clarity (carbon: grey; nitrogen: blue; oxygen: red). 
Jozimine A2 (85) is the first natural dimeric Dioncophyllaceae-type naphthylisoquinoline 
alkaloid, consisting of two identical 4'-O-demethyldioncophylline A halves. It has a third 
85   
 8   
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rotationally hindered biaryl axis and, thus, an additional stereogenic element as in the case of 
shuangancistrotectorine A (8) (Figure 28).[27] The structurally as yet closest known analogs of 
85 are the – albeit 6'-coupled and additionally side-chain oxygenated – jozipeltine A (87),[144] 
and the – albeit 5-coupled – dimer of dioncophylline A (6), jozimine A (88),[145] and they are, 
both, synthetic compounds, like the other jozimines. 
 
Figure 28. Structures of the structurally closely related known natural shuangancistrotectorine A (8), 
the synthetic dioncopeltine A dimer, jozipeltine A (87), and the likewise unnatural dioncophylline A 
dimer, jozimine A (88). 
Besides the new alkaloids 84 and 85, four well-known[22,130,131,135,139-141] monomeric 
alkaloids were isolated from the Ancistrocladus species and identified as ancistrocladine (5a), 
hamatine (5b), dioncophylline A (6), and ancistrobrevine C (86), by means of HPLC-MS, 
HPLC co-elution, and by comparison of NMR, m.p., and optical rotation data with those of 
authentic samples, previously obtained by isolation[22,130,131,135,139] or synthesis[140,141] in our 
group. 
4.3  Conclusion 
The phytochemical investigation of the investigated African Ancistrocladus species seems 
to occupy an exceptional chemotaxonomical position, since it produces 
Ancistrocladaceae-type (i.e., with an oxygen function at C-6 and S-configuration at C-3) e.g., 
ancistrocladine (5a), and hamatine (5b), Dioncophyllaceae-type (i.e., devoid of an oxygen 
function at C-6 and R-configuration at C-3) e.g., dioncophylline A (6), and jozimine A2 (85), 
and mixed Ancistrocladaceae/Dioncophyllaceae-type (i.e., with an oxygen function at C-6 and 
8                     87 
 
88 
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R-configuration at C-3) naphthylisoquinoline alkaloids e.g., 6-O-demethylancistrobrevine C 
(84) and ancistrobrevine C (86). In this respect, this Ancistrocladus species is remarkable in 
that it is one of the very few plants, like A. abbreviatus,[142,146,147] and A. barteri,[148] that 
simultaneously contain typical representatives of all three classes of alkaloids. The discovery 
will definitely contribute to the phytochemical and taxonomic classification of this African 
Ancistrocladus species. 
4.4  Bioactivities of the New Naturally Occurring Alkaloids 
Because of the known pronounced bioactivities of naphthylisoquinoline 
alkaloids,[27,32,33,37-39] the new compounds 60−62, 64−66 (except for 63 and 67, which were 
not biotested due to the presence of too small quantities), and 84−85 were tested for their in 
vitro activities against protozoan parasites (Table 2). Three of the metabolites, 61, 62a, and 
62b, exhibited strong antiplasmodial activities against the strain K1 of Plasmodium 
falciparum. With IC50 values of 0.08, 0.07, and 0.03 μM, respectively, they are 3−7 times 
more active than the standard chloroquine (IC50 = 0.26 μM), and are, thus, in the range of the 
most active naturally occurring naphthylisoquinoline alkaloid, dioncophylline C (68) (IC50 = 
0.01 μM against the strain K1).[31] In addition, given their extremely weak cytotoxicities, 61, 
62a, and 62b possess high selectivity indexes of up to >3000, and should, thus, according to 
the TDR/WHO guidelines[149], be considered as lead compounds. Remarkably, the alkaloid 
62b, which is M-configured, showed the best antiplasmodial activity in this study, much better 
even than its P-configured atropo-diastereomer 62a; simultaneously, 62b had a lower 
cytoxicity on L6 cells than 62a. This result shows the impact of axial chirality on the 
biological properties. 
Jozimine A2 (85) showed an excellent antiplasmodial activity (against the strain NF54) in 
the low-nanomolar ranges (IC50 = 1.4 nM) (Table 2), much better than those of the three 
alkaloids, 61, 62a and 62b above, and dioncophylline C (68) (IC50 = 8 nM against the strain 
NF54),[31] thus being far more active than any of the ca. 140 naturally occurring mono- and 
dimeric naphthylisoquinoline alkaloids tested as yet.[27,30-33,37] Moreover, jozimine A2 (85) had 
no cytotoxicity (IC50 = 15.9 μM) against rat skeletal myoblast (L6) cells, and thus, possessed a 
very high selectivity index of >15,900. In consequence, jozimine A2 (85) can also be 
considered as a highly new lead structure. 
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Moreover, jozimine A2 (85) showed an exceptionally increased antiplasmodial activity 
compared to its corresponding monomeric half 4′-O-demethyldioncophylline A (89) (structure 
shown in Scheme 3 in Chapter 5) (IC50 = 0.24 μM, unpublished paper). This significantly 
enhanced potency may be explained by the increased lipophilicity for jozimine A2, as 
estimated by the cLogP (the calculated 1-octanol-water partition coefficient), which is the 
most important molecular property compared to other physical properties, e.g., molecular 
mass, the numbers of hydrogen-bond donors, hydrogen-bond acceptors, and aromatic 
rings.[150,151] More specifically, jozimine A2 (85) has a cLogP value of 9.381 in contrast to a 
value of 4.84 for 4′-O-demethyldioncophylline A. Since the lipophilicity value (cLogP) is 
logarithmic, an increase of ca. 4.5 units in cLogP from 4′-O-demethyldioncophylline A (89) to 
jozimine A2 (85) equals a ligand concentration in the highly lipophilic cellular membranes, 
which is ca. 30,000 times higher. Hence, the improved potency can be explained by the highly 
elevated number of interactions due to the significantly enhanced concentration of jozimine 
A2 (85) in the tested cells. However, this interpretation contradicts our previous result that the 
synthetic dimer jozimine C (Figure 29) showed a distinctively lower antiplasmodial activity 
than its natural monomeric alkaloid dioncophylline C (68),[26] despite jozimine C has the same 
cLogP, molecular weight, the numbers of OH plus NH count, and O atoms as those for 
jozimine A2 (85). Since no unambiguous conclusion is possible, the natural product 85 still 
remains a highly promising compound despite of possessing a high lipophilicity value and a 
large molecular weight. 
 
Figure 29. Structures of the natural product jozimine A2 (85) and the synthetic dimer jozimine C. 
                                                        
1 All the mentioned cLogP values here were calculated by OSIRIS Property Explorer on the internet 
http://www.organic-chemistry.org/prog/peo/ 
jozimine A2                       jozimine C 
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Table 2. Anti-infective activities of the compounds 60−62, 64−66, and 84−85. 
 IC50 [μM] 
 60 61 62a 62b 64 65 66 84 85 
P. falciparuma 
S: chloroquine 0.26 (on K1) 0.57 0.08 0.07 0.03 0.68 4.20 2.80 2.4  
S: chloroquine 0.003 (on NF54)         0.0014 
          T. cruzi 
S: benznidazole 2.0 118.9 95.0 108.5 135.4 62.2 142.1 >213 137.3 13.7 
          T. brucei rhodesiense 
S: melarsoprol 0.007 16.7 28.3 7.3 21.1 17.6 17.9 38.8 14.0 0.8 
          T. brucei brucei 
S: pentamidin 0.0029 ND 34.0 19.9 12.3 16.4 40.0 ND ND ND 
          L. donovani 
S: miltefosine 0.351 >228 >220 >220 >220 92.5 >220 >213 78.0 80.2 
          Cytotoxicity (L6 cells) 
S: podophyllotoxin 0.017 94.6 51.7 49.4 100.1 32.8 47.3 22.5 59.3 15.9 
          Selectivity index for the antiplasmodial 
activityb 166 646 705 3,340 48 11 8 25 15,900 
ND: not determined. S: Standard. 
a For compounds 60−62, 64−66, and 84, the activities against P. falciparum were measured on the strain K1, and for compound 85 on the strain NF54. 
b The index is calculated as the ratio of the IC50 values concerning L6 cells to the IC50 data relative to P. falciparum.
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In addition, no activities were found against other protozoan parasites causing tropical 
diseases, like Trypanosoma cruzi, T. brucei rhodesiense, T. brucei brucei (for 61, 62, 64, 65, 
84, and 85, 60 and 66 not measured for lack of substance), and Leishmania donovani, showing 
the remarkably high specificity of the antiplasmodial activity of 61, 62a, and 62b. This 
specificity was further confirmed by the lack of activities against other, bacterial test systems, 
like Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Enterococcus 
faecium, Escherichia coli, Pseudomonas aeruginosa, Yersinia pseudotuberculosis, and 
Yersinia pestis (results not shown) exemplarily for the better available alkaloids 61 and 65. 
Although the crude extract of the Chinese plant A. tectorius had been reported to show 
antitumoral activity in vivo in the literature,[117] the antitumoral activity of its isolated 
chemical constituents, the naphthylisoquinoline alkaloids, had not been investigated yet. 
Therefore, the three main alkaloids, ancistrocladine (5a), hamatine (5b), and (+)-ancistrocline 
(78), which largely dominate the extract of the Chinese plant, were tested against the human 
tumor cell line INA-6 (derived from a patient with multiple myeloma). Interestingly, only 
hamatine (5b) and (+)-ancistrocline (78) displayed moderate activities against the tested cell 
line (EC50 = 32 μM for each compound). Ancistrocladine (5a), the atropo-diastereomer of 5b, 
was inactive, probably because it was not sufficiently soluble in these concentrations. The 
results thus warrant further investigations on the minor alkaloids, which might be the 
compounds responsible for the reported activity of the extract.
A Congolese Ancistrocladus species    41 
  
5  Semi-synthesis of Unprecedented Dimeric Naphthylisoquinoline 
Alkaloids 
5.1  Synthesis of Jozimine A2 (85) and its 3'-epi-Atropo-diastereomer (3'-epi-85) 
The unprecedented dimeric structure of jozimine A2 (85), and its excellent bioactivities (see 
Chapter 4) made 85 and its as yet unknown atropo-diastereomer 3'-epi-85 attractive synthetic 
targets: For a further structural confirmation, for the directed search of its as yet unknown 
3'-atropo-diastereomer in the plant, and for a comparative analysis of the antiplasmodial 
activities depending on the configuration of the central axis. On the other hand, the synthesis 
of 85 imposed a true challenge, since all other synthetically prepared dimers[144,145,152-155] 
contained a significantly less hindered central axis (only two ortho-substituents, see, e.g. the 
structure of jozipeltine A (87) in Figure 28 in Chapter 4). In view of the high steric hindrance 
to be overcome in the coupling step, a biomimetic phenol-oxidative coupling of the assumed 
natural monomeric precursor 89 or an adequately protected analog, seemed appropriate. 
Recently, the directed, atropo-selective total synthesis of the – as yet unknown – 
‘monomeric’ alkaloid 89 has been successfully achieved in small quantities by applying the 
“lactone concept” as developed in our lab (unpublished paper). Although this, the occurrence 
of large quantities of its known[22] and also synthetically available[140] O-methyl analog, 
dioncophylline A (6), in the same plant, even dominating its spectrum of secondary 
metabolites, made it easier to take advantage of this easily available, alkaloid for a 
semi-synthetic access to jozimine A2 (85). 
The isolated natural dioncophylline A (6) was mono-O-demethylated by using 
trimethylsilyl iodide in CHCl3 in an almost quantitative yield (Scheme 3). Resolution of the 
obtained 1:1 mixture (determined by HPLC) of the two regioisomeric 4'- and 5'-O-demethyl 
derivatives 89 and 90[156,157] succeeded by preparative HPLC on a reverse-phase column. 
Their structures were evidenced by an NOE interaction of 5'-OMe to H-6' in 89 and of 
4'-OMe to H-3' in 90. Oxidative coupling of 89 using Pb(OAc)4[152] or Ag2O[153] led to 
complex product mixtures, which necessitated the introduction of specific protection groups 
for the secondary amino function and the 8-OH group, leaving free only the required OH 
function at C-4'. In analogy to a related transformation on the known[156] natural product 90, 
the N,O-dibenzyl derivative of 89 was prepared and submitted to an oxidative coupling with 
Pb(OAc)4 (Scheme 3). After purification on silica gel, HPLC analysis showed only one peak, 
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while NMR revealed the presence of a 1:1 mixture of the two expected atropo-diastereomers, 
91 and 3'-epi-91, which were inseparable on diverse reverse-phase columns. Different from 
all previous oxidative couplings to – less hindered – dimeric naphthylisoquinoline alkaloids, 
the typical deep-violet color of a transient over-oxidated diphenoquinone was not observed 
(as a consequence of the high steric hindrance at the newly generated axis). The expected 
coupling was firmly corroborated by HRESIMS in combination with NMR data. The less 
extreme high-field shift (δ = 2.10 ppm) of 2'-CH3 in the coupling product in 91 as compared 
to 1.86 ppm in 85 can be ascribed to the additional deshielding effect of the 8-O-benzyl group. 
The non-separable mixture of 91 and 3'-epi-91 was directly N,O-deprotected, furnishing the 
dimeric target molecule, 85, along with 3'-epi-85 – non-separable atropo-diastereomer, which 
were eventually resolved and purified by preparative HPLC. 
 
Scheme 3. Semi-synthesis of jozimine A2 (85) and its unnatural atropo-diastereomer, 3'-epi-jozimine 
A2 (3'-epi-85) from dioncophylline A (6). 
The CD spectrum of the new atropisomer 3'-epi-85 was expectedly opposite to that of its 
natural isomer, 85, clearly evidencing the chiroptical dominance of the – hence P-configured 
– central axis over all other stereogenic elements.[27] 
6                             89 (49%)                90 (49%) 
91 and 3'-epi-91 (30%) (1:1)        85 (41%)         3'-epi-85 (44%) 
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This efficient semi-synthesis of jozimine A2 (85), which, given the synthetic availability of 
89 (unpublished paper) and 6,[140] simultaneously constitutes a formal total synthesis of 85, 
firmly corroborates its full absolute stereostructure. 
Moreover, the first synthesis of its yet unknown atropo-diastereomer, 3'-epi-85 permitted its 
directed search in the extracts of the Ancistrocladus species. A thorough HPLC analysis of the 
extract from which 85 had been isolated, however clearly revealed the complete absence of 
3'-epi-85 and also of 89 in the plant, showing that jozimine A2 (85) is produced from 89 in a 
highly atroposelective and efficient way in the living cell, with a high degree of enzymatic 
control. 
5.2  Synthesis of Jozimine A3 (93) 
The first attempt to obtain jozimine A3 (93) via the phenol-oxidative coupling of the 
N,O-bis-benzylated derivative of 90 using Pb(OAc)2[158] led to the formation of an unstable 
compound, which presumably possessed an additional hydroxy or an acetoxy group 
evidenced by HRESIMS. Then, inspired from the synthesis of jozipeltine A (87) (Figure 28 in 
Chapter 4),[144] Ag2O was likewise employed on the N,O-bis-benzylated derivative of 90, 
giving rise to a deeply violet-colored reaction mixture. Next, as had been described in some 
previous cases,[158-160] the intermediate diphenoquinone crude product was reduced by 
hydrogenation in the presence of Pd/C under acidic conditions. The cleavage of the protective 
groups completed the synthesis of 93 (Scheme 4). 
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Scheme 4. Synthesis of jozimine A3 (93) from 90 and selected HMBC (red single arrows) and ROESY 
(blue double arrows) interactions indicative of its constitution. 
The successful coupling in the 6′-position of the naphthalene ring was deduced by the 
symmetric structure evident from 1D-NMR experiments, HMBC correlations from H-6 and 
H-8′ to C-1′, ROESY interactions between H-7′ and H-8′ (Scheme 4), and the HRESIMS 
spectrum. The novel quateraryl 93 was named jozimine A3, since it was a structural isomer of 
jozimine A2 (85)[161] and jozimine A (88).[145] Another similar structure to 93 was jozipeltine 
A (87), which possessed side oxygen functions in the two naphthalene rings instead of the 
methyl groups in 93. The newly introduced 6′,6′′-biaryl axis in 93 does not constitute an 
additional element of chirality as in the case of jozipeltine A (87). 
The semi-synthesis of jozimine A3 (93) from the secondary metabolite dioncophylline A (6) 
suggests that 93 might also be a natural co-occurring product in the same African 
Ancistrocladus species that produces the predominant alkaloid 6.[161] With 93 in hands, a 
co-eluted HPLC analysis, however, revealed that the dimer 93 was not produced by the plant, 
at least at a not detectable quantity. 
 
 
90 
93 (27%) 
92 
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5.3  One-step Synthesis of Dioncotetralones A (94a) and B (94b) 
Treatment of dioncophylline A (6) without any protective groups with Pb(OAc)4[152,154] 
was carried out in the presence of BF3•OEt2 (Scheme 5). After filtration of the reaction 
mixture over Celite, the subsequent purification on preparative HPLC afforded two, 
unexpected, non-dimeric main products. The trivial name dioncotetralone A (94a) was 
proposed for the more rapidly eluting compound and dioncotetralone B (94b) for the more 
slowly eluting one. 
 
Scheme 5. Synthesis of dioncotetralones A (94a) and B (94b) from dioncophylline A (6). 
The molecular formulas of 94a and 94b, both were C23H25NO4, as evidenced by 
HRESIMS. Furthermore, 94a and 94b exhibited nearly identical 1H NMR (≤ 0.03 ppm), 13C 
NMR (≤ 0.5 ppm), and 2D NMR spectra. By contrast, the specific optical rotation values and 
the CD spectra of both compounds entirely differed, thus, the relationship of 94a and 94b 
were assumed to be diastereomeric. 
The 1H and 13C NMR spectra of dioncotetralone A (94a) and of dioncotetralone B (94b) 
showed a complete set of signals for the “isoquinoline” unit and the non-methyl-bearing part 
of the “naphthalene” moiety like that in dioncophylline A (6), together with the two doublets 
of H-3 (3.00 and 3.36 ppm), a singlet of CH3-2' (1.36 ppm), and C-3' (44.9 ppm), C-2' (59.5 
ppm) and a missing methyl group at the 4'-OMe function (Figure 30a). Based on this 
information, an oxygen function was accordingly linked at C-2'. Two keto functions at C-8 
and C-4', and a 7,1'-double bond was deduced by the combination with the chemical shift of 
C-4' (204.7 ppm), which interacted with H-3' in the HMBC, and the signal of C-1' (160.8 
ppm), which correlated with CH3-2', H-3', and H-8' (Figure 30b). 
The most remarkable property of the structures of 94a and 94b is the “biaryl axis” since it 
is a C,C-double bond instead of a single bond, so that the “isoquinoline” and the 
“naphthalene” moiety tend to be planar to each other, which has never been reported among 
natural or synthetic naphthylisoquinoline alkaloids. 
6                        94a (30%)                 94b (32%) 
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Figure 30. Selected NMR shifts of diocotetralone A (94a) (a) and selected HMBC interactions (red 
single arrows) and NOESY (blue double arrows) in 94a and 94b indicative of their constitutions. 
The CH3-2' group of 94a showed an NOE correlation with one of the H-3' protons, while 
an interaction with the other 3'-hydrogen was not observed. Thus, the CH3-2' function should 
be in the axial position and was, thus, not able to interact with H-3'ax. This was probably due 
to the hydrogen bond between OH-2' and the oxygen atom at C-8, and therefore OH-2' was 
assigned to be equatorial, as shown in Figure 30b. This was in agreement with the existence 
of an NOE correlation from H-6 to H-3'ax, and no one from H-6 to H-3'eq. The 7,1'-double 
bond was assigned to be Z-configured by an NOE interaction between H-8' and H-6. 
Furthermore, the configurations at C-1 and C-3 both remained the same as those in 
dioncophylline A (6), which was evidenced by the NOE correlations between CH3-1 and H-3 
(Figure 30b). Hence, the constitution of the stereoisomer 94b was fully elucidated by the 
same methodology as for 94a (Figure 30c). 
Determination of the absolute configuration of the two diasteromers 94a and 94b was 
rather difficult, due to the new chromophoric system that was introduced by the 7,1'-double 
bond and the closely attached additional stereogenic center at C-2'. Therefore, a combination 
of electronic circular dichroism (CD) spectroscopy with quantum chemical CD calculations 
was applied, a reliable and powerful tool for the elucidation of the absolute stereostructure of 
novel compounds. This work is currently performed by Y. Hemberger from our group. 
A detailed reaction mechanism cannot be described due to the lack of evidence, but the 
4'-O-demethylation, followed by oxidation, and finally the addition of water, seems very 
plausible, which is depicted in Scheme 6. The lead atom is linked to the oxygen atom at C-8 
with release of acetic acid, and BF3•Et2O acts as a Lewis acid weakening the O-CH3 bond. 
An acetoxy group will attack the 4'-O-methyl group, which sends an electron to the oxygen at 
94a 
94b 
94a 
a b 
c 
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C-4', further migrating to the lead atom, en route to the 1',7-biaryl axis and end at the oxygen 
at another acetoxy function, as described in structure 95. Simultaneously, the two ketone 
functions at C-8 and C-4' are formed, and the “naphthalene” ring will rotate anticlockwise 
around the 7,1'-biaryl axis followed by the formation of the 7,1'-double bond. Therefore, the 
orthogonal stereo-orientation between the “naphthalene” and the “isoquinoline” moiety is 
changed into a nearly planar orientation in intermediate 96, affording a 7,1'-trans 
configuration. Even though there is still a significant steric hindrance between CH3-2' and the 
oxygen atom at C-8 in structure 96, the trans-configured intermediate is more energetically 
favored than the imaginable cis-configured one. Such twisting force might be immediately 
released by addition of H2O to the 2',3'-double bond, yielding the two products 
dioncotetralones A (94a) and B (94b). 
 
Scheme 6. Proposed mechanism for the formation of dioncotetralones A (94a) and B (94b). 
5.4  Further Semi-Syntheses from Dioncophylline A (6) 
  Before we succeeded in the synthesis of jozimine A2 (85) and its 3'-epimer 3'-epi-85, 
several other reactions, described in the following part, had been performed. 
The 8-O- and N-dibenzylated derivative 98 of dioncophylline A was subjected to an 
oxidative coupling reaction with Pb(OAc)4, but no reaction was observed (Scheme 7). 
6                                                 95 
97                                              96 
94a and 94b 
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Scheme 7. The attempted dimerization of 8-O,N-dibenzylated dioncophylline A (6). 
In an attempt to prepare mono-O-demethyldioncophylline A, 6 was heated to 120 °C in 
DMF in the presence of sodium thiomethoxide,[51] however, the two atropodiastereomers 
4',5'-O-didemethyldioncophylline A 99a and 99b were obtained in an almost 1:1 ratio 
(Scheme 8). 
 
Scheme 8. O-Demethylation on dioncophylline A (6). 
5.5  Bioactivities of the Synthetic Alkaloids 
The two newly synthesized naphthylisoquinoline dimers 3′-epi-85 and 93 exhibited, albeit 
weaker than that of the natural product jozimine A3 (85), still very good antiplasmodial 
activities (on strain NF54), with extraordinary IC50 values of 0.017 μM for 3′-epi-85 and of 
0.015 μM for 93 (Table 3). Furthermore, the two compounds 3′-epi-85 and 93 possessed high 
or moderate selectivity indexes despite much lower than that of 85. Dioncotetralone A (94a) 
showed an excellent activity (IC50 = 0.09 μM) against the chloroquine-resistant strain K1 of P. 
falciparum, even stronger than that of the standard chloroquine (IC50 = 0.16 μM), in contrast 
to weak antiplasmodial activity (IC50 = 3.4 μM) for its atropo-diastereomer dioncotetralone B 
(94b), which shows the significant influence of chirality on the bioactivities (Table 3). The 
antiplasmodial activities of 3′-epi-85, 93, and 94a are specific, since they exhibit only weak 
activities against the likewise protozoan parasites T. brucei rhodesiense, T. cruzi, and L. 
donovani. According to the recommendations of the World Health Organization, WHO,[149] 
they can be considered as new lead structures.  
As for the antitumoral bioactivities of naphthylisoquinoline alkaloids described in Chapter 
6                          99a (50%)               99b (50%) 
6                                   98 
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4, the three alkaloids dioncophylline A (6), 4'-O-demethyldioncophylline A (89), and 
5'-O-demethyldioncophylline A (90) were biotested and found to display excellent activities 
against the myeloma cell lines, even stronger than dioncoquinones B (10), C (102) (structure 
shown in Chapter 6), the epoxide 175 (structure shown in Chapter 9), or the standard 
melphalan (Table 4). Further in vivo biotesting of these three alkaloids and investigations in 
the mode of action will be part of the future work. 
Table 3. Comparison of bioactivities of the synthetic dimers 3′-epi-85 and 93, and the two 
atropo-diastereomers 94a and 94b with the natural product jozimine A2 (85). 
 IC50 [μM] 
 85 3′-epi-85 93 94a 94b 
P. falciparuma 
S: chloroquine 0.16 (on K1)     0.09 3.4 
S: chloroquine 0.003 (on NF54) 0.0014 0.017 0.015   
      T. cruzi 
S: benznidazole 0.62 13.7 59.1 5.4 34.8 113.2 
      T. brucei rhodesiense 
S: melarsoprol 0.003 0.8 9.4 1.1 11.3 41.2 
            L. donovani 
S: miltefosine 0.25 80.2 >138 81.8 140.9 116.9 
      Cytotoxicity (L6 cells) 
S: podophyllotoxin 0.008 15.9 49.4 1.9 6.6 46.2 
      Selectivity index for the 
antiplasmodial activityb 15,900 2,906 127 73 14 
a For compounds 85, 3′-epi-85, and 93, the activities against P. falciparum were measured on the strain 
NF54 and for compounds 94a and 94b on the strain K1. 
b The index is calculated as the ratio of the IC50 values concerning L6 cells to the IC50 data relative to 
P. falciparum. 
Table 4. EC50 values (µM) of INA-6 multiple myeloma cells and peripheral mononuclear blood cells 
(PBMCs) treated with compounds 10, 102, 175, 6, 89, or 90 or with melphalan. 
 10 102 175 6 89 90 Melphalan 
INA-6a 11 14 3.5 0.22 2.5 1.5 2 
PBMCs NR NR NR NR NR NR 3 
NR: not reached.  
a Multiple myeloma cells were treated with different concentrations of 10, 102, 175, 6, 89, or 90, or 
melphalan. The viable fractions of the treated cells were determined by annexin V-FITC/PI staining.
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6  Isolation and Characterization of Naphthoquinones from Cell Cultures 
of Triphyophyllum peltatum 
6.1  Compounds Isolated from Cell Cultures of T. peltatum 
Besides the isolation and the synthesis of antiplasmodial naphthylisoquinoline alkaloids, 
the obtainment of biosynthetically related antitumoral napthoquinones was carried out. 
Dioncoquinones A (9) and B (10) were such known compounds showing excellent activities 
against multiple-myeloma cell lines without any significant cytotoxicities on normal blood 
cells.[54] In the course of the isolation of compounds 9 and 10 by Dr. S. Rüdenauer and A. 
Irmer, some traces of further naphthoquinones were detected by HPLC analysis. Thus, larger 
quantities of cell cultures of T. peltatum were phytochemically reinvestigated, giving rise to 
the isolation of three new natural products, dioncoquinones C (102), D (103), and E (104), 
and the known,[162,163] but new to the plant, 8-hydroxydroserone (105), together with the 
known[35,136] plumbagin (100), droserone (101), ancistronaphthoic acid B (106), and the new 
triphoquinol A (107) (Figure 31). 
 
Figure 31. Naphthoquinones isolated from T. peltatum cell cultures, dioncoquinones A (9), B (10), 
plumbagin (100), droserone (101), dioncoquinones C (102), D (103), and E (104), 8-hydroxydroserone 
(105), together with ancistronaphthoic acid B (106), and triphoquinol A (107). 
6.2  T. peltatum 
T. peltatum, Habropeltatum dawei and Dioncophyllum thollonii are the only three species 
of the extremely small family Dioncophyllaceae.[47] Of these, T. peltatum as a particularly 
9: R = D-Glu        100               101                102: R = H               
10: R = H                     103: R = Me                                           
 
104               105                 106               107                                           
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rewarding plant is the by far most widely investigated species. It thus occupies an outstanding 
position in our group. The research fields on T. peltatum mainly include activity screening of 
the extracts,[23,30] phytochemical studies,[28,47,52,156,164-172] cultivation of the plant,[173-176] and 
biosynthetic investigation.[49-51] 
6.3  Results and Discussion 
  The calli of the cell cultures were removed from the medium, lyophilized, ground, and 
extracted with CH2Cl2/MeOH (1:1 v/v). The crude extract was subjected to an ion-exchange 
column to remove naphthylisoquinoline alkaloids, followed by normal-phase chromatography 
permitting isolation of three main naphthoquinones: dioncoquinones A (9) and B (10) and 
droserone (101).[54] In the course of these investigations, three further naphthoquinones, 
102−104, were found in trace quantities, but easily recognized already by their UV absorption 
spectra. Specifically, the maximum UV absorption, around 419 nm, is characteristic of 
3,5-dihydroxy substituted naphthoquinones.[177] In addition, a 3,5,8-trihydroxy substituted 
naphthoquinone, 105, was found, possessing a maximum absorption at 485 nm. All these 
natural products were isolated and purified by preparative HPLC and characterized 
by 1H-, 13C- and 2D-NMR spectroscopy. 
Naphthoquinones 102−104 all showed one aromatic proton by 1H NMR, suggesting that 
their ring systems were higher-substituted as compared to those of dioncoquinones A (9) and 
B (10). The highly polar dioncoquinones C (102) and E (104) were found to have, both, 
molecular formulas of C12H10O6, as deduced from the number of signals in the 13C NMR 
spectrum and from HRESIMS, which is more than that of 10 by 30 units (corresponding to 
CH2O). The substitution pattern of these naphthoquinones was established using 2D-NMR 
spectroscopy. The spectra of dioncoquinone C (102) showed HMBC correlations from the 
methyl protons at δ 1.98 (2-CH3) and the only aromatic proton at δ 7.27 (H-8) to the carboxyl 
carbon at δ 184.2 (C-1), suggesting that this aromatic proton was located at C-8 (Figure 32). 
The NOESY correlation between H-8 and the methoxy group at δ 4.01 indicated that the latter 
was at C-7. In the naphthoquinone 104, by contrast, no such NOESY correlation was 
observed between the methoxy group and the aromatic proton, while the methoxy protons at δ 
3.91 (6-OCH3) and H-8 at δ 7.09 displayed HMBC correlations to the carbon signal at δ 
139.7 (C-6), indicating that the methoxy group was located at C-6 in 104. In the structure of 
naphthoquinone 103, an additional O-methyl group was found to be linked to the oxygen 
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function at C-3 as compared to that of 102. The fourth naphthoquinone isolated from the 
callus cultures was identified as the known 8-hydroxydroserone (105), previously found 
in Droseraceae and Nepenthaceae,[162,163] but not yet in T. peltatum. Its structure has one more 
chelated hydroxy group as compared to those in compounds 102−104 (Figure 31). This is in 
agreement with the larger wavelength (485 nm) of maximum UV absorption observed for 105 
compared to the one (416 nm) for dioncoquinone B (10) (Figure 33). From a biosynthetic 
point of view, the new naphthoquinones 102−104 and the known one, 105, are apparently 
closely related to their less oxygenated analogs, plumbagin (100) and droserone (101). 
 
Figure 32. Selected NMR data of 102 (in CD3COCD3) and 104 (in CD3OD): 1H and 13C NMR shifts 
(δ in ppm), NOESY correlations (double blue arrows) and HMBC couplings (single red arrow) 
indicative for their constitutions. 
 
Figure 33. Comparison of the wavelengths of the UV absorption maxima of 105 and 10. 
Ancistronaphthoic acid B (106) was isolated for the first time from a Dioncophyllaceae 
species; it had previously been found in the stem bark and leaves of Ancistrocladus 
ealaensis[35] and in the roots of Ancistrocladus likoko (Ancistrocladaceae).[136] 
The promising bioactivities of dioncoquinones A (9) and B (10),[54] in particular the high 
and selective activity (EC50 = 11 µM) of 10 against multiple-myeloma cells, encouraged us to 
test the isolated four natural analogs 102−105 in the same system. Dioncoquinone C (102) 
showed an activity (EC50 = 14 µM) comparable to that of dioncoquinone B (10), while it was 
inactive against normal blood cells. Dioncoquinones D (103) and E (104), and 
102                                   104                                
 
105                                       10                                     
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8-hydroxydroserone (105) were less active than 10 and 102. SAR studies for antitumoral 
naphthoquinones will be discussed in Chapter 8. 
Different from the 1H NMR signals in naphthoquinones, 9, 10, and 100−106, compound 
107 displayed the signals for one chelated hydrogen at δ 9.53 ppm (s, 1H), three neighboring 
aromatic protons at δ 7.39 (d, J = 7.8 Hz, 1H), 7.28 (dd, J = 7.8, 7.8 Hz, 1H), and 6.72 ppm (d, 
J = 7.8 Hz, 1H) and one singlet aromatic hydrogen at δ 7.31 ppm (s, 1H), together with a 
signal for a methoxy group at δ 3.98 ppm (s, 3H) and a methyl group at δ 2.15 ppm (s, 3H). 
The crosspeaks in NOESY established the series {2-CH3 ↔ H-1 ↔ H-8 ↔ H-7 ↔ H-6 ↔ 
5-OCH3 ↔ 4-OH} (Figure 34), from which the fragment of 2-methyl-5-methoxynaphth-4-ol 
(C11H11O2) was deduced. This, in combination with the molecular formula of C24H22O4, as 
revealed by HRESIMS, and an optical rotation value of −65° suggested that 107 should be 
C2-symmetric. Further, the linkage position at C-3 was demonstrated by an NOE interaction 
between 4-OH and 2'-CH3, and the chemical shift of C-3 (120.3 ppm). Therefore, the 
binaphthalene 107 was established as 2,2'-dimethyl-5,5'-dimethoxy-3,3'-binaphalene-4,4'-diol, 
and was given a trivial name triphoquinol A. 
A chiral HPLC analysis on 107 gave only one peak, hinting probably a highly 
enantiomerical purity. The CD spectra of 107 displayed a positive Cotton effect at 224 nm (Δε, 
+39.0) and a negative Cotton effect at 242 nm (Δε, −25.1). Thus, the absolute configuration at 
the biaryl axis of 107 should be M-configured. 
 
Figure 34. Selected 1H and 13C NMR data (δ in ppm) (a), and NOESY (blue double arrows) 
correlations for the constitution of 107. 
Similar naturally occurring binaphthols are stypandrol (108), which had been previously 
isolated from Stypandra imbricate,[178] diospyrol (109), and lemuninols B (110) and C (111) 
(Figure 35) from Diospyros species.[179,180] The steric hindrance (four ortho substituents) next 
to the biaryl axes in 110 and 111 was comparable to those in some of the 
naphthylisoquinoline alkaloids like, e.g., in ancistrocladine (5a) and hamatine (5b). Therefore, 
a                                  b                                       
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the biaryl axes in 110 and 111 should be rotationally hindered, and should constitute 
stereogenic elements. However, the issue of the axial chirality was not discussed by the 
authors,[180] and even the specific optical rotation values were not measured for 110 and 111. 
 
Figure 35. Flat structures of known related naturally occurring binaphthols 108−111 (* presumably 
chiral axis). 
6.4  Conclusion 
The discovery of the three new, highly oxygenated naphthoquinones, 102−104, one 
naphthalene dimer 107, and two additional known compounds, 105 and 106, from cell 
cultures of T. peltatum shows the great potential of this plant to produce a broad variety of 
structurally interesting metabolites. Dioncoquinone C (102) possesses an additional methoxy 
group at C-7 position as comparable to dioncoquinone B (10). Moreover, dioncoquinone C 
(102) demonstrates an excellent activity against multiple-myeloma cell lines without any 
significant toxicity on normal cells, and thus, it can be considered as a new lead compound. 
 
 
108 
 
 
 
 
 
109   
 
110: R = H 
111: R = Me 
Nepenthaceae 55 
  
7  Phytochemical Investigations on Nepenthaceae 
7.1  Introduction and Results 
Closely related to the Ancistrocladaceae and Dioncophyllaceae are the Nepenthaceae,[123] 
which had long attracted the interest of biologists in various fields, including the mechanism 
to capture and digest insects, the physiological and anatomical features, and the phylogeny 
and structural evolution.[181-183] In contrast to numerous biological publications on the 
Nepenthaceae, only three papers were published on their natural products.[162,184,185] 
Plumbagin (100), droserone (101), 8-hydroxydroserone (105), and nepenthones A (112 or 
113), C (114), D (115), and E (116) were detected or isolated from the roots of N. rafflesiana 
and N. thorelii,[162,184] and plumbagin (100), rossoliside (117) and plumbaside A (118) (Figure 
36) were discovered from N. insignis in our group.[185] To search for naphthoquinones 
hopefully possessing anti-MM activities, the three species Nepenthes alata, N. intermedia, 
and N. khashiama were now chosen for investigation on the secondary metabolites. 
 
 
Figure 36. Structures of the naphthoquinones plumbagin (100), droserone (101), 8-hydroxydroserone 
(105), nepenthones A (112 or 113), C (114), D (115), E (116), rossoliside (117), and plumbaside A 
(118), isolated from N. raflesiana, N. thorelii, and N. insignis. 
Leaves of plants of the three species of N. alata, N. intermedia, and N. khashiama were 
collected in the Botanical Garden of Würzburg University and extracted with MeOH : 
CH2Cl2 : 0.01 N aqueous HCl solution (1 : 1 : 0.01 v/v). A thorough HPLC analysis of the 
three crude extracts was carried out. None of the peaks showed any absorption at the 
typical[177] UV wavelength above 400 nm, showing that no detectable quantities of 
     R1     R2                                                                    R1    R2      X1   X2  
112: H    Me                  115: X = OH           117: H    β-Glu H  OH 
113: Me   H                                        118: β-Glu H    OH H 
114: X = H 
100                       101                         105 
116: X = OMe 
Nepenthaceae 56 
  
naphthoquinones were produced by the three plants. 
The crude extract of N. alata was submitted to liquid-liquid separation with CH2Cl2 and 
aqueous 5% NaHCO3 solution. The water layer was further purified on Sephadex LH-20 
eluting with MeOH, leading to the isolation of three known[186-188] flavonoids, 119−121 
(Figure 37). 
 
Figure 37. Structures of the three flavonoids 119−121 isolated from N. alata. 
7.2  Conclusion 
HPLC analysis revealed that the three plants of N. alata, N. intermedia, and N. khashiama 
do not produce naphthoquinones, while flavonoids dominate the spectra of secondary 
metabolites. The three well-known[186-188] flavonoids 119−121 (Figure 37) were isolated from 
the plant N. alata for the first time. 
 
119: OH   β-D-glucuronide 
120: OH   α-L-rhamnopyranoside 
121: H    α-L-rhamnopyranoside 
  
 
X          R  
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8  Synthesis of Dioncoquinones B (10) and C (102), and their Analogs 
8.1  Synthesis of Dioncoquinones B (10) and C (102) 
Dioncoquinone B (10) showed a strong in vitro activity against multiple-myeloma cell lines, 
without any significant toxicity towards normal blood cells.[54] These pharmacological 
properties made it rewarding to explore the overall effects of dioncoquinone B (10) in vivo, in 
model mice, to test its tolerance and efficacy. For this, a prerequisite was to get a large 
quantity of dioncoquinone B (10), which could be in principle accomplished by isolation from 
plant material. This would have required a large quantity of precious cell cultures of T. 
peltatum, and would also have been time-uneconomical. Thus, an alternative access to 
dioncoquinone B (10) should be achieved by synthetic work. Before the present work, two 
synthetic pathways to prepare dioncoquinone B (10), had been described by A. Hager[114] and 
M. Moos[189] in their diploma theses (Schemes 9 and 10). In this thesis, a 3rd, improved new 
route (Scheme 11) for obtaining dioncoquinone B (10) and its application on the synthesis of 
active dioncoquinone C (102) are described (Scheme 12). 
8.1.1  The First Route to Dioncoquinone B (10): by a Stobbe Approach 
  The synthesis of highly substituted naphthoquinones has been well studied during the past 
decades.[190] Many strategies have been developed to build up these systems, among them the 
Dötz reaction,[112] the Hauser-Kraus annulation,[104] and [4+2]-cycloadditions.[93] In analogy to 
previous work,[191] the initial approach to dioncoquinone B (10) was based on the 
well-developed Stobbe condensation route to a naphthalene, which was then oxidized and 
modified to provide the required naphthoquinone. This pathway, thus, started with the 
synthesis of the naphthalene 42 from the known[191] bromo veratrum aldehyde 122 (Scheme 
9). A Stobbe condensation[192] with dimethyl succinate resulted in the formation of the 
E-configured (NMR) acid 123, which was cyclized in acetic anhydride in the presence of 
sodium acetate[193] to produce the naphthalene 124. Using palladium on charcoal in methanol 
in the presence of K2CO3,[194] the bromine and the acetate protecting groups were removed to 
give the free naphthol 125 in an almost quantitative yield. Reduction of the ester group using 
LiAlH4[194] and palladium on charcoal[194] provided the methylnaphthalene 42[99] in a 94% 
yield over two steps. By oxidation of 42 with CuCl in the presence of air,[195] the 
para-naphthoquinone 127[99] was obtained in a 66% yield, accompanied by the respective 
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ortho-quinone 126 (ratio 6.5:1). The required α-hydroxy functionality of the target molecule 
was introduced by epoxidation of the 2,3-double bond[196,197] of 127, followed by ring 
opening[198] of the resulting α,β-epoxydiketone. Under optimized conditions using sulfuric 
acid on silica gel, this reaction sequence provided ancistroquinone C (128), a natural product 
that had been previously isolated from the related plant, Ancistrocladus 
abbreviatus.[54] O-Demethylation of 128 with boron tribromide furnished dioncoquinone B 
(10) in a 98% yield, thus completing its first total synthesis (Scheme 9). 
 
Scheme 9. First total synthesis of dioncoquinone B (10), via a Stobbe-condensation route. 
This first synthetic route, although reliably providing access to dioncoquinone B (10) and 
offering the possibility to synthesize derivatives of this natural product by varying the starting 
materials, contains some tedious isolation and purification steps, which prompted us to 
explore less time-consuming alternatives. The improved second-generation synthesis of the 
same naphthalene intermediate 42 is discussed in the following section. 
122                        123                           124 
126                       42                            125 
127                         128                           10 
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8.1.2  Diels-Alder Route to Precursors of Dioncoquinone B (10) and Dioncoquinone C (102), 
and to the Related Naphthol 132 
For a better access to naphthols 42, 131, and 132, a strategy was envisioned based on the 
Diels-Alder (DA) reaction between benzynes as dienophiles and lithiated unsaturated amides 
as dienes established by Watanabe et al.[99] This required the amide 129 and 
3,4-dimethoxybenzyl bromide (130) as starting materials for the DA reaction, through which 
42 and its congeners 131 and 132 were prepared, with different substitution patterns in the left 
ring part. This synthetic route permitted a concise access to several derivatives of 
dioncoquinone B (10). The yield of the naphthalene products depended on the number of 
electron-donating groups in the benzyne ring. The best results were achieved using mono- and 
di-substituted bromobenzenes (Scheme 10). 
 
Scheme 10. Synthesis of naphthols via a Diels-Alder route. 
With this Diels-Alder route to the intermediates 42, 131, and 132, a significantly shorter 
synthetic route to dioncoquinone derivatives was established, yet in unsatisfactory yields. 
8.1.3  The Grignard Approach to Precursors of Dioncoquinone B (10) and Dioncoquinone C 
(102), as developed in this thesis 
Therefore, another pathway to naphthols 42 and 131 was established, this time based on the 
addition of a Grignard reagent derived from benzamides 135 and 136 to an allyl 
bromide.[100-102,199] This route started with the commercially available benzoic acids 133 and 
134, which were converted to the known[200,201] benzamides 135 and 136 using procedures 
described for other compounds.[202,203] After the directed ortho-deprotonation of 135 and 136 
using s-BuLi, the resulting lithium species was transmetallated with freshly prepared the 
MgBr2▪2Et2O solution (very important! See 8.2.4),[103] providing Grignard reagents 137 and 
138, respectively. Their reaction with 2-methylallyl bromide (139) resulted in the formation of 
the new ortho-allyl benzamides 140 and 141 in satisfactory yields. By treatment with methyl 
129                    130  
42: X1 = OMe, X2 = H, 31% 
131: X1 = OMe, X2 = OMe, 21% 
132: X1 = H, X2 = H, 35%        
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lithium at −78 °C,[100-102,199] 140 and 141 were converted to the desired naphthalenes 42 and 
131 in excellent yields (Scheme 11). This route enabled us to synthesize these key 
intermediates in a very short manner and with high yields. 
 
Scheme 11. Synthesis of the key intermediates 42 and 131 by Grignard reaction of the benzamides 135 
and 136, and 2-methylallyl bromide (139), and MeLi-induced cyclization. 
8.1.4  Synthesis of Dioncoquinone C (102) and Its Analogs 
This good synthetic access to several differently substituted naphthalene compounds 42 and 
131 now permitted to synthesize a small library of further dioncoquinone B analogs, among 
them the natural product dioncoquinone C (102) (Scheme 12 and Table 5). 
 
Scheme 12. Synthesis of derivatives of dioncoquinone B (10) possessing an additional oxygen 
102:  H    H  Me 
145:  H     H  H 
146:  Me    H  H 
 
 
R1    R2  R3 
133, 134                   135 (99%), 136 (80%)                  137, 138 
139 
42 (99%), 131 (80%) 140 (60%),  
141 (45%) 
42, 133, 135, 137, 140   H 
131, 134, 136, 138, 141  OMe 
 
X 
131 
142 (45%)                          144 
 
143 (40%) 
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function at C-7. 
Table 5. Yields of 102, 145, and 146 using different reaction conditions in the last step. 
Entry BBr3 (eq.) Time (h) T (°C) 102 (%)a 145 (%)a 146 (%)a 
1 2 2 −78 0 0 0 
2 3 2 −78→0 41 10 15 
3 10 2 −78→0 67 13 15 
4 10 16 −78→rt 0 98 0 
a Yields after normal-phase column chromatography and preparative HPLC on reversed-phase 
material. 
8.2  Synthesis of Analogs of Dioncoquinone B (10) 
8.2.1  Synthesis of the Dioncoquinone B Analog 150 
To evaluate the contribution of the 5-OH function to the anti-MM activity of dioncoquinone 
B (10), compound 150, i.e., the analog without that hydroxy group, was prepared. The 
synthesis started with the preparation of the new triflate 148 by treatment of the 
known[194,204,205] naphthol 147 with triflic anhydride (Scheme 13). Selective oxidation of 148 
using periodic acid and chromium trioxide[206] at 0 °C afforded the new naphthoquinone 149. 
Epoxidation of the 2,3-double bond in 149 with concomitant cleavage of the triflate ester, 
followed by epoxide opening, produced the dihydroxynaphthoquinone 150. For the 
preparation of the monophenolic derivative 152,[207] the naphthol 151 obtained from the 
triflate 149[208] was epoxidized, O-methylated, and then converted to the target compound 152 
under acidic conditions. 
 
147                            148                           149 
 
152                            151                           150 
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Scheme 13. Synthesis of dioncoquinone B derivatives without a hydroxy function at C-5. 
8.2.2  Synthesis of the Dioncoquinone B (10) Analog 155 
To explore the effect of the 6-OH group of dioncoquinone B (10) on its antitumoral 
properties, the analog 155 bearing an additional Me substituent at C-6 instead of a hydroxy 
group was synthesized. To prepare 155, the known[209] dinaphthol 153 was oxidized to 
naphthoquinone 154, followed by an introduction of a hydroxy group at C-3 (Scheme 14). 
Besides the strategy of building up 153 by introduction of two methyl groups into 
1,8-dinaphthol according to the literature,[209] two other known approaches are based on the 
introduction of two α-hydroxy groups into 2,6-dimethylnaphthalene by means of 
biotransformation,[210] or by oxidation with H2O2 catalyzed by metalloporphyrins,[211] but both 
in low yields. 
 
Scheme 14. Synthesis of the 6-methyl analog 155 of dioncoquinone B (10). 
8.2.3  Synthesis of the Dioncoquinone B (10) Analog 161 
In addition to 155 with its an electron-donating methyl substituent at C-6, another 
dioncoquinone B analog, 161, bearing an electron-withdrawing Cl substituent, was prepared. 
The method to synthesize precursors of dioncoquinones B (10) and C (102), as described in 
8.1.3, was likewise applied in the preparation of their derivative 161 (Scheme 15). 
153                            154                             155 
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Scheme 15. Synthesis of the 6-chloro analog 161 of dioncoquinone B (10). 
8.2.4  Attempts to Prepare the Grignard Reagent 138 
Before the successful use of the Grignard approach for the preparation of precursors of 
dioncoquinones B (10) and C (102) and their derivatives, the unsuccessful reactions as 
described in Scheme 16 had been carried out. The key step was to prepare substance 138 from 
the amide 136. The starting material 136 was ortho-deprotonated using s-BuLi, providing the 
intermediate lithiated species (structure not shown here), to which commercially available 
MgBr2▪Et2O or MgBr2 was added, followed by addition of 2-methylallyl bromide (139). As a 
result, only compound 136 was recovered. In a third attempt, the bromide 162 prepared from 
136 was employed to provide a Grignard reagent for access to 138, which was, however, 
unsuccessful due to the presence of the strongly electron-withdrawing group amide (Scheme 
16). The three attempts revealed that it is essential to use freshly prepared the MgBr2▪2Et2O 
solution for the success of this reaction. 
156                            157         139 
158 
161                              160                            159 
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Scheme 16. Failed reactions to prepare 138 from benzamide 136. 
8.3  SAR Studies of Prepared Naphthoquinones 
To identify the pharmacophore of these molecules, a number of synthetic intermediates and 
isolated compounds were examined for their biological activities against multiple-myeloma 
cells. The results are summarized in Table 6. 
The first results of our biological tests enabled us to localize the preliminary structural 
elements of naphthoquinone derivatives that are responsible for their anti-MM activity and 
cytotoxicity. To examine the individual roles of the hydroxy functions at the C-3, C-5, and 
C-6 positions in dioncoquinone B (10), we synthesized or isolated derivatives that each 
contains only two hydroxy groups. The test results (structures 101, 150 and 165 in Table 6) 
show that removal of one OH group in any of these positions leads to an almost complete loss 
of bioactivity. The observation that substance 165 bearing two hydroxy groups at C-5 and C-6 
exhibits lower activity and higher toxicity than 10, combined with the activities of compounds 
150 and 151, jointly evidence that the lack of a hydroxy function at C-3 makes the compound 
more toxic against normal blood cells. This tendency is supported by the pairwise comparison 
of the properties of compounds 127 and 128, of 142 and 144, of 154 and 155, of 160 and 174, 
of 163 and 168, of 170 and 171, and of 172 and 173 with respect to the structural variation at 
C-3 (Table 6). A possible reason for this is that the hydroxy group and other substituents at 
C-3 may block Michael addition reactions of possible nucleophiles (e.g., SH groups of 
proteins) in the cell to the α,β-unsaturated carbonyl fragments in naphthoquinones 127, 142, 
154, 160, 163, 170, and 172 thereby inhibiting a variety of cellular functions that direct the 
136 
139 
139 
162 
138 
139 
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cells into apopotosis.[212] On the other hand, the possibility of a Michael addition reaction 
seems to be necessary for the anti-MM activities of these compounds, too. It is worth 
mentioning that shifting the OH groups along the aromatic ring has a significant impact on the 
biological activities of naphthoquinones. Hydroxy shifts from position 5, 6 to 6, 7 (structure 
164) or 5, 8 (structure 105) both result in a decrease of the activities of the corresponding 
compounds. The introduction of an additional OH function in position 7 of 10 as in the 
naphthoquinone 145 does not have any significant effect on the anti-MM activity of this 
compound, while its toxicity is increased. No pronounced toxicity was observed, however, in 
the 7-O-methylated derivative of 145, dioncoquinone C (102), while its bioactivity was still 
high (Table 6). The replacement of an OH group at C-6 of dioncoquinone B (10) with a Me 
group for 155, or with a Cl substituent for 161 resulted in a decrease of anti-MM activity, 
which was also observed for substances 171, 173, and 174. Among the numerous derivatives 
tested, 102 was the most active candidate, with no measurable cytotoxicity against peripheral 
mononuclear blood cells (PBMCs). This activity is highly specific, and thus rewarding, 
because in our tests all other mixed OH/OMe/Cl/Me/COOMe- or completely OMe-substituted 
structures were entirely inactive (structures 128, 144, 152, 155, 161, 166−169, 171, and 
173−174). 
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Table 6. EC50 values of INA-6 multiple-myeloma cells and PBMCs treated with naphthoquinones. 
 
Compd. X1 X2 X3 X4 X5 EC50 [µM] (INA-6)a 
EC50 [µM] 
(PBMC)b 
10 OH OH OH H H 11 NR 
101 OH OH H H H >100 NR 
102 OH OH OH OMe H 14 NR 
105 OH OH H H OH >100 NR 
127 H OMe OMe H H 15 13 
128 OH OMe OMe H H >100 NR 
142 H OMe OMe OMe H 8 7.5 
144 OH OMe OMe OMe H >100 NR 
145 OH OH OH OH H 7 70 
150 OH H OH H H >100 NR 
151 H H OH H H 13 17 
152 OH H OMe H H >100 50 
154 H OH Me H H 2.3 4 
155 OH OH Me H H 75 NM 
160 H OMe Cl H H 7 5 
161 OH OH Cl H H >100 NM 
163 H H OMe OMe H 6 6.5 
164 OH H OH OH H 52 NR 
165 H OH OH H H 75 100 
166 OH OH OMe H H >100 NR 
167 OMe OH OH H H >100 NR 
168 OH H OMe OMe H >100 NR 
169 H OMe H H H 4 16 
170 H H Me H H 4.8 3.5 
171 OH H Me H H 55 NM 
172 H H COOMe H H 3.3 1.2 
173 OH H COOMe H H 80 NM 
174 OH OMe Cl H H 45 NM 
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NR: not reached. NM: not measured. 
a Activity against the multiple-myeloma cell line INA-6. 
b Cytotoxicity against normal peripheral mononuclear blood cells (PBMC). 
In summary, for a good balance of activity versus toxicity, it seems essential to have OH 
groups in positions 3, 5, and 6, while position 7 has little influence, which can be seen from 
the similar activities of dioncoquinone B (10), dioncoquinone C (102), and 
7-hydroxydioncoquinone B (145) (Table 6). The role of an OH group in position 8 is not quite 
clear, but - at least in combination with the lack of oxygen functions at C-6 and C-7 - it seems 
to lower the activity as seen in structure 105. 
8.4  Conclusion 
For the synthetic access to the antitumoral product dioncoquinone B (10) in sufficient 
quantities for in vivo tests, two other approaches[114,189] had been described in our group 
before the present thesis, and here a third one was established based on a directed ortho 
metalation (DOM) reaction. It proved to be the best one as compared to the first two 
approaches, which required either too many steps or gave too low overall yields. Utilizing the 
third strategy, the likewise highly antitumoral metabolite dioncoquinone C (102) was 
synthesized, too. For the elaboration of the first preliminary SAR studies, a number of 
dioncoquinone B analogs were obtained by synthesis and by isolation from cell cultures of T. 
peltatum. Among them, only the new dioncoquinone C (102) strongly induced apoptosis in 
the multiple-myeloma cell lines INA-6 without any significant toxicity. Thus, the two natural 
products dioncoquinones B (10) and C (102) constitute two promising basic structures to 
develop anti-MM candidates. Remarkably both antitumoral compounds have three hydroxy 
functions at C-3, C-5, and C-6, which are required for their biological properties. Extended 
SAR studies to further optimize the structures and to explore the in vivo anti-MM activity of 
10 and 102 and their analogs are currently in progress. 
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9  Synthesis of Epoxides and SAR Studies 
The synthetic intermediate 175 was found to show an excellent activity (EC50 = 3.5 µM) 
against the multiple-myeloma cell lines INA-6 without cytotoxicity towards normal cells, thus, 
being even more promising than dioncoquinones B (10) and C (102). To evaluate the 
contribution of the 6-OMe group on the anti-MM property of 175, compounds 176 and 177 
bearing Me and COOMe functions at C-6 were prepared (Figure 38, Schemes 17 and 19). 
 
 
Figure 38. Structures of the bioactive dioncoquinones B (10) and C (102), the epoxide 175, and the 
two synthetic targets 176 and 177. 
9.1  Synthesis of 2,6-Dimethyl-1,4-naphthoquinone-2,3-epoxide (176) 
The oxidizing agents converting varying 2-methylnaphthalenes to the corresponding 
naphthoquinones can be divided into two groups: with a metal catalysis and without. The 
former involves chromium (VI) or cerium (IV) compounds in combination with an oxygen 
source,[92] and the latter uses aqueous hydrogen peroxide in the presence of glacial acetic 
acid[213] or hexafluoroacetone hydrate,[214] or m-chloroperbenzoic acid.[215] 
Of the oxidizing agents, H5IO6/CrO3 was used for 2-methylnaphthalene providing a ratio 
of 19:1 of 1,4-naphthoquinone to the 5,8-isomer.[206] Additionally, other oxidizing procedures 
and the regioselective ratios were reported, e.g., H2O2/methyltrioxorhenium (89:11),[216] 
KHSO3/Mn-porphyrins (53:47),[217] CH3CO3H/Mn-porphyrins (100:0).[218] 
Based on the high oxidative efficiency and the easy availability of H5IO6/CrO3, this 
reagent combination was applied to 2,6-dimethylnaphthalene providing the quinone 170.[206] 
The following two steps for epoxidation and ring-opening to give 171 were similar to those 
described before (Scheme 17).[196] 
dioncoquinone B (10)    dioncoquinone C (102)    epoxide 175        176: R = Me 
EC50: 11 µM           EC50: 29 µM            EC50: 3.5 µM       177: R = COOMe 
CT50: not reached       CT50: not reached        CT50: not reached 
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Scheme 17. Synthesis of 2,6-dimethyl-1,4-naphthoquinone-2,3-epoxide (176) and naphthoquinone 
171. 
9.2  Synthesis of 6-methoxycarbonyl-2-methyl-1,4-naphthoquinone-2,3-epoxide (177) 
The attempted conversion of 178 to the carboxylic acid 181 by aerobic photooxidation in 
the presence of HBr was unsuccessful,[219] affording only the mono- and the dialdehyde 179 
and 180 (Scheme 18). 
 
Scheme 18. Aerobic photooxidation on 2,6-dimethylnaphthalene (178). 
Oxidation of 178 by utilizing potassium permanganate[220,221] afforded the acid 181 in a 
respectable yield. After conversion of 181 to the methyl ester 182, it was regioselectively 
oxidized affording the quinone 172. Introduction of a hydroxy group at C-3 of 172 via the 
epoxide 177 afforded the desired compound 173 in two steps (Scheme 19). The two synthetic 
parts (9.1 and 9.2) were performed by the bachelor student B. Wanner under my supervision. 
 
Scheme 19. Synthesis of 6-methoxycarbonyl-2-methyl-1,4-naphthoquinone-2,3-epoxide (177) and 
naphthoquinone 173. 
170                          176                              171 
178                            181                            182 
173                           177                             172 
181                    178                    179              180 
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9.3  SAR Studies on Epoxides 
The epoxide 175 showed an extraordinary activity (EC50 = 3.5 µM) against MM cell lines 
as compared to all synthesized naphthoquinones and their synthetic intermediates. Moreover, 
no significant toxicity was observed for 175 against normal blood cells. All other tested 
epoxides, 176, 177, and 183−186 showed high toxicities against normal cells (Table 7). In 
conclusion, compound 175 exhibited the by far best and highly specific antitumoral activity. 
Work on further structural optimization, in vivo biotestings and investigation of the mode of 
action is still ongoing. 
Table 7. EC50 values of INA-6 multiple myeloma cells and PBMCs treated with epoxides. 
 
Compound X1 X2 X3 
EC50 [µM] 
(INA-6)a 
EC50 [µM] 
(PBMC)b 
175 H OMe H 3.5 NR 
176 H Me H 2 2 
177 H COOMe H 0.6 0.4 
183 OMe OMe H 3 7 
184 OMe OMe OMe 2 4 
185 H OH H 13 37 
186 OMe Cl H 3 5 
NR: not reached. 
a Activity against the multiple-myeloma cell line INA-6. 
b Cytotoxicity against normal peripheral mononuclear blood cells (PBMC).
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10  Total Synthesis of Triphoquinone (187a) 
10.1  Introduction 
A library of naphthoquinones[54] and naphthalene-related metabolites, e.g., naphthalene 
dimers, and naphthalene-naphthoquinone dimers (unpublished paper) were recently isolated 
from cell and root cultures of T. peltatum (Dioncophyllaceae) in our group. Of these, one 
unprecedented axially chiral dimer triphoquinone (187a) (Figure 39) was found, consisting of 
a 1,2-naphthoquinone moiety and a naphthalene unit. To obtain sufficiently large quantities of 
this substance for bioassays, the total synthesis of 187a was pursued. The strategy was to 
synthesize the racemate of triphoquinone rac-187, whose separation should be achieved by 
column chromatography on a chiral phase. 
 
Figure 39. Structure of the target triphoquinone (187a). 
10.2  Retrosynthetic Analysis 
Key step of the synthesis of rac-187 (Scheme 20) was the construction of the binaphthalene 
rac-188, with its extremely sterically hindered axis between the two highly oxygenated parts, 
by an intramolecular or intermolecular C-C coupling reaction. To save precious precursor 
material, the plan was to optimize the coupling conditions on racemic 
2,2'-dimethyl-1,1'-binaphthalene (rac-195) as a simplified test system (Scheme 21). 
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Scheme 20. Retrosynthetic disconnection of rac-187. 
 
 
Scheme 21. Synthesis of the simplified binaphthalene rac-195 by Suzuki-Miyaura coupling. 
10.3  Synthesis of Biaryls 
One of the most successful concepts in the preparation of a biaryl axis is the 
well-established intramolecular “lactone methodology” in our group.[141] This strategy permits 
the synthesis of either of the two atropisomers, even with sterically hindered axes, in high 
chemical and optical yields. A basic requirement within this concept is to construct an ester 
bridge for the prefixation of the two coupling units,[222,223] which is possible, however, 
difficult to be constructed in the target 187a. 
A pioneer approach in the stereoselective synthesis of 195 was initially established by 
Meyers and Cram,[224-226] using an artificial chiral auxiliary moiety in the proximity of the 
axis as a stereochemically controlling unit. The disadvantage of this strategy is the need of 
additional steps to attach and remove the chiral auxiliary. An alternative approach to 
enantiomerically pure 195 described by Hayashi and Ito[227] involved a chiral ligand and a 
nickel-catalyzed asymmetric coupling between (2-methylnaphthalen-1-yl) magnesium 
bromide and 2-methylnaphthalen-1-yl bromide. The wide application of this strategy was 
rac-187                      rac-188        
                      190 X = Br, I, Bpin, or B(OH)2            
191: X = Br             193: X = B(OH)2               rac-195   
192: X = I              194: X = Bpin                
196  
189 
Ligand:  
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hampered by the required functionality patterns necessary for the preparation of Grignard 
reagents. 
Today, Suzuki-Miyaura cross-coupling reactions are certainly the most widely used method 
for the construction of biaryl and binaphthyl axes for a number of well known reasons, such 
as its tolerance of a broad range of functional groups and its relatively environment-friendly 
nature.[228] Despite a growing success, the Suzuki-Miyaura coupling reaction between two 
sterically hindered partners and the control of a biaryl axial chirality remain great 
challenges.[229,230] Numerous reports[231-235] demonstrated that achieving satisfactory yields is 
a practicable, but a difficult task, in particularly when four ortho-substituents are present 
around the biaryl axis in the synthetic target, as exemplarily shown for the synthesis of 195. 
The successful examples[231-235] of the synthesis of 195 involved the coupling 
1-iodo-2-methylnaphthalene (192) and the boronic acid 193, or 192 and the boron ester 194 
by employing the ligands that were synthesized in several steps by the authors. In this thesis, 
commercially available ligands were used for the racemic coupling reaction between 191 
(bromo- instead of iodo-naphthalene) and 193, or between 191 and 194. Subsequently, the 
optimized reaction condition would be likewise applied on the synthesis of rac-188. 
Significant achievements towards the preparation of highly hindered biaryls have been 
made particularly in Buchwald’s and Fu’s groups,[236-240] by applying increasingly efficacious 
supporting ligands. Of great importance are the commercially available catalyst systems 
Pd2(dba)3/P(t-Bu)3 and Pd2(dba)3/S-Phos (196), which were first applied in the synthesis of 
the binaphthalene rac-195 in the present thesis. 
The two boron species 193 and 194 were prepared from 191 according to known 
procedures.[241,242] The conditions for the coupling were modified regarding base-solvent 
combinations, boron esters vs. boronic acid, and temperature. Selected results are summarized 
in Table 8. A low yield of 33% of 195 (entry 1) was obtained in the presence of 
Pd2(dba)3/P(t-Bu)3,[240] while a respectable yield of 66% (entry 2) was provided by using 
Pd2(dba)3/ S-Phos (196).[236,237] The yields did not substantially alter when CsF/toluene (entry 
3), CsF/THF (entry 4), or K3PO4 /DME (entry 6) was employed. The yield was improved up 
to 90% when using CsF /DME (entry 5). The yields were reduced when the boronate ester 
194 replaced the boronic acid 193 (entries 7−9). In conclusion, the combination of 
Pd2(dba)3/S-Phos/DME/CsF proved to be the best coupling reaction, which should, thus, now 
be applied on the synthesis of rac-188. 
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Table 8. Selected results from the symmetric Suzuki-Miyaura couplings.a 
Entry Boron species Solvent Base  T. [° C] Yield (%)b 
1 193 THF KF 80 33%c 
2 193 toluene K3PO4 100 66% 
3 193 toluene CsF 100 70% 
4 193 THF CsF 60 54% 
5 193 DME CsF 80 90% 
6 193 DME K3PO4 80 74% 
7 194 DME CsF 80 40% 
8 194 DME/H2Od CsF 80 85% 
9 194 DME/H2Od K3PO4 80 48% 
a Pd2(dba)3 and Buchwald’s ligand 196 were used in all reactions except for entry 1; Reactant ratio: 
bromide (191) / boron species 193 or 194 = 1.2 : 1; all reactions were run for 20 h; other catalyst 
systems, e.g., Pd(dppf)Cl2, Pd2(dba)3/dppf, Pd(OAc)2/dppf, Pd2(dba)3/PCy3, were tried, but no 
coupling was observed. 
b Determination after isolation by preparative HPLC and/or by analytic HPLC.  
c Pd2(dba)3 and P(t-Bu)3 were used as catalyst and ligand. 
d DME/H2O = 10 : 1. 
The strategy to prepare the naphthol 42 described in Scheme 11 in 8.1.3 was likewise 
applied to synthesize its 6-demethoxy derivative 200 (Scheme 22). Bromination of 42 and 200 
yielded the desired monobromonaphthols 201 and 202 according to the literature.[243] 
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Scheme 22. Synthesis of the bromonaphthalenes 203–206. Reagents, conditions, and yields; i: 203, 
iPr-I, NaH, THF/DMF, rt; 204, TBDMSCl, imidazole, DMF, 60 °C; 205, MOMCl, NaH, THF/DMF, rt; 
206, MOMCl, NaH, THF/DMF, rt. 
Another problem was the choice of suitable protecting groups for 201 and 202 compatible 
with the subsequent three reactions: a) the Suzuki-Miyaura coupling reaction, b) 
transformation of the two methoxy groups at the ortho-position of 188 into a 1,2-diketone, 
and c) removal of the protecting groups. Thus, the naphthol 201 was O-derivatized with 
isopropyl (i-Pr), tert-butyldimethylsilyl (TBDMS), or methoxylmethyl (MOM) groups to give 
the corresponding O-protected naphthols 203, 204, or 205. 
Starting from the isopropyloxy[244] naphthalene 203 by using cerium (IV) ammonium 
nitrate (CAN)[245-249] in aqueous acetonitrile, the 1,2-naphthoquinone 207 was prepared in a 
quantitative yield. For cleaving the O-isopropyl group, BCl3[250-252] was used, but 
unexpectedly no reaction was observed, probably due to the strong electron-withdrawing 
effect of the two carbonyl groups. The even stronger O-dealkylating reagent BBr3, by contrast, 
led to decomposition. The oxidation reaction of the silyl ether protected[253-255] naphthol 204 
using CAN afforded the known[99] 1,4-naphthoquinone 127, instead. Treatment of the 
O-methoxymethyl-protected[241,256] intermediate 205 with CAN provided the 
1,2-naphthoquinone 208. Subsequently, the MOM group was successfully cleaved in 3% 
HCl−MeOH[256] affording the 1,2-quinone 209 (Scheme 23). 
133                          135 (99%)     
197                          198 (100%)                140 (60%) 
199 (53%) 
139 
201 (69%)                        42 (99%)                 
202 (83%)                        200 (97%)                                       
133, 135, 140, 42, 201  OMe                          
197, 198, 199, 200, 202  H 
X 
203:  OMe  i-Pr (49% from 201) 
204:  OMe  Sit-BuMe2 (94% from 201) 
205:  OMe  MOM (95% from 201) 
206:  H     MOM (80% from 202) 
X    R 
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Scheme 23. Synthesis of the naphthoquinone 209. Reagents, condition, and yields. 
With a suitable protecting group in hands, compound 202 was converted into the 
corresponding MOM ether 206. Compounds 205 and 206 were used to prepare the pinacol 
boronic esters 210 and 213, boronic acids 211 and 214, and iodides 212 and 215 according to 
known methods (Scheme 24).[234,241,242,257] The already optimized coupling conditions (entry 5, 
Table 8) were likewise applied on the coupling reactions between 210 and 206, 210 and 215, 
211 and 206, 211 and 215, 213 and 205, 213 and 212, 214 and 205, and 214 and 212. 
However, only dehalogenated and deboronated products were formed and the desired dimer 
rac-188 was not detected in any of these reactions. This may be due to the significantly 
increased electronic density of the two coupling partners as compared to that in the two 
simplified substrates in the model reaction. This assumption was also supported by the fact 
that highly oxygenated binaphthyls or biaryls with highly sterically hindered axes have never 
been prepared via Suzuki coupling reactions according to the literature investigations. 
 
 
 
 
203                              207                           209 
 
 
 
 
 
204                              127 
 
 
 
 
 
 
205                              208                           209 
210: OMe  Bpin (80% from 205) 
211: OMe  B(OH)2 (92% from 205) 
212: OMe  I (94% from 205) 
213: H     Bpin (55% from 206) 
214: H     B(OH)2 (90% from 206) 
215: H     I (92% from 206) 
X1       X2 
205: X = OMe 
206: X = H 
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Scheme 24. Synthesis of compounds 210–215. Reagents, condition, and yields; i: 210, K2CO3, 
bispinacolatodiboron, Pd(PPh3)4, DMF, 120 °C; 211, B(OMe)3, n-BuLi, THF, −78 °C; 212, I2, n-BuLi, 
THF, −78 °C; 213, K2CO3, bispinacolatodiboron, Pd(dppf)Cl2·DCM, toluene/H2O, 90 °C; 214, 
B(OMe)3, n-BuLi, THF, −78 °C; 215, I2, n-BuLi, THF, −78 °C. 
10.4  Conclusion 
The Buchwald’s ligand 196 in combination with Pd2(dba)3 was proven to be a powerful 
catalyst system. Specifically, the coupling reaction conditions demonstrated an unprecedented 
activity and succeeded in the binaphthyls with extremely highly hindered axes (four ortho 
substituents) by a coupling reaction between the naphthyl bromide 191 and the naphthyl 
boron derivatives 193 or 194. By contrast, it failed between the two still highly hindered, but 
electron-rich, coupling partners in the synthesis of rac-188, which could be due to the highly 
oxygenated (OMe/OMOM) coupling partners. Therefore, a more powerful catalyst system or 
an alternative synthetic strategy e.g., a “lactone concept” had to be explored for the total 
synthesis of rac-187.
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11  Cyclodysidins A−D, Cyclic Lipopeptides from the Streptomyces Strain 
RV15 Derived from a Marine Sponge 
11.1  Cyclic Peptides from Streptomyces Strain 
Bacteria-derived metabolites exhibit a wide variety of bioactivities, including anti-infective, 
anti-inflammatory, and anticancer activities and include structurally highly diverse natural 
products, among them polyketides, alkaloids, fatty acids, terpenes, and peptides.[17,258-260] 
Cyclic lipopeptides were previously isolated from different bacterial genera like e.g., 
Streptomyces, Mycobacterium, Pseudomonas, and Bacillus[261-264] and found to show 
antimicrobial and anticancer acitivities.[265-267] Prof. U. Hentschel’s group further reported the 
phylogenetic identification of a Streptomyces strain RV15 associated with the sponge Dysidea 
tupha.[268] Here, the isolation and full structural elucidation of four new cyclic lipopeptides 
216−219 (Figure 40) from this marine strain is described. This work was jointly done in 
cooperation with Dr. U. Abdelmohsen.[269] 
 
Figure 40. Structures of four new compounds 216−219. 
11.2  Results and Discussion 
Cyclodysidin A showed a molecular formula of C45H71N11O15 by HR-ESIMS analysis (m/z 
1006.5207 for [M+1]+), with 16 degrees of unsaturation. The presence of several doublets and 
doublets of doublets at 4−5 ppm, attributed to α-protons of amino acids, and the characteristic 
chemical shifts for the amide carbonyls at 170−180 ppm suggest the peptidic nature of the 
molecule. In agreement with the possible occurrence of amide functionalities, the IR spectrum 
cylcodysidin A (216): 
cylcodysidin B (217): 
cylcodysidin C (218): 
cylcodysidin D (219): 
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showed bands at 3345 and 1638 cm−1. The compounds turned purple with ninhydrin reagent 
only upon hydrolysis with 6 M HCl, which gave a first hint at a cyclic structure.  
The 13C NMR spectrum displayed 11 ester/amide-type carbonyls (δ 172.4, 172.9, 173.0, 
173.7, 174.1, 174.3, 174.4, 174.5, 174.9, 175.1, and 176.6), seven α-methine carbons (δ 52.3, 
52.4, 55.6, 56.9, 57.2, 57.4, and 60.0), two primary carbinols (δ 62.3 and 62.4), a secondary 
carbinol (δ 67.3), aromatic signals for a di-substituted phenyl ring (131.3, 129.0, 157.3, and 
116.4), and distinct signals at δ 23.6, 30.1−30.4, 35.7, and 14.4, which is consistent with a 
terminal hydrocarbon side chain supporting the presence of a lipopeptide metabolite. Analysis 
of the COSY, HSQC, ROESY, and HMBC data assigned seven partial structures (Table 8): 
two asparagine (Asn) units, one glutamine (Gln), two serine (Ser), one tyrosine (Tyr), and one 
threonine (Thr) moiety. 
The COSY, HSQC, and HMBC experiments also correlated with a deshielded methylene 
(H-2, δ 2.43) and a deshielded methane signal (H-3, δ 4.13), contiguous methylene resonances 
(H4-5 to H11-12, δ 1.25−1.31, brs), and a terminal methyl signal (H-13, δ 0.88), delineating 
an amino fatty acid residue (β-AFA), which accounted for the presence of a 
β-aminotridecanoic acid fragment. HMBC correlations from each α-proton (β-proton in the 
case of β-aminotridecanoic acid) to the carbonyl carbon of the neighboring amino acid and to 
its own carbonyl carbon were detected. Since only 15 of the calculated 16 degrees of 
unsaturation accounted for the functionalities in the eight individual fragments, it became 
obvious that cyclodysidin A had a cyclic structure (Figure 41). 
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Table 9. NMR-spectroscopic data of cyclodysidin A (216) in methanol-d4 (1H: 600 MHz; 13C: 150 
MHz) 
AA δC δH, mult COSY (J in Hz) HMBC ROESY 
Asn1      
CO 173.7     
α 52.4 4.65, dd  β (7.5, 6.4) CO, β, γ, Tyr-CO Tyr-β 
β 37.1 2.76/2.72, m α CO, α, γ  
γ 174.9     
Asn2      
CO 174.3     
α 52.3 4.51, dd  β (7.9, 5.7) CO, β, γ, Gln-CO  
β 37.4 2.52/2.44, m α CO, α, γ Gln-α 
γ 175.1     
Gln      
CO 174.1     
α 55.6 4.19, dd  β (8.3, 5.8) CO, β, γ, 
 
Asn2-β 
β 27.1 2.17/2.10, m α, γ  CO, α, γ, δ   
γ 32.9 2.47, m β α, β, δ  
δ 176.6     
Ser1      
CO 172.9     
α 57.4 4.37, t  β (5.6) CO, β, Asn1-CO Asn1-β 
β 62.4 3.84, m α CO, α Thr-β 
Ser2      
CO 173.0     
α 57.2 4.31, t  Β (5.3) CO, β, 
 
β-AFA-2 
β 62.3 3.92, m α CO, α  
Thr      
CO 172.4     
α 60.0 4.28, d  β (2.6) CO, β, γ, 
 
 
β 67.3 4.40, m α, γ CO, α, γ Ser1-β 
γ 20.4 1.16, d  β (6.5) α, β  
Tyr      
CO 174.4     
α 56.9 4.46, dd  β (9.2, 4.8) CO, β, Asn2-CO, 
 
 
β 36.4 3.14/2.85, 
  
α (14.2,4.7) CO, α, 1, 2, 6 Asn1-α 
Bz-I 129.0     
Bz-o 131.3 7.06, d  Bz-m (8.5) Bz-I, Bz-m, Bz-p  
Bz-m 116.4 6.71, d  Bz-o (8.4) Bz-I, Bz-o, Bz-p  
Bz-p 157.3     
β-AFA      
CO 174.5     
2 42.1 2.43, m 3 CO, 3, 4 Ser2-α 
3 48.8 4.14, m 2, 4 CO, 2, 4, Thr-CO  
4 35.7 1.5, m 3, 5-12 2, 3  
5-12 23.6-33.1 1.25-1.31, 
 
4, 13 4, 13  
13 14.4 0.88, t  5-12 (7.1) 5-12  
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Figure 41. Selected HMBC (red single arrows) and ROESY (blue double arrows) interactions 
indicative of the constitution of cyclodysidin A (216). 
By using CID (collision-induced dissociation) MS/MS, sequence information was derived 
from the mass differences between the b-series ions[270] and between the y-series ions[270] 
(Table 10). 
The sequential arrangement of amino acids was accomplished by interpretation of HMBC 
and ROESY data as well as fragmentation by CID-MS/MS. The structure of cyclodysidin A 
(216) was thus established as cyclo-(ß-AFA-Ser-Gln-Asn-Tyr-Asn-Ser-Thr). 
In addition, three related compounds were isolated by reversed-phase HPLC, showing very 
similar chromatographic and spectroscopic properties, subsequently named cyclodysidins B 
(217), C (218), and D (219). By HR-ESIMS (TOF) analysis, compound 217 was found to 
possess a molecular formula of C46H73N11O15, metabolite 218 of C47H75N11O15, and peptide 
219 of C49H79N11O15, i.e., each with 16 degrees of unsaturation. Thus, 217−219 were 
apparently higher homologs of 216, differing from 216 by the presence of one or more 
additional CH2 groups. In the NMR spectra the only differences between these four new 
metabolites were in the aliphatic part (δ 1.25−1.28 ppm), i.e., in the signals corresponding to 
hydrocarbon part of the β-amino fatty acid, which, despite a large signal overlap, suggested 
the same composition in the β-amino acid parts. The UV spectra of all compounds were 
nearly identical, indicating the same array of chromophores. By CID-MS/MS experiments, 
the connectivities of the amino acids, as qualitatively determined by NMR (see above), were 
established to be cyclo-(ß-AFA-Ser-Gln-Asn-Tyr-Asn-Ser-Thr) for all these new cyclic 
peptides (Figure 40). These compounds had not previously been isolated from other sources. 
 
216 
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Table 10. Annotated MS fragments for cyclodysidin A (216)  
Experimental 
(Da) 
Predicted 
(Da) Fragmentation 
Sequence 
after first cleavage 
Fragment 
after second 
cleavage 
478.18 478.18 b/b4-1 NYNSTxSQ NYNS 
505.32 505.32 b/y4 QNYNSTxS QNYN 
583.23 583.24 b/z5+1 xSQNYNST NYNST 
642.39 642.38 b/y5-H2O YNSTxSQN TxSQN 
787.42 787.43 b/b6-H2O TxSQNYNS TxSQNY 
833.49 833.48 b6 TxSQNYNS TxSQNY 
849.53 849.46 b/a7-1 NYNSTxSQ NYNSTxS 
878.47 878.46 b/y7-H2O QNYNSTxS NYNSTxS 
897.52 897.49 b/c7+2 NYNSTxSQ NYNSTxS 
919.52 919.49 b/y7-H2O STxSQNYN TxSQNYN 
989.54 989.52 M-H2O+1   
1006.46 1006.52 M   
 
Except for the establishment of the constitution of the new metabolites 216−219, the 
determination of absolute configurations of the constituting α- and ß- amino acids was 
achieved by the collaboration partners.[269] 
11.3  Conclusion 
In conclusion, cyclodysidins A−D (216−219), four new cyclic lipopeptides with α- and 
ß-amino acids, were isolated from the marine sponge-derived Streptomyces strain RV15. Their 
structures were established as cyclo-(ß-AFA-Ser-Gln-Asn-Tyr-Asn-Ser-Thr) by spectroscopic 
analysis using 2D NMR techniques and CID-MS/MS.
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12  Summary 
Plant-derived natural products and their analogs continue to play an important role in the 
discovery of new drugs for the treatment of human diseases. Potentially promising 
representatives of secondary metabolites are the naphthylisoquinoline alkaloids, which show a 
broad range of activities against protozoan pathogens, such as plasmodia, leishmania, and 
trypanosoma. Due to the increasing resistance of those pathogens against current therapies, 
highly potent novel agents are still urgently needed. Thus, it is worthy to discover new 
naphthylisoquinoline alkaloids hopefully with pronounced bioactivities by isolation from 
plants or by synthesis. 
The naphthylisoquinoline alkaloids are biosynthetically related to another class of 
plant-derived products, the naphthoquinones, some of which have been recently found to 
display excellent anti-multiple myeloma activities without showing any cytotoxicities on 
normal blood cells. Multiple myeloma still remains incurable, although remissions may be 
induced with co-opted therapeutic treatments. Therefore, more potent naphthoquinones are 
urgently required, and can be obtained by isolation from plants or by synthesis. 
In detail, the results in this thesis are listed as follows: 
1) Isolation and characterization of naphthylisoquinoline alkaloids from the stems of a 
Chinese Ancistrocladus tectorius species. 
 Nine new naphthylisoquinoline alkaloids, named ancistectorine A1 (60), 
N-methylancistectorine A1 (61), ancistectorine A2 (62a), 5-epi-ancistectorine A2 (62b), 
4'-O-demethylancistectorine A2 (63), ancistectorine A3 (64), ancistectorine B1 (65), 
ancistectorine C1 (66), and 5-epi-ancistrolikokine D (67) were isolated from the Chinese 
A. tectorius and fully characterized by chemical, spectroscopic, and chiroptical methods. 
Furthermore, the in vitro anti-infectious activities of 60−62 and 63−66 have been tested. 
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 Three of the metabolites, 61, 62a, and 62b, exhibited strong antiplasmodial activities 
against the strain K1 of P. falciparum without showing significant cytotoxicities. With 
IC50 values of 0.08, 0.07, and 0.03 μM, respectively, they were 3−7 times more active 
than the standard chloroquine (IC50 = 0.26 μM). Moreover, these three compounds 
displayed high antiplasmodial selectivity indexes ranging from 100 to 3300. According to 
the TDR/WHO guidelines, they could be considered as lead compounds. 
 In addition, seven alkaloids, 69−74 (structures not shown here), were isolated from A. 
tectorius that were known, but new to the plant, together with another fourteen known 
compounds (of these, only the structures of the three main alkaloids, 5a, 5b, and 78 are 
shown here), which had been previously found in the plant. The three metabolites 
ancistrocladine (5a), hamatine (5b), and (+)-ancistrocline (78) were found to show no or 
moderate activities against the MM cell lines. 
 
2) Isolation and characterization of naphthylisoquinoline alkaloids from the root bark of a 
new, botanically yet undescribed Congolese Ancistrocladus species. 
 An unprecedented dimeric Dioncophyllaceae-type naphthylisoquinoline alkaloid, 
60: R = H                                   62b                   64  
61: R = Me 
65                            66                            67   
5a                  5b                       78   
62a: R = Me 
63: R = H 
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jozimine A2 (84), as first recognized by G. Bauckmann from an as yet undescribed 
Ancistrocladus species, was purified and characterized as part of this thesis. Its full 
structural assignment was achieved by spectroscopic and chiroptical methods, and further 
confirmed by an X-ray diffraction analysis, which had never succeeded for any other 
dimeric naphthylisoquinoline alkaloids before. Structurally, the dimer is composed of two 
identical 4'-O-demethyldioncophylline A halves, coupled through a sterically hindered 
central axis at C-3',3'' of the two naphthalene moieties. Pharmacologically, jozimine A2 
(84) showed an extraordinary antiplasmodial activity (IC50 = 1.4 nM) against the strain 
NF54 of P. falciparum. 
 Beside jozimine A2 (85), another new alkaloid, 6-O-demethylancistrobrevine C (84), and 
four known ones, ancistrocladine (5a), hamatine (5b), ancistrobrevine C (86), and 
dioncophylline A (6) were isolated from the Ancistrocladus species, the latter in a large 
quantity (~500 mg), showing that the plant produces Ancistrocladaceae-type, 
mixed-Ancistrocladaceae/Dioncophyllaceae-type, and Dioncophyllaceae-type naphthyl- 
isoquinoline alkaloids. Remarkably, it is one of the very few plants, like A. abbreviatus, 
and A. barteri, that simultaneously contain typical representatives of all the above three 
classes of alkaloids. 
 
3) Semi-synthesis of jozimine A2 (85), 3'-epi-85, jozimine A3 (93) and other alkaloids from 
dioncophylline A (6). 
 The dimeric naphthylisoquinoline alkaloids, jozimine A2 (85) and 3'-epi-85, constitute 
rewarding synthetic targets for a comparative analysis of their antiplasmodial activities 
and for a further confirmation of the assigned absolute configurations of the isolated 
84 
 
 
 
 
 
86 
 
 
 
 
 
6 
   
85 
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natural product of 85. They were semi-synthesized in a four-step reaction sequence from 
dioncophylline A (6) in cooperation with T. Büttner. The key step was a biomimetic 
phenol-oxidative dimerization at C-3' of the N,O-dibenzylated derivative of 89 by utilizing 
Pb(OAc)4. This is the first time that the synthesis of such an extremely sterically hindered 
(four ortho-substituents) naphthylisoquinoline alkaloid – with three consecutive biaryl 
axes! – has been successfully achieved. 
  
6                              89 (49%)                90 (49%) 
91 and 3'-epi-91 (30%) (1:1)        85 (41%)             3'-epi-85 (44%) 
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 A novel dimeric naphthylisoquinoline, jozimine A3 (93), bearing a 6',6''-central biaryl 
axis, was semi-synthesized from 5'-O-demethyldioncophylline A (90) by a similar 
biomimetic phenol-oxidative coupling reaction as a key step, by employing Ag2O. 
 
 HPLC analysis with synthetic reference material of 3'-epi-85 and 93 for co-elution 
revealed that these two alkaloids clearly are not present in the crude extract of the 
Ancistrocladus species from which jozimine A2 (85) was isolated. This evidences that 
jozimine A2 (85) is very specifically biosynthesized by the plant with a high regio- and 
stereoslectivity. 
 Remarkably, the two synthetic novel dimeric naphthylisoquinoline alkaloids 3'-epi-85 and 
93 were found to display very good antiplasmodial activities, albeit weaker than that of 
the natural and semi-synthetic product 85. Additionally, the two compounds 3′-epi-85 and 
93 possessed high or moderate selectivity indexes, which were much lower than that of 85. 
However, they can still be considered as new lead structures. 
 Two unprecedented oxidative products of dioncophylline A, the diastereomeric 
dioncotetralones A (94a) and B (94b), were synthesized from dioncophylline A (6) in a 
one-step reaction. Remarkably, the aromatic properties in the “naphthalene” and the 
“isoquinoline” rings of 94a and 94b are partially lost and the “biaryl” axis has become a 
C,C-double bond, so that the two halves are nearly co-planar to each other, which has 
never been found among any natural or synthetic naphthylisoquinoline alkaloid. Their 
90 
92 
93 (27%) 
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full structural characterization was accomplished by spectroscopic methods and 
quantum-chemical CD calculations (done by Y. Hemberger). The presumed reaction 
mechanism was proposed in this thesis. In addition, one of the two compounds, 94a, 
exhibited a highly antiplasmodial activity (IC50 = 0.09 μM) with low cytotoxicity, and 
thus, can be considered as a new promising lead structure. Its 2'-epi-isomer, 94b, was 
inactive, evidencing a significant effect of chirality on the bioactivity. 
 
 Of a number of naphthylisoquinoline alkaloids tested against the multiple-myeloma cell 
lines, the three compounds, dioncophylline A (6), 4'-O-demethyldioncophylline A (89), 
and 5'-O-demethyldioncophylline A (90) showed excellent activities, even much stronger 
than dioncoquinones B (10), C (102), the epoxide 175, or the standard drug melphalan. 
4) Isolation and characterization of bioactive naphthoquinones from cell cultures of 
Triphyophyllum peltatum. 
 Three new naphthoquinones, dioncoquinones C (102), D (103), and E (104), the known 
8-hydroxydroserone (105), which is new to this plant, and one new naphthol dimer, 
triphoquinol A (107), were isolated from cell cultures of T. peltatum in cooperation with 
A. Irmer. Dioncoquinone C (102) showed an excellent activity against the MM cells, very 
similar to that of the previously found dioncoquinone B (10), without showing any 
inhibitory effect on normal cells. The other three naphthoquinones, 103−105, were 
inactive or only weakly active. 
 
 
5) Establishment of a new strategy for a synthetic access to dioncoquinones B (10) and C 
(102) on a large scale for in vivo experiments and for the synthesis of their analogs for 
first SAR studies. 
6                                 94a                    94b 
102: R = H              104               105               107 
103: R = Me                     
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 Before the synthesis of dioncoquinone B (10) described in this thesis, two synthetic 
pathways had previously been established in our group. The third approach described 
here involved the preparation of the joint synthetic intermediate 42 with the previous two 
routes. The tertiary benzamide 135 was ortho-deprotonated by using s-BuLi/TMEDA, 
followed by transmetallation with MgBr2▪2Et2O, and reaction with 2-methylallyl 
bromide (139). It resulted in the formation of ortho-allyl benzamide 140, which was 
cyclized by using methyl lithium to afford the naphthol 42. This strategy proved to be the 
best among the established three approaches with regard to its very low number of steps 
and high yields. By starting with 136, this third strategy yielded the related bioactive 
natural product, dioncoquinone C (102), which was accessed by total synthesis for the 
first time. 
 
 
 To identify the pharmacophore of the antitumoral naphthoquinones, a library of 
dioncoquinone B (10) and C (102) analogs were synthesized for in vitro testing. Among 
the numerous naphthoquinones tested, the synthetic 7-O-demethyldioncoquinone C (or 
7-O-hydroxyldioncoquinone B) (145), constitutes another promising basic structure to 
develop a new anti-MM agent. Furthermore, preliminary SAR results evidence that the 
three hydroxy functions at C-3, C-5, and C-6 are essential for the biological properties as 
exemplarily shown through the compounds 10, 102, and 145. All other mixed OH/OMe- 
or completely OMe-substituted structures were entirely inactive. 
 
 By a serendipity the expoxide 175 was found to display the best anti-MM activity of all 
the tested isolated metabolites from T. peltatum, the synthesized naphthoquinones, and 
their synthetic intermediates. Toxic effects of 175 on normal cells were not observed, in 
contrast to the high toxicities of all other epoxides. Thus, the anti-MM activity of 175 is 
140 (60%), 141 (45%)                  
135, 136                                                  42 (60%), 131 (80%)  139 
42, 135, 140   H 
131, 136, 141  OMe 
 
X 
10                         102                          145 
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of high selectivity. The preliminary SAR studies revealed that the 6-OMe group in 175 is 
required, thus differed with the above described naphthoquinones (where 6-OH is a 
requisite in 10, 102, and 145), which evidenced potentially different modes of action for 
these two classes of compounds. 
 
6) The first attempted total synthesis of the new naturally occurring triphoquinone (187a), 
which was recently isolated from the root cultures of T. peltatum in our group. 
 A novel naphthoquinone-naphthalene dimer, 187a (structure shown in Chapter 10), was 
isolated in small quantities from the root cultures of T. peltatum. Thus, its total synthesis 
was attempted for obtaining sufficient amounts for selected biotestings. The key step was 
planned to prepare the extremely sterically hindered (four ortho-substituents) 
binaphthalene 188 by a coupling reaction between the two 2-methylnaphthalene 
derivatives. Test reactions involving a system of two simplified 2-methylnaphthylboron 
species and 2-methylnaphthyl bromide proved the Buchwald ligand as most promising. 
The optimized conditions were then applied to the two true - highly oxygenated - 
coupling substrates, between the 2-methylnaphthylboron derivatives 210, 211, 213, or 
214 and the 2-methylnaphthyl iodides (or bromides) 215 (206), 215 (206), 212 (205), or 
212 (205), respectively. Unfortunately, this crucial step failed although various bases and 
solvent systems were tested. This could be due to the high electron density of the two 
coupling substrates, both bearing strongly OMOM/OMe-donating function groups. 
Therefore, a more powerful catalyst system or an alternative synthetic strategy must be 
explored for the total synthesis of 187a. 
175 
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7) Phytochemical investigation of the Streptomyces strain RV-15 derived from a marine 
sponge. 
 Cyclodysidins A−D (216−219), four new cyclic lipopeptides with α- and ß-amino acids, 
were isolated from the Streptomyces strain RV15 derived from a marine sponge by Dr. U. 
Abdelmohsen. Their structures were established as cyclo-(ß-AFA-Ser-Gln-Asn-Tyr-Asn- 
Ser-Thr) by spectroscopic analysis using 2D NMR techniques and CID-MS/MS in the 
course of this thesis. 
 
     In conclusion, the present work contributes to the discovery of novel antiplasmodial 
naphthylisoquinoline alkaloids and antitumoral naphthoquinones, which will pave the way 
for future studies on these two classes of compounds. 
 
210: OMe  Bpin (80% from 205) 
211: OMe  B(OH)2 (92% from 205) 
212: OMe  I (94% from 205) 
213: H     Bpin (55% from 206) 
214: H     B(OH)2 (90% from 206) 
215: H     I (92% from 206) 
 
X1       X2 
cylcodysidin A (216): 
cylcodysidin B (217): 
cylcodysidin C (218): 
cylcodysidin D (219): 
205: X = OMe 
205: X = H 
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13  Zusammenfassung 
Naturstoffe pflanzlichen Ursprungs und deren Derivate waren seit jeher eine wichtige 
Quelle für die Entdeckung neuer Arzneistoffe. Darunter stellen die 
Naphthylisochinolin-Alkaloide eine besonders bedeutsame Klasse an Sekundärmetaboliten 
dar, die gegen eine breite Vielfalt an pathogenen Protozoen, wie z.B. Plasmodien, 
Leishmanien und Trypanosomen, aktiv sind. Die zunehmende Resistenz dieser 
Krankheitserreger gegen vorhandene Therapeutika macht die Erschließung neuer 
hochwirksamer Substanzen – durch direkte Isolierung aus Pflanzenmaterial oder chemische 
Synthese – zu einer lohnenswerten Aufgabe. 
Kürzlich wurde entdeckt, dass Naphthochinone, eine biosynthetisch eng mit den 
Naphthylisochinolin-Alkaloiden verwandte Naturstoffklasse, exzellente Aktivitäten gegen das 
Multiple Myelom aufweist. Diese Krebserkrankung ist mit gegenwärtigen Arzneimitteln nicht 
heilbar, wenngleich unterstützende Therapeutika zu einer Remission führen können. Die 
Suche nach pharmakologisch wirksamen Naphthochinonen, mittels Isolierung aus Pflanzen 
oder durch chemische Synthese, ist daher dringend geboten. 
Die Ergebnisse dieser Arbeit umfassen im Detail die folgenden Teilbereiche: 
1) Isolierung diverser Naphthylisochinolin-Alkaloide aus dem Stamm der chinesischen 
Ancistrocladus tectorius Spezies. 
 Es Wurch neun neue Naphthylisochinlin-Alkaloide aus der in China beheimateten 
Pflanze A. tectorius. Diese umfassten die sechs 5,1'-gekuppelten Verbindungen 
Ancistectorin A1 (60), N-Methylancistectorin A1 (61), Ancistectorin A2 (62a), 
5-epi-Ancistectorin A2 (62b), 4'-O-Demethylancistectorin A2 (63), Ancistectorin A3 (64), 
das 7,1'-gekuppelte Ancistectorin B1 (65), das 7,8'-verknüpfte Ancistectorin C1 (66), 
sowie das 5,8'-verknüpfte 5-epi-Ancistrolikokin D (65) die allesamt vollständig 
charakterisiert und auf ihre antiplasmodiale Aktivität untersucht wurden. 
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 Drei dieser Metabolite, 61, 62a, und 62b, zeigten eine starke antiplasmodiale Aktivität 
gegen den Stamm K1 von P. falciparum und dennoch keine signifikante Cytotoxizität. 
Mit IC50-Werten von 0.08, 0.07 und 0.03 μM waren sie 3−7 mal aktiver als der Standard 
Chloroquin (IC50 = 0.26 μM). Darüber hinaus verfügten diese drei Verbindungen über 
einen hohen antiplasmodialen Index von 100 bis 300. Laut WHO-Richtlinien können 
diese erfolgversprechenden Antimalaria-Wirkstoffe als neue Leitstrukturen angesehen 
werden. 
 Des Weiteren wurden sieben bekannte Alkaloide, 69−74 (nicht abgebildet), erstmals aus A. 
tectorius isoliert. 14 weitere, aus dieser Pflanze bereits bekannte, Verbindungen (z.B. 5a, 
5b, und 78) wurden ebenfalls gefunden. Die drei Hauptalkaloide Ancistrocladin (5a), 
Hamatin (5b) und (+)-Ancistroclin (78) hatten jedoch keine bzw. nur mäßige Aktivitäten 
gegen MM-Zelllinien.  
 
2) Isolierung der Naphthylisochinolin-Alkaloide aus der Stammrinde einer neuen und 
botanisch noch unbeschriebenen, kongolesichen Ancistrocladus Spezies. 
 Ein beispielloses dimeres Naphthylisochinolin-Alkaloid aus der Klasse der 
60: R = H                                   62b                   64  
61: R = Me 
65                            66                          67 
5a                  5b                       78   
62a: R = Me 
63: R = H 
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Dioncophyllaceae, Jozimin A2 (85), wurde aus einer bis dahin noch nicht beschriebenen 
Ancistrocladus Spezies in Zusammenarbeit mit G. Bauckmann isoliert. Mithilfe von 
spektroskopischen und chiroptischen Methoden erfolgte die vollständige 
Strukturaufklärung. Zum ersten Mal bei einem dimeren Naphthylisochinolin-Alkaloid 
wurde darüber hinaus dessen Struktur mittels Röntgenstrukturanalyse verifiziert. Die 
Struktur weist zwei identische miteinander verknüpfte 4'-O-Demethyldioncophyllin A 
Hälften auf, die in den Naphthalin-Einheiten an C-3' und C-3'' sterisch so stark gehindert 
sind, dass eine dritte rotationsstabile – und daher chirale – Achse vorliegt. Jozimin A2 (85) 
ragt pharmakologisch betrachtet durch die beste bis dahin gemessene antiplasmodiale 
Aktivität (IC50 = 1.4 nM, P. falciparum NF54) aller natürlichen monomeren und dimeren 
Naphthylisochinoline heraus. 
 Neben Jozimin A2 (85) wurde ein weiteres neues Alkaloid, 6-O-Demethylancistrobrevin 
C (84), und die vier bekannten Monomere Ancistrocladin (5a), Hamatin (5b), 
Dioncophyllin A (6), und Ancistrobrevin C (86) aus dieser Ancistrocladus Spezies isoliert. 
Man konnte zeigen, dass die Pflanze Naphthylisochinolin-Alkaloide vom 
Ancistrocladaceae Typ, vom gemischten Ancistrocladaceae/Dioncophyllaceae Typ und 
vom Dioncophyllaceae Typ produziert. Dies ist umso bemerkenswerter, als dass nur 
wenige Pflanzen wie A. abbreviatus und A. barteri bekannt sind, die typische Vertreter 
aller drei Alkaloid-Klassen beinhalten.  
 
3) Semi-Synthese des dimeren Naphthylisochinolin-Alkaloids Jozimine A2 (85) und seiner 
Derivate. 
85 
84 
 
 
 
 
 
86 
 
 
 
 
 
6 
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 Aufgrund seiner exzellenten antiplasmodialen Aktivität stellte das 
Naphthylisochinolin-Alkaloid Jozimin A2 (85), eine lohneswerte Zielstruktur für eine 
Synthese dar. Die Verbindung wurde durch Semisynthese in vier Stufen aus 
Dioncophyllin A (6) in Zusammenarbeit mit T. Büttner erschlossen. Als Schlüsselschritt 
erwies sich die biomimetische, oxidative Kupplung von 89 an C-3’ unter Verwendung 
von Pb(OAc)4. Der Aufbau einer solch sterisch gehinderten, zentralen Achse mit vier 
ortho-Substituenten wurde zum ersten Mal an Naphthylisochinolin-Alkaloiden erfolgreich 
durchgeführt. Zusammen mit Jozimin A2 (85) erhielt man sein 3',3''-Atropisomer 
3′-epi-85.  
 
 Parallel dazu wurde Jozimine A3 (93) dargestellt, dessen 6',6''-Zentral-Achse ebenfalls 
ausgehend von Dioncophyllin A (6) in einer Schlüsselsequenz mittels Ag2O aufgebaut 
wurde. 
 HPLC-Coelutionsexperimente der synthetisch erhaltenen Verbindungen 3'-epi-85 und 93 
zeigten zweifelsfrei, dass die beiden Alkaloide nicht im Rohextrakt der bisher 
unbestimmten Ancistrocladus-Art, aus welcher Jozimin A2 (85) isoliert wurde, vorhanden 
waren. Die Biosynthese von 85 erfolgt in der Pflanze offensichtlich mit hoher Spezifität. 
6                              89 (49%)                 90 (49%) 
91 and 3'-epi-91 (30%) (1:1)          85 (41%)  3'-epi-85 (44%) 
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 Die neuen synthetisch hergestellten, dimeren Naphthylisochinolin-Alkaloide 3'-epi-85 und 
93 zeigten sehr gute, wenn auch im Vergleich zum natürlichen und semi-synthetisch 
erhaltenen 85 schwächere, antiplasmodiale Aktivitäten. Desweiteren besitzen die beiden 
Verbindungen 3′-epi-85 und 93 hohe bzw. moderate Selektivitäts-Indices, welche 
allerdings weit unter dem Wert von 85 liegen. Nichtsdestotrotz können sie als neue 
Leitstrukturen betrachtet werden. 
 Im Verlauf der Synthese von Jozimin A2-Derivaten wurden des weiteren die zwei 
unbekannten Diastereoisomere, Dioncophynon A (94a) and B (94b), synthetisiert. Man 
erhielt diese in einer Stufe aus Dioncophyllin A (6). Die Strukturen von 94a und 94b 
zeichneten sich durch einen partiellen Verlust der Aromatizität am Naphthalin-Ring und 
eine C,C-Doppelbindung an der früheren Biarylachse aus. Die gefundenen Strukturmotive 
waren bis dahin weder von natürlichen noch von synthetischen Naphthylisochinolinen 
bekannt. Die vollständige Charakterisierung gelang durch spektroskopische Methoden 
und quantenchemische CD-Berechnungen (Y. Hemberger). Ein möglicher Mechanismus 
zur Bildung dieser Moleküle wurde ebenfalls in dieser Arbeit vorgestellt. Darüber hinaus 
zeigte eine dieser Verbindungen, 94a, eine hohe antiplasmodiale Aktivität (IC50 = 0.09 μM) 
bei gleichzeitig nur geringer Toxizität und konnte daher als vielversprechende Leitstruktur 
betrachtet werden. Dagegen war 94b inaktiv, was den signifikanten Effekt stereogener 
Elemente auf die Bioaktivität unterstrich. 
90 
92 
93 (27%) 
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 Aus einer ganzen Reihe von Naphthylisochinolin-Alkaloiden, die bzgl. ihrer Aktivität 
gegen das Multiple Myelom getestet wurden, zeigten v.a. drei Verbindungen, nämlich 
Dioncophyllin A (6), 4'-O-Demethyldioncophyllin A (89) und 5'-O-Demethyldioncophyllin 
A (90), exzellente Wirksamkeiten und übertrafen dabei sogar die Dioncochinone B (10) 
und C (102), das Epoxid 175 und die Referenzsubstanz Melphalan. 
4) Isolierung der bioaktiven Naphthochinone  aus Zellkulturen von Triphyophyllum 
peltatum. 
 Drei neue Dioncochinone C (102), D (103) und E (104), das für diese Pflanze noch 
unbekannte 8-Hydroxydroseron (105) und ein neues Naphthalin-Dimer 107 wurden aus 
Zellkulturen von T. peltatum in Kooperation mit A. Irmer isoliert. Dioncochinon C (102) 
wies eine ausgezeichnete Aktivität gegen MM-Zellen, ähnlich zu der von Dioncochinon 
B, auf, wobei jedoch kein inhibierender Effekt auf normale Zellen beobachtet wurde. Die 
anderen drei Naphthochinone 103−105 waren inaktiv oder nur sehr schwach aktiv 
gegenüber MM-Zellen.  
 
 
5) Etablierung neuer Strategien für einen Zugang zu den Dioncochinonen B und C im 
großen Maßstab für In-vivo-Biotests sowie Synthese von Dioncochinon B-Analoga für 
SAR-Untersuchungen. 
 Vor Beginn dieser Arbeiten zur Synthese von Dioncochinon B (10) existierten bereits 
zwei, in unserem Arbeitskreis erschlossene, Synthesewege. Die hier beschriebene dritte 
Möglichkeit zur Darstellung von Dioncochinon B (10) etablierte einen neuen Zugang zu 
dem gemeinsamen Intermediat 42. Man ortho-deprotonierte zunächst das tertiäre Amid 
135 mit sec-BuLi/TMEDA, führte anschließend eine Transmetallierung mit 
102: R = H              104               105              107 
103: R = Me                     
6                                 94a                     94b 
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MgBr2▪2Et2O durch und setzte das Intermediat mit 2-Methylallylbromid (139) zum 
ortho-Allylbenzamid 140 um, welches schließlich mit Methyllithium zum Naphthol 42 
zyklisiert wurde. Diese Strategie war den beiden früheren Ansätzen hinsichtlich der 
hohen Ausbeute und der geringen Anzahl an Synthesestufen überlegen. Darauf aufbauend 
gelang die erste Totalsynthese des bioaktiven Naturstoffes Dioncochinon C (102). 
 
 
 Zur Untersuchung der Struktur-Wirkungs-Beziehung und zur Identifizierung des 
Pharmakophors der antitumoralen Naphthochinone wurden ca. 30 Analoga von 
Dioncochinon B (10) und C (102) synthetisiert und auf ihre Anti-MM-Wirkung getestet. 
Unter den zahlreichen dabei untersuchten Derivaten stellte die synthetische Verbindung 
7-O-Demethyldioncochinon C (oder 7-O-Hydroxyldioncochinon B) (145) eine weitere 
vielversprechende Leitstruktur für die Entwicklung neuer Anti-MM-Kandidaten dar. Als 
besonders bemerkenswert erwiesen sich die antitumoralen Eigenschaften der 
Verbindungen 10, 102, und 145. Diese besitzen drei Hydroxygruppen an C-3, C-5 und 
C-6, die für Ihre biologischen Eigenschaften essentiell zu sein scheinen, da alle anderen 
Strukturen mit einem gemischten OH/OMe-Muster und jene vollständig 
OMe-substituierten Verbindungen inaktiv waren.. 
 
 Das Expoxid 175, zeigte unter allen natürlich vorkommenden als auch synthetischen 
Naphthochinonen und deren Derivaten die beste Aktivität gegen das Multiple Myelom. 
Gleichzeitig wurde keine Toxizität gegenüber normalen Zellen festgestellt. Dies stand im 
Gegensatz zu anderen Epoxiden, die über recht hohe Toxizitäten verfügten, wenngleich 
bei sehr guten Anti-MM-Aktivitäten. Umso bemerkenswerter ist die hohe Selektivität von 
175 gegenüber Multiple-Myelom-Zellen. Einleitende SAR Studien zu 175 zeigten, dass 
die O-Me-Gruppe unbedingt erforderlich ist. Dies lässt auf einen von den 
140 (60%), 141 (45%)                  
135, 136                                                  42 (60%), 131 (80%)  139 
42, 135, 140   H 
131, 136, 141  OMe 
 
X 
10                          102                          145 
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Naphthochinonen 10, 102 und 145 verschiedenen Wirkmechanismus schließen, da die 
drei genannten Verbindungen an C-6 eine OH-Funktionalität tragen. 
 
6) Die erste Totalsynthese eines neuen natürlichen Dimers aus T. peltatum, bestehend aus 
einer Naphthalin- und einer 1,2-Naphthochinon-Einheit. 
 Man isolierte nur in Spuren ein neuartiges Naphthochinon-Naphthalin-Dimer 187a aus 
Wurzelkulturen von T. peltatum. Die Totalsynthese von 187a sollte deshalb ausreichende 
Mengen für ausgewählte Biotests verfügbar machen. Den Schlüsselschritt stellte die 
Kupplung von zwei sterisch sehr stark gehinderten 2-Methylnaphthalin-Ringen mit 
jeweils zwei ortho-Substituenten dar. Die Kupplung der 2-Methylnaphthylboronsäure 
-Derivate mit 2-Methylnaphthylbromid führte unter Verwendung des von Buchwald 
entwickelten Liganden 196, Pd2(dba)3 und geeigneten Lösungsmitteln und Basen zum 
racemischen Produkt. Die für das oben beschriebene System optimierten Bedingungen 
wurden auf die beiden genuinen – hoch-oxygenierten – Substrate die 2-Methylnaphthyl 
boronsäure-Derivate 210, 211, 213, oder 214 und 2-Methylnaphthyliodide (oder -bromide) 
215 (206), 215 (206), 212 (205) oder 212 (205) angewandt. Leider führten zahlreiche 
Versuche unter Erprobung diverser Basen- und Lösungsmittelsysteme nicht zum Erfolg. 
Eine mögliche Erklärung liegt in der hohen Elektronendichte der beiden 
Kupplungspartner, die von den zwei bzw. drei Sauerstoffsubstituenten herrührt. Eine 
alternative Synthesestrategie oder der Einsatz eines leistungsfähigeren Katalysatorsystems 
muss deshalb zur Totalsynthese von 187a in Erwägung gezogen werden. 
175 
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7) Phytochemische Untersuchung des marinen Streptomyces-Stammes RV-15 aus 
Schwämmen. 
 Die vier neuen cyclischen Lipopeptide Cyclodysidin A-D (216−219), welche sowohl aus 
- als auch - Aminosäuren aufgebaut sind, wurden aus RV-15, einem Streptomyces- 
Stamm, der mit Schwämmen vergesellschaft ist, isoliert. In Zusammenarbeit mit Dr. U. 
Abdelmohsen identifizierte man deren Struktur als Cyclo-(ß-AFA-Ser-Gln-Asn-Tyr-Asn- 
Ser-Thr) mithilfe von 2D-NMR-Spektroskopie und CID-MS/MS. 
 
 
 
X1       X2 
cylcodysidin A (216): 
cylcodysidin B (217): 
cylcodysidin C (218): 
cylcodysidin D (219): 
205: X = OMe 
206: X = H 
210: OMe  Bpin (80% from 205) 
211: OMe  B(OH)2 (92% from 205) 
212: OMe  I (94% from 205) 
213: H     Bpin (55% from 206) 
214: H     B(OH)2 (90% from 206) 
215: H     I (92% from 206) 
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Experimental Section 
1  General Aspects 
1.1  Analytical Apparatuses 
Melting point (m.p.): Melting points were recorded on a Reichert-Jung 
Thermovar-Kofler-Heiztisch microscope and are uncorrected. 
Ultraviolet spectroscopy (UV): The UV-spectra were recorded at room temperature with a 
Varian Cary 50 Conc UV-Visible Spectrophotometer. The UV-spectra of solution media was 
measured as background. Varian-Cary-WinUV-Simple-scan-Application software was 
employed for processing of the measurements. 
Infrared spectroscopy (IR): The IR spectra were determined on a Jasco FT/IR-410 
spectrometer. The spectra were measured at room temperature. ν  refers to the wavelength 
number. The intensity of the absorption bands is described by: s = strong, m = middle, w = 
weak, and br = broad. 
Nuclear magnetic resonance spectroscopy (1H NMR, 13C NMR): The 1H NMR (400 MHz, 600 
MHz) and 13C NMR (100 MHz, 150 MHz,) spectra were measured at room temperature on 
either an AMX 400 or on a DMX 600 spectrometer (both from Bruker). The chemical shifts 
of the signals are given in units on the δ-scale, with reference to δTMS = 0. Calibration of the 
spectra was performed by means of an internal standard using the trace protons from the 
deuterated solvent, for 1H NMR: δ (CDCl3) = 7.26; δ (CD3OD) = 3.31; δ (acetone-d6) = 2.05; 
and for 13C NMR: δ (CDCl3) = 77.01; δ (CD3OD) = 49.15; δ (acetone-d6) = 29.82. 
Processing of the spectra was performed using XWIN-NMR-software from Bruker. Signal 
multiplicity is given using the following abbreviations: singlet = s, doublet = d, doublet of 
doublets = dd, triplet = t, doublet of triplets = dt, quartet = q, and multiplet = m. The coupling 
constants are described in Hertz (Hz), where nJ gives the number of bonds. 
Mass spectrometry (MS): Electronic ionization (EI) and high-resolution electronic ionization 
(HREIMS) mass spectra were measured on a Finnigan MAT 8200 apparatus with an 
ionization potential of 70 eV. The bracketed numbers display the intensity of the signals 
relative to the base peak (I = 100%). Electrospray ionization (ESI) and high-resolution 
electrospray ionization HRMS (ESI) mass spectra were measured on a Bruker Daltonics 
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microTOF focus, for calculation of the respective mass values of the isotopic distribution, the 
software modul IsotopePattern of the software Compass 1.1 from Bruker Daltonics was used. 
HPLC-ESI-MS analyses were carried out on an Agilent 1100 Series System consisting of an 
HPLC pump, an MSD Ion Trap mass spectrometer (capillary temperature: 350 °C; 
ESI-voltage: 3500 V; N2 as the heating gas), and a diode-array detector (DAD) (all Agilent 
Technologies). 
X-ray diffraction analysis: The X-ray crystallography was carried out by Dr. Thomas Kupfer 
(Prof. Braunschweig’s group) in the Institute of Inorganic Chemistry of the University of 
Würzburg. The crystal data was collected on a Bruker X8APEX diffractometer with a CCD 
area detector and multi-layer mirror monochromated MoK radiation. The structure was 
solved using direct methods, refined with the Shelx software package[271] and expanded using 
Fourier techniques. All non-hydrogen atoms were refined anisotropically. Hydrogen atoms 
were included in the structure factors calculations. All hydrogen atoms were assigned to 
idealized geometric positions. 
GC-MSD: For the GC-MSD analyses a Hewlett Packard 5890 II gas chromatography was 
utilized with a Hewlett Packard Ultra 2 (cross linked 5% Ph Me silicone 25 m × 0.32 mm × 
0.52 μm Film) capillary column connected to a Hewlett Packard 59822B ionization gauge 
controller and a mass-selective detector called Hewlett Packard 5917A. 
Optical rotation: The optical rotation values were recorded on a Jasco P-1020-polarimeter at 
the sodium-D-line (λ = 589 nm). 
Circular dichroism (CD): The CD spectra were recorded at room temperature on a Jasco 
J-715 spectropolarimeter with quartz crystal cells. The CD spectra were measured 3 times in 
the interval from 200 nm to 600 nm using the software Jasco-Borwin Version 1.50 and 
processed with the Jasco spectra manager software. The differential absorptions coefficient 
ε∆[cm2/mol] at different wavelengths λ [nm] was measured in the given solvent. For baseline 
correction a blank sample of eluent was measured. 
1.2  Other Apparatuses 
Plant material handling: Air-dried plant material was ground using a Retsch-SM1 impact mill 
with a wire netting of 1 mm hole size. 
Freeze-drying: For freeze-drying a Christ-Alpha 1-4 equipped with a vacUUbrand RZ 8 
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high-vacuum pump was used. 
Kryomat: For low-temperature reactions the desired temperature was achieved using a 
Kryomat-400. 
Autoclave: Cultural medium and devices for aseptic works were sterilized with a Variclave 
500 E (Fa H+P Labortechnique GmbH) at 121 °C, 20 min and at 210 kPa. 
1.3  Chromatographical Methods 
Thin layer chromatography (TLC): All reactions were monitored by TLC controls using 
Merck aluminum foil silica gel 60 F254 plates. TLC control of substances containing basic 
nitrogen atoms was undertaken in an NH3 atmosphere. To detect substances on the TLC plates, 
fluorescent light at either 254 nm or 365 nm, development in iodine chamber, and staining 
with 5% sulphuric acid in methanol and dried with hot air, Ekkards reagent, or Draggendorff 
reagent was used. 
Column chromatography: The silica gel used was purchased from Merck (0.063−0.2 mm), for 
use with compounds containing nitrogen the silica gel was deactivated by addition of 7.5% 
(by mass) ammonia. For gel chromatography Sephadex LH-20 was used. 
High-pressure liquid chromatography (HPLC): Analytical HPLC was performed using 
equipment from Jasco; pump PU-1580, degassing unit DG-1580, auto sampler AS-2055 Plus, 
mixer LG-1580, column oven CO-1560, diode-array detector MD-2010 Plus. Processing of 
the measurements was done using the Borwin software from Jasco. Unless otherwise noted 
the HPLC-UV, HPLC-MS experiments were carried out using a Symmetry-C18 column 
(Waters; 4.6 × 250 mm, 5 μm) with mobile phases consisting of H2O + 0.05% TFA (A), 
MeCN + 0.05% TFA (B); flow rate: 1 mL min−1 or 0.8 mL min−1. Preparative HPLC was 
performed using in an online connected a Waters-600E pump, a Rheodyne-7125i injector, and 
a Waters-996 diode-array detector. For processing of the measurements and controlling the 
Millenium Software Version 2.15 from Waters was employed. The chromatographical 
separations were performed on a SymmetryPrep-C18 column (Waters; 19 × 300 mm, 7 μm). 
1.4  Chemicals 
Solvents: All used solvents (methanol, acetone, dichloromethane, chloroform, ethyl acetate, 
n-hexane and petroleum ether 40−60 °C) were distilled. Water for the HPLC was purified 
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with Millipore-Q. Acetonitrile and methanol for the HPLC, UV, CD and specific rotation 
value measurement as well as trifluoroacetic acid were purchased from Merck without other 
purification procedures performed. 
Other chemicals: For the preparation of the cultural medium, the used inorganic salts were 
purchased (if nothing else given) from Sigma-Aldrich, the organic materials (phytohormones, 
vitamins, Gelrite, etc.) from Carl Roth (Karlsruhe). All the other chemicals for synthesis were 
purchased from Sigma-Aldrich. 
1.5  Cell Cultures of T. peltatum 
General devices and processes: The pH value of the culture medium was adjusted to 5.8 using 
aqueous NaOH and HCl solutions, respectively. Each 100-mL Erlenmeyer flask containing a 
modified MS medium was covered with a cellulose stopper (Neolab Migge 
Laborbedarf-Vertriebs GmbH, Heidelberg), in addition with an aluminum cap, and then 
sterilization was carried out by 20-min autoclavation at 121 °C and 210 kPa. All used devices 
(tweezers, scalpel, scissors, pipettes) were sterilized likewise by autoclavation before use and 
by fire for several times during every application. For maintains and propagation, the calli 
were transferred to fresh solid medium every 2 months. The work under aseptic conditions 
was performed in a Laminar Flow Hood (Biohazard Laminar Flow Class II, Fa UniEquip lab 
equipment making). 
Temperature and light: The cultures were kept constantly at 24 ± 2 °C. In winter this was 
guaranteed by a thermostat-regulated additional heating. The cultures were kept under 
fluorescent light with a 14-h photoperiod at 51 μM m−2 s−1 photosynthetically active radiation 
(Osram L58W/77 FLUORA in combination with Osram L58W/954 Lumilux de Luxe 
Daylight). 
Medium: The content of the main nutrition elements in the modified MS medium[272] was 
reduced to 1/5 (20%), with the exception of the calcium and magnesium concentration, whose 
ratio was reduced to 1/4 (25%) of the original concentration. The modified medium had the 
following composition, which is shown in Table 11. 
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Table 11. Composition of the modified Murashige & Skoog medium (MS medium), which was used 
for the cell cultures of T. peltatum. 
  modified  
MS-Medium [mg L−1] 
Inorganic mainnutrients KNO3 380 
NH4NO3 330 
KH2PO4 34 
 CaCl2 × 2 H2O 88 
 MgSO4 × 7 H2O 74 
 FeSO4 × 7 H2O 27.8 
 Na2EDTA 37.3 
Inorganic 
micronutrients 
KI 0.83 
MnSO4 × H2O 16.9 
 H3BO3 6.2 
 ZnSO4 × 7 H2O 10.59 
 Na2MoO4 × 2 H2O 0.25 
 CuSO4 × 5 H2O 0.025 
 CoCl2 × 6 H2O 0.025 
Organic components nicotinic acid  0.5 
 thiamine × HCl 250 
 pyridoxal × HCl 0.5 
 myo-inositol 100 
 glycine 2 
 saccharose 30 000 
 gelrite 3 500 
Phytohormones 6-benzylaminopurine (BAP) 2 
 1-naphthylacetic acid (NAA) 0.1 
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2  Phytochemical Investigation on A. tectorius 
2.1  Extraction and Isolation 
Air-dried twigs from the Chinese plant A. tectorius (1500 g) were ground and extracted 
with 95% EtOH at room temperature. The extract was concentrated in vacuum to give around 
30 g of residue, which was dissolved in MeOH and filtered, subsequently submitted to fast 
centrifugal partition chromatography (FCPC) using a two-phase solvent system consisting of 
n-heptane/EtOAc/MeOH/H2O (1:9:1:9). The lower phase served as the stationary phase (flow 
rate 10 mL min−1, rotational speed 800 min−1, ascending mode) to get rid of the high-polarity 
impurities. The total alkaloid part came out first with the mobile phase, then concentrated 
under reduced pressure to give a fraction of 10 g. After about 60 min, the stationary phase was 
flushed out in reversed mode by using MeOH. This 10 g raw extract were subjected to an 
open silica gel column chromatography with a gradient CH2Cl2/MeOH. The above work had 
been performed by Dr. M. Xu in our group. Four unresolved fractions were completed for 
further phytochemical research in the present thesis. 
  From the four fractions 29 alkaloids (see Table 12) were isolated using normal-phase 
column chromatography in combination with preparative HPLC on a Symmetry Prep C18 
column (19 × 300 mm, 5 μm, Waters) and Chromolith Prep C18 column (4.6 × 50 mm, 5 μm, 
Merck) with a solvent system consisting of (A) H2O (0.05% trifluoroacetic acid) and (B) 
MeOH (0.05% trifluoroacetic acid) or (A) H2O (0.05% trifluoroacetic acid) and (B) CH3CN 
(0.05% trifluoroacetic acid). 
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Table 12. The methods of isolation of 29 alkaloids from the Chinese plant A. tectorius. 
La Nb Nc Gradient TR [min] Mobile phase Column 
5,1′- 5a 1-2-1 25%-30% 20.0 CH3CN/H2O Symmetry 
 5b 1-1-1 5%-45% 6.2 CH3CN/H2O Chromolith 
 60 1-2-2 25%-30% 24.0 CH3CN/H2O Symmetry 
 61 4-2-2-1 15%-55% 25.0  CH3CN/H2O Symmetry 
 62a 2-4-1 25%-30% 23.4 CH3CN/H2O Symmetry 
 62b 2-3-1-1 30%-60% 32.7 CH3OH/H2O Symmetry 
 63 2-4-3-1 40%-67% 30.6 CH3CN/H2O Symmetry 
 64 2-4-4-2 25%-30% 29.4 CH3CN/H2O Symmetry 
 69 1-1-3 5%-45% 6.5 CH3CN/H2O Chromolith 
 70 2-4-4-1 25%-35% 29.0 CH3CN/H2O Symmetry 
 71 2-3-3 24%-29% 30.0 CH3CN/H2O Symmetry 
 75 4-4-5 15%-55% 26.0 CH3CN/H2O Symmetry 
 76 1-2-4 25%-30% 25.2 CH3CN/H2O Symmetry 
 77 4-4-7 15%-55% 28.0 CH3CN/H2O Symmetry 
 78 4-2-1 15%-50% 21.4 CH3CN/H2O Symmetry 
 79 4-6-10 15%-50% 17.3 CH3CN/H2O Symmetry 
 80 4-6-8-1 35%-60% 27.6 CH3CN/H2O Symmetry 
5,8′- 67 2-5-1 30%-45% 19.0 CH3CN/H2O Symmetry 
7,1′- 72 4-6-6b-2 15%-50% 28.5 CH3CN/H2O Symmetry 
 73 2-2-2 24%-29% 28.0 CH3CN/H2O Symmetry 
 74 4-2-2-2 15%-55% 26.2 CH3CN/H2O Symmetry 
 78 2-2-1 24%-29% 23.7 CH3CN/H2O Symmetry 
 81 4-6-8-2 15%-50% 29.3 CH3CN/H2O Symmetry 
7,3′- 82 2-5-2 30%-45% 20.7 CH3CN/H2O Symmetry 
7,8′- 66 3-2-2a 15%-55% 23.7 CH3CN/H2O Symmetry 
N,C- 7 3-6 30%-70% 26.9 CH3CN/H2O Symmetry 
 83 3-7 30%-70% 28.8 CH3CN/H2O Symmetry 
La: linkage pattern. Nb: the numbering of structures described in this thesis. Nc: the code of structures 
described during the course of isolation. 
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2.2  Ancistectorine A1 (60) 
Colorless amorphous powder (3.0 mg). 
M.p. 190 °C (MeOH). 
[α] 20D  = +19.1 (c = 0.10, MeOH). 
UV (MeOH): λmax (logε) = 308 (0.44), 321 (0.37), 337 (0.33) nm. 
CD (CH3OH): λmax (Δε) = 200 (+2.6), 210 (−7.3), 238 (+7.5), 287 (−0.8) nm. 
IR (ATR): ν  = 2524 (m), 1669 (m), 1612 (m), 1583 (m), 1428 (w), 1393 (w), 1356 (w), 
1333 (w), 1259 (w), 1181 (m), 1129 (m), 1076 (m), 1014 (w), 964 (w), 941 (w), 836 (w), 799 
(w) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.19 (3H, d, 3J = 6.8 Hz, CH3-3), 1.72 (3H, d, 3J = 6.8 Hz, 
CH3-1), 2.09 (1H, dd, 2J = 15.8, 3J = 3.4 Hz, H-4eq), 2.10 (3H, s, CH3-2'), 2.28 (1H, dd, 2J = 
17.0, 3J = 11.6 Hz, H-4ax), 3.20 (1H, m, H-3), 3.92 (3H, s, OCH3-8), 4.08 (3H, s, OCH3-5'), 
4.68 (1H, q, 3J = 7.2 Hz, H-1), 6.61 (1H, s, H-7), 6.75 (1H, dd, 3J = 7.5, 4J = 1.2 Hz, H-8'), 
6.82 (1H, s, H-3'), 6.88 (1H, dd, 3J = 7.5, 4J = 1.2 Hz, H-6'), 7.19 (1H, dd, 3J = 7.8, 3J = 7.8 
Hz, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.8 (CH3-1), 20.3 (CH3-3), 20.4 (CH3-2'), 33.2 (C-4), 
50.9 (C-3), 52.1 (C-1), 56.1 (OCH3-8), 57.0 (OCH3-5'), 99.4 (C-7), 104.9 (C-6'), 113.8 (C-3'), 
114.6 (C-9), 115.2 (C-10'), 118.6 (C-5), 119.5 (C-8'), 123.5 (C-1'), 127.7 (C-7'), 135.0 (C-10), 
137.1 (C-9'), 139.2 (C-2'), 155.4 (C-4'), 157.0 (C-6), 158.2 (C-5'), 158.7 (C-8) ppm. 
MS (EI, 70 eV): m/z (%) = 393 [M]+ (3), 392 [M−1]+ (7), 378 [M−15]+ (100). 
HRESIMS m/z calcd for C24H28NO4, 394.2013 [M+1]+; found 394.2012. 
 
60 
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2.3  N-Methylancistectorine A1 (61) 
Colorless amorphous powder (3.0 mg). 
M.p. 131 °C (MeOH). 
[α] 20D  = +81.3 (c = 0.10, MeOH). 
UV (MeOH): λmax (logε) = 210 (3.28), 285 (1.19), 334 (0.92) nm. 
CD (CH3OH): λmax (Δε) = 200 (+3.2), 210 (−6.8), 226 (−3.5), 238 (+4.4), 286 (−3.2) nm. 
IR (ATR): ν  = 2524 (m), 1669 (m), 1612 (m), 1583 (m), 1428 (w), 1393 (w), 1356 (w), 
1333 (w), 1259 (w), 1181 (m), 1129 (m), 1076 (m), 1014 (w), 964 (w), 941 (w), 836 (w), 799 
(w) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.25 (3H, d, 3J = 6.8 Hz, CH3-3), 1.72 (3H, d, 3J = 6.8 Hz, 
CH3-1), 2.09 (3H, s, CH3-2'), 2.17 (1H, dd, 2J = 17.2, 3J = 3.4 Hz, H-4eq), 2.40 (1H, dd, 2J = 
17.2, 3J = 11.0 Hz, H-4ax), 3.01 (3H, s, CH3-N), 3.20 (1H, m, H-3), 3.92 (3H, s, OCH3-8), 
4.08 (3H, s, OCH3-5'), 4.68 (1H, q, 3J = 7.2 Hz, H-1), 6.63 (1H, s, H-7), 6.75 (1H, dd, 3J = 
7.5, 4J = 1.2 Hz, H-8'), 6.82 (1H, s, H-3'), 6.87 (1H, dd, 3J = 7.5, 4J = 1.2 Hz, H-6'), 7.19 (1H, 
dd, 3J = 7.8, 3J = 7.8 Hz, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.2 (CH3-1), 20.1 (CH3-3), 20.4 (CH3-2'), 33.0 (C-4), 
41.8 (CH3-N), 56.2 (OCH3-8), 56.9 (OCH3-5'), 60.4 (C-3), 62.1 (C-1), 99.4 (C-7), 104.9 
(C-6'), 113.8 (C-3'), 114.5 (C-9), 115.2 (C-10'), 118.3 (C-5), 119.6 (C-8'), 123.1 (C-1'), 127.7 
(C-7'), 134.7 (C-10), 137.4 (C-9'), 139.4 (C-2'), 155.6 (C-4'), 157.4 (C-6), 157.9 (C-8), 158.3 
(C-5') ppm. 
MS (EI, 70 eV): m/z (%) = 407 [M]+ (3), 406 [M−1]+ (10), 392 [M−15]+ (100). 
HRESIMS m/z calcd for C25H30NO4, 408.2169 [M+1]+; found 408.2169. 
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2.4  Ancistectorine A2 (62a) 
Colorless amorphous powder (3.1 mg). 
M.p. 235 °C (MeOH). 
[α] 20D  = −17.0 (c = 0.09, MeOH). 
UV (MeOH): λmax (logε) = 290 (0.61), 305 (0.61), 320 (0.49), 335 (0.42) nm. 
CD (CH3OH): λmax (Δε) = 200 (+13.2), 227 (−15.0), 240 (+6.9), 284 (−1.6) nm. 
IR (ATR): ν  = 3199 (w), 2989 (w), 2541 (w), 1666 (m), 1598 (m), 1583 (m), 1454 (w), 
1390 (w), 1333 (w), 1259 (w), 1197 (m), 1126 (m), 1074 (m), 1044 (m), 1005 (w), 970 (w), 
837 (w), 798 (w) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.21 (3H, d, 3J = 6.6 Hz, CH3-3), 1.69 (3H, d, 3J = 6.6 Hz, 
CH3-1), 2.05 (3H, s, CH3-2'), 2.15 (1H, dd, 2J = 17.8, 3J = 11.8 Hz, H-4ax), 2.26 (1H, dd, 2J = 
17.8, 3J = 4.8 Hz, H-4eq), 3.58 (3H, s, OCH3-6), 3.64 (1H, m, H-3), 3.92 (3H, s, OCH3-5'), 
3.96 (3H, s, OCH3-4'), 4.79 (1H, q, 3J = 6.8 Hz, H-1), 6.59 (1H, s, H-7), 6.79 (1H, dd, 3J = 
8.4, 4J = 0.9 Hz, H-8'), 6.85 (1H, dd, 3J = 8.4, 4J = 0.9 Hz, H-6'), 6.89 (1H, s, H-3'), 7.19 (1H, 
dd, 3J = 8.4, 3J = 8.4 Hz, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.5 (CH3-1), 19.3 (CH3-3), 20.4 (CH3-2'), 33.2 (C-4), 
45.3 (C-3), 49.6 (C-1), 56.1 (OCH3-6), 57.0 (OCH3-5'), 57.2 (OCH3-4'), 98.9 (C-7), 107.3 
(C-6'), 110.6 (C-3'), 113.9 (C-9), 117.9 (C-10'), 118.8 (C-8'), 119.9 (C-5), 126.0 (C-1'), 127.9 
(C-7'), 132.8 (C-10), 137.0 (C-2'), 137.8 (C-9'), 156.0 (C-8), 157.8 (C-4'), 158.9 (C-5'), 159.4 
(C-6) ppm. 
MS (EI, 70 eV): m/z (%) = 407 [M]+ (12), 406 [M−1]+ (11), 392 [M−15]+ (100). 
HRESIMS m/z calcd for C25H30NO4, 408.2169 [M+1]+; found 408.2169. 
 
62a 
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2.5  5-epi-Ancistectorine A2 (62b) 
Colorless amorphous powder (1.9 mg). 
M.p. 230 °C (MeOH). 
[α] 20D  = +24.4 (c = 0.10, MeOH). 
UV (MeOH): λmax (logε) = 290 (0.61), 305 (0.61), 320 (0.49), 335 (0.42) nm. 
CD (CH3OH): λmax (Δε) = 200 (−16.6), 227 (+29.2), 240 (−13.6), 284 (+1.0) nm. 
IR (ATR): ν  = 2917 (w), 2535 (w), 1671 (m), 1598 (w), 1582 (w), 1498 (m), 1462 (w), 
1390 (w), 1332 (w), 1259 (w), 1200 (m), 1126 (m), 1093 (m), 1073 (w), 1045 (w), 974 (w), 
835 (w), 799 (w) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.19 (3H, d, 3J = 6.6 Hz, CH3-3), 1.69 (3H, d, 3J = 6.6 Hz, 
CH3-1), 2.06 (1H, dd, 2J = 16.8, 3J = 10.4 Hz, H-4ax), 2.08 (3H, d, 3J = 6.6 Hz, CH3-2'), 2.37 
(1H, dd, 2J = 16.8, 3J = 5.6 Hz, H-4eq), 3.68 (1H, m, H-3), 3.58 (3H, s, OCH3-6), 3.92 (3H, s, 
OCH3-5'), 3.95 (3H, s, OCH3-4'), 4.80 (1H, q, 3J = 7.2 Hz, H-1), 6.59 (1H, s, H-7), 6.71 (1H, 
dd, 3J = 8.1, 4J = 0.9 Hz, H-8'), 6.85 (1H, dd, 3J = 8.1, 4J = 0.9 Hz, H-6'), 6.90 (1H, s, H-3'), 
7.16 (1H, dd, 3J = 8.1, 3J = 8.1 Hz, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.5 (CH3-1), 19.3 (CH3-3), 20.7 (CH3-2'), 33.0 (C-4), 
45.3 (C-3), 49.6 (C-1), 56.1 (OCH3-6), 57.0 (OCH3-4'), 57.1 (OCH3-5'), 98.8 (C-7), 107.2 
(C-6'), 110.6 (C-3'), 113.8 (C-9), 118.0 (C-10'), 119.0 (C-8'), 119.9 (C-5), 126.2 (C-1'), 127.7 
(C-7'), 132.8 (C-10), 136.6 (C-2'), 137.9 (C-9'), 155.9 (C-8), 157.8 (C-4'), 158.9 (C-5'), 159.4 
(C-6) ppm. 
MS (EI, 70 eV): m/z (%) = 407 [M]+ (12), 406 [M−1]+ (9), 392 [M−15]+ (100).  
HRESIMS m/z calcd for C25H30NO4, 408.2169 [M+1]+; found 408.2169. 
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2.6  4'-O-Demethylancistectorine A2 (63) 
Colorless amorphous powder (0.6 mg). 
M.p. 181 °C (MeOH). 
[α] 20D  = −15.1 (c = 0.10, MeOH). 
UV (MeOH): λmax (logε) = 230 (2.20), 310 (0.40), 335 (0.29) nm. 
CD (CH3OH): λmax (Δε) = 200 (+12.5), 225 (−15.0), 239 (+7.7), 286 (−2.9) nm. 
IR (ATR): ν  = 2940 (w), 2532 (w), 1669 (m), 1629 (w), 1600 (w), 1577 (m), 1499 (w), 
1428 (w), 1393 (w), 1367 (w), 1332 (w), 1256 (w),1180 (m), 1134 (m), 1081 (m), 1045 (w), 
967 (w), 837 (w), 799 (w) cm−1. 
1H NMR (CD3OD, 600 MHz): δ = 1.21 (3H, d, 3J = 6.6 Hz, CH3-3), 1.68 (3H, d, 3J = 6.6 Hz, 
CH3-1), 2.00 (3H, s, CH3-2'), 2.14 (1H, dd, 2J = 17.8, 3J = 11.6 Hz, H-4ax), 2.26 (1H, dd, 2J = 
16.8, 3J = 5.0 Hz, H-4eq), 3.58 (3H, s, OCH3-6), 3.63 (1H, m, H-3), 4.08 (3H, s, OCH3-5'), 
4.78 (1H, m, H-1), 6.58 (1H, s, H-7), 6.77 (1H, s, H-3'), 6.80 (1H, dd, 3J = 8.1, 4J = 0.9 Hz, 
H-8'), 6.86 (1H, dd, 3J = 8.1, 4J = 0.9 Hz, H-6'), 7.17 (1H, dd, 3J = 8.1, 3J = 8.1 Hz, H-7') ppm. 
13C NMR (CD3OD, 150 MHz): δ = 18.5 (CH3-1), 19.4 (CH3-3), 20.3 (CH3-2'), 33.2 (C-4), 
45.2 (C-3), 49.7 (C-1), 56.1 (OCH3-6), 56.9 (OCH3-5'), 98.7 (C-7), 104.7 (C-6'), 113.7 (C-3'), 
113.8 (C-9), 115.1 (C-10'), 119.6 (C-8'), 119.6 (C-5), 124.3 (C-1'), 127.4 (C-7'), 133.0 (C-10), 
137.1 (C-9'), 138.2 (C-2'), 155.2 (C-4'), 156.0 (C-8), 158.1 (C-5'), 159.5 (C-6) ppm. 
MS (EI, 70 eV): m/z (%) = 393 [M]+ (11), 392 [M−1]+ (16), 378 [M−15]+ (100). 
HRESIMS m/z calcd. for C24H28NO4 [M+1]+: 394.2013; found 394.2012. 
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2.7  Ancistectorine A3 (64) 
Colorless amorphous powder (1.5 mg). 
M.p. 140 °C (MeOH). 
[α] 20D  = −146 (c = 0.10, MeOH). 
UV (MeOH): λmax (logε) = 320 (0.48), 335 (0.49) nm. 
CD (CH3OH): λmax (Δε) = 208 (+20.6), 228 (−17.9), 244 (+8.6), 300 (−7.4), 338 (−9.4) nm. 
IR (ATR): ν  = 3388 (w), 3209 (w), 2981 (w), 1667 (m), 1628 (m), 1573 (m), 1508 (w), 
1429 (w), 1395 (w), 1354 (w), 1321 (w), 1286 (w), 1260 (w), 1178 (s), 1127 (s), 1080 (s), 964 
(w), 939 (w), 836 (m), 799 (m) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.21 (3H, d, 3J = 6.6 Hz, CH3-3), 2.06 (3H, s, CH3-2'), 
2.30 (1H, dd, 3J = 16.8, 10.4 Hz, H-4ax), 2.39 (1H, dd, 2J = 16.8, 3J = 5.6 Hz, H-4eq), 2.80 
(3H, s, CH3-1), 3.63 (1H, m, H-3), 4.04 (3H, s, OCH3-8), 4.07 (3H, s, OCH3-5'), 6.70 (1H, s, 
H-7), 6.80 (1H, s, H-3'), 6.82 (1H, dd, 3J = 8.1, 4J = 0.9 Hz, H-8'), 6.88 (1H, dd, 3J = 8.1, 4J = 
0.9 Hz, H-6'), 7.22 (1H, dd, 3J = 8.1, 3J = 8.1 Hz, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.1 (CH3-3), 20.4 (CH3-2'), 24.9 (CH3-1), 32.9 (C-4), 
49.1 (C-3), 56.8 (OCH3-8), 57.0 (OCH3-5'), 99.5 (C-7), 105.0 (C-6'), 108.8 (C-9), 113.7 
(C-3'), 115.2 (C-10'), 119.2 (C-8'), 121.1 (C-5), 122.0 (C-1'), 128.0 (C-7'), 137.0 (C-9'), 139.0 
(C-2'), 142.8 (C-10), 156.0 (C-4'), 158.3 (C-5'), 166.0 (C-8), 167.7 (C-6), 175.6 (C-1) ppm. 
MS (EI, 70 eV): m/z (%) = 392 [M+1]+ (29), 391 [M]+ (100), 376 [M−15]+ (22). 
HRESIMS m/z calcd for C24H26NO4, 392.1856 [M+1]+; found 392.1856. 
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2.8  Ancistectorine B1 (65) 
Colorless amorphous powder (10.1 mg). 
M.p. 211 °C (MeOH). 
[α] 20D  = +32.9 (c = 0.09, MeOH). 
UV (MeOH): λmax (logε) = 305 (0.55), 320 (0.45), 335 (0.37) nm. 
CD (CH3OH): λmax (Δε) = 205 (−9.2), 228 (+12.1), 247 (+0.5), 254 (+1.8), 284 (−2.8), 307 
(+0.3) nm. 
IR (ATR): ν  = 3323 (w), 2938 (w), 2541 (m), 1666 (m), 1613 (w), 1584 (m), 1455 (w), 
1392 (w), 1357 (w), 1336 (w), 1261 (w), 1188 (m), 1127 (m), 1093 (m), 1068 (w), 1014 (w), 
975 (w), 934 (w), 898 (w), 836 (w), 798 (w) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.50 (3H, d, 3J = 6.6 Hz, CH3-3), 1.62 (3H, d, 3J = 6.6 Hz, 
CH3-1), 2.18 (3H, s, CH3-2'), 2.86 (1H, dd, 2J = 17.5, 3J = 11.4 Hz, H-4ax), 3.12 (3H, s, 
CH3O-8), 3.15 (1H, dd, 2J = 17.5, 3J = 4.8 Hz, H-4eq), 3.87 (1H, m, H-3), 3.91 (3H, s, 
OCH3-5'), 3.95 (3H, s, OCH3-4'), 4.72 (1H, q, 3J = 6.8 Hz, H-1), 6.58 (1H, s, H-5), 6.85 (1H, 
dd, 3J = 8.1, 4J = 0.9 Hz, H-6'), 6.89 (1H, dd, 3J = 8.1, 4J = 0.9 Hz, H-8'), 6.90 (1H, s, H-3'), 
7.20 (1H, dd, 3J = 8.1, 3J = 8.1 Hz, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 19.4 (CH3-3), 19.6 (CH3-1), 21.0 (CH3-2'), 34.6 (C-4), 
45.3 (C-3), 49.9 (C-1), 57.0 (OCH3-4'), 57.1 (OCH3-5'), 60.4 (OCH3-8), 107.2 (C-6'), 110.3 
(C-3'), 111.5 (C-5), 117.9 (C-10'), 118.6 (C-9), 119.9 (C-7), 119.9 (C-8'), 123.7 (C-1'), 127.6 
(C-7'), 133.2 (C-10), 137.6 (C-2'), 138.1 (C-9'), 157.3 (C-8), 157.6 (C-6), 158.3 (C-4'), 158.7 
(C-5') ppm. 
MS (EI, 70 eV): m/z (%) = 407 [M]+ (9), 406 [M−1]+ (11), 392 [M−15]+ (100). 
HRESIMS m/z calcd for C25H30NO4, 408.2169 [M+1]+; found 408.2169. 
65 
Phytochemical Investigation of A. tectorius 115 
  
2.9  Ancistectorine C1 (66) 
Colorless amorphous powder (2.0 mg). 
M.p. 161 °C (MeOH). 
[α] 20D  = +5.9 (c = 0.09, MeOH). 
UV (MeOH): λmax (logε) = 210 (3.08), 305 (0.70) nm. 
CD (CH3OH): λmax (Δε) = 209 (+5.6), 216 (+2.0), 236 (−6.3), 284 (+1.57) nm. 
IR (ATR): ν  = 2957 (m), 2850 (w), 1682 (s), 1611 (s), 1585 (s), 1455 (w), 1413 (w), 1384 
(w), 1322 (w), 1262 (w), 1171 (s), 1142 (w), 1093 (m), 1072 (m), 827 (m) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.60 (3H, d, 3J = 6.6 Hz, CH3-3), 1.74 (3H, d, 3J = 6.6 Hz, 
CH3-1), 2.32 (3H, s, CH3-2'), 3.02 (2H, m, H-4), 3.07 (3H, s, CH3-N), 3.15 (3H, s, CH3O-8), 
3.42 (1H, m, H-3), 3.93 (3H, s, OCH3-4'), 3.96 (3H, s, OCH3-5'), 4.62 (1H, q, 3J =6.8 Hz, 
H-1), 6.62 (1H, s, H-5), 6.79 (1H, d, 4J = 1.2 Hz, H-3'), 6.83 (1H, s, 4J = 1.2 Hz, H-1'), 6.94 
(1H, d, 3J = 8.0 Hz, H-6'), 7.22 (1H, d, 3J = 8.0 Hz, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.4 (CH3-3), 20.9 (CH3-1), 22.2 (CH3-2'), 35.4 (C-4), 
42.3 (CH3-N), 56.9 (OCH3-5'), 57.1 (OCH3-4'), 61.1 (C-3), 61.2 (OCH3-8), 62.6 (C-1), 106.5 
(C-6'), 110.0 (C-3'), 111.4 (C-5), 117.6 (C-10'), 118.3 (C-9), 119.3 (C-1'), 122.0 (C-7), 124.6 
(C-8'), 130.9 (C-7'), 134.7 (C-10), 137.7 (C-2'), 137.7 (C-9'), 157.8 (C-8), 157.8 (C-6), 158.7 
(C-4'), 158.7 (C-5') ppm. 
MS (EI, 70 eV): m/z (%) = 421 [M]+ (2), 406 [M−15]+ (100), 390 [M−31]+ (6). 
HRESIMS m/z calcd for C26H32NO4, 422.2326 [M+1]+; found 422.2326. 
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2.10  5-epi-Ancistrolikokine D (67) 
Colorless amorphous powder (0.6 mg). 
M.p. 168 °C (MeOH). 
[α] 20D  = +33.2 (c = 0.10, MeOH). 
UV (MeOH): λmax (logε) = 310 (0.47), 320 (0.47), 335 (0.46) nm. 
CD (CH3OH): λmax (Δε) = 214 (−6.0), 231 (+5.6), 250 (−2.9), 311 (+1.0), 321 (+1.4), 355 
(+0.6) nm. 
1H NMR (CD3OD, 600 MHz): δ = 1.20 (3H, d, 3J = 6.6 Hz, CH3-3), 2.26 (3H, s, CH3-2'), 
2.27 (1H, dd, 2J = 17.8, 3J = 10.2 Hz, H-4ax), 2.70 (1H, dd, 2J = 17.8, 3J = 5.2 Hz, H-4eq), 
2.79 (3H, s, CH3-1), 3.78 (1H, m, H-3), 4.04 (3H, s, OCH3-8), 4.12 (3H, s, OCH3-5'), 6.53 
(1H, d, 4J = 1.2 Hz, H-1'), 6.68 (1H, s, H-7), 6.68 (1H, d, 4J = 1.2 Hz, H-3'), 6.95 (1H, d, 3J = 
8.4, H-6'), 7.14 (1H, d, 3J = 8.4 Hz, H-7') ppm. 
13C NMR (CD3OD, 150 MHz): δ = 17.9 (CH3-3), 22.0 (CH3-2'), 25.0 (CH3-1), 32.9 (C-4), 
49.0 (C-3), 56.8 (OCH3-8), 56.9 (OCH3-5'), 99.3 (C-7), 104.5 (C-6'), 108.5 (C-9), 113.5 
(C-3'), 114.9 (C-10'), 116.5 (C-1'), 122.5 (C-5), 126.1 (C-8'), 129.8 (C-7'), 137.2 (C-9'), 139.6 
(C-2'), 142.7 (C-10), 156.3 (C-4'), 158.1 (C-5'), 165.9 (C-8), 167.8 (C-6), 175.5 (C-1) ppm. 
MS (EI, 70 eV): m/z (%) = 392 [M+1]+ (29), 391 [M]+ (70), 376 [M−15]+ (12), 188 [M−15]2+ 
(12), 69 [M−322]+ (100), 43 [M−348]+ (37), 44 [M−347]+ (74), 45 [M−346]+ (99). 
HRESIMS m/z calcd. for C24H26NO4 [M+1]+: 392.1856; found 392.1856. 
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2.11  Known Alkaloids 
Ancistrocladine (5a) 
Colorless amorphous solid (30.2 mg). 
M.p. 260−263 °C (MeOH). 
Lit.: 263−265 °C (MeOH).[146] 
[α] 20D  = −15.4 (c = 0.08, MeOH).
 
Lit.: −19 (c = 0.10, MeOH).[273]  
Lit.: −20 (c = 0.15, CHCl3).[146] 
UV (MeOH): λmax (logε) = 307 (0.57), 322 (0.48), 337 (0.43) nm. 
CD (CH3OH): λmax (Δε) = 200 (+22.9), 226 (−23.3), 240 (+9.9), 284 (−1.5) nm. 
IR (ATR): ν  = 2979 (w), 1670 (w), 1585 (w), 1449 (w), 1392 (w), 1362 (w), 1337 (w), 1260 
(w), 1200(w), 1127 (w), 1110 (w), 1077 (w), 833 (w), 798 (w) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.21 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.65 (d, 3J = 6.8 Hz, 3H, 
CH3-1), 2.10 (s, 3H, CH3-2'), 2.15 (dd, 2J = 17.2, 3J = 11.2 Hz, 1H, H-4ax), 2.27 (dd, 2J = 
17.0, 3J = 4.8 Hz, 1H, H-4eq), 3.60 (m, 1H, H-3), 3.90 (s, 3H, OCH3-4'), 3.90 (s, 3H, 
OCH3-8), 3.94 (s, 3H, OCH3-5'), 4.78 (q, 3J = 7.2 Hz, 1H, H-1), 6.61 (1H, s, H-7), 6.85 
(dd, 3J = 8.4, 4J = 1.2 Hz, 1H, H-8'), 6.87 (dd, 3J = 8.4, 4J = 1.2 Hz, 1H, H-6'), 6.92 (s, 1H, 
H-3'), 7.22 (dd, 3J = 7.9, 3J = 8.1 Hz, 1H, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.8 (1-CH3), 19.3 (3-CH3), 20.4 (2'-CH3), 33.2 (C-4), 
45.1 (C-3), 49.2 (C-1), 56.2 (4'-OCH3), 57.0 (8-OCH3), 57.1 (5'-OCH3), 98.9 (C-7), 107.4 
(C-6'), 110.6 (C-3'), 114.7 (C-9), 117.9 (C-10'), 118.7 (C-5), 118.8 (C-8'), 125.2 (C-1'), 128.1 
(C-7'), 133.0 (C-10), 137.7 (C-2'), 137.9 (C-9'), 157.0 (C-6), 157.8 (C-8), 158.0 (C-4'), 158.8 
(C-5') ppm. 
1H NMR (CDCl3, 400 MHz): δ = 1.27 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.65 (d, 3J = 6.8 Hz, 3H, 
CH3-1), 2.10 (s, 3H, CH3-2'), 2.15 (dd, 2J = 17.2, 3J = 11.2 Hz, 1H, Hax-4), 2.34 (dd, 2J = 
17.0, 3J = 4.8 Hz, 1H, Heq-4), 3.47 (m, 1H, H-3), 3.90 (s, 3H, OCH3-4'), 3.96 (s, 3H, 
OCH3-8), 3.99 (s, 3H, OCH3-5'), 4.81 (q, 3J = 7.2 Hz, 1H, H-1), 6.56 (1H, s, H-7), 6.77 
(dd, 3J = 8.4, 4J = 1.2 Hz, 1H, H-6'), 6.80 (s, 1H, H-3'), 6.86 (dd, 3J = 8.4, 4J = 1.2 Hz, 1H, 
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H-8'), 7.24 (dd, 3J = 7.9, 3J = 8.1 Hz, 1H, H-7') ppm. 
13C NMR (CDCl3, 100 MHz): δ = 18.6 (1-CH3), 18.7 (3-CH3), 20.1 (2'-CH3), 32.0 (C-4), 
44.3 (C-3), 48.0 (C-1), 55.6 (4'-OCH3), 56.4 (8-OCH3), 56.6 (5'-OCH3), 97.3 (C-7), 106.1 
(C-6'), 109.2 (C-3'), 115.0 (C-9), 116.4 (C-5), 116.7 (C-10'), 116.9 (C-8'), 120.2 (C-1'), 127.8 
(C-7'), 131.9 (C-10), 136.7 (C-9'), 138.9 (C-2'), 154.0 (C-6), 156.7 (C-8), 157.7 (C-4'), 157.8 
(C-5') ppm. 
MS (EI, 70 eV): m/z (%) = 407 [M]+ (4), 406 [M−1]+ (5), 392 [M−15]+ (100). 
HRMS (ESI): calcd. for C25H30NO4 [M+1]+: 408.2169; found 408.2169. 
The spectroscopic data are in good agreement with those previously published.[130,146,273] 
 
Hamatine (5b) 
Colorless amorphous powder (20.5 mg). 
M.p. 235−237 °C (MeOH).  
Lit.: 240−242 °C (MeOH).[131] 
[α] 20D  = +47.0 (c = 0.09, CH3OH).
 
Lit.: +64.0 (c = 0.32, CHCl3).[146] 
Lit.: +77.0 (c = 0.86, CHCl3).[132] 
UV (MeOH): λmax (logε) = 210 (3.43), 304 (0.59), 335 (0.37) nm. 
CD (CH3OH): λmax (Δε) = 200 (−16.8), 228 (+25.6), 242 (−8.0), 284 (+0.7) nm. 
IR (ATR): ν  = 2517 (m), 1668 (w), 1584 (w), 1452 (w), 1392 (w), 1362 (w), 1338 (w), 1292 
(w), 1260 (w), 1198(m), 1127 (m), 1110 (m), 1076 (w), 1013 (w), 971 (w), 833 (w), 810 (w), 
798 (w) cm−1. 
1H NMR (CD3OD, 600 MHz): δ = 1.19 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.62 (d, 3J = 6.8 Hz, 3H, 
CH3-1), 2.06 (dd, 2J = 17.0, 3J = 11.2 Hz, 1H, H-4ax), 2.15 (s, 3H, CH3-2'), 2.27 (dd, 2J = 
17.0, 3J = 5.1 Hz, 1H, H-4eq), 3.68 (m, 1H, H-3), 3.92 (s, 3H, OCH3-8), 3.92 (s, 3H, 
OCH3-5'), 3.96 (s, 3H, OCH3-4'), 4.78 (q, 3J = 7.2 Hz, 1H, H-1), 6.60 (1H, s, H-7), 6.78 
(dd, 3J = 8.4, 4J = 1.2 Hz, 1H, H-8'), 6.86 (dd, 3J = 8.4, 4J = 1.2 Hz, 1H, H-6'), 6.93 (s, 1H, 
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H-3'), 7.19 (dd, 3J = 7.9, 3J = 8.1 Hz, 1H, H-7') ppm.  
13C NMR (CD3OD, 100 MHz): δ = 18.8 (1-CH3), 19.3 (3-CH3), 20.7 (2'-CH3), 33.0 (C-4), 
45.1 (C-3), 49.2 (C-1), 56.2 (8-OCH3), 57.0 (5'-OCH3), 57.0 (4'-OCH3), 98.9 (C-7), 107.2 
(C-6'), 110.6 (C-3'), 114.5 (C-9), 118.0 (C-10'), 118.8 (C-5), 118.9 (C-8'), 125.2 (C-1'), 127.9 
(C-7'), 133.0 (C-10), 137.2 (C-2'), 137.9 (C-9'), 157.1 (C-6), 157.8 (C-8), 158.1 (C-4'), 159.0 
(C-5') ppm. 
MS (EI, 70 eV): m/z (%) = 407 [M]+ (4), 406 [M−1]+ (4), 392 [M−15]+ (100). 
HRESIMS m/z calcd. for C25H30NO4 [M+1]+: 408.2169; found 408.2169.  
The spectroscopic data are in good agreement with those previously published.[131,132,146]  
 
Ancistrocladinium A (7) 
Pale-yellow amorphous powder (10.0 mg). 
UV (MeOH): λmax (logε) = 214 (2.73), 325(2.69), 335 (1.65) nm. 
 
 
 
P-Ancistrocladinium A (7a) 
1H NMR (CD3OD, 400 MHz): δ = 1.21 (d, 3J = 6.8 Hz, 3H, CH3-3), 2.47 (s, 3H, CH3-1), 
2.47 (s, 3H, CH3-2'), 3.15 (dd, 2J = 17.0, 3J = 2.6 Hz, 1H, H-4eq), 3.65 (dd, 2J = 17.0, 3J = 6.4 
Hz, 1H, H-4ax), 3.96 (s, 3H, OCH3-4'), 4.00 (s, 3H, OCH3-5'), 4.03 (s, 3H, OCH3-6), 4.04 (s, 
3H, OCH3-8), 4.52 (m, 1H, H-3), 6.74 (d, 4J = 2.2 Hz, 1H, H-7), 6.77 (d, 4J = 2.2 Hz, 1H, 
H-5), 6.84 (d, 4J = 1.0 Hz, 1H, H-1'), 6.94 (d, 3J = 8.3 Hz, 1H, H-3'), 7.04 (d, 4J = 1.0 Hz, 
H-6'), 7.60 (d, 3J = 8.3 Hz, 1H, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 16.1 (3-CH3), 22.3 (2'-CH3), 24.4 (1-CH3), 35.9 (C-4), 
56.9 (4'-OCH3), 57.0 (5'-OCH3), 57.1 (6-OCH3), 57.2 (8-OCH3), 62.3 (C-3), 99.1 (C-7), 
105.9 (C-6'), 108.9 (C-5), 110.9 (C-3'), 111.3 (C-9), 113.6 (C-1'), 117.4 (C-8'), 127.2 (C-7'), 
130.9 (C-10'), 132.7 (C-9'), 141.7 (C-2'), 142.9 (C-10), 159.9 (C-4'), 160.9 (C-5'), 166.4 (C-8), 
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170.7 (C-6), 178.0 (C-1) ppm. 
 
M-Ancistrocladinium A (7b) 
1H NMR (CD3OD, 400 MHz): δ = 1.31 (d, 3J = 6.8 Hz, 3H, CH3-3), 2.51 (s, 3H, CH3-2'), 
2.52 (s, 3H, CH3-1), 3.13 (dd, 2J = 17.0, 3J = 2.6 Hz, 1H, H-4eq), 3.82 (dd, 2J = 17.0, 3J = 6.4 
Hz, 1H, H-4ax), 3.96 (s, 3H, OCH3-4'), 4.00 (s, 3H, OCH3-5'), 4.03 (s, 3H, OCH3-6), 4.04 (s, 
3H, OCH3-8), 4.25 (m, 1H, H-3), 6.74 (d, 4J = 2.2 Hz, 1H, H-7), 6.77 (d, 4J = 2.2 Hz, 1H, 
H-5), 6.97 (d, 4J = 1.0 Hz, 1H, H-3'), 6.98 (d, 3J = 8.3 Hz, 1H, H-6'), 7.09 (d, 4J = 1.0 Hz, 1H, 
H-1'), 7.46 (d, 3J = 8.3 Hz, 1H, H-7') ppm.  
13C NMR (CD3OD, 100 MHz): δ = 15.6 (3-CH3), 22.3 (2'-CH3), 24.8 (1-CH3), 35.0 (C-4), 
56.9 (4'-OCH3), 57.0 (5'-OCH3), 57.1 (6-OCH3), 57.2 (8-OCH3), 59.6 (C-3), 99.1 (C-7), 
104.9 (C-6'), 109.4 (C-5), 111.2 (C-3'), 111.3 (C-9), 113.2 (C-1'), 118.1 (C-8'), 127.2 (C-7'), 
129.9 (C-10'), 132.1 (C-9'), 142.0 (C-2'), 142.2 (C-10), 159.9 (C-4'), 161.0 (C-5'), 166.4 (C-8), 
170.7 (C-6), 178.1 (C-1) ppm. 
MS (EI, 70 eV): m/z (%) = 420 [M]+ (9), 419 [M−1]+ (15), 405 [M−15]+ (26), 201 [M−16]2+ 
(100). 
HRMS (ESI): calcd. for C26H30NO4 [M]+: 420.2175; found 420.2174. 
The ratio of 7a and 7b is determined as ca. 1 : 4 by 1H NMR spectroscopy. 
The spectroscopic data are in good agreement with those previously published.[40] 
 
5'-O-Demethylhamatine (69) 
Colorless amorphous powder (20.0 mg). 
M.p. 170−174 °C (MeOH).  
Lit.: 174−180 °C (MeOH).[124] 
[α] 20D  = +45.3 (c = 0.09, MeOH). 
Lit.: +26 (c = 0.10, MeOH).[124] 
UV (MeOH): λmax (logε) = 307 (0.57), 322 (0.48), 337 (0.43) nm. 
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CD (CH3OH): λmax (Δε) = 200 (−13.3), 228 (+22.5), 239 (−8.6), 284 (+0.1) nm. 
IR (ATR): ν  = 2514 (w), 1669 (m), 1608 (w), 1427 (w), 1392 (w), 1362 (w), 1334 (w), 
1198 (m), 1110 (m), 1077 (m), 1018 (w), 957 (w), 834 (w), 814 (w), 799 (w) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.19 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.62 (d, 3J = 6.8 Hz, 3H, 
CH3-1), 2.08 (dd, 2J = 18.0, 3J = 11.6 Hz, 1H, Hax-4), 2.13 (s, 3H, CH3-2'), 2.38 (dd, 2J = 
18.0, 3J = 4.9 Hz, 1H, Heq-4), 3.68 (m, 1H, H-3), 3.92 (s, 3H, OCH3-8), 4.12 (s, 3H, 
OCH3-4'), 4.78 (q, 3J = 6.8 Hz, 1H, H-1), 6.60 (1H, s, H-7), 6.62 (dd, 3J = 8.4, 4J = 1.2 Hz, 
1H, H-8'), 6.72 (dd, 3J = 8.4, 4J = 1.2 Hz, 1H, H-6'), 6.93 (1H, s, H-3'), 7.15 (dd, 3J = 8.4, 3J = 
8.4 Hz, 1H, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.8 (1-CH3), 19.3 (3-CH3), 20.7 (2'-CH3), 32.9 (C-4), 
45.1 (C-3), 49.3 (C-1), 56.2 (8-OCH3), 57.1 (4'-OCH3), 98.9 (C-7), 108.2 (C-3'), 110.6 (C-6'), 
114.5 (C-9), 115.3 (C-10'), 117.0 (C-5), 118.6 (C-8'), 126.1 (C-1'), 128.9 (C-7'), 132.9 (C-10), 
136.8 (C-9'), 137.5 (C-2'), 156.3 (C-5'), 157.1 (C-6), 157.4 (C-4'), 157.8 (C-8) ppm. 
1H NMR (CDCl3, 600 MHz): δ = 1.23 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.62 (d, 3J = 6.8 Hz, 3H, 
CH3-1), 2.13 (dd, 2J = 18.0, 3J = 12.0 Hz, 1H, Hax-4), 2.13 (s, 3H, CH3-2'), 2.27 (dd, 2J = 
17.0, 3J = 4.0 Hz, 1H, Heq-4), 3.54 (m, 1H, H-3), 3.85 (s, 3H, OCH3-8), 4.09 (s, 3H, 
OCH3-4'), 4.80 (q, 3J = 7.2 Hz, 1H, H-1), 6.55 (1H, s, H-7), 6.69 (dd, 3J = 8.4, 4J = 1.2 Hz, 
1H, H-8'), 6.76 (s, 1H, H-3'), 6.84 (dd, 3J = 8.4, 4J = 1.2 Hz, 1H, H-6'), 7.23 (dd, 3J = 8.4, 3J = 
8.4 Hz, 1H, H-7') ppm. 
13C NMR (CDCl3, 150 MHz): δ = 18.6 (1-CH3), 18.7 (3-CH3), 20.7 (2'-CH3), 31.8 (C-4), 
44.4 (C-3), 47.9 (C-1), 55.6 (8-OCH3), 56.4 (4'-OCH3), 97.5 (C-7), 106.7 (C-3'), 111.0 (C-6'), 
114.2 (C-10'), 114.8 (C-9), 115.9 (C-5), 116.1 (C-8'), 122.0 (C-1'), 129.5 (C-7'), 131.4 (C-10), 
136.2 (C-9'), 136.6 (C-2'), 153.9 (C-6), 155.0 (C-5'), 156.8 (C-4'), 156.8 (C-8) ppm. 
MS (EI, 70 eV): m/z (%) = 393 [M]+ (3), 392 [M−1]+ (5), 378 [M−15]+ (100). 
HRESIMS m/z. calcd. for C24H28NO4 [M+1]+: 394.2019; found 394.2021. 
The spectroscopic data are in good agreement with those previously published.[124] 
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5'-O-Demethylhamatinine (70) 
Yellow amorphous powder (2.4 mg). 
M.p. >230 °C (MeOH). 
Lit.: not reported (MeOH).[124] 
[α] 20D  = +19.3 (c = 0.10, MeOH). 
Lit.: +25.0 (c = 0.10, MeOH).[124] 
UV (MeOH): λmax (logε) = 230 (2.23), 310 (0.40), 335 (0.38) nm. 
CD (CH3OH): λmax (Δε) = 213 (−12.0), 229 (+8.3), 243 (−6.9), 296 (+2.0), 318 (−2.0), 338 
(+1.3) nm. 
IR (ATR): ν  = 3436 (w), 3223 (w), 2934 (w), 1671 (m), 1575 (m), 1502 (w), 1435 (w), 
1353 (w), 1321 (w), 1286 (w), 1267 (w), 1200 (m), 1131 (m), 1079 (m), 840 (w), 801 (w) 
cm−1. 
1H NMR (CD3OD, 600 MHz): δ = 1.19 (d, 3J = 6.6 Hz, 3H, CH3-3), 2.15 (s, 3H, CH3-2'), 
2.23 (dd, 2J = 16.8, 3J = 11.2 Hz, 1H, H-4ax), 2.49 (dd, 2J =16.8, 3J = 5.6 Hz, 1H, H-4eq), 
2.79 (d, 3J = 1.2 Hz, 3H, CH3-1), 3.76 (m, 1H, H-3), 4.05 (s, 3H, OCH3-8), 4.13 (s, 3H, 
OCH3-4'), 6.63 (dd, 3J = 8.1, 4J = 0.9 Hz, 1H, H-8'), 6.70 (s, 1H, H-7), 6.73 (dd, 3J = 8.1, 4J = 
0.9 Hz, 1H, H-6'), 6.94 (s, 1H, H-3'), 7.17 (dd, 3J = 8.1, 3J = 8.1 Hz, 1H, H-7') ppm. 
13C NMR (CD3OD, 150 MHz): δ = 18.1 (3-CH3), 20.6 (2'-CH3), 24.9 (1-CH3), 32.7 (C-4), 
49.1 (C-3), 56.8 (8-OCH3), 56.9 (4'-OCH3), 99.5 (C-7), 108.0 (C-3'), 108.8 (C-9), 110.9 
(C-6'), 115.2 (C-10'), 116.7 (C-8'), 121.0 (C-5), 124.6 (C-1'), 129.2 (C-7'), 137.1 (C-2'), 137.4 
(C-9'), 142.7 (C-10), 156.4 (C-5'), 157.7 (C-4'), 166.0 (C-8), 167.5 (C-6), 175.6 (C-1) ppm. 
MS (EI, 70 eV): m/z (%) = 392 [M+1]+ (100), 391 [M]+ (73), 376 [M−15]+ (33). 
HRESIMS m/z calcd. for C24H26NO4 [M+1]+: 392.1856; found 392.1856. 
The spectroscopic data are in good agreement with those previously published.[124]  
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Ancistrocladinine (71a) and Hamatinine (71b) 
Colorless amorphous powder (15.0 mg). 
UV (MeOH): λmax (logε) = 215 (3.31), 285 (0.88), 320 (0.76), 350 (0.71) nm. 
IR (ATR): ν  = 3180 (w), 2979 (w), 1667 (m), 1632 (w), 1574 (m), 1503 (w), 1440 (w), 
1391 (w), 1357 (w), 1319 (w), 1288 (w), 1260 (w), 1181 (s), 1125 (s), 1096 (m), 1073 (m), 
973 (w), 937 (w), 835 (w), 810 (m) cm−1. 
 
 
  
       
Ancistrocladinine (71a)  
1H NMR (CD3OD, 600 MHz): δ = 1.21 (d, 3J = 6.6 Hz, 3H, CH3-3), 2.12 (d, 3J = 6.6 Hz, 3H, 
CH3-2'), 2.31 (dd, 2J = 16.8, 3J = 10.4 Hz, 1H, H-4ax), 2.39 (dd, 2J =16.8, 3J = 5.6 Hz, 1H, 
H-4eq), 2.80 (s, 3H, CH3-1), 3.75 (m, 1H, H-3), 3.92 (s, 3H, OCH3-5'), 3.97 (s, 3H, 
OCH3-4'), 4.04 (s, 3H, OCH3-8), 6.71 (s, 1H, H-7), 6.80 (dd, 3J = 8.1, 4J = 0.9 Hz, 1H, H-8'), 
6.88 (dd, 3J = 8.1, 4J =0.9 Hz, 1H, H-6'), 6.92 (s, 1H, H-3'), 7.23 (dd, 3J = 8.1, 3J = 8.1 Hz, 
1H, H-7') ppm. 
13C NMR (CD3OD, 150 MHz): δ = 18.1 (3-CH3), 20.6 (2'-CH3), 24.9 (1-CH3), 32.9 (C-4), 
49.1 (C-3), 56.9 (8-OCH3), 57.0 (4'-OCH3), 57.1 (5'-OCH3), 99.5 (C-7), 107.4 (C-6'), 108.8 
(C-9), 110.3 (C-3'), 118.0 (C-10'), 118.3 (C-8'), 121.4 (C-5), 123.6 (C-1'), 128.4 (C-7'), 137.4 
(C-2'), 137.9 (C-9'), 142.7 (C-10), 158.6 (C-4'), 159.2 (C-5'), 166.0 (C-8), 167.6 (C-6), 175.6 
(C-1) ppm. 
 
Hamatinine (71b) 
1H NMR (CD3OD, 600 MHz): δ = 1.18 (d, 3J = 6.6 Hz, 3H, CH3-3), 2.15 (d, 3J = 6.6 Hz, 3H, 
CH3-2'), 2.20 (dd, 2J = 16.8, 3J = 10.4 Hz, 1H, H-4ax), 2.49 (dd, 2J = 16.8, 3J = 5.6 Hz, 1H, 
H-4eq), 2.80 (s, 3H, CH3-1), 3.75 (m, 1H, H-3), 3.92 (s, 3H, OCH3-5'), 3.97 (s, 3H, 
OCH3-4'), 4.04 (s, 3H, OCH3-8), 6.71 (s, 1H, H-7), 6.75 (dd, 3J = 8.1, 4J = 0.9 Hz, 1H, H-8'), 
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6.88 (dd, 2J = 8.1, 4J = 0.9 Hz, 1H, H-6'), 6.92 (s, 1H, H-3'), 7.23 (dd, 3J = 8.1, 3J = 8.1 Hz, 
1H, H-7') ppm. 
13C NMR (CD3OD, 150 MHz): δ = 18.1 (3-CH3), 20.6 (2'-CH3), 24.9 (1-CH3), 32.8 (C-4), 
49.1 (C-3), 56.9 (8-OCH3), 57.0 (4'-OCH3), 57.1 (5'-OCH3), 99.5 (C-7), 107.4 (C-6'), 108.8 
(C-9), 110.3 (C-3'), 118.0 (C-10'), 118.6 (C-8'), 121.4 (C-5), 123.7 (C-1'), 128.3 (C-7'), 137.4 
(C-2'), 137.9 (C-9'), 142.7 (C-10), 158.6 (C-4'), 159.2 (C-5'), 166.0 (C-8), 167.6 (C-6), 175.6 
(C-1) ppm. 
MS (EI, 70 eV): m/z (%) = 406 [M+1]+ (38), 405 [M]+ (100), 404 [M−1]+ (25), 392 [M−13]+ 
(17), 391 [M−14]+ (5), 390 [M−15]+ (12). 
HRESIMS m/z calcd. for C25H28NO4 [M+1]+ 406.2013; found 406.2012. 
The ratio of 71a and 71b is determined as ca. 1 : 2 by 1H NMR spectroscopy. 
The spectroscopic data are in good agreement with those previously published.[274]  
 
1,2-Dihydroancistrocladisine (72) 
Colorless amorphous powder (27.2 mg). 
M.p. 260−262 °C (MeOH).  
Lit.: 260−262 °C (MeOH).[24] 
[α] 20D  = +34.2 (c = 0.1, CHCl3).  
Lit.: +49.7 (c = 1.44, CHCl3).[126]  
UV (MeOH): λmax (logε) = 210 (2.84), 305 (0.67) nm. 
CD (CH3OH): λmax (Δε) = 206 (−9.3), 230 (+14.6), 246 (−0.6), 284 (−2.5) nm. 
IR (ATR): ν  = 2524 (m), 1669 (m), 1612 (m), 1583 (m), 1428 (w), 1393 (w), 1356 (w), 
1333 (w), 1259 (w), 1181 (m), 1129 (m), 1076 (m), 1014 (w), 964 (w), 941 (w), 836 (w), 799 
(w) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.52 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.64 (d, 3J = 6.8 Hz, 3H, 
CH3-1), 2.14 (s, 3H, CH3-2'), 2.94 (dd, 2J = 17.6, 3J = 11.3 Hz, 1H, Hax-4), 3.13 (s, 3H, 
OCH3-8), 3.23 (dd, 2J = 17.6, 3J = 4.8 Hz, 1H, Heq-4), 3.62 (s, 3H, OCH3-6), 3.91 (s, 3H, 
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OCH3-5'), 3.91 (m, 1H, H-3), 3.98 (s, 3H, OCH3-4'), 4.76 (q, 3J = 7.2 Hz, 1H, H-1), 6.73 (1H, 
s, H-5), 6.81 (dd, 3J = 7.5, 4J = 1.2 Hz, 1H, H-8'), 6.84 (dd, 3J = 7.5, 4J = 1.2 Hz, 1H, H-6'), 
6.88 (s, 1H, H-3'), 7.18 (dd, 3J = 7.8, 3J = 7.8 Hz, 1H, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 19.4 (3-CH3), 19.5 (1-CH3), 20.9 (2'-CH3), 34.9 (C-4), 
45.3 (C-3), 50.0 (C-1) 56.4 (6-OCH3), 57.0 (4'-OCH3), 57.1 (5'-OCH3), 60.5 (8-OCH3), 
107.2 (C-6'), 107.4 (C-5), 110.3 (C-3'), 117.8 (C-10'), 119.8 (C-8'), 120.0 (C-9), 121.2 (C-7), 
124.0 (C-1'), 127.6 (C-7'), 133.6 (C-10), 137.2 (C-2'), 138.0 (C-9'), 157.1 (C-8), 158.2 (C-4'), 
158.7 (C-5'), 159.9 (C-6) ppm. 
MS (EI, 70 eV): m/z (%) = 421 [M]+ (10), 420 [M−1]+ (2), 406 [M−15]+ (100). 
HRESIMS m/z calcd. for C26H32NO4 [M+1]+: 422.2326; found 422.2326.  
The spectroscopic data are in good agreement with those previously published.[24,126,275]  
 
6-O-Demethyl-8-O-methyl-7-epi-ancistrobrevine D (73) 
Colorless amorphous powder (9.0 mg). 
M.p. 170−172 °C (MeOH). 
Lit.: not reported.[127] 
[α] 20D  = +30.8 (c = 0.09, MeOH). 
Lit.: +51.8 (c = 0.71, CHCl3).[127] 
UV (MeOH): λmax (logε) = 305 (0.48), 320 (0.39), 335 (0.32) nm. 
CD (CH3OH): λmax (Δε) = 208 (−3.5), 224 (+4.8), 249 (+0.5), 255 (+1.0), 284 (−2.0), 309 
(+0.9), 342 (−0.2), 352 (+0.2) nm. 
1H NMR (CD3OD, 400 MHz): δ = 1.59 (d, 3J = 6.6 Hz, 3H, CH3-3), 1.72 (d, 3J = 6.6 Hz, 3H, 
CH3-1), 2.17 (s, 3H, CH3-2'), 3.02 (overlapped in N-CH3, 2H, H-4), 3.06 (s, 6H, OCH3-8, 
N-CH3), 3.45 (m, 1H, H-3), 3.91 (s, 3H, OCH3-5'), 3.96 (s, 3H, OCH3-4'), 4.58 (m, 1H, H-1), 
6.63 (s, 1H, H-5), 6.85 (dd, 3J = 8.1, 4J = 0.9 Hz, 1H, H-6'), 6.91 (s, 1H, H-3'), 6.96 (dd, 3J = 
8.1, 4J = 0.9 Hz, 1H, H-8'), 7.21 (dd, 3J = 8.1, 3J = 8.1 Hz, 1H, H-7') ppm. 
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13C NMR (CD3OD, 100 MHz): δ = 18.3 (3-CH3), 20.7 (1-CH3), 21.0 (2'-CH3), 35.5 (C-4), 
42.0 (N-CH3), 57.0 (4'-OCH3), 57.1 (5'-OCH3), 60.7 (8-OCH3), 60.9 (C-3), 62.8 (C-1), 107.1 
(C-6'), 110.5 (C-3'), 111.4 (C-5), 117.8 (C-10'), 118.6 (C-9), 119.9 (C-8'), 120.6 (C-7), 123.6 
(C-1'), 127.7 (C-7'), 134.8 (C-10), 137.8 (C-2'), 138.1 (C-9'), 157.5 (C-6), 157.5 (C-8), 158.3 
(C-4'), 158.8 (C-5') ppm. 
MS (EI, 70 eV): m/z (%) = 421 [M]+ (10), 406 [M−15]+ (100). 
HRESIMS m/z calcd. for C26H32NO4 [M+1]+: 422.2326; found 422.2326.  
The spectroscopic data are in good agreement with those previously published.[127] 
 
7-epi-Ancistrobrevine D (74) 
Colorless amorphous powder (3.9 mg). 
M.p. 170−173 °C (MeOH).  
Lit.: 177−178 °C.[127] 
[α] 20D  = +38.9 (c = 0.1, MeOH).  
Lit.: +46.1 (c = 0.1, CHCl3).[127]  
UV (MeOH): λmax (logε) = 210 (3.43), 304 (0.59), 335 (0.37) nm. 
CD (CH3OH): λmax (Δε) = 210 (−7.0), 230 (+6.0), 273 (+0.45) nm. 
1H NMR (CD3OD, 400 MHz): δ = 1.60 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.77 (d, 3J = 6.8 Hz, 3H, 
CH3-1), 2.10 (s, 3H, CH3-2'), 3.09 (overlapped in N-CH3, 2H, H-4), 3.10 (s, 3H, CH3-N), 
3.50 (m, 1H, H-3), 3.60 (s, 3H, OCH3-6), 3.92 (s, 3H, OCH3-5'), 3.97 (s, 3H, OCH3-4'), 4.63 
(q, 3J = 7.2 Hz, 1H, H-1), 6.56 (1H, s, H-5), 6.78 (dd, 3J = 7.5, 4J = 1.2 Hz, 1H, H-8'), 6.84 
(dd, 3J = 7.5, 4J = 1.2 Hz, 1H, H-6'), 6.92 (s, 1H, H-3'), 7.15 (dd, 3J = 7.8, 3J = 7.8 Hz, 1H, 
H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.2 (3-CH3), 19.5 (1-CH3), 20.7 (2'-CH3), 35.9 (C-4), 
41.5 (N-CH3), 56.3 (6-OCH3), 57.0 (4'-OCH3), 57.2 (5'-OCH3), 60.7 (C-3), 62.9 (C-1), 103.5 
(C-5), 107.3 (C-6'), 110.7 (C-3'), 114.8 (C-9), 115.7 (C-7), 118.1 (C-10'), 119.3 (C-8'), 122.0 
(C-1'), 127.6 (C-7'), 134.6 (C-10), 138.5 (C-9'), 138.5 (C-2'), 153.1 (C-8), 158.5 (C-4'), 158.9 
(C-5'), 159.4 (C-6) ppm. 
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MS (EI, 70 eV): m/z (%) = 421 [M]+ (4), 406 [M−15]+ (100). 
HRESIMS m/z calcd. for C26H32NO4 [M+1]+: 422.2326; found 422.2326.  
The spectroscopic data are in good agreement with those previously published.[127] 
 
6-O-Methylhamatine (75a) and 6-O-Methylancistrocladine (75b) 
Colorless amorphous powder (30.0 mg). 
UV (MeOH): λmax (logε) = 307 (057), 322 (0.48), 337 (0.43) nm. 
               
 
 
  
6-O-Methylancistrocladine (75a) 
1H NMR (CD3OD, 400 MHz): δ = 1.20 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.66 (d, 3J = 6.8 Hz, 3H, 
CH3-1), 2.04 (s, 3H, CH3-2'), 2.16 (dd, 2J =17.2, 3J = 11.2 Hz, 1H, Hax-4), 2.29 (dd, 2J = 
17.0, 3J = 4.8 Hz, 1H, Heq-4), 3.60 (m, 1H, H-3), 3.67 (s, 3H, OCH3-6), 3.93 (s, 3H, 
OCH3-5'), 3.96 (s, 3H, OCH3-4'), 4.01 (s, 3H, OCH3-8), 4.81 (q, 3J = 7.2 Hz, 1H, H-1), 6.75 
(1H, s, H-7), 6.78 (dd, 3J = 8.4, 4J = 1.2 Hz, 1H, H-8'), 6.86 (dd, 3J = 8.4, 4J = 1.2 Hz, 1H, 
H-6'), 6.89 (s, 1H, H-3'), 7.19 (dd, 3J = 7.9, 3J = 8.1 Hz, 1H, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.7 (1-CH3), 19.2 (3-CH3), 20.4 (2'-CH3), 33.1 (C-4), 
45.1 (C-3), 49.3 (C-1), 56.4 (6-OCH3), 57.0 (8-OCH3), 57.0 (4'-OCH3), 57.1 (5'-OCH3), 95.6 
(C-7), 107.2 (C-6'), 110.6 (C-3'), 115.5 (C-9), 117.9 (C-10'), 118.7 (C-8'), 120.8 (C-5), 125.8 
(C-1'), 127.9 (C-7'), 133.0 (C-10), 137.0 (C-2'), 137.7 (C-9'), 157.8 (C-6), 157.8 (C-8), 158.9 
(C-4'), 159.6 (C-5') ppm. 
 
6-O-Methylhamatine (75b) 
1H NMR (CD3OD, 400 MHz): δ = 1.19 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.65 (d, 3J = 6.8 Hz, 3H, 
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CH3-1), 2.07 (s, 3H, CH3-2'), 2.08 (dd, 2J = 17.2, 3J = 11.2 Hz, 1H, Hax-4), 2.40 (dd, 2J = 
17.0, 3J = 4.8 Hz, 1H, Heq-4), 3.65 (m, 1H, H-3), 3.64 (s, 3H, OCH3-6), 3.92 (s, 3H, 
OCH3-5'), 3.96 (s, 3H, OCH3-4'), 4.01 (s, 3H, OCH3-8), 4.81 (q, 3J = 7.2 Hz, 1H, H-1), 6.67 
(dd, 3J = 8.4, 1.2 Hz, 1H, H-8'), 6.78 (1H, s, H-7), 6.85 (dd, 3J = 8.4, 4J = 1.2 Hz, 1H, H-6'), 
6.91 (s, 1H, H-3'), 7.15 (dd, 3J = 7.9, 3J = 8.1 Hz, 1H, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.7 (1-CH3), 19.2 (3-CH3), 20.7 (2'-CH3), 32.9 (C-4), 
45.1 (C-3), 49.3 (C-1), 56.4 (6-OCH3), 57.0 (8-OCH3), 57.0 (4'-OCH3), 57.1 (5'-OCH3), 95.6 
(C-7), 107.2 (C-6'), 110.6 (C-3'), 115.3 (C-9), 117.9 (C-10'), 118.9 (C-8'), 120.8 (C-5), 125.9 
(C-1'), 127.9 (C-7'), 133.0 (C-10), 136.6 (C-2'), 137.7 (C-9'), 157.8 (C-6), 157.8 (C-8), 158.9 
(C-4'), 159.6 (C-5') ppm. 
MS (EI, 70 eV): m/z (%) = 406 [M−1]+ (5), 407 [M−15]+ (100), 421 [M]+ (4). 
HRESIMS m/z calcd. for C26H32NO4 [M+1]+: 422.2326; found 422.2326. 
The ratio of 75a and 75b is determined as ca. 1 : 2 by 1H NMR spectroscopy. 
The spectroscopic data are in good agreement with those previously published.[124,132]  
 
4'-O-Demethylancistrocladine (76) 
Colorless amorphous powder (9.0 mg). 
M.p. 183−185 °C (MeOH). 
Lit.: not reported.[120] 
[α] 20D  = −4.6 (c = 0.09, MeOH). 
Lit.: +2.5 (c = 1.0, MeOH).[120] 
UV (MeOH): λmax (logε) = 308 (0.58), 322 (0.51), 337 (0.47) nm. 
CD (CH3OH): λmax (Δε) = 200 (+18.6), 224 (−19.0), 239 (+9.1), 284 (−3.0) nm. 
IR (ATR): ν  = 2936 (w), 2508 (w), 1666 (w), 1612 (w), 1430 (w), 1396 (w), 1362 (w), 1333 
(w), 1293 (w), 1258 (w), 1181(m), 1134 (m), 1110 (m), 1079 (m), 1019 (w), 963 (w), 836 
(w), 798 (w) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.22 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.64 (d, 3J = 6.8 Hz, 3H, 
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CH3-1), 2.05 (s, 3H, CH3-2'), 2.15 (dd, 2J = 17.2, 3J = 11.2 Hz, 1H, Hax-4), 2.27 (dd, 2J = 
17.0, 3J = 4.8 Hz, 1H, Heq-4), 3.62 (m, 1H, H-3), 3.92 (s, 3H, OCH3-8), 4.08 (s, 3H, 
OCH3-5'), 4.78 (q, 3J = 7.2 Hz, 1H, H-1), 6.61 (1H, s, H-7), 6.81 (s, 1H, H-3'), 6.86 (dd, 3J = 
8.4, 4J = 1.2 Hz, 1H, H-8'), 6.88 (dd, 3J = 8.4, 4J = 1.2 Hz, 1H, H-6'), 7.22 (dd, 3J = 7.9, 3J = 
8.1 Hz, 1H, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.8 (1-CH3), 19.3 (3-CH3), 20.2 (2'-CH3), 33.2 (C-4), 
45.1 (C-3), 49.3 (C-1), 56.2 (8-OCH3), 57.0 (5'-OCH3), 98.9 (C-7), 104.9 (C-6'), 113.8 (C-3'), 
114.6 (C-9), 115.3 (C-10'), 118.6 (C-5), 119.5 (C-8'), 123.5 (C-1'), 127.7 (C-7'), 133.2 (C-10), 
137.2 (C-9'), 138.9 (C-2'), 155.4 (C-4'), 157.2 (C-6), 158.2 (C-8), 158.8 (C-5') ppm. 
1H NMR (CDCl3, 400 MHz): δ = 1.29 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.64 (d, 3J = 6.8 Hz, 3H, 
CH3-1), 2.07 (s, 3H, CH3-2'), 2.15 (dd, 2J = 17.2, 3J = 11.2 Hz, 1H, Hax-4), 2.34 (dd, 2J = 
17.0, 3J = 4.8 Hz, 1H, Heq-4), 3.48 (m, 1H, H-3), 3.87 (s, 3H, OCH3-8), 4.10 (s, 3H, 
OCH3-5'), 4.81 (q, 3J = 7.2 Hz, 1H, H-1), 6.54 (1H, s, H-7), 6.78 (dd, 3J = 8.4, 4J = 1.2 Hz, 
1H, H-6'), 6.87 (dd, 3J = 8.4, 4J = 1.2 Hz, 1H, H-8'), 6.90 (s, 1H, H-3'), 7.23 (dd, 3J = 7.9, 3J = 
8.1 Hz, 1H, H-7') ppm. 
13C NMR (CDCl3, 100 MHz): δ = 18.6 (1-CH3), 18.7 (3-CH3), 19.8 (2'-CH3), 32.1 (C-4), 
44.2 (C-3), 47.9 (C-1), 55.7 (8-OCH3), 56.5 (5'-OCH3), 97.2 (C-7), 104.1 (C-6'), 113.7 (C-3'), 
114.4 (C-10'), 115.1 (C-9), 116.0 (C-5), 118.3 (C-8'), 118.6 (C-1'), 127.3 (C-7'), 132.0 (C-10), 
136.1 (C-9'), 140.7 (C-2'), 154.0 (C-6), 155.3 (C-4'), 156.8 (C-8), 156.9 (C-5') ppm. 
MS (EI, 70 eV): m/z (%) = 393 [M]+ (6), 392 [M−1]+ (16), 378 [M−15]+ (100). 
HRESIMS m/z calcd. for C24H28NO4 [M+1]+: 394.2013; found 394.2012. 
The spectroscopic data are in good agreement with those previously published.[120]  
 
6-O-Methyl-4'-O-demethylancistrocladine (77) 
Colorless amorphous powder (6.5 mg). 
[α] 20D  = −27.5 (c = 0.1, MeOH). 
Lit.: −3.5 (c = 0.38, MeOH).[121] 
UV (MeOH): λmax (logε) = 290 (0.61), 305 (0.61), 320 (0.49), 335 (0.42) nm. 
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CD (CH3OH): λmax (Δε) = 210 (−11), 226 (−30), 240 (+19), 284 (−3.2) nm. 
IR (ATR): ν  = 3199 (w), 2989 (w), 2541 (w), 1666 (m), 1598 (m), 1583 (m), 1454 (w), 
1390 (w), 1333 (w), 1259 (w), 1197 (m), 1126 (m), 1074 (m), 1044 (m), 1005 (w), 970 (w), 
837 (w), 798 (w) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.22 (d, 3J = 6.6 Hz, 3H, CH3-3), 1.66 (d, 3J = 6.6 Hz, 3H, 
CH3-1), 2.00 (s, 3H, CH3-2'), 2.16 (dd, 2J = 17.8, 3J = 11.8 Hz, 1H, H-4ax), 2.28 (dd, 2J = 
17.8, 3J = 4.8 Hz, 1H, H-4eq), 3.66 (m, 1H, H-3), 3.67 (s, 3H, OCH3-6), 4.00 (s, 3H, 
OCH3-8), 4.08 (s, 3H, OCH3-5'), 4.80 (q, 3J = 6.8 Hz, 1H, H-1), 6.76 (dd, 3J = 8.4, 4J = 0.9 
Hz, 1H, H-8'), 6.77 (s, 2H, H-7, 3'), 6.86 (dd, 3J = 8.4, 4J = 0.9 Hz, 1H, H-6'), 7.17 (dd, 3J = 
8.4, 3J = 8.4 Hz, 1H, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.7 (1-CH3), 19.3 (3-CH3), 20.2 (2'-CH3), 33.1 (C-4), 
45.2 (C-3), 49.4 (C-1), 56.4 (6-OCH3), 56.4 (8-OCH3), 56.9 (5'-OCH3), 95.7 (C-7), 104.8 
(C-3'), 113.7 (C-6'), 115.2 (C-10'), 115.3 (C-9), 119.5 (C-8'), 120.7 (C-5), 124.1 (C-1'), 127.5 
(C-7'), 133.1 (C-10), 137.0 (C-9'), 138.2 (C-2'), 155.3 (C-4'), 158.1 (C-8), 158.2 (C-5'), 159.9 
(C-6) ppm. 
MS (EI, 70 eV): m/z (%) = 407 [M]+ (12), 406 [M−1]+ (11), 392 [M−15]+ (100). 
HRESIMS m/z calcd. for C25H30NO4 [M+1]+: 408.2169; found 408.2169. 
The spectroscopic data are in good agreement with those previously published.[121] 
 
(+)-Ancistrocline (78) 
Colorless amorphous powder (30.0 mg). 
M.p. 220−222 °C (MeOH). 
Lit.: 223−224 °C (MeOH).[118] 
[α] 20D  = +58.6 (c = 1.3, CHCl3). 
Lit.: +59.1 (c = 0.1, CHCl3).[118] 
UV (MeOH): λmax (logε) = 307 (0.57), 322 (0.48), 337 (0.43) nm. 
CD (CH3OH): λmax (Δε) = 200 (+15.8), 222 (−16.3), 237 (+18.5) nm. 
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1H NMR (CDCl3, 400 MHz): δ = 0.94 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.43 (d, 3J = 6.8 Hz, 3H, 
CH3-1), 1.87 (dd, 2J = 16.0, 3J = 2.8 Hz, 1H, Heq-4), 2.10 (dd, 2J = 16.0, 3J = 10.8 Hz, 1H, 
Hax-4), 2.16 (s, 3H, CH3-2'), 2.30 (m, 1H, H-3), 2.42 (s, 3H, N-CH3), 3.74 (m, 1H, H-1), 3.86 
(s, 3H, OCH3-8), 3.93 (s, 3H, OCH3-5'), 3.97 (s, 3H, OCH3-4'), 6.51 (1H, s, H-7), 6.73 (dd, 3J 
= 8.4, 4J = 1.2 Hz, 1H, H-8'), 6.78 (s, 1H, H-3'), 6.85 (dd, 3J = 8.4, 4J = 1.2 Hz, 1H, H-6'), 
7.19 (dd, 3J = 7.9, 3J = 8.1 Hz, 1H, H-7') ppm. 
13C NMR (CDCl3, 100 MHz): δ = 20.6 (2'-CH3), 21.2 (3-CH3), 22.9 (1-CH3), 36.1 (C-4), 
41.2 (N-CH3), 55.0 (C-3), 55.3 (8-OCH3), 56.4 (4'-OCH3), 56.5 (5'-OCH3), 57.2 (C-1), 96.4 
(C-7), 106.0 (C-6'), 109.0 (C-3'), 115.6 (C-9), 116.5 (C-10'), 117.8 (C-8'), 121.2 (C-5), 121.7 
(C-1'), 127.3 (C-7'), 136.7 (C-10), 136.9 (C-9'), 138.3 (C-2'), 152.2 (C-6), 156.8 (C-8), 157.2 
(C-4'), 157.6 (C-5') ppm. 
MS (EI, 70 eV): m/z (%) = 421 [M]+ (12), 420 [M−1]+ (11), 406 [M−15]+ (100). 
HRESIMS m/z calcd. for C26H32NO4 [M+1]+: 422.2326; found 422.2326. 
The spectroscopic data are in good agreement with those previously published.[118]  
 
6-O-Methyl-4'-O-demethylancistrocladinine (79) 
Colorless amorphous powder (4.0 mg). 
[α] 20D  = −40.5 (c = 0.10, CH3OH). 
Lit.: +41.7 (c = 0.29, CH3OH) (for its 5,1'-epi-isomer).[119]  
UV (MeOH): λmax (logε) = 227 (3.84), 280 (3.32), 321 (3.10), 336 (3.15) nm. 
CD (CH3OH): λmax (Δε) = 208 (+3.4), 228 (−1.5), 244 (−0.4), 300 (−1.2) nm. 
1H NMR (CD3OD, 400 MHz): δ = 1.20 (d, 3J = 6.8 Hz, 3H, CH3-3), 2.02 (s, 3H, CH3-2'), 
2.34 (dd, 2J = 17.6, 3J = 11.3 Hz, 1H, Hax-4), 2.41 (dd, 2J = 17.6, 3J = 4.8 Hz, 1H, Heq-4), 
2.82 (d, 4J = 1.3 Hz, 3H, CH3-1), 3.73 (m, 1H, H-3), 3.84 (s, 3H, OCH3-6), 4.09 (s, 3H, 
OCH3-5'), 4.15 (s, 3H, OCH3-8), 6.74 (dd, 3J = 7.5, 4J = 1.2 Hz, 1H, H-8'), 6.79 (1H, s, H-3'), 
6.86 (s, 1H, H-7), 6.87 (dd, 3J = 7.5, 4J = 1.2 Hz, 1H, H-6'), 7.20 (dd, 3J = 7.8, 3J = 7.8 Hz, 1H, 
H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.0 (3-CH3), 20.4 (2'-CH3), 25.0 (1-CH3), 32.6 (C-4), 
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49.3 (C-3), 57.0 (5'-OCH3), 57.1 (6-OCH3), 57.2 (8-OCH3), 96.1 (C-7), 105.0 (C-6'), 109.3 
(C-9), 113.6 (C-3'), 115.1 (C-10'), 119.3 (C-8'), 122.3 (C-1'), 122.3 (C-5), 127.9 (C-7'), 136.8 
(C-9'), 138.6 (C-2'), 141.6 (C-10), 155.8 (C-4'), 158.3 (C-5'), 166.5 (C-8), 168.6 (C-6), 176.1 
(C-1) ppm.  
MS (EI, 70 eV): m/z (%) = 405 [M]+ (100), 390 [M−15]+ (48). 
HRESIMS m/z calcd. for C25H28NO4 [M+1]+: 406.2012; found 406.2013. 
The spectroscopic data are in good agreement with the data, provided by Dr. M. Xu 
(unpublished paper in our group). 
 
6-O-Methylhamatinine (80) 
Colorless amorphous powder (2.2 mg). 
[α] 20D  = +15.6 (c = 0.10, CH3OH). 
Lit.: +34.1 (c = 0.10, CHCl3).[127] 
UV (MeOH): λmax (logε) = 235 (0.98), 320 (0.48), 335 (0.49) nm. 
CD (CH3OH): λmax (Δε) = 210 (−16.8), 229 (+12.3), 242 (−8.0) nm. 
1H NMR (CD3OD, 400 MHz): δ = 1.20 (d, 3J = 6.8 Hz, 3H, CH3-3), 2.09 (s, 3H, CH3-2'), 
2.22 (dd, 2J =17.6, 3J = 11.3 Hz, 1H, Hax-4), 2.52 (dd, 2J = 17.6, 3J = 4.8 Hz, 1H, Heq-4), 
2.82 (d, 4J = 1.3 Hz, 3H, CH3-1), 3.78 (m, 1H, H-3), 3.84 (s, 3H, OCH3-6), 3.93 (s, 3H, 
OCH3-5'), 3.97 (s, 3H, OCH3-4'), 4.16 (s, 3H, OCH3-8), 6.68 (dd, 3J = 7.5, 4J = 1.2 Hz, 1H, 
H-8'), 6.86 (1H, s, H-7), 6.86 (dd, 3J = 7.5, 4J = 1.2 Hz, 1H, H-6'), 6.91 (s, 1H, H-3'), 7.20 
(dd, 3J = 7.8, 3J = 7.8 Hz, 1H, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.0 (3-CH3), 20.5 (2'-CH3), 25.0 (1-CH3), 32.6 (C-4), 
49.1 (C-3), 57.0 (4'-OCH3), 57.1 (5'-OCH3), 57.1 (6-OCH3), 57.2 (8-OCH3), 96.1 (C-7), 
107.4 (C-6'), 109.3 (C-9), 110.2 (C-3'), 117.9 (C-10'), 118.5 (C-8'), 122.6 (C-5), 123.9 (C-1'), 
128.2 (C-7'), 137.0 (C-2'), 137.7 (C-9'), 141.6 (C-10), 158.4 (C-4'), 159.1 (C-5'), 166.5 (C-8), 
168.5 (C-6), 176.0 (C-1) ppm. 
MS (EI, 70 eV): m/z (%) = 419 [M]+ (10), 418 [M−1]+ (2), 404 [M−15]+ (100). 
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HRESIMS m/z calcd. for C26H30NO4 [M+1]+: 420.2101; found 420.2101.  
The spectroscopic data are in good agreement with those previously published.[124,127]  
 
Ancistrotectoriline B (81) 
Colorless amorphous powder (5.0 mg). 
[α] 20D  = +65.1 (c = 0.1, CH3OH). 
Lit.: +79.1 (c = 0.1, CHCl3).[121] 
UV (MeOH): λmax (logε) = 210 (3.43), 304 (0.59), 335 (0.37) nm. 
CD (CH3OH): λmax (Δε) = 205 (−12.7), 231 (+17.6) nm. 
1H NMR (CD3OD, 400 MHz): δ = 1.52 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.64 (d, 3J = 6.8 Hz, 3H, 
CH3-1), 2.09 (s, 3H, CH3-2'), 2.93 (dd, 2J = 17.6, 3J = 11.6 Hz, 1H, H-4ax), 3.12 (s, 3H, 
OCH3-8), 3.27 (dd, 2J = 17.6, 3J = 4.9 Hz, 1H, H-4eq), 3.62 (s, 3H, OCH3-6), 3.92 (m, 1H, 
H-3), 4.08 (s, 3H, OCH3-5'), 4.75 (m, 1H, H-1), 6.73 (1H, s, H-5), 6.77 (s, 1H, H-3'), 6.81 
(dd, 3J = 7.8, 4J = 1.2 Hz, 1H, H-8'), 6.85 (dd, 3J = 7.8, 4J = 1.2 Hz, 1H, H-6'), 7.16 (dd, 3J = 
7.8, 3J = 7.8 Hz, 1H, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 19.3 (3-CH3), 19.4 (1-CH3), 20.6 (2'-CH3), 34.7 (C-4), 
45.2 (C-3), 49.6 (C-1), 56.3 (6-OCH3), 56.8 (5'-OCH3), 60.3 (8-OCH3), 104.5 (C-6'), 107.2 
(C-5), 113.4 (C-3'), 114.9 (C-10'), 119.8 (C-9), 120.5 (C-8'), 120.8 (C-7), 122.1 (C-1'), 127.0 
(C-7'), 133.3 (C-10), 137.1 (C-9'), 138.3 (C-2'), 155.5 (C-4'), 157.0 (C-8), 157.8 (C-5'), 159.9 
(C-6) ppm. 
MS (EI, 70 eV): m/z (%) = 407 [M]+ (8), 406 [M−1]+ (13), 392 [M−15]+ (100). 
HRESIMS m/z calcd. for C25H30NO4 [M+1]+: 408.2169; found 408.2169. 
The spectroscopic data are in good agreement with those previously published.[121]  
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Ancistrotanzanine C (82) 
Colorless amorphous powder (5.0 mg). 
M.p. 147−149 °C (MeOH). 
Lit.: not reported.[276] 
[α] 20D  = −30.4 (c = 0.01, CH3OH).  
[α] 20D  = −20.0 (c = 0.01, CHCl3). 
Lit.: −75.5 (c = 0.1, CHCl3).[276]  
UV (MeOH): λmax (logε) = 285 (0.39), 305 (0.32), 320 (0.33), 335 (0.36) nm. 
CD (CH3OH): λmax (Δε) = 204 (−7.2), 216 (+24.6), 237 (−15.2), 265 (−0.2), 319 (−2.0), 338 
(−1.6) nm. 
IR (ATR): ν  = 2947 (w), 2508 (w), 1667 (w), 1610 (w), 1578 (w), 1435 (w), 1360 (w), 1271 
(w), 1183(m), 1130 (m), 1089 (m), 1065 (m), 967 (w), 941(w), 839 (w), 798 (w) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.58 (d, 3J = 6.6 Hz, 3H, CH3-3), 1.73 (d, 3J = 6.6 Hz, 3H, 
CH3-1), 2.15 (s, 3H, CH3-2'), 3.00 (m, 2H, H-4), 3.04 (s, 3H, N-CH3), 3.35 (s, 3H, OCH3-8), 
3.40 (m, 1H, H-3), 4.06 (s, 3H, OCH3-5'), 4.62 (q, 3J = 6.6 Hz, 1H, H-1), 6.59 (1H, s, H-5), 
6.89 (dd, 3J = 8.4, 4J = 0.9 Hz, 1H, H-6'), 7.25 (s, 1H, H-1'), 7.32 (dd, 3J = 8.4, 3J = 8.4 Hz, 
1H, H-7'), 7.35 (dd, 3J = 8.4, 4J = 0.9 Hz, 1H, H-8') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.5 (3-CH3), 20.7 (2'-CH3), 20.9 (1-CH3), 35.3 (C-4), 
42.4 (N-CH3), 56.9 (5'-OCH3), 60.7 (8-OCH3), 61.1 (C-3), 62.5 (C-1), 104.9 (C-6'), 111.3 
(C-5), 114.8 (C-10'), 117.6 (C-3'), 118.1 (C-9), 118.7 (C-7), 120.1 (C-1'), 122.2 (C-8'), 127.4 
(C-7'), 134.4 (C-10), 138.1 (C-9'), 139.1 (C-2'), 153.1 (C-4'), 157.5 (C-6), 157.7 (C-8), 157.8 
(C-5') ppm. 
1H NMR (CDCl3, 400 MHz): δ = 1.67 (d, 3J = 6.6 Hz, 3H, CH3-3), 1.77 (d, 3J = 6.6 Hz, 3H, 
CH3-1), 2.14 (s, 3H, CH3-2'), 2.92 (m, 1H, H-4), 2.92 (s, 3H, N-CH3), 3.21 (m, 1H, H-4), 
3.27 (m, 1H, H-3), 3.33 (s, 3H, OCH3-8), 4.05 (s, 3H, OCH3-5'), 4.58 (q, 3J = 6.6 Hz, 1H, 
H-1), 6.67 (1H, s, H-5), 6.80 (dd, 3J = 8.4, 4J = 0.9 Hz, 1H, H-6'), 7.31 (s, 1H, H-1'), 7.38 
(dd, 3J = 8.4, 3J = 8.4 Hz, 1H, H-7'), 7.39 (dd, 3J = 8.4, 4J = 0.9 Hz, 1H, H-8'), 9.81 (s, 1H, 
OH-4'). ppm. 
13C NMR (CDCl3, 100 MHz): δ = 19.1 (3-CH3), 20.2 (1-CH3), 20.4 (2'-CH3), 33.4 (C-4), 
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43.8 (N-CH3), 56.4 (5'-OCH3), 59.6 (C-3), 59.6 (C-1), 60.7 (8-OCH3), 104.3 (C-6'), 110.5 
(C-5), 113.5 (C-10'), 113.8 (C-3'), 116.0 (C-7), 117.8 (C-9), 120.4 (C-1'), 121.5 (C-8'), 127.2 
(C-7'), 133.5 (C-10), 137.0 (C-9'), 138.2 (C-2'), 152.3 (C-4'), 154.5 (C-6), 156.3 (C-8), 156.3 
(C-5') ppm. 
MS (EI, 70 eV): m/z (%) = 408 [M+1]+ (1), 406 [M−1]+ (2), 393 [M−14]+ (29), 392 [M−15]+ 
(100), 196 [M−15]2+ (11). 
HRESIMS m/z calcd. for C25H30NO4 [M+1]+: 408.2169; found 408.2169. 
The spectroscopic data are in good agreement with those previously published.[276,277]  
 
4'-O-Demethylancistrocladinium A (83) 
Pale-yellow amorphous powder (3.8 mg). 
M.p. >230 °C (MeOH). 
Lit.: >230 °C (MeOH).[39] 
[α] 20D = −8.9 (c = 0.10, CH3OH). 
Lit.: −5.5 (c = 0.05, CH3OH).[39] 
UV (MeOH): λmax (logε) = 210 (3.32), 305 (0.91), 320 (0.89) nm. 
CD (CH3OH): λmax (Δε) = 215 (−0.7), 230 (+0.8), 242 (−0.9), 332 (+0.5) nm. 
1H NMR (600 MHz, CD3OD): δ = 1.31 (d, 3J = 6.8 Hz, 3H, CH3-3), 2.46 (s, 3H, CH3-2'), 
2.53 (s, 3H, CH3-1), 3.13 (dd, 2J = 17.0, 3J = 2.6 Hz, 1H, H-4eq), 3.82 (dd, 2J = 17.0, 3J = 6.4 
Hz, 1H, H-4ax), 4.03 (s, 3H, OCH3-6), 4.05 (s, 3H, OCH3-8), 4.17 (s, 3H, OCH3-5'), 4.26 (m, 
1H, H-3), 6.74 (d, 4J = 2.2 Hz, 1H, H-7), 6.77 (d, 4J = 2.2 Hz, 1H, H-5), 6.88 (d, 4J = 1.0 Hz, 
1H, H-3'), 7.00 (d, 3J = 8.3 Hz, 1H, H-6'), 7.02 (d, 4J = 1.0 Hz, H-1'), 7.46 (d, 3J = 8.3 Hz, 1H, 
H-7') ppm. 
13C NMR (150 MHz, CD3OD): δ = 15.5 (3-CH3), 22.1 (2'-CH3), 24.8 (1-CH3), 35.0 (C-4), 
57.1 (8-OCH3), 57.2 (6-OCH3), 57.5 (5'-OCH3), 59.5 (C-3), 99.0 (C-7), 103.6 (C-6'), 109.5 
(C-5), 111.3 (C-9), 112.2 (C-1'), 115.5 (C-3'), 115.6 (C-8'), 126.8 (C-7'), 131.1 (C-10'), 131.6 
(C-9'), 142.1 (C-10), 143.2 (C-2'), 157.2 (C-4'), 159.9 (C-5'), 166.5 (C-8), 170.8 (C-6), 178.0 
(C-1) ppm. 
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MS (EI, 70 eV): m/z (%) = 406 [M]+ (9), 405 [M−1]+ (15), 391 [M−15]+ (100). 
HRESIMS m/z calcd. for C25H28NO4 [M]+: 406.2012; found 406.2013. 
The spectroscopic data are in good agreement with those previously published.[39]
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3  Phytochemical Investigation on a Congolese Ancistrocladus species 
3.1  Extraction and Isolation 
Air-dried root bark from a Congolese Ancistrocladus species (150 g) was ground and 
sequentially extracted with CH2Cl2 / MeOH (1:1 v/v). The extract was concentrated in vacuo 
to give 20 g of a crude residue. This residue was subjected to cation exchange 
chromatography (Amberlyst-15 from Fluka, Ø 3 cm, filling height 20 cm) in portions of 5 g. 
After eluting unbound material from the column with H2O and MeOH, the alkaloidal fraction 
was eluted with saturated aqueous NaCl solution. This fraction was extracted with CH2Cl2 
and the organic layer was concentrated in vacuo to give total 1.5 g of a dry residue. 
The residue was dissolved in CH2Cl2 and filtered to give pure 500 mg of diocophylline A 
(6), and further resolved by preparative HPLC, with the following gradient: H2O (0.05% 
trifluoroacetic acid) (A) / MeOH (0.05% trifluoroacetic acid) (B), 0 min 45% B, 30 min 75% 
B to afford two new naphthylisoquinoline alkaloids, 6-O-demethylancistrobrevine C (84) and 
jozimine A2 (85), together with three known metabolites, ancistrocladine (5a), hamatine (5b), 
and ancistrobrevine C (86).  
3.2  6-O-Demethylancistrobrevine C (84) 
Colorless amorphous powder (3.7 mg). 
M.p. 145 °C (MeOH). 
[α] 20D = +33.6 (c = 0.18, CH3OH). 
CD (CH3OH): λmax (Δε) = 207 (−3.4), 229 (+2.9), 242 (−0.9), 268 (+0.4) nm. 
IR (ATR): ν  = 3393 (w), 2508 (w), 1674 (m), 1598 (m), 1391 (w), 1197 (m), 1120 (m), 
1074 (m), 827 (w), 797 (w), 752 (w), 718 (w) cm−1. 
1H NMR (600 MHz, CD3OD): δ = 1.49/1.50 (d, 3J = 6.8 Hz, 3H, CH3-3)*, 2.17/2.19 (s, 3H, 
CH3-2')*, 2.76 (s, 3H, CH3-1), 2.88/2.91 (dd, 2J = 18.0, 3J = 11.2 Hz, 1H, Hax-4)*, 3.12 
(dd, 2J = 17.0, 3J = 5.1Hz, 1H, Heq-4), 3.93 (s, 3H, OCH3-5'), 3.99 (s, 3H, OCH3-4'), 3.99 (m, 
1H, H-3), 6.55 (1H, s, H-5), 6.87−6.91 (m, 2H, H-6', 8'), 6.94 (s, 1H, H-3'), 7.23/7.24(dd, 3J = 
7.8, 3J = 7.8 Hz, 1H, H-7')* ppm. 
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13C NMR (150 MHz, CD3OD): δ = 18.28 (3-CH3), 20.46/20.49 (2'-CH3)*, 24.61/24.62 
(1-CH3)*, 35.35/35.37 (C-4)*, 49.67 (C-3), 56.71 (4'-OCH3), 56.94 (5'-OCH3), 107.29 (C-6'), 
107.65/107.67 (C-10)*, 109.79/109.81 (C-5)*, 110.33 (C-3'), 114.94 (C-7), 118.14 (C-10'), 
118.42 (C-8'), 119.46 (C-1'), 128.02, 128.06 (C-7'), 138.23/138.28 (C-9')*, 139.38/139.42 
(C-2')*, 141.92/141.96 (C-9)*, 158.96, 159.07 (C-4', 5'), 162.63/162.65 (C-8)*, 166.38/166.40 
(C-6)*, 175.95/175.98 (C-1)* ppm. 
*: These signals separated for the two isomers. 
HRESIMS m/z calcd. for C24H26NO4 [M+1]+: 392.1856; found 392.1854. 
3.3  Jozimine A2 (85) 
White crystals (3.0 mg). 
 
M.p. 238−240°C (MeOH). 
 
[α] 20D = −29.8 (c = 0.20, MeOH). 
 
UV (MeOH): λmax (logε) = 284 (1.15), 300 (1.23), 325 (1.11), 335 (1.06) nm. 
CD (CH3OH): λmax (Δε) = 206 (−3.2), 229 (+6.2), 243 (−4.2), 305 (+0.9) nm. 
IR (ATR): ν  = 2850 (w), 1673 (s), 1434 (m), 1392 (m), 1200 (s), 1132 (s), 799 (m), 758 (m) 
cm−1. 
1H NMR (600 MHz, CD3OD): δ = 1.53 (d, 3J = 6.0 Hz, 6H, CH3-3 and CH3-3'''), 1.69 (d, 3J = 
6.0 Hz, 6H, CH3-1 and CH3-1'''), 1.83 (s, 6H, CH3-2' and CH3-2''), 2.96 (dd, 2J = 17.6, 3J = 
11.8 Hz, 2H, H-4ax and Hax-4'''), 3.23 (dd, 2J = 17.6, 3J = 4.7 Hz, 2H, H-4eq and Heq-4'''), 
3.90 (m, 2H, H-3 and H-3'''), 4.11 (s, 6H, OCH3-5' and OCH3-5''), 4.88 (m, 2H, H-1 and 
H-1'''), 6.88 (d, 3J = 7.8 Hz, 2H, H-5 and H-5'''), 6.92 (dd, 3J = 7.8, 4J = 1.2 Hz, 2H, H-8' and 
H-8''), 7.00 (d, 3J = 7.8 Hz, 4H, H-6, 6' and H-6''', 6''), 7.25 (dd, 3J = 7.8, 3J = 7.8 Hz, 2H, H-7' 
and H-7'') ppm. 
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13C NMR (150 MHz, CD3OD): δ = 18.07 (CH3-2' and CH3-2''), 18.11 (CH3-1 and CH3-1'''), 
19.45 (CH3-3 and CH3-3'''), 34.62 (C-4 and C-4'''), 45.36 (C-3 and C-3'''), 50.00 (C-1 and 
C-1'''), 57.28 (5'-OCH3 and 5''-OCH3), 105.68 (C-6' and C-6''), 115.23 (C-10' and C-10''), 
120.65 (C-8' and C-8''), 121.14 (C-5 and C-5'''), 121.36 (C-3' and C-3''), 122.15 (C-9 and 
C-9'''), 125.93 (C-7 and C-7'''), 126.28 (C-1' and C-1''), 127.52 (C-7' and C-7''), 132.69 (C-10 
and C-10'''), 132.71 (C-6 and C-6'''), 137.41 (C-9' and C-9''), 138.34 (C-2' and C-2''), 152.13 
(C-4' and C-4''), 152.82 (C-8 and C-8'''), 157.81 (C-5' and C-5'') ppm. 
1H NMR (600 MHz, CD3COCD3): δ = 1.62 (d, 3J = 6.0 Hz, 6H, CH3-3 and CH3-3'''), 1.75 
(d, 3J = 6.0 Hz, 6H, CH3-1 and CH3-1'''), 1.86 (s, 6H, CH3-2' and CH3-2''), 3.09 (dd, 2J = 
17.6, 3J = 11.8 Hz, 2H, H-4ax and Hax-4'''), 3.21 (dd, 2J = 17.6, 3J = 4.7 Hz, 2H, H-4eq and 
Heq-4'''), 4.00 (m, 2H, H-3 and H-3'''), 4.14 (s, 6H, OCH3-5' and OCH3-5''), 5.02 (q, 3J = 6.6 
Hz, 2H, H-1 and H-1'''), 6.87 (d, 3J = 7.8 Hz, 2H, H-5 and H-5'''), 6.95 (d, 3J = 7.8 Hz, 2H, 
H-8' and H-8''), 6.98 (d, 3J = 7.8 Hz, 2H, H-6' and H-6''), 6.99 (d, 3J = 7.8 Hz, 2H, H-6 and 
H-6'''), 7.24 (dd, 3J = 7.8, 3J = 7.8 Hz, 2H, H-7' and H-7''), 9.73 (s, 2H, OH) ppm. 
13C NMR (150 MHz, CD3COCD3): δ = 17.96 (CH3-1 and CH3-1'''), 18.21 (CH3-2' and 
CH3-2''), 19.05 (CH3-3 and CH3-3'''), 34.33 (C-4 and C-4'''), 44.68 (C-3 and C-3'''), 48.84 
(C-1 and C-1'''), 56.92 (5'-OCH3 and 5''-OCH3), 104.84 (C-6' and C-6''), 114.72 (C-10' and 
C-10''), 120.24 (C-8' and C-8''), 121.08 (C-5 and C-5'''), 121.33 (C-3' and C-3''), 122.15 (C-9 
and C-9'''), 124.19 (C-1' and C-1''), 125.60 (C-7 and C-7'''), 126.82 (C-7' and C-7''), 131.82 
(C-6 and C-6'''), 132.79 (C-10 and C-10'''), 136.67 (C-9' and C-9''), 138.28 (C-2' and C-2''), 
151.80 (C-8 and C-8'''), 152.30 (C-4' and C-4''), 157.46 (C-5' and C-5'') ppm. 
HRESIMS m/z calcd. for C46H49N2O6 [M+1]+: 725.3585; found 725.3581. 
Crystal data for 85: C46H48N2O6, Mr = 724.86, colorless needle, 0.58 × 0.08 × 0.06 mm3, 
Orthorhombic space group P212121, a = 12.6900(8) Å, b = 17.1715(13) Å, c = 25.5037(18) Å, 
V = 5557.4(7) Å3, Z = 4, ρcalcd = 0.866 g·cm–3, µ = 0.057 mm–1, F(000) = 1544, T = 100 (2) 
K, R1 = 0.1427, wR2 = 0.3813, 6042 independent reflections [2θ ≤ 52.08°] and 500 parameters. 
Crystallographic data will be deposited with the Cambridge Crystallographic Data Center. 
These data will be obtained free of charge from The Cambridge Crystallographic Data Centre 
via www.ccdc.cam.ac.uk/data_request/cif. 
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3.4  Known Alkaloids 
Dioncophylline A (6) 
Yellowish amorphous powder (500 mg). 
M.p. 214 °C (MeOH). 
Lit.: 214 °C.[22] 
Lit.: 228−229 °C.[146] 
Lit.: 215 °C.[140] 
[α] 20D = −18.0 (c = 0.10, CHCl3). 
Lit.: [α] 20D = −14.9 (c = 1.0, CHCl3).
[22] 
Lit.: [α] 20D = −14 (c = 0.64, CHCl3).
[146] 
Lit.: [α] 20D = −14.9 (c = 0.45, CH2Cl2).
[140] 
UV (MeOH): λmax (logε) = 231 (1.05), 306 (0.52) nm. 
CD (CH3OH): λmax (Δε) = 198 (+3.1), 224 (−27.8), 244 (+20.3) nm.  
1H NMR (400 MHz, CDCl3): δ = 1.31 (d, 3J = 6.2 Hz, 3H, CH3-3), 1.52 (d, 3J = 6.3 Hz, 3H, 
CH3-1), 2.18 (s, 3H, CH3-2'), 2.63 (dd, 2J = 16.5, 3J = 11.0 Hz, 1H, Hax-4), 2.86 (dd, 2J = 
16.5, 3J = 3.8 Hz, 1H, Heq-4), 3.43 (m, 1H, H-3), 3.95 (s, 3H, 4'-OCH3), 3.99 (s, 3H, 
5'-OCH3), 4.50 (q, 1H, H-1), 6.76 (s, 1H, H-3'), 6.76 (d, 3J = 7.6 Hz, 1H, H-6'), 6.76 (d, 3J = 
7.9 Hz, 1H, H-5), 6.87 (d, 3J = 7.9 Hz, 1H, H-6), 6.97 (d, 3J = 8.2 Hz, 1H, H-8'), 7.23 (dd, 3J = 
8.0, 3J = 7.9 Hz, 1H, H-7') ppm. 
MS (EI, 70 eV): m/z (%) = 377 [M]+ (78), 362 [M−15]+ (100). 
HRESIMS m/z calcd. for C24H27NO3 [M+1]+: 377.1991; found 377.1989. 
The spectroscopic data are in good agreement with those previously published.[22,140,146,273] 
6 
Phytochemical Investigation of a Congolese Ancistrocladus species  141 
  
Ancistrobrevine C (88) 
Colorless amorphous powder (8.0 mg). 
M.p. 128−130 °C (MeOH). 
Lit.: 180−183 °C (MeOH).[142] 
Lit.: 160−166 °C (MeOH).[147] 
[α] 20D = +26 (c = 0.26, CHCl3). 
Lit.: [α] 20D  = +13 (c = 0.69, CHCl3).
[142] 
Lit.: [α] 20D  = −13 (c = 0.69, CHCl3).
[147] 
Even small impurities (3-epi-ancistrobrevine C) change the M.p. and [α] 20D  values to an 
unusually large extent, which explains the different values with that in the literature. 
UV (MeOH): λmax (logε) = 215 (2.84), 295 (0.50), 335 (0.44), 350 (0.38) nm. 
CD (CH3OH): λmax (Δε) = 213 (+10.0), 229 (−8.5), 243 (+5.7), 266 (−0.8), 328 (+3.0) nm. 
IR (ATR): ν  = 1671 (w), 1587 (w), 1432 (w), 1200 (w), 1121 (w), 1045 (w), 798 (w), 753 
(w), 720 (w), 669 (w) cm−1. 
1H NMR (CD3OD, 400 MHz): δ = 1.53 (d, 3J = 6.8 Hz, 3H, CH3-3), 2.15 (s, 3H, CH3-2'), 
2.80 (s, 3H, CH3-1), 3.00 (dd, 2J = 18.0, 3J = 11.2 Hz, 1H, Hax-4), 3.23 (dd, 2J = 17.0, 3J = 
5.1 Hz, 1H, Heq-4), 3.75 (s, 3H, OCH3-6), 3.93 (s, 3H, OCH3-5'), 3.98 (s, 3H, OCH3-4'), 
4.06 (m, 1H, H-3), 6.79 (dd, 3J = 7.5, 4J = 1.2 Hz, 1H, H-8'), 6.82 (1H, s, H-5), 6.87 (dd, 3J = 
7.5, 4J = 1.2 Hz, 1H, H-6'), 6.93 (s, 1H, H-3'), 7.21(dd, 3J = 7.8, 3J = 7.8 Hz, 1H, H-7') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 18.2 (CH3-3), 20.4 (CH3-2'), 24.5 (CH3-1), 35.6 (C-4), 
49.8 (C-3), 56.7 (4'-OCH3), 57.0 (5'-OCH3, 6-OCH3), 105.4 (C-5), 107.3 (C-6'), 109.1 (C-10), 
110.3 (C-3'), 116.3 (C-7), 118.1 (C-10'), 118.4 (C-8'), 120.0 (C-1'), 128.0 (C-7'), 138.1 (C-9'), 
138.9 (C-2'), 142.9 (C-9), 158.9 (C-4', 5'), 161.3 (C-8), 167.2 (C-6), 176.6 (C-1) ppm. 
MS (EI, 70 eV): m/z (%) = 405 [M]+ (100), 404 [M−1]+ (10), 390 [M−15]+ (32). 
HRESIMS m/z calcd. for C25H28NO4 [M+1]+: 406.2010; found 406.2008. 
The spectroscopic data are in good agreement with those previously published.[142,147]
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4  Semi-Synthesis of Dimeric Naphthylisoquinoline Alkaloids 
4.1  Synthesis of Jozimine A2 (85) and its 3'-epimer 3'-epi-85 
4'-O-Demethyldioncophylline A (89) and 5'-O-demethyldioncophylline A (90) 
To a solution of dioncophylline A (6) (265.0 mg, 0.70 mmol) in dry chloroform (35 mL), 
iodotrimethylsilane (448 μL, 3.2 mmol) was added portionwise under argon and stirred over 
48 h. The mixture was diluted with water (35 mL) and extracted with chloroform (30 mL × 3). 
The combined organic layers were concentrated under reduced pressure and the two main 
products, 89 and 90, were resolved by preparative HPLC on SymmetryPrep C18, 19 × 300 
mm column (Waters), using the following solvent gradient: H2O + 0.05% TFA (A), MeCN + 
0.05% TFA (B); flow rate: 10 mL min−1; 0 min 30% B, 35 min 60% B, 36 min 95% B, 41 min 
95% B, 42 min 30% B, 46 min 30% B, affording compounds 89 (retention time = 20.9 min) 
as a pale-yellow solid (124.5 mg, 0.34 mmol, 49%) and 90 (retention time = 20.0 min) as a 
pale-yellow solid (124.0 mg, 0.34 mmol, 49%). 
 
4'-O-Demethyldioncophylline A (89) 
Pale-yellow solid. 
M.p. 232−234 °C (MeOH). 
Yield: 124.5 mg, (0.34 mmol, 49%). 
[α] 20D = −4.0 (c = 0.087, CHCl3). 
UV (MeOH): λmax (logε) = 231 (1.05), 306 (0.52) nm. 
1H NMR (400 MHz, CDCl3): 1.60 (d, 3J = 6.2 Hz, 3H, 3-CH3), 1.65 (d, 3J = 6.3 Hz, 3H, 
1-CH3), 2.07 (s, 3H, 2'-CH3), 3.00 (dd, 2J = 17.2, 3J = 4.8 Hz, 1H, Heq-4), 3.14 (dd, 2J = 
17.2, 3J = 11.3 Hz, 1H, Hax-4), 3.75 (m, 1H, H-3), 4.08 (s, 3H, 5'-OCH3), 4.88 (q, 1H, H-1), 
6.73 (d, 3J = 7.4 Hz, 1H, H-6'), 6.78 (s, 1H, H-3'), 6.79 (d, 3J = 7.6 Hz, 1H, H-5), 6.89 (d, 3J = 
7.9 Hz, 1H, H-8'), 6.94 (d, 3J = 7.9 Hz, 1H, H-6), 7.19 (dd, 3J = 7.8, 3J = 7.9 Hz, 1H, H-7') 
ppm.   
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13C NMR (100 MHz, CDCl3): δ = 18.0 (1-CH3), 18.9 (3-CH3), 20.5 (2'-CH3), 34.0 (C-4), 
44.3 (C-3), 48.2 (C-1), 56.4 (5'-OCH3), 104.0 (C-6'), 113.0 (C-6'), 114.1 (C-10'), 119.5 (C-8'), 
120.7 (C-9 or 1'), 120.8 (C-1' or 9), 121.0 (C-5), 123.9 (C-7), 126.9 (C-7'), 130.8 (C-6), 131.8 
(C-10), 136.3 (C-9'), 138.5 (C-2'), 149.8 (C-8), 155.2 (C-4'), 156.5 (C-5') ppm. 
EIMS m/z (rel. int.): 363 [M]+ (12), 349 [M−14]+ (23), 348 [M−15]+ (100). 
HRMS (ESI): calcd. for C23H26NO3 [M+1]+: 364.1907; found 364.1906. 
 
5'-O-Demethyldioncophylline A (90) 
Pale-yellow solid. 
Yield: 124.5 mg, (0.34 mmol, 49%). 
M.p. 232−234 °C (MeOH). 
Lit.: 232−234 °C (MeOH).[156] 
[α] 20D = −10.3 (c = 0.16, CHCl3). 
Lit.: −11.1 (c = 0.015, CHCl3).[156] 
UV (MeOH): λmax (logε) = 231 (1.05), 306 (0.52) nm. 
1H NMR (400 MHz, CDCl3): δ = 1.59 (d, 3J = 6.2 Hz, 3H, 3-CH3), 1.64 (d, 3J = 6.3 Hz, 3H, 
1-CH3), 2.09 (s, 3H, 2'-CH3), 3.04 (dd, 2J = 17.2, 3J = 4.8 Hz, 1H, Heq-4), 3.15 (dd, 2J = 
17.2, 3J = 11.3 Hz, 1H, Hax-4), 3.73 (m, 1H, H-3), 4.07 (s, 3H, 4'-OCH3), 4.88 (q, 1H, H-1), 
6.67 (s, 1H, H-3'), 6.74 (d, 3J = 7.4 Hz, 1H, H-6'), 6.78 (d, 3J = 7.6 Hz, 1H, H-5), 6.79 (dd, 4J 
= 1.2, 3J = 7.9 Hz, 1H, H-8'), 6.91 (dd, 4J = 1.2, 3J = 7.9 Hz, 1H, H-6), 7.20 (dd, 3J = 7.8, 3J = 
7.9 Hz, 1 H, H-7') ppm. 
13C NMR (100 MHz, CDCl3): δ = 18.0 (1-CH3), 18.8 (3-CH3), 20.7 (2'-CH3), 34.0 (C-4), 
44.3 (C-3), 48.2 (C-1), 56.4 (4'-OCH3), 106.8 (C-3'), 110.6 (C-6'), 113.9 (C-10'), 116.8 (C-8'), 
121.0 (C-5 or 7), 121.1 (C-7 or C-5), 123.7 (C-9 or C-1'), 123.7 (C-1' or C-9), 128.8 (C-7'), 
130.5 (C-6), 132.0 (C-10), 136.3 (C-9'), 136.4 (C-2'), 149.6 (C-8), 154.8 (C-5'), 156.6 (C-4') 
ppm. 
EIMS m/z (rel. int.): 363 [M]+ (23), 349 [M−14]+ (33), 348 [M−15]+ (100). 
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HRMS (ESI): calcd. for C23H26NO3 [M+1]+: 364.1907; found 364.1906. 
The spectroscopic data are in agreement with those in the literature.[156] 
 
N,8-O-Dibenzyl-4'-O-demethyldioncophylline A (220) 
A suspension of compound 89 (22.0 mg, 60.4 μmol), Cs2CO3 (43.3 mg, 133 μmol) and 
benzyl bromide (10.3 mg, 60.4 μmol) in acetone (6 mL) was refluxed for 2 h. Another 
equivalent of benzyl bromide (10.3 mg, 60.4 μmol) was then added in portions over a period 
of 6 h. The reaction mixture was dried over MgSO4, filtered, and the solvent was removed in 
vacuo. Column chromatography on deactivated silica gel (7.5% NH3) with a mobile phase of 
PE/EtOAc (10:1) yielded 220 (30.2 mg, 55.6 μmol, 92%) as a pale-yellow solid. 
 
Pale-yellow solid. 
Yield: 30.2 mg, (55.6 μmol, 92%). 
M.p. 162 °C (CH2Cl2). 
[α] 20D  = +32.4 (c = 0.10, CH2Cl2). 
IR (ATM): ν  = 3374 (w), 2922 (w), 2863 (w), 1651 (m), 1558 (m), 1457 (w), 1396 (w), 
1258 (m), 1070 (w) cm-1. 
1H NMR (400 MHz, CDCl3): δ = 1.31−1.37 (m, 6H, 1-CH3 and 3-CH3), 2.26 (s, 3H, 2'-CH3), 
2.74-2.79 (m, 2H, 4-CH2), 3.45 (d, 2J = 14.0 Hz, 1H, N-CH2Ar), 3.57−3.65 (m, 1H, H-3), 
3.95−4.01 (m, 2H, O-CH2Ar), 4.06 (s, 3H, 5'-OCH3), 4.08−4.12 (m, 1H, H-1), 6.41 − 6.43 (m, 
2H, H-5 and H-6), 6.71 (d, 3J = 7.9 Hz, 1H, H-6'), 6.83 (s, 1H, H-3'), 6.96−7.42 (m, 12H, H-7', 
H-8' and Ar-H), 9.41 (s, 1H, 4'-OH). 
13C NMR (100 MHz, CDCl3): δ = 19.4 (1-CH3), 20.6 (2'-CH3), 21.3 (3-CH3), 32.7 (C-4), 
43.2 (C-3), 45.4 (C-1), 46.7 (N-CH2Ar), 52.2 (5'-OCH3), 72.1 (O-CH2Ar), 103.2 (C-6'), 112.9 
(C-3'), 113.5 (C-4'a), 119.4 (C-8'), 121.6 (C-5), 124.5 (C-1'), 126.1 (Ar-C), 126.2 (C-7'), 126.6 
(Ar-C), 127.3 (C-8a), 127.4 (Ar-C), 127.5 (C-7), 127.6 (C-6), 130.1 (Ar-C), 131.0 (Ar-C), 
133.4 (Ar-C), 134.2 (C-4a), 137.9 (C-8'a), 138.2 (C-2'), 138.3 (Ar-C), 140.6 (Ar-C), 150.5 
(C-8), 154.3 (C-4'), 156.8 (C-5'). 
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EIMS (70 eV) m/z (rel int.): 528 (100) [M-CH3]+, 437 (6) [M-Bn-CH3]+, 91 (89) [Bn]+. 
HRESIMS m/z: calculated for C37H38NO3 [M+H]+: 544.2846; found: 544.2843. 
 
Jozimine A2 (85) and its 3'-epimer 3'-epi-85 
To a solution of 220 (25.0 mg, 46.0 μmol) in CH2Cl2 (4 mL), BF3▪Et2O (14.4 mg, 101 
μmol) was added at 0 °C and the mixture was stirred for 5 min. A solution of Pb(OAc)4 (22.4 
mg, 50.6 µmol) in CH2Cl2 (1 mL) was added dropwise and stirring was continued for another 
5 min. The reaction was quenched with a saturated aqueous Na2SO3 solution (5 mL), and the 
aequeous phase was extracted with CH2Cl2 (3 mL × 2). The combined organic phases were 
dried over MgSO4, and insoluble parts were filtered off. The residue was concentrated under 
reduced pressure followed by purification on deactivated silica gel with PE/EtOAc (5:1) as 
the mobile phase, yielding a mixture of M-91 and P-91 (7.51 mg, 6.92 μmol, 30%) as a 
pale-yellow solid. Given that the two atropisomers were not separable on SiO2 or on 
preparative HPLC, the mixture of the isomers was used for debenzylation without 
characterization. HRESIMS m/z: calculated for C74H73N2O6: 1085.5463; found: 1085.5459 
[M+H]+. The above-obtained mixture of the two atropisomers 91 (7.01 mg, 6.46 μmol) and 
Pd/C (10%, 1.01 mg) were suspended in EtOH (4 mL). The mixture was stirred for 12 h under 
normal H2 pressure. After filtration over a short pad of Celite, the solvent was removed in 
vacuo. Jozimine A2 (85) (1.92 mg, 2.65 μmol, 41%, white crystals) and 3',3''-epi-jozimine A2 
(3'-epi-85) (2.04 mg, 2.82 μmol, 44 %, white solid) were separated by preparative HPLC, 
using the following column and solvent gradient: Chromolith-SemiPrep column RP-C18 
(Merck, 10 × 100 mm); H2O + 0.05% TFA (A), MeCN + 0.05% TFA (B); flow rate: 10 mL 
min−1; 0 min 10% B, 7 min 50% B, 9 min 100% B, 11 min 100% B, 12 min 10% B, 15 min 
30% B.  
Jozimine A2 (85) 
Colorless solid. 
M.p. 237−239 °C (MeOH). 
[α] 20D  = −27.3 (c = 0.10, MeOH). 
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Analytical data of 85 are in complete agreement with the data of the authentic sample, as 
described in 3.3. 
 
3'-epi-jozimine A2 (3'-epi-85) 
 
Colorless solid. 
M.p. 238−239 °C (MeOH). 
[α] 20D  = +14.2 (c = 0.10, MeOH). 
UV (MeOH): λmax (logε) = 232, 285, 307, 323, 337 nm. 
CD (CH3OH): λmax (Δε) = 340 (+1.2), 304 (−0.7), 243 (+3.5), 230 (−5.8), 215 (+3.4), 207 
(−1.4). 
IR (ATM): ν  = 2853 (w), 1672 (s), 1456 (m), 1398 (m), 1199 (s), 1132 (s), 798 (m) cm-1. 
1H NMR (600 MHz, MeOD): δ = 1.52 (d, 3J = 6.7 Hz, 3H, 3-CH3 and 3'''-CH3), 1.67 (d, 3J = 
6.8 Hz, 3H, 1-CH3 and 1'''-CH3), 1.82 (s, 3H, 2'-CH3 and 2''-CH3), 2.97 (dd, 2J = 17.5 Hz, 3J 
= 11.6 Hz, 1H, Hax-4 and Hax-4'''), 3.25 (dd, 2J = 17.3 Hz, 3J = 5.0 Hz, 1H, Heq-4 and 
Heq-4'''), 3.88 (m, 1H, H-3 and H-3'''), 4.15 (s, 3H, 5'-OCH3 and 5''-OCH3), 4.87 (q, 3J = 6.6 
Hz, 1H, H-1 and H-1'''), 6.90 (d, 3J = 7.8 Hz, 1H, H-5 and H-5'''), 6.93 (d, 3J = 7.7 Hz, 1H, 
H-8' and H-8''), 7.04 (d, 3J = 7.8 Hz, 1H, H-6 and H-6'''), 7.06 (d, 3J = 8.5 Hz, 1H, H-6' and 
H-6''), 7.25 (dd, 3J = 8.5 Hz, 3J = 7.8 Hz, 1H, H-7' and H-7''). 
13C NMR (150 MHz, MeOD): δ = 18.2 (1-CH3 and 1'''-CH3), 18.3 (2'-CH3 and 2''-CH3), 19.4 
(3-CH3 and 3'''-CH3), 34.8 (C-4 and C-4'''), 45.5 (C-3 and C-3'''), 50.1 (C-1 and C-1'''), 57.3 
(5'-OCH3 and 5''-OCH3), 105.8 (C-6' and C-6''), 115.4 (C-4a' and C-4a''), 120.6 (C-8' and 
C-8''), 121.2 (C-5 and C-5'''), 121.8 (C-3' and C-3''), 122.2 (C-8a and C-8'''a), 126.1 (C-7 and 
C-7'''), 126.4 (C-1' and C-1''), 127.4 (C-7' and C-7''), 132.7 (C-6 and C-6'''), 132.9 (C-4a and 
C-4'''a), 137.3 (C-8'a and C-8''a), 138.7 (C-2' and C-2''), 152.6 (C-4' and C-4''), 152.6 (C-8 and 
C-8'''), 157.6 (C-5' and C-5'') ppm. 
HRESIMS m/z: calculated for C46H49N2O6 [M+H]+: 725.3585; found: 725.3592. 
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4.2  Synthesis of Jozimine A3 (93) 
N,8-O-Dibenzyl-5'-O-demethyldioncophylline A (92) 
A suspension of compound 90 (56.8 mg, 156.0 μmol), Cs2CO3 (111.7 mg, 343.2 μmol) and 
benzyl bromide (26.6 mg, 156.0 μmol) in acetone (10 mL) was refluxed for 2 h. Another 
equivalent of benzyl bromide (26.6 mg, 156.0 μmol) was then added in portions over a period 
of 12 h. The reaction mixture was dried over Na2SO4, filtered, and the solvent was removed 
in vacuo. Column chromatography on deactivated silica gel (7.5% NH3) with a mobile phase 
of PE/EtOAc (20:1) yielded 92 (72.0 mg, 132.6 μmol, 85%) as a pale-yellow solid. 
 
Pale-yellow solid. 
Yield: 72.0 mg, (132.6 μmol, 85%). 
[α] 20D = +28.0 (c = 0.1, CHCl3). 
Lit.: +28.8 (c = 0.51, CHCl3).[157] 
Lit.: +28.8 (c = 0.51, CHCl3).[156] 
1H NMR (400 MHz, CD3OD): δ = 1.34 (d, 3J = 6.8 Hz, 3H, 1-CH3), 1.40 (d, 3J = 6.6 Hz, 3H, 
3-CH3), 2.82 (m, 2H, H-4), 3.52 (d, 3J = 14.0 Hz, 1H, N-CH2Ar), 3.65 (m, 1H, H-3), 3.99 (m, 
1H, N-CH2Ar), 4.01-4.18 (m, 3H, O-CH2Ar and 1-H), 4.22 (s, 3H, 4'-OCH3), 6.47-7.48 (m, 
16H, Ar-H) ppm. 
13C NMR (100 MHz, CD3OD): δ = 20.0 (1-CH3), 20.5 (3-CH3), 21.0 (2'-CH3), 32.9 (C-4), 
46.6 (C-3), 50.8 (N-CH2Ar), 52.3 (H-1), 56.8 (4'-OCH3), 75.5 (O-CH2Ar), 107.8, 110.0, 
110.1, 114.7, 117.6, 125.5, 127.5, 128.4, 128.5, 128.7, 128.8, 129.1, 129.4, 130.6, 131.0, 
134.0, 136.1, 136.8, 137.3, 138.1, 142.0, 155.8, 155.9, 156.1, 156.6 ppm. 
EIMS m/z (rel. int.): 420 [M−123]+ (20), 528 [M−15]+ (100). 
The spectroscopic data are in good agreement with those in the literature.[156,157] 
 
Jozimine A3 (93) 
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To a solution of 92 (17.7 mg, 32.5 μmol) in CHCl3 (5 mL) and NEt3 (10 μL), freshly 
prepared dry Ag2O (271.0 mg, 1.17 mmol) was added and stirred for 8 h under air at room 
temperature. The reaction mixture was filtered on a short pad of Celite using CH2Cl2/CH3OH 
(100 : 1) as a mobile phase. After evaporation of the solvent in vacuo, the deep-violet colored 
crude product (16.0 mg) was hydrogenated in ethanol (6 mL) in the presence of Pd/C (4.0 mg) 
under normal H2 pressure for 4 h. 2 N aqueous HCl solution (20 µL) was added into the 
mixture and stirred for another 12 h at room temperature. After filtration over a short pad of 
Celite eluting with CH2Cl2/CH3OH (100 : 1), the solvent was removed under reduced 
pressure. Jozimine A3 (93) (3.1 mg, 4.4 μmol, 28%) was isolated by preparative HPLC on 
SymmetryPrep C18, 19 × 300 mm column (Waters) and the following solvent gradient: H2O + 
0.05% TFA (A), MeCN + 0.05% TFA (B); flow rate: 10 mL min−1; 0 min 20% B, 35 min 60% 
B, 36 min 95% B, 41 min 95% B, 42 min 20% B, 46 min 20% B. 
 
Colorless solid. 
Yield: 3.1 mg, (4.4 μmol, 28%). 
 
M.p. dec. ≥ 230 °C (MeOH). 
[α] 20D  = +37.5 (c = 0.1, MeOH). 
UV (MeOH): λmax (logε) = 235, 263, 286, 312, 329, 339 nm. 
CD (CH3OH): λmax (Δε) = 224 (−6.2), 268 (+2.9), 280 (+7.1), 302 (−3.1), 343 (+1.1). 
IR (ATR): ν  = 3733 (s), 1734 (m), 1682 (m), 1601 (m), 1201 (w), 1146 (w), 1051 (m), 799 
(m) cm−1. 
1H NMR (600 MHz, CD3OD): δ = 1.53 (d, 3J = 6.8 Hz, 3H, CH3-3 and CH3-3'''), 1.72 (d, 3J = 
6.8 Hz, 3H, CH3-1 and CH3-1'''), 2.18 (s, 3H, CH3-2' and CH3-2''), 2.94 (dd, 2J = 17.6, 3J = 
11.8 Hz, 1H, H-4ax and Hax-4'''), 3.24 (dd, 2J = 17.6, 3J = 5.2 Hz, 1H, H-4eq and Heq-4'''), 
3.91 (m, 1H, 3-H and 3''''-H), 4.13 (s, 3H, OCH3-4' and OCH3-4''), 4.89 (q, 1H, 3J = 6.8 Hz, 
H-1 and H-1'''), 6.75 (d, 3J = 8.7 Hz, 1H, H-8' and H-8''), 6.89 (d, 3J = 8.0 Hz, 1H, H-5 and 
H-5''''), 6.97 (s, 1H, H-3' and H-3''), 6.98 (d, 3J = 8.0 Hz, 1H, H-6 and H-6''''), 7.22 (d, 3J = 8.7 
Hz, 1H, H-7' and H-7'') ppm. 
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13C NMR (150 MHz, CD3OD): δ = 18.0 (CH3-1 and CH3-1'''), 19.3 (CH3-3 and CH3-3'''), 
20.7 (CH3-2' and CH3-2''), 34.5 (C-4 and C-4'''), 45.2 (C-3 and C-3'''), 49.9 (C-1 and C-1'''), 
56.7 (4'-OCH3 and 4''-OCH3), 108.4 (C-3' and C-3''), 115.3 (C-10' and C-10''), 116.9 (C-8' 
and C-8''), 120.8 (C-6' and C-6''), 121.3 (C-5 and C-5'''), 122.2 (C-9 and C-9'''), 125.7 (C-7 
and C-7'''), 126.9 (C-1' and C-1''), 132.0 (C-7' and C-7''), 132.5 (C-10 and C-10'''), 132.6 (C-6 
and C-6'''), 137.0 (C-2' and C-2''), 137.2 (C-9' and C-9''), 152.3 (C-8 and C-8'''), 152.6 (C-5' 
and C-5''), 157.7 (C-4' and C-4'') ppm. 
HRESIMS m/z: calculated for C30H31NO3: 725.3585 [M+H]+; found: 725.3583. 
 
4.3  Synthesis of Dioncotetralones A (94a) and B (94b) 
To a solution of dioncophylline A (6) (11.0 mg, 28.0 μmol) in CH2Cl2 (2 mL), BF3▪Et2O 
(73.0 μmol) was added at 0 °C and the mixture was stirred for 5 min. A solution of Pb(OAc)4 
(14.7 mg, 33.6 μmol) in CH2Cl2 (1 mL) was added dropwise and stirring was continued for 
another 5 min. The reaction mixture was filtered on a short pad of Celite eluting with a mobile 
phase of CH2Cl2/MeOH (8 : 2). After removal of the organic solvents, the residue was 
purified on preparative HPLC using the following column and a linear gradient: 
Chromolith-SemiPrep column RP-C18 (Merck, 10 × 100 mm); H2O + 0.05% TFA (A), MeCN 
+ 0.05% TFA (B); flow rate: 10 mL min−1; 0 min 5% B, 7 min 45% B, 9 min 100% B, 11 min 
100% B, 12 min 5% B, 15 min 5% B, yielding 94a (3.2 mg, 8.4 μmol, 30%, retention time = 
3.8 min) and 94b (3.4 mg, 8.9 μmol, 32%, retention time = 4.0 min), both as yellowish solids. 
 
Dioncotetralone A (94a) 
Colorless solid. 
Yield: 3.2 mg, (8.4 μmol, 30%). 
M.p. >230 °C (CH3OH). 
[α] 20D  = +135 (c = 0.21, CH3OH). 
UV (MeOH): λmax (logε) = 255 (0.51), 285 (0.31), 310 (0.34) nm. 
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CD (CH3OH): λmax (Δε) = 216 (−10.5), 235 (+15.2), 345 (−0.22) nm. 
IR (ATR): ν  = 3380 (w), 2934 (w), 2837 (w), 1625 (m), 1588 (m), 1460 (w), 1431 (m), 
1292 (w), 1243 (w), 1122 (w), 1086 (m), 1045 (m), 1023 (m), 877 (w), 753 (w) cm−1.  
1H NMR (600 MHz, CD3OD): δ = 1.36 (s, CH3-2'), 1.49 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.75 
(d, 3J = 6.8 Hz, 3H, CH3-1), 2.85 (dd, 3J =11.1, 2J = 17.4 Hz, 1H, Hax-4), 3.00 (d, 2J = 19.4 
Hz, 1H, Hax-3'), 3.15 (dd, 3J = 4.4, 2J = 17.4 Hz, 1H, Heq-4), 3.36 (d, 2J = 19.4 Hz, 1H, 
Heq-3'), 3.84 (m, 1H, H-3), 3.92 (s, 3H, OCH3-5'), 4.78 (q, 3J = 6.8 Hz, 1H, H-1), 6.53 (d, 3J 
= 8.4 Hz, 1H, H-8'), 6.78 (d, 3J = 8.4 Hz, 1H, H-5), 6.95 (d, 3J = 8.4 Hz, 1H, H-6), 6.97 (d, 3J 
= 8.4 Hz, 1H, H-6'), 7.49 (dd, 3J = 8.4, 3J = 8.4 Hz, 1H, H-7') ppm. 
13C NMR (150 MHz, CD3OD): δ = 18.2 (3-CH3), 19.1 (1-CH3), 22.8 (2'-CH3), 34.5 (C-4), 
44.9 (C-3'), 46.0 (C-3), 49.4 (C-1), 56.4 (5'-OCH3), 59.5 (C-2'), 111.7 (C-6'), 114.7 (C-10'), 
117.9 (C-10), 118.9 (C-8'), 123.3 (C-5), 124.1 (C-6), 124.3 (C-9'), 132.7 (C-9), 134.4 (C-7), 
138.6 (C-7'), 155.3 (C-8), 159.3 (C-5'), 160.8 (C-1'), 204.7 (C-4') ppm. 
MS (EI, 70 eV): m/z (%) = 362 [M−17]+ (70), 364 [M−15]+ (100), 378 [M−1]+ (16). 
HRMS (ESI): calcd. for C23H26NO4 [M+1]+: 380.1848; found 380.1849. 
 
Dioncotetralone B (94b) 
Colorless solid. 
Yield: 3.9 mg, (8.9 μmol, 32%). 
M.p. 162−165 °C (CH3OH). 
[α] 20D = −206 (c = 0.21, CH3OH). 
UV (MeOH): λmax (logε) = 255 (0.45), 285 (0.20), 310 (0.27) nm.  
CD (CH3OH): λmax (Δε) = 218 (+10.5), 236 (−18.8), 341 (+0.16) nm. 
IR (ATR): ν  = 3380 (w), 3016 (w), 2839(w), 1671 (m), 1591 (m), 1481 (w), 1435 (w), 1273 
(m), 1179 (m), 1129 (m), 1033 (w), 831 (w), 799 (m), 782 (w), 721 (m) cm−1. 
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1H NMR (600 MHz, CD3OD): δ = 1.36 (s, CH3-2'), 1.49 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.78 
(d, 3J = 6.8 Hz, 3H, CH3-1), 2.85 (dd, 3J = 11.1, 2J = 17.4 Hz, 1H, Hax-4), 3.00 (d, 2J = 19.4 
Hz, 1H, Hax-3'), 3.15 (dd, 3J = 4.4, 2J = 17.4 Hz, 1H, Heq-4), 3.36 (d, 2J = 19.4 Hz, 1H, 
Heq-3'), 3.84 (m, 1H, H-3), 3.93 (s, 3H, OCH3-5'), 4.79 (q, 3J = 6.8 Hz, 1H, H-1), 6.52 (d, 3J 
= 8.4 Hz, 1H, H-8'), 6.78 (d, 3J = 8.4 Hz, 1H, H-5), 6.96 (d, 3J = 8.4 Hz, 1H, H-6), 6.98 (d, 3J 
= 8.4 Hz, 1H, H-6'), 7.51 (dd, 3J = 8.4, 3J = 8.4 Hz, 1H, H-7') ppm. 
13C NMR (150 MHz, CD3OD): δ = 18.5 (3-CH3), 19.0 (1-CH3), 22.8 (2'-CH3), 34.5 (C-4), 
44.9 (C-3'), 46.1 (C-3), 49.9 (C-1), 56.4 (5'-OCH3), 59.6 (C-2'), 111.7 (C-6'), 114.5 (C-10'), 
118.1 (C-10), 118.9 (C-8'), 123.2 (C-5), 124.1 (C-6), 124.3 (C-9'), 132.7 (C-9), 134.3 (C-7), 
138.7 (C-7'), 155.2 (C-8), 159.3 (C-5'), 160.6 (C-1'), 204.6 (C-4') ppm. 
MS (EI, 70 eV): m/z (%) = 362 [M−17]+ (70), 364 [M−15]+ (100), 378 [M−1]+ (16). 
HRMS (ESI): calcd. for C23H26NO4 [M+1]+: 380.1848; found 380.1849. 
 
4.4  Synthesis of 4',5'-O,O-Didemethyldioncophylline A (99a/99b) 
To the solution of dioncophylline A (6) (64.0 mg, 169 μmol) in DMF (5 mL), NaSMe (35.6 
mg, 508 μmol) was portionwise added under argon and the reaction mixture was stirred at 120 
°C overnight. DMF was removed by evaporation under reduced pressure. The residue was 
filtered on a short pad of Celite and directedly submitted for NMR measurement. 
 
Colorless powder. 
Yield: 58.9 mg, (169 μmol, 100%). 
UV (MeOH): λmax (logε) = 231 (1.45), 306 (0.70) nm. 
1H NMR (400 MHz, CD3OD): δ = 1.52 (d, 3J = 6.8 Hz, 3H, CH3-3), 1.53 (d, 3J = 6.8 Hz, 3H, 
CH3-3), 1.68 (d, 3J = 6.8 Hz, 3H, CH3-1), 1.69 (d, 3J = 6.8 Hz, 3H, CH3-1), 2.07 (s, 3H, 
CH3-2'), 2.08 (s, 3H, CH3-2'), 2.85-2.98 (m, 2H, Hax-4), 3.18-3.30 (m, 2H, Heq-4), 3.90 (m, 
2H, H-3),* 4.86 (m, 2H, H-1), 6.64-6.70 (m, 4H, H-6', 8'),* 6.73 (s, 1H, H-3'), 6.74 (s, 1H, 
H-3'), 6.84 (d, 3J = 8.4 Hz, 2H, H-5),* 6.92 (d, J = 8.4 Hz, 2H, H-6),* 7.08 (d, 3J = 8.4, 3J = 
8.4 Hz, 2H, H-7') ppm.* 
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13C NMR (100 MHz, CD3OD): δ = 18.0 (1-CH3),* 19.2 (3-CH3),* 20.6 (2'-CH3),* 20.7 
(2'-CH3),* 34.6 (C-4), 45.4 (C-3), 50.1 (C-1), 108.9 (C-8'),* 112.2 (C-3'),* 115.0 (C-9'),* 
118.1 (C-6'), 121.2 (C-5), 122.0 (C-10), 124.6 (C-1'), 126.0 (C-7), 127.9 (C-7'),* 128.0 
(C-7'),* 132.2 (C-9), 132.7 (C-6), 137.9 (C-2'),* 138.0 (C-10'),* 152.3 (C-8), 155.6 (C-4'),* 
155.7 (C-5') ppm.* 
*: These signals overlapped for the two isomers. 
MS (EI, 70 eV): m/z (%) = 349 [M−1]+ (14), 334 [M−15]+ (100). 
HRMS (ESI): calcd. for C22H24NO3 [M+1]+: 350.1746; found 350.1744. 
The spectroscopic data are in agreement with those in the literature.[273]
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5  Phytochemical Investigation on T. peltatum 
5.1  Extraction and Isolation 
Seeds from T. peltatum were obtained from the Parc de Tai, Ivory Coast. Voucher 
specimens of plant species have been deposited in the Herb. Bringmann, University of 
Würzburg [Nos. 2, 35, and 36 (T. peltatum)]. 
35.2 g lyophilized cell cultures of T. peltatum were ground and extracted with CH2Cl2 : 
CH3OH (1 : 1 v/v). The extract was condensed under reduced pressure to give 6.6 g of a crude 
residue, which was subjected to a cation exchange column chromatography eluting 
successively with methanol, aqueous saturated NaCl solution, methanol, water, acetone and 
methanol. From the first methanol fraction, the three known main metabolites were detectable 
by HPLC (TR = 2.84 min for 9, 4.81 min for 10, and 6.33 min for 101), together with some 
other minor compounds, 100 and 102−107. 
The three main naphthoquinones, dioncoquinones A (9) and B (10) and droserone (101), 
were isolated on normal-phase silica gel using the gradient of the mixing solvents (CHCl3: 
CH3OH : HCOOH = 1 : 0 : 0 → 1 : 0 : 0.005 → 1 : 0 : 0.008 → 1 : 0.05 : 0.008 → 1 : 0.1 : 
0.01 → 1 : 0.15 : 0.01 v/v). The other four naphthoquinones, dioncoquinone C (102) (TR = 
10.9 min), dioncoquinone D (103) (TR = 18.9 min), dioncoquinone E (104) (TR = 11.2 min), 
and 8-hydroxydroserone (105) (TR = 11.0 min) were isolated by preparative HPLC 
[Symmetry RP-18 (19 × 300 mm, 7 μm); H2O + 0.05% TFA (A) / CH3OH + 0.05% TFA (B), 
0 min 53% A, 35 min 20% A, 37 min 5% A, 42 min 5% A, 43 min 53% A, 48 min 53% A]. 
In addition, triphoquinol A (107) (TR = 8.0 min) was obtained by preparative HPLC [Merck 
Chromolith RP-18 (4.6 × 100mm, 5 μm); H2O + 0.05% TFA (A) / CH3CN + 0.05% TFA (B), 
0 min 50% A, 10 min 40% A, 12 min 3% A, 14 min 3% A, 15 min 50% A;], and plumbagin 
(100) was detectable. 
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5.2  Dioncoquinone C (102) 
Yellow solid (1.0 mg). 
M.p. > 340 °C (MeOH). 
UV (MeOH): λmax (logε) = 255 (2.17), 305 (1.78), 425 (1.11) nm. 
1H NMR (MeOD, 600 MHz): δ = 1.97 (s, 3H, CH3-2), 3.99 (s, 1H, 7-OCH3), 7.29 (s, 1H, H-8) 
ppm. 
13C NMR (MeOD, 150 MHz): δ = 8.6 (CH3-2), 56.9 (7-OCH3), 105.1 (C-8), 110.3 (C-10), 
121.5 (C-2), 125.5 (C-9), 140.0 (C-6), 151.2 (C-5), 154.0 (C-7), 156.4 (C-3), 185.7 (C-4 or 
C-1), 185.8 (C-1 or C-4) ppm. 
1H NMR (CD3COCD3, 600 MHz): δ = 1.98 (s, 3H, CH3-2), 4.01 (s, 1H, 7-OCH3), 7.27 (s, 
1H, H-8) ppm. 
13C NMR (CD3COCD3, 150 MHz): δ = 8.6 (CH3-2), 56.8 (7-OCH3), 104.8 (C-8), 109.8 
(C-10), 121.0 (C-2), 125.3 (C-9), 139.4 (C-6), 150.5 (C-5), 153.6 (C-7), 154.8 (C-3), 184.2 
(C-1), 185.1 (C-4) ppm. 
MS (EI, 70 eV): m/z (%) = 250 [M]+ (47), 233 [M−18]+ (23), 220 [M−30] (7), 204 [M−46] 
(5). 
HRESIMS m/z calcd. for C12H9O6 [M−1]+: 249.0399; found 249.0404. 
 
5.3  Dioncoquinone D (103) 
Yellow solid (1.0 mg). 
M.p. > 340 °C (MeOH). 
UV (MeOH): λmax (logε) = 255 (2.17), 305 (1.78), 425 (1.11) nm. 
1H NMR (CDCl3, 600 MHz): δ = 2.05 (s, 3H, CH3-2), 4.01 (s, 3H, 7-OCH3), 4.05 (s, 3H, 
3-OCH3), 7.26 (s, 1H, H-8), 11.82 (s, 1H, 5-OH) ppm. 
13C NMR (CDCl3, 150 MHz): δ = 9.6 (CH3-2), 58.0 (7-OCH3), 61.3 (3-OCH3), 103.6 (C-8), 
102 
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110.1 (C-10), 124.4 (C-9), 133.3 (C-2), 138.2 (C-6), 149.2 (C-5), 151.3 (C-7), 157.1 (C-3), 
184.4 (C-1), 185.6 (C-4) ppm. 
MS (EI, 70 eV): m/z (%) = 264 [M]+ (43), 247 ([M−18]+ (21), 233 [M−32]+ (11), 217 [M−47] 
(6). 
HRESIMS m/z calcd. for C13H11O6 [M−1]+: 263.0557; found 263.0561. 
 
5.4  Dioncoquinone E (104) 
Yellow solid (1.6 mg). 
M.p. > 340 °C (MeOH). 
UV (MeOH): λmax (logε) = 250 (2.26), 300 (1.89), 405 (1.48) nm. 
1H NMR (MeOD, 600 MHz): δ = 1.96 (s, 3H, CH3-2), 3.91 (s, 3H, 6-OCH3), 7.09 (s, 1H, H-8) 
ppm. 
13C NMR (MeOD, 150 MHz): δ = 8.5 (CH3-2), 61.1 (6-OCH3), 109.1 (C-10), 110.2 (C-8), 
121.2 (C-2), 130.2 (C-9), 139.7 (C-6), 157.0 (C-3), 157.3 (C-5), 158.6 (C-7), 184.9 (C-4), 
185.8 (C-1) ppm. 
MS (EI, 70 eV): m/z (%) = 259 [M]+ (53), 233 [M−18]+ (27), 220 [M−39] (5), 204 [M−55] 
(9).  
HRESIMS m/z calcd. for C12H9O6 [M−1]+: 249.0399; found 249.0404. 
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5.5  Triphoquinol A (107) 
Colorless powder (3.0 mg). 
M.p. 106 °C (MeOH). 
[α] 20D  = −65.0 (c = 0.08, CH3OH). 
UV (MeOH): λmax (logε) = 250 (1.73), 265 (1.64), 310 (1.30) nm. 
CD (CH3OH): λmax (Δε) = 224 (+39.0), 242 (−25.1), 291 (+2.7), 336 (−8.6). 
1H NMR (CDCl3, 600 MHz): δ = 2.15 (s, 3H, CH3-2), 3.98 (s, 3H, CH3O-5), 6.72 (d, 3J = 7.8 
Hz, 1H, H-6), 7.28 (dd, 3J = 7.8, 3J = 7.8 Hz, 1H, H-7), 7.31 (s, 1H, H-1), 7.39 (d, 3J = 7.8 Hz, 
1H, H-8), 9.53 (s, 1H, OH-4) ppm. 
13C NMR (CDCl3, 150 MHz): δ = 20.5 (CH3-2), 56.2 (5-OCH3), 103.4 (C-6), 113.8 (C-10), 
119.2 (C-1), 120.3 (C-3), 121.5 (C-8), 125.6 (C-7), 136.4 (C-9), 138.1 (C-2), 150.9 (C-4), 
156.4 (C-5) ppm. 
MS (EI, 70 eV): m/z (%) = 374 [M]+ (100), 187 [M/2]+ (14), 172 [M/2−15]+. 
HRESIMS m/z calcd. for C24H23O4 [M+1]+: 375.1518; found 375.1516. 
 
5.6  Known Compounds 
Dioncoquinone A (9) 
Yellow solid (110.0 mg). 
M.p. 191 °C (MeOH). 
Lit.: 189 °C (MeOH).[54] 
UV (MeOH): λmax (logε) = 250 (2.26), 284 (1.84), 415 (0.94) nm. 
IR (ATR): ν  = 3405 (br, m), 2923 (m), 2853 (w), 1638 (s), 1458 (m), 1365 (w), 1262 (m), 
1074 (s), 842 (w), 641 (w) cm−1. 
1H-NMR (CD3OD, 400 MHz): δ = 1.99 (s, 3H, CH3-2), 3.2−3.5 (m, 4H, 2′, 3′, 4′, 5′-H), 3.70 
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(dd, 3J = 11.4, 3J = 2.3 Hz, 1H, 6′-H), 3.90 (d, 2J = 11.4 Hz, 1H, 6′-H), 5.06 (d, 3J = 7.1 Hz, 
1H, 1′-H), 7.43 (d, 3J = 7.2 Hz, 1H, 7-H), 7.54 (m, 3J = 7.2 Hz, 1H, 8-H) ppm. 
MS (EI, 70 eV): m/z (%) = 220 [M−162]+ (100), 192 [M−180]+ (24), 163 [M−219]+ (19). 
The spectroscopic data are in good agreement with that in the literature.[54] 
 
Dioncoquinone B (10) 
Orange solid (44.0 mg). 
M.p. 220 °C (MeOH). 
Lit.: 218 °C (MeOH).[54] 
UV (MeOH): λmax (logε) = 250 (2.28), 295 (1.94), 415 (1.28) nm. 
IR (ATR): ν  = 3408 (br, m), 2922 (m), 2853 (w), 1618 (s), 1459 (m), 1297 (s), 1209 (w), 
1105 (m), 430 (w) cm−1. 
1H-NMR (CDCl3, 400 MHz): δ = 2.07 (s, 3H, 2-CH3), 6.03 (s, 1H, 6-OH), 7.02 (s, 1H, 3-OH), 
7.15 (d, 3J = 8.2 Hz, 1H, H-7), 7.61 (d, 3J = 8.2 Hz, 1H, H-8), 11.19 (s, 1H, 5-OH) ppm. 
MS (EI, 70 eV): m/z (%) = 220 [M]+ (46), 192 [M−18]+ (15), 163 [M−57]+ (13), 146 [M−74]+ 
(12). 
The spectroscopic data are in good agreement with that in the literature.[54] 
 
Droserone (101) 
Yellow solid (50.0 mg). 
M.p. 178−180 °C (MeOH). 
Lit.: 179−181 °C (MeOH).[52] 
1H NMR (CDCl3, 400 MHz): δ = 2.10 (s, 3H, CH3-2), 7.19 (s, 1H, 3-OH), 7.19 (dd, 3J = 
8.1, 4J = 1.5 Hz , 1H, H-8), 7.60−7.67 (m, 2H, H-6, H-7), 11.09 (s, 1H, 5-OH) ppm. 
13C NMR (CDCl3, 100 MHz): δ = 8.8 (CH3-2), 117.0 (C-10), 119.7 (C-6), 121.8 (C-2), 123.2 
(C-8), 132.7 (C-9), 137.5 (C-7), 152.8 (C-3), 161.2 (C-5), 184.5 (C-4), 190.0 (C-1) ppm. 
10 
101 
Phytochemical Investigation of T. peltatum  158 
  
MS (EI, 70 eV): m/z (%): 204 [M]+ (100), 176 [M−28]+ (24), 147 [M−57]+ (36), 121 [M−83]+ 
(29). 
The spectroscopic data are in good agreement with that in the literature.[278] 
 
8-Hydroxydroserone (105) 
Red solid (3.0 mg). 
M.p. 193 °C (CDCl3). 
Lit.: 193 °C (CDCl3).[162] 
UV (MeOH): λmax (logε) = 290 (1.70), 485 (1.41) nm. 
1H-NMR (CDCl3, 400 MHz): δ = 2.09 (s, 3H, CH3-2), 7.27 (d, 3J = 8.0 Hz, 1H, H-7), 7.16 
(d, 3J = 8.0 Hz, 1H, H-6), 7.27 (br, s, 1 H, 3-OH), 11.47 (d, 1H, 5-OH), 12.81 (d, 1H, 8-OH) 
ppm. 
13C-NMR (CDCl3, 100 MHz): δ = 8.5 (CH3-2), 110.4 (C-10), 111.0 (C-9), 121.7 (C-2), 127.7 
(C-6), 131.7 (C-7), 154.0 (C-3), 157.3 (C-8), 157.8 (C-5), 182.2 (C-4), 189.1 (C-1) ppm. 
HRESIMS m/z calcd. for C11H7O5 [M−1]+: 219.0296; found 219.0299. 
The spectroscopic data are in good agreement with that in the literature.[162,279] 
 
Ancistronaphthoic acid B (106) 
Colorless powder (3.8 mg). 
M.p. 225 °C (MeOH). 
Lit.: 233 °C.[136] 
Lit.: 238 °C (CHCl3).[35] 
UV (MeOH): λmax (logε) = 250 (1.84), 300 (1.42), 340 (1.27) nm. 
1H NMR (CD3COCD3 : C5D5N = 1 : 1 v/v, 600 MHz): δ = 4.10 (s, 3H), 7.08 (dd, 3J = 8.0, 4J 
= 1.2 Hz, 1H, H-6), 7.49 (dd, 3J = 8.0, 3J = 8.0 Hz, 1H, H-7), 7.58 (dd, 3J = 8.0, 4J = 1.2 Hz, 
1H, H-8), 7.65 (d, 3J = 1.2 Hz, 1H, H-3), 8.48 (d, 4J = 1.2 Hz, 1H, H-1) ppm. 
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13C NMR (CD3COCD3 : C5D5N = 1 : 1 v/v, 150 MHz): δ = 56.6 (CH3O-4), 104.1 (C-3), 
113.2 (C-6), 117.3 (C-10), 120.9 (C-8), 125.2 (C-1), 129.0 (C-7), 130.2 (C-2), 136.7 (C-9), 
155.4 (C-5), 157.1 (C-4), 168.7 (COOH) ppm. 
1H NMR (CD3OD, 600 MHz): δ = 4.13 (s, 3H), 6.93 (dd, 3J = 6.6, 4J = 1.2 Hz, 1H), 
7.43–7.40 (m, 3H), 8.17 (d, 4J = 1.2 Hz, 1H) ppm. 
13C NMR (CD3OD, 150 MHz): δ = 56.8 (CH3O-4), 103.9 (C-3), 113.8 (C-6), 117.9 (C-10), 
121.5 (C-8), 126.0 (C-1), 129.4 (C-7), 129.4 (C-2), 137.3 (C-9), 155.8 (C-5), 157.8 (C-4), 
169.6 (COOH) ppm. 
1H NMR (CD3COCD3, 600 MHz): δ = 4.12 (s, 3H), 6.93 (dd, 3J = 6.6, 4J = 1.2 Hz, 1H), 7.52 
– 7.41 (m, 3H), 8.20 (d, 4J = 1.2 Hz, 1H) ppm.  
1H NMR (C5D5N, 400 MHz): δ = 3.91 (s, 3H), 7.19 (m, overlapped in the NMR solvent 
signal, 1H), 7.48 (dd, 3J = 8.0, 3J = 8.0 Hz, 1H), 7.50 (m, overlapped in the NMR solvent 
signal, 1H), 7.75 (d, 4J = 1.2 Hz, 1H), 8.67 (d, 4J = 1.2 Hz, 1H) ppm. 
MS (EI, 70 eV): m/z (%) = 218 [M]+ (100), 203 [M−15]+ (24), 175 [203−28] + (34). 
HRESIMS m/z calcd. for C12H10O4 [M]+: 218.0579; found 218.0580. 
The spectroscopic data are in good agreement with that in the literature.[35,136] 
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6  Phytochemical Investigation on N. alata 
6.1  Extraction and Isolation 
Stem and leaves of Nepenthes alata, N. intermedia, and N. khashiama were collected in the 
Botanical Garden of the University of Würzburg. 
Two pieces of leaves of each plant of N. alata, N. intermedia, and N. khashiama were 
ground and extracted with CH2Cl2 : CH3OH : 0.01 N HCl (1 : 1 : 0.01 v/v). The crude 
extracts were concentrated in vacuo and analyzed by HPLC [Merck Chromolith RP-18 (4.6 × 
100 mm, 5 μm); H2O + 0.05% TFA (A) / CH3OH + 0.05% TFA (B), 0 min 90% A, 5 min 
50% A, 7 min 3% A, 9 min 3% A, 10 min 90% A]. HPLC analysis revealed that the 
secondary metabolites in each plant showed rapid rention times ranging from 1.0 to 4.0 min 
and the maximum UV absorption wavelength below 400 nm. Based on this information, the 
absence of naphthoquinones in the plants can be concluded. 
N. alata was phytochemically investigated for characterization of the main metabolites. 60 
gram of the air dried plant were powdered and then extracted with CH3OH : CH2Cl2 : 0.01 N 
HCl (1 : 1 : 0.01 v/v) for three times. The crude extract was submitted to liquid-liquid 
separation in CH2Cl2 and aqueous 5% NaHCO3 solution. The organic layer was condensed 
by evaporation in vacuo and then fractionated by Sephadex LH-20 chromatography eluting 
with CH3OH, leading to isolation of three known flavonoids 119−121. 
6.2  Known Compounds 
Quercetin-3-O-β-D-glucuronide (119) 
Yellow powder (22.4 mg). 
M.p. 158−160 °C (MeOH). 
Lit.: 190−192 °C.[280] 
[α] 20D  = −90.3 (c = 0.92, CH3OH). 
Lit.: −24.3 (c = 0.66, CH3OH).[186] 
UV (MeOH): λmax (logε) = 203 (4.09), 258 (1.35), 360 (1.08) nm. 
119 
Phytochemical Investigation of N. alata 161 
  
1H NMR (DMSO, 400 MHz): δ = 3.3 (m, 2H, H-3'', 5''), 3.4 (m, 1H, H-2''), 3.58 (m, 1H, 
H-4''), 5.50 (d, 3J = 7.3 Hz, 1H, H-1''), 6.22 (d, 4J = 2.0 Hz, 1H, H-6), 6.43 (d, 4J = 2.0 Hz, 1H, 
H-8), 6.84 (d, 3J = 8.4 Hz, 1H, H-5'), 7.53 (d, 4J = 2.1 Hz, 1H, H-2'), 7.61 (dd, 3J = 8.4, 4J = 
2.1 Hz, 1H, H-6'), 9.26 (s, 1H), 9.81 (s, 1H), 10.97 (s, 1H), 12.56 (s, 1H, 5-OH) ppm. 
13C NMR (DMSO, 100 MHz): δ = 71.4 (C-2''), 73.8 (C-3''), 76.0 (C-5''), 76.1 (C-4''), 93.7 
(C-8), 98.8 (C-6), 101.1 (C-1''), 103.9 (C-10), 115.3 (C-5'), 116.0 (C-2'), 120.9 (C-1'), 121.8 
(C-6'), 133.1 (C-3), 145.0 (C-3'), 148.7 (C-4'), 156.2 (C-2 or 9), 156.3 (C-9 or 2), 161.2 (C-5), 
164.3 (C-7), 169.8 (C-6''), 177.2 (C-4) ppm. 
HRESIMS m/z calcd. for C21H17Na2O13 [M+Na]+: 523.0459; found 523.0465. 
The spectroscopic data are in good agreement with that in the literature.[186] 
 
Quercetin-3-O-α-L-rhamnopyranoside (120) 
Yellow powder (7.0 mg). 
M.p. 166−170 °C (MeOH). 
Lit.: 175−177 °C.[187] 
[α] 20D  = −258.1 (c = 0.5, CH3OH). 
Lit.: −144.9.[187] 
UV (MeOH): λmax (logε) = 203 (1.56), 256 (0.70), 354 (0.52) nm. 
1H NMR (CD3OD, 400 MHz): δ = 0.94 (d, 3J = 6.0 Hz, 3H, H-6''), 3.34 (m, 1H, H-4''), 3.41 
(m, 1H, H-5''), 3.75 (dd, 3J = 9.3, 3J = 3.4 Hz, 1H, H-3''), 4.22 (dd, 3J = 3.5, 3J = 1.8 Hz, 1H, 
H-2''), 5.35 (d, 3J = 1.6 Hz, 1H, H-1''), 6.20 (d, 4J = 2.1 Hz, 1H, H-6), 6.37 (d, 4J = 2.1 Hz, 1H, 
H-8), 6.91 (d, 3J = 8.4 Hz, 1H, H-5'), 7.30 (dd, 3J = 8.0, 4J = 2.1 Hz, 1H, H-6'), 7.32 (d, 4J = 
2.1 Hz, 1H, H-2') ppm. 
13C NMR (CD3OD, 100 MHz): δ = 17.8 (C-6''), 72.1 (C-2''), 72.2 (C-5''), 72.3 (C-3''), 73.4 
(C-4''), 94.9 (C-8), 100.0 (C-6), 103.7 (C-1''), 106.1 (C-10), 116.5 (C-5'), 117.1 (C-2'), 123.0 
(C-6'), 123.1 (C-1'), 136.4 (C-3), 146.6 (C-3'), 150.0 (C-4'), 158.7 (C-9), 159.5 (C-2), 163.4 
(C-5), 166.0 (C-7), 179.8 (C-4) ppm. 
HRESIMS m/z calcd. for C21H20NaO11 [M+Na]+: 471.0903; found 471.0898. 
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The spectroscopic data are in good agreement with that in the literature.[187] 
 
Kaempferol-3-O-α-L-rhamnopyranoside (121) 
Yellow powder (3.2 mg). 
M.p. 164−166 °C (MeOH). 
Lit.: 164−166 °C.[188] 
UV (MeOH):λmax (logε) = 203 (1.34), 267 (0.31), 347 (0.09) nm. 
1H NMR (CD3OD, 600 MHz): δ = 0.92 (d, 3J = 5.8 Hz, 3H, H-6''), 3.3 (m, 2H, H-4'', 5''), 3.7 
(m, 1H, H-3''), 4.22 (dd, 3J = 3.2, 3J = 1.6 Hz, 1H, H-2''), 5.37 (d, 3J = 6.8 Hz, 4J = 1.8 Hz, 2H, 
H-3', H-5'), 7.77 (dd, 3J = 6.8, 4J = 1.8 Hz, 2H, H-2', 6') ppm. 
13C NMR (CD3OD, 150 MHz): δ = 72.1 (C-2''), 17.8 (C-6''), 72.2 (C-5''), 72.3 (C-3''), 73.3 
(C-4''), 94.9 (C-8), 100.0 (C-6), 103.7 (C-1''), 106.1 (C-10), 116.7 (C-2', C-6'), 122.8 (C-1'), 
132.1 (C-3', C-5'), 136.4 (C-3), 158.7 (C-9), 161.8 (C-4'), 159.5 (C-2), 163.4 (C-5), 166.1 
(C-7), 179.8 (C-4) ppm. 
HRESIMS m/z calcd. for C21H20NaO10 [M+Na]+: 455.0903; found 455.0897. 
The spectroscopic data are in good agreement with that in the literatures.[186-188] 
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7  Synthesis of Naphthoquinones 
7.1  Synthesis of the Dioncoquinone B Precursor 42 
N,N-Diethyl-2,3-dimethoxybenzamide (135) 
A mixture of thionyl chloride (19.6 g, 164.7 mmol, 11.7 mL) and 2,3-dimethoxy-benzoic 
acid (10 g, 54.9 mmol) in a 100 mL one-necked flask was refluxed at 80 °C overnight. The 
excess of thionyl chloride was evaporated under reduced pressure to give the acyl chloride. It 
was added carefully with stirring at 0 °C to diethylamine (12.0 g, 164.7 mmol, 17.0 mL) in 
anhydrous THF (80 mL) in a 250-mL one-necked flask. The reaction was continued at room 
temperature with stirring overnight. The mixture was diluted with water, acidified with 0.5 N 
aqueous HCl solution, and neutralized with saturated aqueous NaHCO3 solution. THF was 
removed on a rotatry evaporator and the suspension was extracted with CHCl3 (100 mL × 3), 
dried with anhydrous Na2SO4, concentrated in vacuo, and subjected to column 
chromatography to afford the product. 
 
Dark brown liquid. 
Yield: 12.7 g, (53.8 mmol, 100%). 
IR (ATR): ν  = 2977 (w), 2935 (w), 1629 (s), 1598 (s), 1460 (s), 1423 (s), 1290 (m), 1220 
(m), 1086 (s), 1034 (s), 1003 (s), 810 (s) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 0.99 (t, 3J = 7.0 Hz, 3H, CH3), 1.21 (t, 3J = 7.0 Hz, 3H, 
CH3), 3.13 (q, 3J = 7.0 Hz, 2H, CH2), 3.40 and 3.66 (broad signal, 2H, CH2), 3.81 (s, 3H, 
CH3O), 3.84 (s, 3H, CH3O), 6.75 (dd, 3J = 8.4, 4J = 1.2 Hz, 1H, Ar-H), 6.88 (dd, 3J = 8.4, 4J = 
1.2 Hz, 1H, Ar-H), 6.87 (dd, 3J = 8.4, 3J = 8.4 Hz, 1H, H-5) ppm. 
13C NMR (100 MHz, CDCl3): δ = 12.9 (CH3), 14.0 (CH3), 38.9 (CH2), 43.0 (CH2), 55.9 
(CH3O), 61.6 (CH3O), 112.7 (CH), 119.0 (C), 124.7 (CH), 132.6 (C), 144.9 (C), 152.8 (C), 
168.4 (CO) ppm. 
EIMS m/z (rel. int.): 237 [M]+ (17), 236 [M−1]+ (19), 165 [M−72]+ (100). 
The spectroscopic data are in agreement with those reported in the literature.[200] 
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N,N-Diethyl-2,3-dimethoxy-6-(2-methylallyl)benzamide (140) 
Preparation of MgBr2▪2Et2O following a literature known[103] procedure (yet in German):  
To 2.43 g magnesium (100 equiv.) in dry diethylether (50 mL) in a three-neck flask under 
argon, 1,2-dibromoethane (0.5 mL) was added by syringe injection. After the reaction had 
started, the remaining 1,2-dibromoethane (7.9 mL, total 97.4 mmol) was added under reflux. 
After 30 min, the flask was cooled to room temperature. The lower, brown phase, containing 
the MgBr2▪2Et2O solution (2.62 N) was freshly utilized for the transmetalation step. 
To the solution of the benzamide 135 (10.3 g, 43.4 mmol) in THF (100 mL) s-BuLi (34.0 
mL, 47.7 mmol, 1.1 equiv.) and TMEDA (7.1 mL, 47.7 mmol, 1.1 equiv.) were added at 
−90 °C under argon by syringe injection and the mixture was stirred for 1.5 h. The solution of 
the resultant lithiated species was then warmed to −78 °C over 30 min and freshly prepared 
MgBr2▪2Et2O (33.0 mL, 86.8 mmol, 2 equiv.) was added. The mixture was stirred for 30 min, 
allowed to warm to room temperature, again cooled to −78 °C, and stirred for 1 h. The freshly 
distilled 3-bromo-2-methylpropene (8.7 mL, 86.8 mmol) was added and the solution was 
allowed to warm to room temperature, and stirred overnight. The reaction mixture was treated 
with saturated aqueous NH4Cl solution. Removal of THF by rotary evaporation, extraction 
with CH2Cl2, drying with Na2SO4, removal of the solvent, and purification by column 
chromatography gave 140 as a slightly yellow liquid. 
 
Slight yellow liquid. 
Yield: 7.60 g, (26.0 mmol, 60%). 
IR (ATR): ν  = 2977 (w), 2937 (w), 1627 (s), 1430 (s), 1376 (w), 1272 (s), 1058 (s), 890 (w), 
804 (w) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.08 (t, 3J = 7.0 Hz, 3H, CH3), 1.27 (t, 3J = 7.0 Hz, 3H, 
CH3), 1.72 (s, 3H, CH3), 3.18 (m, 2H, CH2), 3.25 (m, 2H, CH2), 3.61 (m, 2H, CH2), 3.85 (s, 
3H, CH3O), 3.88 (s, 3H, CH3O), 4.62 (s, 1H, CH2a), 4.85 (s, 1H, CH2b), 6.88 (s, 3J = 8.0 Hz, 
1H, Ar-H), 6.92 (s, 3J = 8.0 Hz, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 12.5 (CH3), 13.5 (CH3), 22.1 (CH3), 38.2 (CH2), 40.0 
(CH2), 42.7 (CH2), 55.5 (CH3O), 61.1 (CH3O), 112.0 (CH2), 112.4 (CH), 125.1 (CH), 128.3 
(C), 132.4 (C), 143.8 (C), 144.5 (C), 150.6 (C), 167.2 (CO) ppm. 
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EIMS m/z (rel. int.): 291 [M]+ (8), 219 [M−72]+ (100), 218 [M−73]+ (58). 
HRMS (ESI): calcd. for C18H27NNaO4 [M+Na]+: 314.1732; found 314.1735. 
 
5,6-Dimethoxy-2-methyl-4-naphthol (42) 
To the ortho-allyl benzamide 140 (4.82 g, 16.5 mmol) in 50 mL THF, 2.2 equiv. of MeLi 
were added with stirring at −78 °C. The reaction mixture was slowly warmed up to 0 °C over 
5 h, followed by addition of saturated aqueous NH4Cl solution, evaporation of THF under 
reduced pressure, and extraction with EtOAc. The organic layer was dried with Na2SO4, and 
concentrated in vacuo. The crude product was purified by column chromatography to afford 
the naphthol 42 as a colorless solid. 
 
Yield: 3.57 g, (16.4 mmol, 98%). 
M.p. 36−37 °C (PE/EtOAc). 
Lit.: 36−37 °C (EtOAc).[99]  
IR (ATR): ν  = 3341 (br w), 2914 (w), 2359 (m), 2341 (m), 1610 (m), 1575 (w), 1356 (m), 
1267 (m), 1045 (s), 976 (m), 947 (m), 843 (m), 802 (m), 784 (m), 684 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.41 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 4.08 (s, 3H, 
OCH3), 6.73 (d, 1H, 4J = 1.6 Hz, Ar-H), 7.06 (d, 1H, 4J = 1.6 Hz, Ar-H), 7.20 (d, 1H, 3J = 8.0 
Hz, Ar-H), 7.47 (d, 1H, 3J = 8.0 Hz, Ar-H), 9.55 (s, 1H, OH) ppm. 
13C NMR (100 MHz, CDCl3): δ = 21.7 (CH3), 57.2 (CH3O), 62.1 (CH3O), 112.5 (CH), 115.7 
(CH), 116.4 (C), 118.3 (CH), 124.6 (C), 131.9 (C), 135.6 (C), 143.3 (C), 146.7 (C), 153.3 (C) 
ppm. 
EIMS m/z (rel. int.): 218.0 [M]+ (100), 203 [M−15]+ (62), 175 [M−43]+ (32). 
The spectroscopic data are in agreement with those in the literature.[99] 
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7.2  Synthesis of Dioncoquinone C (102) 
N,N-Diethyl-2,3,4-trimethoxybenzamide (136) 
A mixture of thionyl chloride (1.4 g, 11.8 mmol, 837 μL) and 2,3,4-trimethoxybenzoic acid 
(134) (500.3 mg, 2.36 mmol) in a 10 mL one-necked flask was refluxed at 80 °C overnight. 
The excess of thionyl chloride was evaporated under reduced pressure to give the acyl 
chloride. It was added carefully with stirring at 0 °C to diethylamine (517.8 mg, 7.1 mmol, 
732 μL) in anhydrous THF (10 mL) in a 100-mL one-necked flask. The reaction was 
continued at room temperature with stirring overnight. The mixture was diluted with water, 
acidified with 0.5 N aqueous HCl solution, and neutralized with saturated aqueous NaHCO3 
solution. THF was removed on a rotary evaporator and the residue was extracted with CHCl3 
(100 mL × 3), dried with anhydrous Na2SO4, concentrated in vacuo, and subjected to column 
chromatography to afford the product. 
 
Light yellow liquid. 
Yield: 504 mg, (1.89 mmol, 80%). 
IR (ATR): ν  = 2972 (w), 2937 (w), 1610 (s), 1458 (s), 1433 (s), 1315 (m), 1265 (s), 1220 
(m), 1002 (s), 837 (m), 794 (s), 758 (s) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.01 (t, 3J = 7.0 Hz, 3H, CH3), 1.21 (t, 3J = 7.0 Hz, 3H, 
CH3), 3.15 (q, 2J = 7.0 Hz, 2H, CH2), 3.20 and 3.40 (broad signal, 2H, CH2), 3.77 (s, 3H, 
OCH3), 3.86 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 6.64 (d, 3J = 8.4 Hz, 1H, Ar-H), 6.87 (d, 3J 
= 8.4 Hz, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 12.7 (CH3), 13.9 (CH3), 39.0 (CH2), 43.1 (CH2), 56.0 
(CH3O-4), 60.9 (CH3O-2), 61.6 (CH3O-3), 107.6 (C-5), 121.6 (C-6), 124.8 (C-1), 142.0 
(C-2), 149.8 (C-3), 154.2 (C-4), 168.4 (CO) ppm.  
EI-MS (70eV) m/z (%): 267 [M]+ (19), 195 [M−72]+ (100). 
In the literature,[201] no spectroscopic data were reported. 
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N,N-Diethyl-2,3,4-trimethoxy-6-(2-methylallyl)benzamide (141) 
To the solution of the benzamide 136 (10.3 g, 9.3 mmol) in THF (100 mL), s-BuLi (7.3 mL, 
10.3 mmol, 1.1 equiv.) and TMEDA (1.5 mL, 10.3 mmol, 1.1 equiv.) were added at −90 °C 
under argon by syringe injection and the mixture was stirred for 1.5 h. The solution of the 
lithiated species was then warmed to −78 °C over 30 min and freshly prepared MgBr2▪2Et2O 
(7.1 mL, 18.6 mmol, 2 equiv.) was added. The mixture was stirred for 30 min, allowed to 
warm to room temperature, again cooled to −78 °C, and stirred for 1 h. The freshly distilled 
3-bromo-2-methylpropene (1.9 mL, 18.6 mmol) was added and the solution was allowed to 
warm to room temperature, and stirred overnight. The reaction mixture was treated with 
saturated aqueous NH4Cl. Removal of THF by rotary evaporation, extraction with CH2Cl2, 
drying with Na2SO4, removal of the solvent, and purification by column chromatography 
gave 141 as a slightly yellow liquid. 
 
Light yellow liquid. 
Yield: 1.35 g (4.2 mmol, 45%). 
IR (ATR): ν  = 2977 (w), 2937 (w), 1625 (s), 1456 (s), 1425 (s), 1400 (s), 1319 (m), 1284 
(m), 1141 (s), 1105 (s), 1033 (s), 890 (w) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.03 (t, 3J = 7.0 Hz, 3H, CH3), 1.22 (t, 3J = 7.0 Hz, 3H, 
CH3), 1.68 (s, 3H, CH3), 3.09 (m, 2H, CH2), 3.15 (s, 2H, CH2), 3.54 (m, 2H, CH2), 3.82 (s, 
3H, CH3O), 3.85 (s, 3H, CH3O), 3.87 (s, 3H, CH3O), 4.70 (s, 1H, CH2a), 4.84 (s, 1H, CH2b), 
6.52 (s, 1H, Ar-H). 
13C NMR (100 MHz, CDCl3): δ = 12.8 (CH3), 13.9 (CH3), 22.5 (CH3), 38.6 (CH2), 41.0 
(CH2), 43.1 (CH2), 56.2 (CH3O), 61.1 (CH3O), 61.8 (CH3O), 108.7 (CH2), 113.1 (CH), 
125.1 (C), 131.7 (C), 140.4 (C), 144.0 (C), 149.6 (C), 153.5 (C), 167.7 (CO). 
EIMS m/z (rel. int.): 321 [M]+ (10), 249 [M−72]+ (100). 
HRMS (ESI): calcd. for C17H25NNaO3 [M+23]+: 344.1833; found 344.1834. 
 
5,6,7-Trimethoxy-2-methyl-4-naphthol (131) 
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To the ortho-allyl benzamide 141 (1.35 g, 4.2 mmol) in 50 mL THF, 2.2 equiv. of MeLi 
were added with stirring at −78 °C. The reaction mixture was slowly warmed up to 0 °C over 
5 h, followed by addition of saturated aqueous NH4Cl solution, evaporation of THF on a 
rotary evaporator, and extraction with EtOAc. The combined organic layers were dried with 
Na2SO4, and concentrated in vacuo. The crude product was purified by column 
chromatography to afford the naphthol 131 as a colorless solid. 
 
Colorless solid. 
Yield: 790 mg, (3.2 mmol, 76%). 
M.p. 80−81 °C (PE/EOAc). 
Lit.: 80−81 °C (Ethanol).[281] 
1H NMR (250 MHz, CDCl3): δ = 2.39 (s, 3H, OCH3), 3.94 (s, 6H, OCH3), 4.13 (s, 3H, 
OCH3), 6.63 (s, 1H, Ar-H), 6.83 (s, 1H, Ar-H), 6.97 (s, 1H, Ar-H), 9.34 (s, 1H, OH) ppm. 
13C NMR (100 MHz, CDCl3): δ = 21.7 (CH3), 55.8 (CH3O), 61.2 (CH3O), 62.2 (CH3O), 
102.9 (CH), 110.5 (CH), 110.9 (C), 117.3 (CH), 132.8 (C), 137.1 (C), 139.0 (C), 148.3 (C), 
152.9 (C), 155.6 (C) ppm. 
EIMS m/z (rel. int.): 248 [M]+ (100), 233 [M−15]+ (42), 205 [M−43]+ (19). 
The spectroscopic data are in agreement with those in the literature.[281] 
 
5,6,7-Trimethoxy-2-methyl-1,4-naphthoquinone (142) 
A suspension of CuCl (238 mg, 2.38 mmol) and methylnaphthol 131 (760 mg, 3.1 mmol) 
in acetonitrile (50 mL) was stirred for 2 h with a strong current of oxygen bubbling through it. 
The reaction mixture was diluted with water (100 mL) and extracted with CH2Cl2 (100 mL × 
3). The combined organic layers were dried over Na2SO4, concentrated and purified by 
column chromatography on silica gel (PE/EtOAc) to give 142 as an orange-colored solid. 
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Yellow powder. 
Yield: 365 mg, (1.4 mmol, 45%). 
M.p. 142−143 °C (PE/EOAc). 
Lit.: 142−143 °C (Ethanol).[281] 
IR (ATR): ν  = 2945 (w), 2837 (w), 1654 (s), 1629 (m), 1572 (s), 1484 (m), 1457 (m), 1433 
(w), 1408 (m), 1375 (w), 1355 (s), 1315 (s), 1279 (s), 1224 (m), 1198 (m), 1181 (m), 1159 (m), 
1116 (s), 1077 (m), 1019 (m), 1005 (s), 987 (m), 934 (m), 911 (m), 900 (m), 865 (m), 820 (m), 
811 (m), 781 (m), 722 (m), 701 (m), 650 (w), 631 (w) cm−1. 
1H NMR (250 MHz, CDCl3): δ = 2.11 (s, 3H, CH3), 3.91 (s, 3H, OCH3), 3.95 (s, 3H, OCH3), 
3.99 (s, 1H, OCH3), 6.66 (s, 1H, Ar-H), 7.46 (s, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 15.8 (CH3), 56.4 (CH3O), 61.3 (CH3O), 61.6 (CH3O), 
106.3 (C), 119.7 (C), 129.5 (C), 132.5 (C), 137.6 (C), 145.5 (C), 147.9 (C), 154.0 (C), 157.2 
(C), 183.6 (C), 185.1 (C) ppm.  
EIMS m/z (rel. int.): 262 [M]+ (100), 247 [M−15]+ (69). 
The spectroscopic data are in agreement with those in the literature.[281] 
 
6,7,8-Trimethoxy-3-methyl-1,2-naphthoquinone (143) 
Red powder. 
Yield: 384 mg, (1.46 mmol, 47%). 
M.p. 182 °C (PE/EOAc). 
Lit.: 184 °C (PE/EOAc).[189] 
IR (ATR): ν  = 3092 (w), 2945 (w), 2920 (w), 2847 (w), 2359 (w), 1661 (s), 1648 (s), 1632 
(s), 1575 (s), 1491 (s), 1455 (m), 1406 (m), 1368 (m), 1329 (s), 1267 (s), 1200 (s), 1147 (s), 
1084 (m), 1030 (m), 1000 (m), 976 (m), 964 (m), 934 (m), 919 (m), 865 (m), 809 (m), 780 (m), 
738 (m), 686 (m), 668 (m), 647 (m) cm−1. 
1H NMR (250 MHz, CDCl3): δ = 2.14 (s, 3 H, CH3), 3.92 (s, 3 H, OCH3), 3.97 (s, 3 H, 
OCH3), 6.72 (s, 1 H, H-3), 7.17 (s, 1 H, Ar-H), 7.93 (s, 1 H, Ar-H) ppm. 
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13C NMR (100 MHz, CDCl3): δ = 15.5 (CH3), 56.4 (CH3O), 61.4 (CH3O), 61.5 (CH3O), 
109.0 (C), 118.1 (C), 133.2 (C), 135.6 (C), 141.6 (C), 143.7 (C), 158.4 (C), 159.1 (C), 176.8 
(C), 181.8 (C) ppm. 
EIMS m/z (rel. int.): 262 [M]+ (4), 234 [M−28]+ (100), 219 [M−43]+ (88). 
HRMS (ESI): calcd. for C13H12O5Na [M+Na]+: 285.0733; found 285.0733. 
The spectroscopic data are in agreement with those in the literature.[189] 
 
5,6,7-Trimethoxy-2-methyl-1,4-naphthoquinone-2,3-epoxide (184) 
5,6,7-trimethoxy-2-methyl-naphthoquinone (68.0 mg, 260 μmol) and 130 μL (0.5 equiv.) of 
1 N NaOH aqueous solution were dissolved in 10.5 mL of mixing solvents (MeOH/H2O = 4 : 
1) at room temperature. After stirring at this temperature for 10 minutes, 40 μL of 35% 
aqueous hydrogen peroxide (1.5 equiv.) was added and stirred for 1.5 h. The reaction mixture 
was neutralized with 1 N aqueous HCl solution, and extracted with EtOEt (30 mL × 3). The 
combined organic phases were dried over Na2SO4, and the solvent was concentrated in vacuo. 
The crude product was purified with column chromatography. 
 
Pale-yellow powder. 
Yield: 72.0 mg, (257 μmol, 99%). 
M.p. 110 °C (PE/EOAc). 
Lit.: 110 °C (MeOH/H2O).[189] 
IR (ATR): ν  = 2979 (w), 2946 (w), 1681 (s), 1654 (m), 1631 (w), 1571 (s), 1485 (m), 1461 
(m), 1409 (w), 1346 (s), 1315 (m), 1279 (s), 1193 (m), 1161 (m), 1116 (s), 1099 (s), 1072 (m), 
999 (s), 987 (m), 928 (m), 902 (m), 871 (m), 820 (m), 806 (m), 785 (m), 762 (m), 731 (m) 
cm−1. 
1H NMR (250 MHz, CDCl3): δ = 1.70 (s, 3H, CH3), 3.79 (s, 1H, H-3), 3.94 (s, 6H, OCH3), 
3.97 (s, 3H, OCH3), 7.29 (s, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 14.6 (CH3), 56.4 (CH3O), 61.2 (CH3O), 61.6 (CH3O), 62.1 
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(CH), 106.3 (C), 120.1 (C), 129.0 (C), 137.6 (C), 148.2 (C), 153.5 (C), 157.7 (C), 183.6 (C), 
185.1 (C) ppm. 
EIMS m/z (rel. int.): 278 [M]+ (95), 235 [M−43]+ (100). 
HRMS (ESI): calcd. for C14H14NaO6 [M+Na]+: 301.0683; found 301.0682. 
The spectroscopic data are in agreement with those in the literature.[189] 
 
3-Hydorxy-5,6,7-trimethoxy-2-methyl-1,4-naphthoquinone (144) 
To the solution of the epoxide (54.0 mg, 194 μmol) in THF (5 mL), silica gel (288 mg) and 
concentrated H2SO4 (248 μL) were added. The solvent was evaporated in vaccum (200 mbar) 
at 60 °C for 20 min on a rotary evaporator. To the resultant red solid, H2O (20 mL) was added, 
neutralized with 5% aqueous K2CO3 solution, and acidified with 1 N aqueous HCl solution. 
The mixture was extracted with CH2Cl2 (30 mL × 3). The combined organic layers were dried 
over anhydrous Na2SO4 and concentrated in vacuo affording the crude product 144 as a 
yellow solid, which was purified by column chromatography. 
 
Yellow powder. 
Yield: 53 mg, (192 μmol, 99%). 
M.p. 175 °C (PE/EtOAc). 
Lit.: 177 °C (CHCl3).[189] 
IR (ATR): ν  = 3329 (s), 2948 (w), 2841(w), 1655 (s), 1641 (m), 1573 (s), 1486 (m), 1460 
(m), 1412 (m), 1382 (m), 1346 (s), 1258 (s), 1210 (s), 1181 (m), 1144 (s), 1105 (m), 1080 (s), 
1021 (m), 998 (s), 965 (m), 910 (m), 869 (m), 816 (w), 787 (m), 761 (m), 746 (s), 720 (m), 704 
(m) cm−1. 
1H NMR (250 MHz, CDCl3): δ = 2.05 (s, 3H, CH3), 3.94 (s, 3H, OCH3), 3.96 (s, 3H, OCH3), 
4.02 (s, 3H, OCH3), 7.54 (s, 1H, OH), 7.66 (s, 1H, Ar-H) ppm. 
13C NMR (CDCl3) : δ = 8.5 (CH3), 56.5 (CH3O), 61.3 (CH3O), 61.6 (CH3O), 106.8 (C), 116.3 
(C), 117.7 (C), 130.7 (C), 146.6 (C), 153.7 (C), 154.7 (C), 158.5 (C), 178.9 (C), 184.3 (C) 
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ppm. 
EIMS m/z (rel. int.): 278.0 [M]+ (100), 263 [M−15]+ (28), 235 [M−43]+ (19). 
HRMS (ESI): calcd. for C14H14NaO6 [M+Na]+: 301.0683; found 301.0682. 
The spectroscopic data are in agreement with those in the literature.[189] 
 
3,5,6-Trihydroxy-7-methoxy-2-methyl-1,4-naphthoquinone (dioncoquinone C, 102) 
A solution of BBr3 in CH2Cl2 (1 M, 1.36 mmol, 1.36 mL) was added dropwise to a 
solution of naphthoquinone 144 (38.0 mg, 136 μmol) in dry CH2Cl2 (3 mL) at −78 °C under 
stirring. The reaction mixture was warmed to 0 °C within 2 h, then diluted with water (10 mL) 
and extracted with CH2Cl2 (10 mL × 3). The organic layer was extracted with 5% aqueous 
K2CO3 solution, and the water layer was acidified with half-concentrated aqueous HCl 
solution, extracted with CH2Cl2 (20 mL × 3). The combined organic layers were dried over 
Na2SO4, concentrated, and subjected to preparative HPLC for purification. 
 
Yellow solid. 
Yield: 22.8 mg, (91.0 μmol, 67%). 
M.p. >340 °C. 
IR (ATR): ν  = 3384 (m), 3921 (w), 1600 (s), 1571 (s), 1463 (w), 1319 (m), 1238 (s), 1151 
(s), 1072 (s), 997 (w), 804 (w), 740 (w) cm−1. 
1H NMR (600 MHz, CD3COCD3): δ = 1.98 (s, 3H, 2-CH3), 4.01 (s, 1H, 7-OCH3), 7.27 (s, 
1H, 8-H) ppm. 
13C NMR (150 MHz, CD3COCD3): δ = 8.6 (2-CH3), 56.8 (7-OCH3), 104.8 (C-8), 109.8 
(C-10), 121.0 (C-2), 125.3 (C-9), 139.4 (C-6), 150.5 (C-5), 153.6 (C-7), 154.8 (C-3), 184.2 
(C-1), 185.1 (C-4) ppm. 
MS (EI, 70 eV): m/z (%) = 250 [M]+ (47), 233 [M−17]+ (23), 220 [M−30]+ (7), 204 [M−46]+ 
(5). 
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HRESIMS m/z calcd. for C12H9O6 [M−1]+: 249.0399; found 249.0405. 
 
3,5,6,7-Tetrahydroxy-2-methyl-1,4-naphthoquinone (145) 
A solution of BBr3 in CH2Cl2 (1 M, 1.04 mmol, 1.04 mL) was added dropwise to a 
solution of naphthoquinone 144 (27.0 mg, 104.0 μmol) in dry CH2Cl2 (3 mL) at −78 °C under 
stirring. The reaction mixture was warmed to room temperature within 2 h, and continued to 
stir overnight, then diluted with water (10 mL) and extracted with CH2Cl2 (10 mL × 3). The 
combined organic layers were extracted with 5% aqueous K2CO3 solution, and the water 
layer was acidified with half-concentrated aqueous HCl solution, extracted with CH2Cl2 (20 
mL × 3). The organic layer was dried over Na2SO4, concentrated, and subjected to column 
chromatography. 
 
Dark red solid. 
Yield: 24.0 mg, (102 μmol, 98%). 
M.p. 245−250 °C (EtOAc). 
IR (ATR): ν  = 3178 (m), 1614 (m), 1463 (m), 1311 (s), 1184 (s), 1090 (m), 1041 (m), 742 
(w) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.94 (s, 3H, 2-CH3), 7.12 (s, 1H, 8-H), 9.24 (s, 1H, OH), 
11.4 (s, 1H, OH) ppm.  
13C NMR (100 MHz, CDCl3): δ = 8.7 (CH3-2), 108.8 (C), 109.7 (CH), 121.1 (C), 126.1 (C), 
137.6 (C), 151.6 (C), 152.5 (C), 155.0 (C), 184.3 (CO), 184.7 (CO) ppm. 
EIMS m/z (rel. int.): 236 [M]+ (100), 208 [M−28]+ (25). 
HRESIMS m/z calcd. for C11H7O6: 235.0248 [M−H]+; found: 235.0249 [M−H]+.  
 
3,6,7-Trihydroxy-5-methoxy-2-methyl-1,4-naphthoquinone (146) 
A solution of BBr3 in CH2Cl2 (1 M, 321 μmol, 321 μL) was added dropwise to a solution 
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of naphthoquinone 144 (30.0 mg, 107 μmol) in dry CH2Cl2 (3 mL) at −78 °C under stirring. 
The reaction mixture was warmed to 0 °C within 2 h, then diluted with water (10 mL) and 
extracted with CH2Cl2 (10 mL × 3). The combined organic layers were extracted with 5% 
aqueous K2CO3 solution, and the water layer was acidified with half-concentrated aqueous 
HCl solution, extracted with CH2Cl2 (20 mL × 3). The combined organic layers were dried 
over Na2SO4, concentrated, and subjected to preparative HPLC. 
 
Yellow solid. 
Yield: 4.0 mg, (16.0 μmol, 15%). 
M.p. > 340 °C (EtOAc). 
IR (ATR): ν  = 3489 (m), 3325 (s), 1647 (s), 1564 (s), 1385 (s), 1331 (s), 1196 (m), 1147 (m), 
1095 (m), 1052 (m), 802 (w), 746 (w) cm−1. 
1H NMR (600 MHz, CD3COCD3): δ = 7.39 (s, 1H, 8-H), 3.86 (s, 1H, 5-OCH3), 1.93 (s, 3H, 
2-CH3) ppm. 
13C NMR (150 MHz, CD3COCD3): δ = 8.5 (CH3-2), 61.6 (CH3O-5), 111.3 (C-8), 116.6 
(C-9), 117.7 (C-2), 127.8 (C-10), 143.8 (C-6), 149.5 (C-5), 152.0 (C-7), 155.3 (C-3), 179.4 
(C-4), 184.8 (C-1) ppm. 
MS (EI, 70 eV): m/z (%) = 250 [M]+ (100). 
HRESIMS m/z calcd. for C12H9O6 [M−1]+: 249.0399; found: 249.0404. 
 
6-Bromo-N,N-diethyl-2,3,4-trimethoxy-benzamide (162) 
s-BuLi (1.22 mL, 1.72 mmol, 1.1 equiv.) and TMEDA (256 μL, 1.72 mmol, 1.1 equiv.) was 
added into N,N-diethyl-2,3,4-trimethoxybenzamide (136) (417 mg, 1.56 mmol) in THF (10 
mL) by syringe injection at −90 °C under nitrogen and the reaction mixture was stirred for 1.5 
h. To the solution of the lithiated species, 1,2-dibromoethane (586 mg, 3.12 mmol, 270 μL) in 
5 mL THF was carefully added at −90 °C. After 1 h, the mixture was allowed to warm to 
room temperature and treated with saturated aqueous NH4Cl solution. The organic solvent 
THF was removed by rotary evaporation and the water layer was extracted with EtOEt (20 
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mL × 3). The combined layers were dried with Na2SO4 and concentrated to dryness. The 
crude product was purified with column chromatography. 
 
Colorless liquid. 
 
Yield: 260 mg, (0.70 mmol, 45%). 
IR (ATR): ν  = 2973 (w), 2936 (w), 1633 (s), 1589 (m), 1455 (m), 1424 (m), 1389 (m), 1302 
(m), 1285 (m), 1136 (m), 1104 (s), 1033 (m), 1009 (m), 936 (w), 844 (w), 793 (w), 738 (w), 
cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.00 (t, 3J = 7.0 Hz, 3H, CH3), 1.16 (t, 3J = 7.0 Hz, 3H, 
CH3), 3.05 (m, 2H, CH2), 3.39 (m, 1H, CH2a), 3.55(m 1H, CH2b), 3.76 (s, 6H, CH3O-2, 
CH3O-4), 3.80 (s, 3H, CH3O-3), 6.76 (s, 1H, H-5) ppm. 
13C NMR (100 MHz, CDCl3): δ = 12.4 (CH3), 13.7 (CH3), 38.9 (CH2), 42.9 (CH2), 56.3 
(CH3O-4 or CH3O-2), 60.9 (CH3O-2 or CH3O-4), 61.8 (CH3O-3), 111.9 (C-5), 112.8 (C-1 or 
6), 126.4 (C-6 or 1), 141.7 (C-2), 150.6 (C-3), 154.1 (C-4), 165.9 (CO) ppm. 
EIMS m/z (rel. int.): 345 [M]+ (20), 347 [M]+ (19), 273 [M−72]+ (100), 275 [M−72]+ (97), 
266 [M−80]+ (50). 
HRMS (ESI): calcd. for C14H20BrNNaO4 [M+Na]+: 368.0468; found 368.0467; 
C14H20BrNNaO5 [M+Na]+: 370.0448; found 370.0447. 
 
5,6,7-Trimethoxy-1-bromo-2-methyl-1,2-naphthoquinone (222) 
BBr3 (22.3 μL, 235 μmol) was added into a solution of 5,6,7-trimethoxy-2-methyl-1,2- 
naphthoquinone (30.8 mg, 117 μmol) in dry CH2Cl2 (3 mL) at −78 °C. The reaction mixture 
was stirred for 1 h, quenched with cold water, and then extracted with CH2Cl2 (20 mL × 3). 
The combined organic layers were dried over anhydrous Na2SO4, and concentrated in vacuo. 
The crude product was purified by column chromatography. 
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Red powder. 
Yield: 32.0 mg, (94 μmol, 40%). 
M.p. 168−170 °C (CH2Cl2). 
IR (ATR): ν  = 2920 (w), 2850 (w), 1661 (m), 1565 (m), 1488 (m), 1462 (m), 1397 (w), 
1322 (m), 1287 (s), 1261 (s), 1149 (m), 1091 (m), 966 (m), 920 (m), 847 (m), 784 (m), 752 
(m), 669 (m) cm−1. 
1H NMR (250 MHz, CDCl3): δ = 2.24 (s, 3H, CH3), 3.91 (s, 3H, OCH3), 3.93 (s, 3H, OCH3), 
4.03 (s, 3H, OCH3), 7.537 (s, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 14.3 (CH3), 56.6 (CH3O), 61.6 (CH3O), 61.9 (CH3O), 
111.3 (CH), 117.6 (C), 132.2 (C), 138.0 (C), 143.1 (C), 144.5 (C), 157.9 (C), 158.5 (C), 176.5 
(CO), 178.9 (CO) ppm. 
MS (EI, 70 eV): m/z (%) = 312 [M−28]+ (70), 314 [M−28]+ (70), 297 [M−56]+ (33), 299 
[M−56]+ (32), 233 [M−110]+ (100). 
HRMS (ESI): calcd. for C14H13BrNaO5 [M+Na]+: 362.9838; found 362.9833; 
C14H13BrNaO5 [M+Na]+: 364.9820; found 364.9816. 
7.3  Synthesis of the Dioncoquinone B Analog 151 
Methyl-6-Methoxy-naphthalene-2-carboxylate (223)  
K2CO3 (6.2 g, 45 mmol) was added into the solution of 6-hydroxy-naphthalene-2-carboxylic 
acid (1.5 g, 8 mmol) in acetone (40 mL) at 0 ºC. The mixture was magnetically stirred for 30 
min, then dimethylsulfate (5.04 g, 3.8 mL, 40 mmol) was injected into the flask via a syring. 
The reaction mixture was refluxed for 2 h, quenched by addition of water (40 mL), and then 
extracted with CH2Cl2 (60 mL × 3) after removal of acetone. The combined organic layers 
were dried with Na2SO4 and concentrated to dryness. The crude product was purified by 
column chromatography with the mobile phase of (PE/EtOAc = 95 : 5). 
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Colorless powder. 
Yield: 1.66 g, (7.7 mmol, 96%). 
M.p. 125−127 °C (PE/EOAc). 
Lit.: 128−129 °C (EtOH).[282] 
IR (ATR): ν  = 2950 (w), 2817 (w), 2847 (w),1705 (m), 1625 (m), 1600 (m), 1484 (m), 1434 
(m), 1290 (m), 1201 (s), 1125 (s), 1095 (m), 1023 (m), 974 (m), 949 (m), 864 (m), 818 (m), 
769 (m), 754 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 3.95 (s, 3H, CH3O-6), 3.97 (s, 3H, COOCH3), 7.16 (d, 4J = 
2.5 Hz, 1H, H-5), 7.19 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, H-7), 7.75 (d, 3J = 8.4 Hz, 1H, H-4), 
7.84 (d, 3J = 8.4 Hz, 1H, H-8), 8.02 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, H-3), 8.53 (d, 4J = 2.5 Hz, 
1H, H-1) ppm. 
13C NMR (100 MHz, CDCl3): δ = 52.0 (COOCH3), 55.5 (CH3O-6), 105.8 (C-5), 119.8 (C-7), 
125.4 (C-3), 126.1 (C-3), 127.0 (C-4), 128.0 (C-10), 131.0 (C-1 and C-8), 137.3 (C-9), 159.7 
(C-6), 167.5 (COOCH3) ppm. 
EIMS m/z (rel. int.): 216 [M]+ (100), 185 [M−31]+ (90), 157 [M−59]+ (34). 
The spectroscopic data are in good agreement with those in the literature.[282] 
 
6-Methoxy-2-hydroxymethylnaphthalene (224) 
LiAlH4 (874 mg, 23 mmol) was dissolved in dry THF (30 mL) in a 100 mL three-neck 
flask. The solution of 223 (1.6 g, 7.4 mmol) in dry THF (40 mL) was dropped into the flaks 
under stirring. The reaction mixture was refluxed for 1.5 h, quenched by addition of water (30 
mL), neutralized with half-concentrated aqueous HCl solution and extracted with CH2Cl2 (50 
mL × 3). The combined organic layers were dried with Na2SO4 and concentrated in vacuo. 
The crude product was purified by column chromatography with the mobile phase of 
PE/EtOAc = 8 : 2. 
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Colorless powder. 
Yield: 1.21 g, (6.4 mmol, 86%). 
M.p. 115−117 °C (PE/EOAc). 
Lit.: 120−122 °C (EtOH).[282]  
IR (ATR): ν  = 3239 (w), 2979 (w), 1632 (w), 1604 (w), 1484 (m), 1453 (m), 1390 (m), 
1263 (m), 1236 (m), 1213 (m), 1160 (m), 1022 (s), 889 (m), 856 (s), 815 (s), 756 (m), 697 (w) 
cm−1. 
1H NMR (400 MHz, CDCl3): δ = 3.92 (s, 3H, CH3O-6), 4.82 (s, 2H, CH2OH), 7.15 (m, 2H, 
Ar-H), 7.45 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, Ar-H), 7.73 (m, 3H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 55.5 (COOCH3), 65.8 (CH2OH), 106.0, 119.2, 125.8, 
126.1, 127.4, 129.0, 129.6, 134.3, 136.3, 158.0 (COOCH3) ppm. 
EIMS m/z (rel. int.): 188 [M]+ (100), 171 [M−16]+ (31). 
HRMS (ESI): calcd. for C12H12NaO2 [M+Na]+: 211.0725; found 211.0725. 
The spectroscopic data are in agreement with those in the literature.[282] 
 
2-Chloromethyl-6-O-methylnaphthalene (225) 
Yield: 0.18 g, (0.89 mmol, 12%). 
M.p. 55−56 °C (PE/EOAc). 
Lit.: 57−59 °C (EtOH).[283]  
IR (ATR): ν  = 2963 (w), 1629 (m), 1603 (m), 1483 (m), 1454 (m), 1390 (m), 1269 (m), 
1231 (s), 1173 (m), 1121 (w), 1027 (s), 899 (m), 854 (m), 816 (m), 757 (m), 705 (s) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 3.72 (s, 3H, CH3O-6), 4.54 (s, 2H, CH2Cl), 6.94 (d, 4J = 2.5 
Hz, 1H, H-5), 7.00 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, H-7), 7.28 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, 
H-3), 7.53 (m, 3H, H-1, H-4, H-8) ppm. 
13C NMR (100 MHz, CDCl3): δ = 47.0 (CH2Cl), 55.4 (CH3O-6), 105.9 (C-5), 119.4 (C-7), 
127.0 (C-3), 127.6 (C-1 or C-8), 127.7 (C-8 or C-1), 128.7 (C-9), 129.6 (C-4), 132.7 (C-2), 
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134.5 (C-10), 158.3 (C-6) ppm. 
EIMS m/z (rel. int.): 206 [M]+ (21), 171 [M−35]+ (100). 
HRMS (ESI): calcd. for C11H12O [M−35]+: 171.0889; found 171.0888. 
The spectroscopic data are in agreement with those in the literature.[283] 
 
6-Methoxy-2-methylnaphthalene (226) 
To a solution of 224 (1.2 g, 6.3 mmol) in methanol (30 mL) in a 100 mL flask was added 
concentrated aqueous HCl solution (1.25 mL) and Pd/C (64 mg, 5%). The reaction mixture 
was stirred in the H2-atomosphere at room temperature for 40 min, and filtered through a 
short pad of Celite and eluted with methanol. The eluent was concentrated by evaporation 
before addition of water (50 mL), and the mixture was extracted with EtOAc (50 mL × 3). 
The combined organic layers were dried with Na2SO4 and concentrated in vacuo affording 
the product. 
 
Colorless powder. 
Yield: 1.1 g, (6.2 mmol, 98%). 
M.p. 71−72 °C (PE/EOAc). 
Lit.: 75−76 °C.[204] 
IR (ATR): ν  = 3003 (w), 2963 (w), 1604 (m), 1502 (s), 1482 (m), 1462 (w), 1388 (m), 1263 
(s), 1226 (s), 1158 (m), 1117 (m), 1032 (s), 927 (w), 853 (s), 803 (s), 754 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.48 (s, 3H, CH3-2), 3.91 (s, 3H, CH3O-6), 7.11 (d, 4J = 2.5 
Hz, 1H, Ar-H), 7.12 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, Ar-H), 7.28 (d, 3J = 8.4 Hz, 1H, Ar-H), 
7.54 (d, 4J = 2.5 Hz, 1H, Ar-H), 7.65 (m, 2H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 21.6 (CH3-2), 55.4 (CH3O-6), 105.9, 118.8, 126.8, 126.9, 
128.8, 128.9, 129.4, 132.9, 133.2, 157.2 (COOCH3) ppm. 
EIMS m/z (rel. int.): 172 [M]+ (100), 129 [M−43]+ (58). 
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The spectroscopic data are in agreement with those in the literature.[204] 
 
6-Hydroxy-2-methylnaphthalene (147) 
A solution of BBr3 in CH2Cl2 (1 M, 8.7 mmol, 8.7 ml) was added dropwise to a solution of 
226 (1.0 g, 5.8 mmol) in dry CH2Cl2 (30 mL) at 0 °C. The reaction mixture was stirred at 
room temperature for 30 min, then diluted with water (40 mL) and extracted with CH2Cl2 
(100 mL × 3). The combined organic layers were dried over Na2SO4, concentrated in vacuo, 
and purified by column chromatography. 
 
Colorless powder. 
Yield: 0.94 g (5.6 mmol, 97%). 
M.p. 115−118 °C (PE/EOAc). 
Lit.: 118−123 °C.[204] 
IR (ATR): ν  = 3245 (w), 1604 (m), 1517 (w), 1481 (w), 1390 (w), 1350 (w), 1206 (m), 1174 
(m), 1145 (m), 1035 (w), 861 (s), 798 (m), 648 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.47 (s, 3H, CH3-2), 7.05 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, 
H-7), 7.10 (d, 4J = 2.5 Hz, 1H, H-5), 7.27 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, H-3), 7.54 (d, 4J = 
2.5 Hz, 1H, H-1), 7.58 (d, 3J = 8.4 Hz, 1H, H-4), 7.65 (d, 3J = 8.4 Hz, 1H, H-8) ppm. 
13C NMR (100 MHz, CDCl3): δ = 21.6 (CH3-2), 109.6 (C-5), 117.9 (C-7), 126.4 (C-4), 127.0 
(C-1), 129.0 (C-3), 129.3 (C-8 or C-10), 129.4 (C-10 or C-8), 132.9 (C-9), 133.3 (C-2), 152.9 
(C-6) ppm. 
EIMS m/z (rel. int.): 158 [M]+ (100), 128 [M−30]+ (18). 
The spectroscopic data in agreement with those in the literature.[204] 
 
2-Methyl-6-[(trifluoromethanesulfonyl)oxyl]-naphthalene (148) 
To a solution of 6-hydroxy-2-methylnaphthalene (0.90 g, 5.4 mmol) in CH2Cl2 (20 mL), 
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NaH (0.65 g of a 60% powder in oil, 16.2 mmol) was added under nitrogen and the solution 
was stirred for 30 min at 0 ºC. A solution of Tf2O (0.82 g, 5.8 mmol) in CH2Cl2 (15 mL) was 
added dropwise over a period of 15 min and after stirring for 5 min, the reaction mixture was 
directly filtered through a short pad of silica gel and then washed with CH2Cl2 giving a white 
solid after removal of the solvent. 
White solid. 
Yield: 1.5 g, (5.3 mmol, 98%). 
M.p. 45 °C (PE/EtOAc). 
IR (ATR): ν  = 1600 (m), 1425 (m), 1402 (m), 1210 (s), 1132 (s), 1105 (m), 920 (m), 884 
(m), 822 (m), 798 (m), 742 (w) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.53 (s, 3H, CH3-2), 7.32 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, 
Ar-H), 7.41 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, Ar-H), 7.66 (d, 4J = 2.5 Hz, 1H, Ar-H), 7.70 (d, 4J 
= 2.5 Hz, 1H, Ar-H), 7.76 (d, 3J = 8.4 Hz, 1H, Ar-H), 7.82 (d, 3J = 8.4 Hz, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 21.6 (CH3-2), 119.0, 119.1 (q, 2J = 320.9 Hz, CF3), 119.5, 
127.0, 127.8, 130.0, 130.0, 131.6, 132.8, 137.3, 146.7 (C-6) ppm. 
EIMS m/z (rel. int.): 290 [M]+ (68), 157 [M−133]+ (100), 129 [M−161]+ (77). 
HRMS (ESI): calcd. for C12H9F3NaO3S [M+Na]+: 313.0117; found 313.0117. 
 
2-Methyl-6-[(trifluoromethanesulfonyl)oxyl]-1,4-naphthoquinone (149) 
To a solution of H5IO6 (2.44 g, 10.7 mmol) and CrO3 (17.8 mg, 178 μmol) in acetonitrile 
(30 mL), the ester (517 mg, 1.78 mmol) in acetonitrile (5 mL) was added dropwise with 
vigorous stirring at 0 ºC. After stirring at 0 ºC overnight, the reaction mixture was filtered 
over a short normal-phase silica gel column, and washed quickly with CH2Cl2. After 
evaporation of the solvent in vacuo, the desired product was purified by column 
chromatography (PE/EtOAc = 97 : 3). 
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Yellow solid. 
Yield: 192 mg, (0.59 mmol, 35%). 
M.p. 82 °C (PE/EtOAc). 
IR (ATR): ν  = 1661 (m), 1595 (m), 1583 (m), 1424 (m), 1352 (w), 1295 (m), 1201 (s), 1132 
(s), 918 (m), 866 (m), 826 (m), 744 (w) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.22 (d, 4J = 1.6 Hz, 3H, CH3-2), 6.93 (d, 4J = 1.6 Hz, 1H, 
H-3), 7.61 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, H-7), 7.94 (d, 4J = 2.5 Hz, 1H, H-5), 8.25 (d, 3J = 
8.4 Hz, 1H, H-8) ppm. 
13C NMR (100 MHz, CDCl3): δ = 16.7 (2-CH3), 117.3 (C-5), 118.8 (q, J = 320.9 Hz, CF3), 
126.5 (C-7), 129.7 (C-8), 131.8 (C-10), 134.6 (C-9), 136.0 (C-3), 149.0 (C-3), 153.1 (C-6), 
183.0 (C-4), 184.0 (C-1) ppm. 
EIMS m/z (rel. int.): 320 [M]+ (100), 188 [M−132]+ (35). 
HRMS (ESI): calcd. for C12H7F3O5SNa [M + 23]+: 342.9858; found 342.9858. 
 
6-Hydroxy-2-methyl-1,4-naphthoquinone-2,3-epoxide (185) 
Aqueous H2O2 solution (30%, 14.8 mmol, 1.46 mL) was added with stirring to the quinone 
149 (53 mg, 165 μmol) in THF (4 mL) at 0 ºC. 874 μL (874 μmol) 1 N aqueous Na2CO3 
solution was added carefully untile the orange solution had turned colorless. Stirring was 
continued at 0 ºC for 3.5 h, and 1.5 mL ice-cold saturated aqueous Na2SO3 solution was 
carefully added. The mixture was stirred for 20 min, diluted with water and extracted with 
CHCl3 (20 mL × 3). The combined organic layers were dried with anhydrous Na2SO4 and 
concentrated in vacuo to give the epoxide 185 as a pure product after column 
chromatography. 
 
Colorless solid. 
Yield: 31.0 mg, (152 μmol, 92%). 
M.p. 181 °C (MeOH/H2O). 
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IR (ATR): ν  = 3417 (w), 1694 (m), 1671 (m), 1592 (m), 1577 (m), 1321 (m), 1257 (m), 
1233 (m), 1218 (m), 1089 (m), 1012 (s), 785 (s), 743 (s) cm−1. 
1H NMR (400 MHz, CD3COCD3): δ = 1.65 (s, 3H, CH3-2), 3.92 and 3.54 (s, 1H, H-3), 7.27 
(dd, 3J = 8.4, 4J = 2.5 Hz, 1H, H-7), 7.32 (d, 4J = 2.5 Hz, 1H, H-5), 7.92 (d, 3J = 8.4 Hz, 1H, 
H-8) ppm. 
13C NMR (100 MHz, CD3COCD3): δ = 15.0 (2-CH3), 62.1 (C-2), 62.4 (C-3), 112.8 (C-5), 
122.4 (C-7), 125.4 (C-10), 130.8 (C-8), 135.4 (C-9), 163.8 (C-6), 191.2 (C-1), 192.3 (C-4) 
ppm. 
EIMS m/z (rel. int.): 204 [M]+ (100), 189 [M−15]+ (99). 
HRMS (ESI): calcd. for C11H8NaO4 [M + 23]+: 227.0315; found: 227. 0315. 
 
3,6-Dihydroxy-2-methyl-1,4-naphthoquinone (150) 
To the solution of the epoxide 185 (7.7 mg, 23.0 μmol) in THF (1 mL), silica gel (35.0 mg) 
and concentrated H2SO4 (28.5 μL) were added. The solvent was evaporated in vaccum (200 
mbar) at 70 °C for 20 min on a rotary evaporator. To the resultant red solid, H2O (10 mL) was 
added and the mixture was extracted with CH2Cl2. The organic layer was extracted with 5% 
aqueous K2CO3 solution until it had turned colorless. The water layer was acidified with 
half-concentrated aqueous HCl solution and extracted with CH2Cl2 until the color in the water 
layer was colorless again. Removal of the organic solvent gave the crude product as a red 
solid, which was purified by column chromatography (PE/EtOAc/FA = 7 : 3 : 0.01). 
 
Yellow solid. 
Yield: 4.2 mg, (12.5 μmol, 54%). 
M.p.> 340 °C (PE/EtOAc). 
IR (ATR): ν  = 3280 (m), 1666 (m), 1651 (m), 1631 (m), 1573 (m), 1375 (m), 1303 (m), 
1258 (m), 1062 (m), 1014 (s), 887 (m), 795 (s) cm−1. 
1H NMR (600 MHz, CD3OD): δ = 1.99 (s, 3H, CH3-2), 7.07 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, 
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H-7), 7.37 (d, 4J = 2.5 Hz, 1H, H-5), 7.89 (d, 3J = 8.4 Hz, 1H, H-8) ppm. 
13C NMR (150 MHz, CD3OD): δ = 8.5 (2-CH3), 112.9 (C-5), 121.0 (C-2), 121.6 (C-7), 126.1 
(C-10), 129.7 (C-8), 133.6 (C-9), 156.4 (C-3), 163.5 (C-6), 182.3 (C-4), 186.6 (C-1) ppm. 
EIMS m/z (rel. int.): 204 [M]+ (100), 176 [M−28]+ (27). 
HRMS (ESI): calcd. for C11H8NaO4 [M+Na]+: 227.0314; found 227.0315. 
 
6-Hydroxy-2-methyl-1,4-naphthoquinone (151) 
To a solution of the trifluoromethanesulfonic ester 149 (150 mg, 470 μmol) in dioxane (2 
mL), 10% aqueous Et4NOH solution (689 mg, 940 μmol, 673 μL) was carefully added at 
ambient temperature. The mixture was stirred for 30 min, diluted with CH2Cl2 (10 mL) and 
water (10 mL), and neutralized with 1 N aqueous HCl solution. The organic layer was dried 
over anhydrous Na2SO4, concentrated in vacuo and purified by column chromatography. 
 
Yellow solid. 
Yield: 44.0 mg, (235 μmol, 50%). 
M.p. 175 °C (PE/EtOAc). 
IR (ATR): ν  = 3361 (s), 1662 (s), 1650 (s), 1594 (s), 1573 (s), 1457 (m), 1350 (m), 1329 
(m), 1267 (m), 1235 (m), 1203 (m), 1134 (m), 887 (m), 848 (m), 692 (m) cm−1. 
1H NMR (400 MHz, CD3OCD3): δ = 2.13 (d, 4J = 1.6 Hz, 3H, CH3-2), 6.82 (d, 4J = 1.6 Hz, 
1H, H-3), 7.22 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, H-7), 7.39 (d, 4J = 2.5 Hz, 1H, H-5), 7.95 (d, 3J 
= 8.4 Hz, 1H, H-8) ppm. 
13C NMR (100 MHz, CD3OCD3): δ = 16.4 (2-CH3), 112.4 (C-5), 121.3 (C-7), 125.9 (C-10), 
130.0 (C-8), 135.6 (C-9), 135.9 (C-3), 149.4 (C-2), 163.4 (C-6), 184.5 (C-1), 185.5 (C-4) 
ppm. 
EIMS m/z (rel. int.): 188 [M]+ (100), 160 [M−28]+ (23). 
HRMS (ESI): calcd. for C11H7O3 [M−1]+: 187.0400; found187.0401. 
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6-Methoxy -2-methyl-1,4-naphthoquinone-2,3-epoxide (175) 
K2CO3 (98.0 mg, 710 μmol) was added to the solution of the epoxide 185 (29.0 mg, 142 μmol) 
in acetone (3 mL) at 0 ºC. The mixture was magnetically stirred for 30 min, then 
dimethylsulfate (89.5 mg, 67.4 μL, 710 μmol) was injected into the flask via a syringe and 
stirred for 3 h. The reaction mixture was quenched by addition of water (20 mL), neutralized 
with 1 N aqueous HCl solution, and the aqueous layer was extracted with CH2Cl2 (20 mL × 
3). The combined organic layers were dried with Na2SO4, concentrated to dryness, purified 
by column chromatography to afford the desired epoxide as a colorless solid. 
 
Colorless solid. 
Yield: 30.3 mg, (139.2 μmol, 98%). 
M.p. 89 °C (MeOH/H2O). 
IR (ATR): ν  = 1684 (s), 1592 (s), 1494 (m), 1433 (m), 1294 (s), 1232 (s), 1192 (m), 1057 
(m), 1026 (m), 948 (m), 856 (s), 780 (m), 740 (s) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.71 (s, 3H, CH3-2), 3.83 (s, 1H, H-3), 3.91 (s, 3H, 
CH3O-6), 7.21 (dd, 3J = 8.4, 4J = 2.5 Hz, 1H, H-7), 7.37 (d, 4J = 2.5 Hz, 1H, H-5), 7.97 (d, 3J 
= 8.4 Hz, 1H, H-8) ppm. 
13C NMR (100 MHz, CDCl3): δ = 15.0 (2-CH3), 56.1 (CH3O-6), 61.4 (C-2), 61.6 (C-3), 
110.0 (C-5), 121.7 (C-7), 125.5 (C-10), 130.1 (C-8), 134.3 (C-9), 164.7 (C-6), 190.8 (C-1), 
192.0 (C-4) ppm. 
EIMS m/z (rel. int.): 218 [M]+ (100), 203 [M−15]+ (82), 119 [M−99]+ (51). 
HRMS (ESI): calcd. for C12H10NaO4: 241.0471 [M+Na]+; found: 241.0470. 
 
3-Hydroxy-6-methoxy-2-methyl-1,4-naphthoquinone (152) 
To the solution of the epoxide 175 (14.0 mg, 64 μmol) in THF (1 mL), silica gel (95.0 mg) 
and concentrated H2SO4 (82 μL) were added. The solvent was evaporated in vaccum (200 
mbar) at 60 °C for 20 min on a rotary evaporator. To the resultant red solid, H2O (10 mL) and 
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CH2Cl2 (20 mL) were added. The mixture was basified with 5% aqueous K2CO3 solution, 
acidified with 1 M aqueous HCl solution, and extracted with CH2Cl2 (20 mL × 3). The 
combined organic layers were dried over Na2SO4, concentrated in vacuo and purified by 
column chromatography. 
Yellow solid. 
Yield: 13.6 mg, (62.7 μmol, 96%). 
M.p. 162−163 °C (PE/EtOAc). 
Lit.: 174−175 °C (Benzene).[207] 
IR (ATR): ν  = 3365 (w), 1720 (w), 1639 (m), 1590 (s), 1495 (s), 1383 (w), 1344 (m), 1316 
(s), 1271 (s), 1231 (s), 1070 (s), 1024 (s), 876 (m), 863 (s), 745 (s) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.08 (s, 3H, CH3-2), 3.93 (s, 3H, CH3O-6), 7.19 (dd, 3J = 
8.4, 4J = 2.5 Hz, 1H, H-7), 7.51 (d, 4J = 2.5 Hz, 1H, H-5), 8.05 (d, 3J = 8.4 Hz, 1H, H-8) ppm. 
13C NMR (100 MHz, CDCl3): δ = 8.8 (2-CH3), 56.1 (CH3O-6), 110.1 (C-5), 120.6 (C-2), 
120.9 (C-7), 126.5 (C-10), 129.2 (C-8), 131.4 (C-9), 153.1 (C-3), 163.6 (C-6), 181.6 (C-4), 
184.7 (C-1) ppm. 
EIMS m/z (rel. int.): 218 [M]+ (100), 190 [M−28]+ (26). 
HRMS (ESI): calcd. for C12H10NaO4: 241.04713 [M+Na]+; found: 241.04718. 
 
In the literature,[207] no spectroscopic data were reported. 
7.4  Synthesis of the Dioncoquinone B Analogs 155 and 161 
1,5-Dimethoxymethoxy naphthalene (227) 
To a solution of 1,5-dihydroxynaphthalene (9.80 g, 61.2 mmol) in dry THF (180 mL) and 
DMF (20 mL), sodium hydride (3.5 g of a 60% powder in oil, 87.5 mmol) was added at 0 °C. 
After stirring for 30 min, a solution of MOMCl (5.10 mL, 68.7 mmol) in dry EtOEt (20 mL) 
was dropwise added. The reaction mixture was heated at 50 °C for 30 min and cooled to room 
temperature. THF and DMF were removed by evaporation under reduced pressure. H2O was 
poured into the flask and the mixture was extracted with CH2Cl2 (20 mL × 3). The combined 
organic layers were dried with Na2SO4, concentrated in vacuo, and purified by crystallization 
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from 20 mL methanol to afford 227. 
Colorless crystal. 
Yield: 4.78 g (19.2 mmol, 31%). 
Lit.: 80%.[209] 
M.p.107 °C (MeOH). 
Lit.: 109 °C (MeOH).[209] 
IR (ATR): ν  = 2995 (w), 2950 (w), 2937 (w), 2830 (w), 1592 (m), 1508 (m), 1419 (m), 
1389 (m), 1340 (w), 1308 (w), 1255 (m), 1203 (w), 1147 (s), 1088 (m), 1011 (s), 914 (s), 862 
(m), 766 (s), 654 (s) cm−1. 
1H NMR (250 MHz, CDCl3): δ = 3.56 (s, 6H, OCH3), 5.42 (s, 4H, CH2), 7.17 (d, 3J = 7.6 Hz, 
2H, Ar-H), 7.43 (dd, 3J = 7.9 Hz, 2H, Ar-H), 7.98 (d, 3J = 8.2 Hz, 2H, Ar-H) ppm. 
MS (EI = 70 eV): m/z (%) 248 [M]+ (31), 45 [M−203]+ (100). 
The physical and spectroscopic data are in agreement with that in the literature.[209] 
 
1,5-Dimethoxymethoxy-2,6-dimethylnaphthalene (228) and 1,5-Dimethoxymethoxy-2-methyl 
naphthalene (229) 
To a solution of naphthalene 227 (1.50 g, 6.04 mmol) in dry EtOEt (60 mL) and distilled 
TMEDA (3.80 mL), s-BuLi (15.1 mL, 1.6 M, 24.2 mmol) was added into the flask slowly at 
−78 °C under nitrogen atmosphere. After stirring for 2 h, the reaction mixture was allowed to 
warm up to room temperature and stirred for another 1 h at 0 °C. MeI (3.1 mL, 49.6 mmol) 
was added into the flask and stirred for 2 h. The reaction mixture was poured into 100 mL 
H2O and the organic solvent was removed by evaporation. The crude product was extracted 
with CHCl3 (50 mL × 3) and the combined organic layers were dried with Na2SO4, 
concentrated in vacuo, and purified by column chromatography (PE/EtOAc = 19 : 1). 
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1,5-Dimethoxymethoxy-2,6-dimethyl naphthalene (228) 
White solid. 
Yield: 475 mg (1.72 mmol, 28%). 
Lit.: 80%.[209] 
M.p. 107 °C (CHCl3). 
Lit.: 105 °C (MeOH).[209]  
IR (ATR): ν  = 2995 (w), 2925 (w), 2827 (w), 1603 (w), 1502 (w), 1465 (w), 1421 (w), 1369 
(m), 1336 (w), 1234 (m), 1151 (m), 1076 (m), 1043 (m), 972 (s), 918 (s), 862 (m), 816 (s), 
750 (w), 723 (m) cm−1. 
1H NMR (250 MHz, CDCl3): δ = 2.49 (s, 6H, CH3), 3.69 (s, 6H, OCH3), 5.16 (s, 4H, CH2), 
7.33 (d, 3J = 8.5 Hz, 2H, Ar-H), 7.83 (d, 3J = 8.5 Hz, 2H, Ar-H) ppm. 
MS (EI = 70 eV): m/z (%) 276 [M]+ (31), 45 [M−231]+ (100). 
The physical and spectral data are in agreement with that in the literature.[209] 
 
1,5-Dimethoxymethoxy-2-methylnaphthalene (229) 
White solid. 
Yield: 398 mg (1.52 mmol, 25%). 
M.p. 48 °C (CHCl3). 
IR (ATR): ν  = 2993 (w), 2939 (w), 2835 (w), 1601 (w), 1506 (w), 1477 (w), 1421 (w), 1369 
(m), 1238 (m), 1151 (s), 1086 (s), 1034 (s), 976 (s), 918 (s), 868 (m), 827 (m), 793 (s), 746 (s), 
700 (w), 665 (m), 611 (w) cm−1. 
1H NMR (250 MHz, CDCl3): δ = 2.56 (s, 3H, CH3), 3.58 (s, 3H, OCH3), 3.72 (s, 3H, OCH3), 
5.20 (s, 2H, CH2), 5.41 (s, 2H, CH2), 7.12 (d, 3J = 7.6 Hz, 1H, Ar-H), 7.37 (d, 3J = 8.5 Hz, 1H, 
Ar-H), 7.45 (t, 3J = 7.9 Hz, 1H, Ar-H), 7.81 (d, 3J = 8.5 Hz, 1H, Ar-H), 8.07 (d, 3J = 8.5 Hz, 
1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 17.0 (CH3), 56.5 (OCH3), 58.0 (OCH3), 95.0 (CH), 100.1 
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(CH), 107.7 (CH), 115.6 (CH), 118.4 (CH), 126.2 (CH), 127.5 (C), 128.9 (C), 130.0 (C), 
151.2 (CO), 153.4 (CO) ppm. 
MS (EI = 70 eV): m/z (%) 262 [M]+ (31), 45 [M−217]+ (100). 
HRMS (ESI): calcd. for C15H18NaO4 [M+Na]+: 285.1097; found 285.1096. 
 
1,5-Dihydroxy-2,6-dimethylnaphthalene (153) 
Compound 228 (120 mg, 507 μmol) was dissolved in methanol (4 mL) and concentrated 
aqueous HCl solution (330 μL). The solution was stirred for 2 h at room temperature followed 
by addition of H2O (10 mL). The precipitation was filtered, washed with water and dried with 
the high vaccum to afford the desired product. 
 
White solid. 
Yield: 91 mg (484 μmol, 95%). 
M.p. 210 °C (CHCl3).  
Lit.: 205 °C (PE).[209] 
IR (ATR): ν  = 3348 (br m), 2921 (w), 2840 (w), 1608 (m), 1504 (m), 1354 (m), 1277 (s), 
1236 (s), 1205 (m), 1173 (s), 953 (w), 877 (s), 806 (s), 677 (s) cm−1. 
1H NMR (250 MHz, CDCl3): δ = 2.39 (s, 6H, CH3), 7.18 (d, 3J = 8.5 Hz, 2H, Ar-H), 7.20 
(d, 3J = 8.5 Hz, 2H, Ar-H), 7.88 (s, 2H, OH) ppm. 
The physical and spectral data are in agreement with those in the literature.[209] 
 
5-Hydroxy-2,6-dimethylnaphthalene (154) 
A suspension of CuCl (42.0 mg, 424 μmol) and 1,5-dihydroxy-2,6-dimethylnaphthalene 
(153) (91.0 mg, 484 μmol) in acetonitrile (10 mL) was stirred at room temperature for 10 h 
with a strong current of oxygen bubbling through it. The reaction mixture was diluted with 
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water (20 mL) and extracted with CH2Cl2 (50 mL × 3). The combined organic layers were 
dried over Na2SO4, concentrated in vacuo, and purified by column chromatography on silica 
gel (PE/EtOAc = 8 : 2) to give 154 as an orange solid.  
 
Orange crystal. 
Yield: 58 mg (287 μmol, 59%). 
M.p. 148 °C (CHCl3). 
Lit.: 152 °C (PE).[209] 
IR (ATR): ν  = 3080 (w), 2921 (w), 2840 (w), 1639 (s), 1601 (m), 1429 (s), 1360 (s), 1252 
(s), 1201 (s), 1138 (m), 1059 (m), 980 (m), 914 (m), 849 (m), 820 (m), 779 (s), 735 (m), 650 
(m) cm−1. 
1H NMR (250 MHz, CDCl3): δ = 3.42 (s, 3H, CH3), 3.61 (s, 3H, CH3), 6.75 (s, 1H, Ar-H), 
7.44 (d, 3J = 7.6 Hz, 1H, Ar-H), 7.53 (d, 3J = 7.6 Hz, 1H, Ar-H), 12.3 (s, 1H, OH) ppm. 
The physical and spectroscropic data are in agreement with those in the literature.[209] 
 
2,3-Epoxy-2,6-dimethyl-1,4-naphthoquinone (230) 
To a solution of naphthoquinone 154 (58.0 mg, 287 μmol) in 1.0 mL H2O/MeOH (1/4 v/v), 
71.0 μL (142 μmol) 2 N aqueous NaOH solution was added at 0 °C. After 10 min, 44.0 μL 
30% aqueous H2O2 solution was added to the reaction mixture and stirred for 4 h at 0 °C. The 
precipitation was filtered and dried in the high vacuum. Aqueous saturated NH4Cl solution 
was added into the dark reaction mixture and extracted with CH2Cl2 (10 mL × 3). The 
combined organic layers were dried over Na2SO4, concentrated in vacuo, and the crude 
product was purified on the column chromatography (PE/EtOEt = 18 : 1). 
 
Colorless powder. 
Yield: 15.0 mg (68.7 μmol, 24%). 
M.p. 74 °C (CHCl3). 
154 
230 
Synthesis of Naphthoquinones 191 
  
IR (ATR): ν  = 2924 (w), 2844 (w), 1689 (s), 1645 (s), 1423 (s), 1340 (s), 1308 (s), 1250 (s), 
1165 (m), 1138 (m), 1092 (m), 1059 (m), 980 (m), 922 (m), 883 (m), 856 (m), 806 (w). 750 
(s), 644 (m) cm−1. 
1H NMR (250 MHz, CDCl3): δ = 1.71 (s, 3H, CH3), 2.32 (s, 3H, CH3), 3.80 (s, 1H, CH), 7.51 
(s, 2H, Ar-H), 11.52 (s, 1H, OH) ppm. 
13C NMR (100 MHz, CDCl3): δ = 14.9 (Me), 16.3 (Me), 61.7 (CH), 119.8 (CH), 138.0 (CH) 
ppm. 
HRMS (ESI): calcd. for C12H10NaO4 [M+Na]+: 241.0471; found 241.0469. 
 
3,5-Dihydroxy-2,6-dimethyl-1,4-naphthoquinone (155) 
To a solution of the epoxide 230 (13.0 mg, 59.6 μmol) in THF (1.0 mL), SiO2 (75.0 mg) 
and concentrated H2SO4 (61 μL) were added. THF was removed in vaccum (200 mbar) at 
60 °C for 20 min on a rotatory evaporator. H2O (20 mL) was poured into the reaction mixture 
and the suspension were extracted with CH2Cl2 (10 mL × 3). The combined organic layers 
were dried over Na2SO4, concentrated under reduced pressure, and purified with column 
chromatography. 
 
Yellow powder. 
Yield: 12.0 mg (55.0 μmol, 92%). 
M.p. 179 °C (CH2Cl2). 
IR (ATR): ν  = 3267 (br m), 2922 (m), 2852 (w), 1711 (w), 1620 (m), 1429 (m), 1360 (m), 
1306 (s), 1254 (s), 1211 (s), 1097 (s), 1059 (s), 984 (m), 837 (m), 737 (s), 671 (s) cm−1. 
1H NMR (250 MHz, CDCl3): δ = 2.08 (s, 3H, CH3), 2.32 (s, 3H, CH3), 7.26 (br, 1H, OH), 
7.46 (d, 3J = 7.8 Hz, 1H, Ar-H), 7.56 (d, 3J = 8.0 Hz, 1H, Ar-H), 11.43 (s, 1H, OH) ppm. 
13C NMR (100 MHz, CDCl3): δ = 9.0 (Me), 16.0 (Me), 112.4 (C), 119.6 (CH), 121.9 (C), 
130.8 (C), 133.9 (C), 138.0 (CH), 152.9 (C), 160.1 (C), 184.5 (CO), 185.0 (CO) ppm. 
HRMS (ESI): calcd. for C12H10NaO4 [M+Na]+: 241.0471; found 241.0470. 
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N,N-Diethyl-3-chloro-2-methoxy-benzamide (157) 
A mixture of thionyl chloride (3.8 g, 32.1 mmol, 2.28 mL) and 3-chloro-2-methoxy- 
benzoic acid (2.0 g, 10.7 mmol) in a 10 mL one-necked flask was refluxed at 80 °C overnight. 
The excess of thionyl chloride was evaporated under reduced pressure affording the acyl 
chloride, which was dissolved in THF (30 mL). To the above solution, diethylamine (2.34 g, 
32.1 mmol, 3.32 mL) in THF (10 mL) was added carefully with stirring at 0 °C. The reaction 
was continued at room temperature with stirring overnight. The mixture was diluted with 
water, acidified with 0.5 N aqueous HCl solution, and neutralized with saturated aqueous 
NaHCO3 solution. THF was evaporated under reduced pressure and the suspension was 
extracted with CH2Cl2 (60 mL × 3). The combined organic layers were dried with anhydrous 
Na2SO4, concentrated in vacuo, and subjected to column chromatography affording the 
product. 
 
Dark brown liquid. 
Yield: 2.5 g, (10.5 mmol, 98%). 
IR (ATR): ν  = 2974 (w), 2937 (w), 1629 (s), 1461 (m), 1471 (m), 1289 (m), 1244 (m), 1099 
(s), 1071 (m), 997 (m), 790 (m), 759 (m), 728 (m), 648 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 0.97 (t, 3J = 7.0 Hz, 3H, CH3), 1.22 (t, 3J = 7.0 Hz, 3H, 
CH3), 3.10 (q, 3J = 7.0 Hz, 2H, CH2), 3.35 and 3.70 (broad signal, 2H, CH2), 3.84 (s, 3H, 
CH3O), 7.0–7.1 (m, 2H, Ar-H), 7.34 (dd, 3J = 8.4, 4J = 2.0 Hz, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 12.8 (CH3), 14.0 (CH3), 39.2 (CH2), 43.1 (CH2), 62.0 
(CH3O), 125.2 (CH), 126.0 (CH), 128.2 (C), 130.9 (CH), 133.6 (C), 151.9 (C), 167.6 (CO) 
ppm. 
EIMS m/z (rel. int.): 241 [M]+ (13), 243 [M]+ (4), 169 [M−72]+ (100), 171 [M−72]+ (28).  
HRMS (ESI): calcd. for C12H16ClNNaO2 [M+Na]+: 264.0762; found 264.0763. 
 
N,N-Diethyl-3-chloro-2-methoxy-(2-methyl-allyl)-benzamide (158) 
To a solution of 157 (1.86 g, 7.69 mmol) in THF (30 mL), s-BuLi (6.03 mL, 8.46 mmol, 
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1.1 equiv.) and TMEDA (1.26 mL, 8.46 mmol, 1.1 equiv.) was added by syringe injection at 
−90 °C under argon and stirred for 1.5 h. The solution of the resultant lithiated species was 
then warmed to −78 °C over 30 min. Freshly prepared MgBr2•2Et2O (5.85 mL, 15.38 mmol, 
2 equiv.) was added to the flask. The mixture was stirred for 30 min, allowed to warm to room 
temperature, again cooled to −78 °C, and stirred for 1 h. Following addition of 
3-bromo-2-methyl-propene (1.6 mL, 15.38 mmol, 2 equiv.), the solution was allowed to warm 
to room temperature overnight. The reaction mixture was treated with saturated aqueous 
NH4Cl solutions, and extracted with CH2Cl2 (80 mL × 3). The combined organic layers were 
dried with Na2SO4, and concentrated to dryness under reduced pressure. The crude product 
was purified with column chromatography. 
 
Colorless liquid. 
Yield: 1.8 g, (6.1 mmol, 79%). 
IR (ATR): ν  = 2972 (w), 2938 (w), 1629 (s), 1461 (m), 1432 (m), 1400 (m), 1282 (m), 1222 
(m), 1098 (m), 1045 (m), 942 (m), 890 (m), 802 (m), 732 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.04 (t, 3J = 7.0 Hz, 3H, CH3), 1.24 (t, 3J = 7.0 Hz, 3H, 
CH3), 1.67 (s, 3H, CH3), 3.06 (q, 3J = 7.0 Hz, 2H, CH2), 3.24 (s, 2H, CH2), 3.56 (q, 3J = 7.0 
Hz, 1H, CH2), 3.84 (s, 3H, CH3O), 4.68 (s, 1H, CH2a), 4.85 (s, 1H, CH2b), 6.94 (s, 3J = 8.0 
Hz, 1H, Ar-H), 7.28 (s, 3J = 8.0 Hz, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 12.8 (CH3), 13.8 (CH3), 22.4 (CH3), 38.7 (CH2), 40.6 
(CH2), 43.1 (CH2), 61.9 (CH3O), 113.4 (CH2), 125.7 (C), 126.4 (CH), 130.0 (CH), 133.8 (C), 
136.5 (C), 143.4 (C), 151.9 (C), 166.8 (CO) ppm. 
EIMS m/z (rel. int.): 295 [M]+ (14), 297 [M]+ (4), 223 [M−72]+ (100), 225 [M−72]+ (36). 
HRMS (ESI): calcd. for C16H22ClNNaO2 [M+Na]+: 318.1231; found 318.1233. 
 
6-Chloro-5-methoxy-2-methyl-4-naphthol (159) 
To a solution of N,N-diethyl-3-chloro-2-methoxy-(2-methyl-allyl)-benzamide (158) (780 
mg, 2.64 mmol) in THF (20 mL), MeLi (2.2 equiv.) was added with stirring at −78 °C. The 
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reaction mixture was slowly warmed upto 0 °C over 5 h, followed by addition of saturated 
aqueous NH4Cl solution, removal of THF, and extraction with EtOAc (30 mL × 3). The 
combined organic layers were dried with Na2SO4, and concentrated in vacuo. The crude 
product was purified by column chromatography (PE/EtOAc = 96 : 4) affording the naphthol 
159 as a colorless solid. 
 
Colorless solid. 
Yield: 342 mg, (1.54 mmol, 58%). 
M.p. 62 °C (PE/EtOAc). 
IR (ATR): ν  = 3352 (w), 2950 (w), 2912 (w),1636 (m), 1596 (m), 1577 (m), 1504 (m), 1443 
(m), 1366 (m), 1347 (s), 1259 (m), 1159 (m), 1094 (m), 1060 (m), 976 (m), 939 (m), 847 (s), 
780 (m), 671 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.43 (s, 3H, CH3), 4.09 (s, 3H, OCH3), 6.81 (d, 1H, 4J = 1.6 
Hz, Ar-H), 7.10 (d, 1H, 4J = 1.6 Hz, Ar-H), 7.31 (d, 1H, 3J = 8.0 Hz, Ar-H), 7.43 (d, 1H, 3J = 
8.0 Hz, Ar-H), 9.27 (s, 1H, OH) ppm. 
13C NMR (100 MHz, CDCl3): δ = 21.8 (CH3), 62.4 (CH3O), 113.5 (CH), 116.4 (C), 118.8 
(CH), 120.8 (C), 125.4 (CH), 127.9 (CH), 135.6 (C), 138.4 (C), 151.5 (C), 153.1 (C) ppm. 
EIMS m/z (rel. int.): 222.0 [M]+ (100), 224 [M]+ (34), 207 [M−15]+ (78), 209 [M−15]+ (26), 
179 [M−43]+ (60), 181 [M−43]+ (20). 
HRMS (ESI): calcd. for C12H11ClNaO2 [M+Na]+: 245.0340; found 245.0340. 
 
6-Chloro-5-methoxy-2-methyl-1,4-naphthoquinone (160) 
To a suspension of CuCl (46.5 mg, 0.46 mmol) in MeCN (20 mL), the naphthol 159 (131 
mg, 0.59 mmol) in MeCN (20 mL) was dropwise added over 15 min under stirring at room 
temperature with a strong current of oxygen bubbling through it. After the starting material 
was consumed completely, the reaction mixture was diluted with water (100 mL) and 
extracted with CH2Cl2 (100 mL × 3). The combined organic layers were dried over Na2SO4, 
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and concentrated in vacuo. The crude product was purified with column chromatography. 
 
Yellow powder. 
Yield: 62.0 mg, (0.26 mmol, 44%). 
M.p. 122−125 °C (PE/EtOAc). 
IR (ATR): ν  = 2952 (w), 2923 (w), 1728 (w), 1656 (s), 1630 (m), 1568 (m), 1460 (m), 1401 
(m), 1356 (m), 1254 (s), 1044 (m), 961 (m), 910 (m), 853 (s), 810 (m), 745 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.14 (s, 3H, CH3), 3.93 (s, 3H, OCH3), 6.75 (s, 1H, Ar-H), 
7.72 (s, 1H, 3J = 8.0 Hz, Ar-H), 7.86 (s, 1H, 3J = 8.0 Hz, Ar-H). 
13C NMR (100 MHz, CDCl3): δ = 16.1 (CH3), 61.8 (CH3O), 123.9 (CH), 126.0 (C), 132.8 
(C), 135.1 (CH), 137.1 (C), 137.5 (CH), 146.6 (C), 155.8 (C), 183.6 (CO), 184.9 (CO). 
EIMS m/z (rel. int.): 236 [M]+ (100), 238 [M]+ (38), 207 [M−30]+ (17), 209 [M−30]+ (6). 
HRMS (ESI): calcd. for C12H9ClNaO3 [M+Na]+: 259.0132; found 259.0133. 
 
6-Chloro-5-methoxy-2-methyl-1,2-naphthoquinone (231) 
 
Red powder. 
Yield: 23.0 mg, (97 μmol, 16%). 
M.p. 108−110 °C (PE/EtOAc).  
IR (ATR): ν  = 2923 (w), 2852 (w), 1726 (w), 1658 (s), 1628 (m), 1569 (m), 1462 (m), 1371 
(m), 1278 (m), 1255 (m), 1207 (m), 1090 (m), 1039 (m), 960 (m), 817 (m), 787 (m) cm−1. 
1H NMR (250 MHz, CDCl3): δ = 2.04 (s, 3H, CH3), 3.95 (s, 3H, OCH3), 6.98 (s, 1H, 3J = 8.0 
Hz, Ar-H), 7.16 (s, 1H, Ar-H), 7.61 (s, 1H, 3J = 8.0 Hz, Ar-H). 
13C NMR (100 MHz, CDCl3): δ = 15.7 (CH3), 61.8 (CH3O), 124.8 (C), 125.8 (CH), 132.4 
(C), 136.0 (C), 136.8 (C), 137.0 (CH), 141.4 (CH), 159.5 (C), 178.0 (CO), 180.9 (CO). 
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EIMS m/z (rel. int.): 208 [M−28]+ (100), 210 [M−28]+ (34). 
HRMS (ESI): calcd. for C12H9ClNaO3 [M+Na]+: 259.0132; found 259.0133. 
 
6-Chloro-5-methoxy-1,4-naphthoquinone-2,3-epoxide (186) 
The quinone 160 (41.0 mg, 173 μmol) and 86 μL (0.5 equiv.) of 1 N aqueous NaOH 
solution were dissolved in 16 mL of mixing solvents (MeOH/H2O/THF = 4 : 1: 1) at room 
temperature. After stirring for 10 minutes, 54 μL of 35% aqueous H2O2 solution (3.0 equiv.) 
was added and stirred for 2 h. The reaction mixture was neutralized with 1 N aqueous HCl 
solution, and extracted with EtOEt (30 mL × 3). The combined organic layers were dried over 
Na2SO4, and concentrated in reduced pressure. The crude product was purified with column 
chromatography. 
 
Colorless powder. 
Yield: 29.0 mg, (122 mmol, 71%). 
M.p. 85 °C (PE/EtOAc). 
IR (ATR): ν  = 2923 (w), 2853 (w), 1699 (s), 1572 (m), 1467 (m), 1404 (m), 1330 (m), 1289 
(m), 1240 (s), 1141 (m), 1075 (m), 1029 (m), 965 (s), 851 (m), 750 (m), 717 (s) cm−1. 
1H NMR (600 MHz, CDCl3): δ = 1.72 (s, 3H, CH3), 3.86 (s, 1H, H-3), 3.97 (s, 3H, OCH3), 
7.70 (s, 2H, Ar-H) ppm.  
13C NMR (150 MHz, CDCl3): δ = 14.7 (CH3), 61.8 (CH), 62.0 (C), 62.8 (CH), 124.0 (CH), 
127.0 (C), 132.5 (C), 135.6 (CH), 136.7 (C), 155.6 (C), 190.9 (C), 191.9 (C) ppm. 
EIMS m/z (rel. int.): 252 [M]+ (91), 254 [M]+ (33), 237 [M−15]+ (52), 239 [M−15]+ (17), 209 
[M−43]+ (100), 211 [M−43]+ (36). 
HRMS (ESI): calcd. for C12H9ClNaO4 [M+Na]+: 275.0082; found 275.0081. 
 
6-Chloro-3-hydorxy-5-methoxy 2-methyl-1,4-naphthoquinone (174) 
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To a solution of 186 (26.0 mg, 103 μmol) in THF (2.0 mL), SiO2 (153.0 mg) and 
concentrated H2SO4 (132 μL) were added. The solvent was rotary evaporated in vaccum (200 
mbar) at 60 ºC for 25 min. The resultant red solid was diluted with H2O (10 mL), basified 
with 5% aqueous K2CO3 solution, neutralized with 1 N aqueous HCl solution, and extracted 
with CH2Cl2 (20 mL × 3). The combined organic layers were dried over anhydrous Na2SO4, 
concentrated in vacuo and purified on a column chromatography affording the product as a 
yellow solid. 
 
Yellow powder. 
Yield: 23.0 mg, (91 mmol, 90%). 
M.p. 155−158 °C (PE/EtOAc). 
IR (ATR): ν  = 3347 (m), 2922 (w), 2851 (w), 1702 (m), 1645 (s), 1569 (m), 1462 (m), 1406 
(m), 1380 (m), 1341 (s), 1273 (m), 1197 (s), 1132 (m), 1090 (s), 1030 (m), 961 (s), 899 (s), 
809 (m), 741 (m), 668 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.08 (s, 3H, CH3), 3.96 (s, 3H, OCH3), 7.53 (s, 1H, OH), 
7.75 (s, 1H, 3J = 8.0 Hz, Ar-H), 7.91 (s, 1H, 3J = 8.0 Hz, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 8.8 (CH3), 61.8 (CH3O), 119.5 (C), 123.3 (C), 124.0 (CH), 
133.5 (C), 136.0 (C), 136.4 (CH), 153.6 (C), 156.2 (C), 179.6 (CO), 184.0 (CO) ppm. 
EIMS m/z (rel. int.): 252 [M]+ (91), 254 [M]+ (33), 234 [M−18]+ (23), 236 [M−18]+ (8), 209 
[M−43]+ (28), 211 [M−43]+ (10). 
HRMS (ESI): calcd. for C12H9ClNaO4 [M+Na]+: 275.0082; found 275.0080. 
 
3,5-Dihydroxy-6-chloro-2-methyl-1,4-naphthoquinone (161) 
BBr3 (32 μL, 336 μmol) was added to a solution of 174 (17.0 mg, 67 μmol) in CH2Cl2 (2 
mL) under stirring and argon at 0 °C. After 2 h, the cold bath was removed. The reaction 
mixture was quenched with water, extracted with CH2Cl2 (20 mL × 3). The combined organic 
layers were dried over anhydrous Na2SO4, and concentrated on a rotary evaporator affording 
the desired product. 
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Yellow powder. 
Yield: 16.0 mg, (67 mmol, 100%). 
M.p. 150−152 °C (CH2Cl2). 
IR (ATR): ν  = 3205 (w), 2921 (w), 2852 (w), 1620 (s), 1431 (s), 1389 (m), 1353 (m), 1285 
(s), 1196 (s), 1123 (s), 1083 (s), 1022 (m), 744 (s), 720 (s) cm−1. 
1H NMR (400 MHz, CD3COCD3): δ = 2.02 (s, 3H, CH3-2), 7.56 (s, 1H, 3J = 8.0 Hz, H-8), 
7.84 (s, 1H, 3J = 8.0 Hz, H-7), 9.66 (s, 1H, OH-3), 11.86 (s, 1H, OH-5) ppm. 
13C NMR (100 MHz, CD3COCD3): δ = 8.8 (CH3-2), 115.5 (C-9), 119.7 (C-8), 122.8 (C-2), 
128.0 (C-6), 132.2 (C-10), 137.6 (C-7), 155.3 (C-3), 157.3 (C-5), 184.2 (C-1), 186.2 (C-4) 
ppm. 
EIMS m/z (rel. int.): 238 [M]+ (100), 240 [M]+ (33), 210 [M−28]+ (27), 212 [M−18]+ (9). 
HRMS (ESI): calcd. for C11H6ClO4 [M−1]+: 236.9960; found 236.9961. 
 
7.5  Synthesis of the Dioncoquinone B Analogs 171 and 173 
2,6-Dimethyl-1,4-naphthoquinone (170) 
To the solution of H5IO6 (1.16 g, 5.09 mmol) and CrO3 (12.8 mg, 0.128 mmol) in 
acetonitrile (20 mL), 2,6-dimethylnaphthalene (200.0 mg, 1.28 mmol) in acetonitirile (7 mL) 
was added dropwise with vigorous stirring at 0 ºC. After several minutes, a white precipitation 
was formed. The reaction mixture was stirred for another 45 min, filtered on a short pad of 
silica gel, and eluted with CH2Cl2. After removal of CH2Cl2, the crude product was purified 
by column chromatography (PE/EtOAc = 90 : 10). 
 
Yellow powder. 
Yield: 142.0 mg, (0.763 mmol, 60%). 
M.p. 130−132 °C (PE/EtOAc).  
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Lit.: 135−136 °C (MeOH).[93] 
IR (ATR): ν  = 3025 (w), 2950 (w), 2923 (w), 2850 (w), 1654 (s), 1596 (s), 1351 (m), 1298 
(s), 1259 (s), 1028 (w), 939 (w), 896 (w), 843 (m), 800 (w), 739 (w), 690 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.07 (s, 3H, CH3), 2.37 (s, 3H, CH3), 6.68 (s, 1H, Ar-H), 
7.39 (d, 3J = 8.0 Hz, 1H, Ar-H), 7.71 (s, 1H, Ar-H), 7.85 (d, 3J = 8.0 Hz, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 16.4 (CH3), 21.8 (CH3), 126.3 (CH), 126.6 (CH), 129.9 
(C), 132.1 (C), 134.3 (CH), 135.4 (CH), 144.7 (C), 148.1 (C), 185.2 (C), 185.3 (C) ppm. 
MS (EI = 70 eV): m/z (%) 186 [M]+ (100), 158 [M−28]+ (49), 118 [M−68]+ (51). 
The spectroscopic data are in agreement with those in the literature.[93] 
 
6-Methyl-1,4-naphthoquinone-2,3-epoxide (176) 
67.0 μL (134 μmol) 2 N NaOH was added with stirring to the naphthoquinone 170 (50.0 
mg, 269 μmol) in 1.0 mL H2O/MeOH (1/4 v/v) at 0 °C. After 10 min, 41.1 μL 30% aqueous 
H2O2 solution was added to the reaction mixture and stirred for 4 h. The precipitation was 
filtered and purified by column chromatography affording the product as a colorless solid. 
 
Colorless solid. 
Yield: 50.4 mg, (249 μmol, 93%). 
M.p.95−96 °C (MeOH/H2O). 
Lit.: 97−98 °C.[284] 
IR (ATR): ν  = 3030 (w), 2929 (w), 2850 (w), 1685 (s), 1599 (s), 1448 (w), 1373 (w), 1338 
(m), 1302 (s), 1248 (m), 1207 (w), 1128 (w), 1051 (w), 945 (m), 860 (s), 781 (m), 733 (s), 
661 (w) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.71 (s, 3H, CH3), 2.46 (s, 3H, CH3), 3.81 (s, 1H, CH), 7.52 
(d, 3J = 7.9 Hz, 1H, Ar-H), 7.72 (s, 1H, Ar-H), 7.89 (d, 3J = 7.9 Hz, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 14.9 (Me), 21.9 (Me), 61.5 (C), 61.6 (CH), 127.3 (CH), 
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127.8 (CH), 129.9 (C), 132.1 (C), 135.5 (CH), 145.8 (C), 191.8 (C), 192.2 (C) ppm. 
MS (EI = 70 eV): m/z (%) 202 [M]+ (57), 187 [M−15]+ (100), 174 [M−28]+ (32). 
In the literature,[284] no spectroscopic data are described. 
 
3-Hydroxy-2,6-methyl-1,4-naphthoquinone (171) 
To the solution of the epoxide 176 (38.0 mg, 188 μmol) in THF (1 mL), SiO2 (285 mg) and 
concentrated H2SO4 (233 μL) was added. THF was removed at 60 °C and in vaccum (200 
mbar) for 10 min on a rotary evaporator. H2O (20 mL) and CH2Cl2 (20 mL) were added to the 
resultant solid. The mixture was basified with 5% aqueous K2CO3 solution, acidified with 1 
N aqueous HCl solution, and extracted with CH2Cl2 (20 mL × 3). The combined organic 
layers were dried over Na2SO4, concentrated in vacuo and purified by crystallization from 
CH2Cl2. 
 
Yellow powder. 
Yield: 36.0 mg (178 μmol, 95%).  
M.p.194 °C (CH2Cl2). 
Lit.: 194 °C (PE).[285] 
IR (ATR): ν  = 3354 (s), 2954 (w), 2929 (w), 2852 (w), 1637 (s), 1595 (s), 1427 (w), 1381 
(m), 1340 (s), 1302 (s), 1271 (s), 1184 (s), 1161 (s), 1074 (s), 1009 (m), 947 (w), 874 (w), 845 
(m), 738 (s), 673 (s) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.08 (s, 3H, CH3), 2.46 (s, 3H, CH3), 7.29 (s, 1H, OH), 
7.52 (d, 3J = 7.8 Hz, 1H, Ar-H), 7.85 (s, 1H, Ar-H), 7.99 (d, 3J = 7.8 Hz, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 8.8 (Me), 21.8 (Me), 120.5 (C), 126.7 (CH), 127.1 (CH), 
129.5 (C), 130.9 (C), 135.6 (CH), 144.1 (C), 153.2 (C), 181.7 (C), 185.2 (C) ppm. 
MS (EI = 70 eV): m/z (%) 202 [M]+ (100), 174 [M−28]+ (33), 131 [M−71]+ (40). 
The spectroscopic data are in agreement with those in the literature.[285] 
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2-Formyl-6-methyl-naphthalene (179) and 2,6-Diformyl-naphthalene (180) 
The solution of 2,6-dimethylnaphthalene (400 mg, 2.56 mmol) in EtOAc (43.0 mL) and 
concentrated aqueous HBr solution (58.3 μL, 512 μmol) was exposed to high pressure 
mercury lamp with 450 watts Hanovia for 17 h under a strong current of oxygen. After 
removal of the solvent on a rotary evaporation, the crude product was purified on silical gel 
column chromatography affording two main products 168 and 169 (PE/EtOAc = 90 : 10). 
 
2-Formyl-6-methylnaphthalene (179) 
White powder. 
Yield: 156.0 mg (838 μmol, 33%). 
M.p. 115 °C (PE/EtOAc). 
Lit.: 120 °C (Hexane).[250] 
IR (ATR): ν  = 3350 (w), 3100 (w), 2926 (w), 2843 (w), 1687 (s), 1623 (m), 1574 (w), 1473 
(m), 1373 (w), 1335 (m), 1263 (m), 1225 (w), 1167 (m), 1115 (m), 974 (w), 895 (m), 833 (s), 
775 (m), 717 (m), 636 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.53 (s, 3H, CH3), 7.39 (d, 3J = 8.5 Hz, 1H, Ar-H), 7.64 (s, 
1H, Ar-H), 7.79 (d, 3J = 8.5 Hz, 1H, Ar-H), 7.86 (d, 3J = 8.5 Hz, 1H, Ar-H), 7.90 (d, 3J = 8.5 
Hz, 1H, Ar-H), 10.1 (s, 1H, CHO) ppm. 
13C NMR (100 MHz, CDCl3): δ = 22.1 (Me), 123.0 (CH), 127.3 (CH), 128.5 (CH), 129.4 
(CH), 129.5 (CH), 131.0 (C), 133.6 (C), 134.5 (CH), 136.9 (C), 139.6 (C), 192.3 (CHO) ppm. 
MS (EI = 70 eV): m/z (%) 170 [M]+ (100), 141 [M−29]+ (81), 115 [M−55]+ (82). 
 
2,6-Diformylnaphthalene (180) 
White powder. 
Yield: 14.0 mg (65.0 μmol, 3%). 
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M.p. 172 °C (PE/EtOAc). 
Lit.: 173 °C (CH3COCH3).[286] 
IR (ATR): ν  = 2924 (w), 2841 (w), 2720 (w), 1682 (s), 1601 (m), 1500 (w), 1373 (w), 1331 
(m), 1273 (m), 1223 (s), 1155 (m), 1107 (m), 980 (w), 893 (m), 818 (m), 758 (s), 630 (w) 
cm−1. 
1H NMR (400 MHz, CDCl3): δ = 8.06 (d, 3J = 8.4 Hz, 2H, Ar-H), 8.12 (d, 3J = 8.2 Hz, 2H, 
Ar-H), 8.40 (s, 2H, Ar-H), 10.2 (s, 2H, CHO) ppm. 
13C NMR (100 MHz, CDCl3): δ = 124.3 (CH), 130.8 (CH), 133.9 (CH), 136.0 (C), 136.4 (C), 
192.0 (CHO) ppm.  
MS (EI = 70 eV): m/z (%) 184 [M]+ (100), 155 [M−29]+ (62), 127 [M−57]+ (55). 
The spectroscopic data are in agreement with those in the literature.[286] 
 
6-Methyl-2-naphthoic acid (181) 
2,6-Dimethylnaphthalene (416 mg, 2.66 mmol) and KMnO4 (2.10 g, 13.3 mmol) in 
pyridine (35 mL) and water (12 mL) was refluxed for 2 h and the other portion of KMnO4 
(0.84 g, 5.32 mmol) was added and kept for 0.5 h. The reaction mixture was cooled to room 
temperature followed by addition of 1 N aqueous NaOH solution (1.0 mL). The mixture was 
filtered with Celite and eluted with methanol (100 mL). The eluent was concentrated in vacuo, 
and the crude product was purified with column chromatography (PE/EtOAc/FA = 80 : 20 : 
5). 
 
White solid. 
Yield: 403 mg (2.16 mmol, 81%). 
M.p.225−227 °C (FA). 
Lit.: 225−227 °C (MeOH).[287] 
IR (ATR): ν  = 3400 (br m), 2980 (w), 2916 (w), 2830 (w), 1670 (s), 1574 (m), 1475 (m), 
1415 (w), 1383 (m), 1290 (m), 1244 (m), 1194 (m), 1099 (m), 958 (w), 906 (w), 877 (w), 800 
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(m), 764 (m), 712 (m), 637 (m) cm−1. 
1H NMR (400 MHz, CD3OD): δ = 2.51 (s, 3H, CH3), 7.39 (d, 3J = 8.4 Hz, 1H, Ar-H), 7.68 (s, 
1H, Ar-H), 7.79 (d, 3J = 8.6 Hz, 1H, Ar-H), 7.86 (d, 3J = 8.4 Hz, 1H, Ar-H), 7.98 (d, 3J = 8.6 
Hz, 1H, Ar-H), 8.52 (s, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CD3OD): δ = 23.4 (Me), 126.6 (CH), 127.7 (CH), 128.3 (CH), 129.5 
(CH), 129.8 (CH), 130.1 (CH), 131.6 (C), 132.3 (C), 137.1 (C), 139.4 (C), 168.6 (COOH) 
ppm. 
MS (EI = 70 eV): m/z (%) 186 [M]+ (100), 169 [M−17]+ (30), 141 [M−45]+ (57). 
The spectroscopic data are in agreement with those in the literature.[287] 
 
Methyl 6-methyl-2-naphthoate (182) 
K2CO3 (162 mg, 1.18 mmol) was added to the solution of carboxylic acid 181 (73.0 mg, 
392 μmol) in acetone (10 mL) at 0 °C. The mixture was magnetically stirred for 30 min, then 
dimethylsulfate (63 μL, 1.22 mmol) was added and refluxed for 1 h. The reaction mixture was 
allowed to cool to room temperature followed by addition of H2O (5 mL). After removal of 
acetone, the mixture was extracted with CH2Cl2 (20 mL × 3). The combined organic layers 
were dried over Na2SO4, condensed in vacuo and purified with column chromatography. 
 
Colorless solid. 
Yield: 66.0 mg (330 μmol, 84 %). 
M.p. 119−120 °C (CH2Cl2). 
Lit.: 116−117 °C (MeOH).[287] 
IR (ATR): ν  = 2954 (w), 2926 (w), 2851 (w), 1707 (s), 1628 (w), 1473 (w), 1435 (m), 1336 
(w), 1286 (s), 1190 (s), 1124 (m), 1093 (s), 972 (m), 897 (m), 843 (w), 810 (s), 777 (m), 750 
(m), 723 (w) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.54 (s, 3H, CH3), 3.97 (s, 3H, CH3), 7.37 (d, 3J = 8.4 Hz, 
1H, Ar-H), 7.64 (s, 1H, Ar-H), 7.77 (d, 3J = 8.6 Hz, 1H, Ar-H), 7.84 (d, 3J = 8.4 Hz, 1H, Ar-H), 
182 
Synthesis of Naphthoquinones 204 
  
8.02 (d, 3J = 8.6 Hz, 1H, Ar-H), 8.56 (s, 1H, Ar-H) ppm.  
13C NMR (100 MHz, CDCl3): δ = 22.1 (Me), 52.3 (Me), 125.5 (CH), 126.8 (C), 127.0 (CH), 
127.6 (CH), 129.1 (CH), 129.3 (CH), 130.1 (C), 131.0 (CH), 136.0 (C), 138.6 (C), 167.6 
(COO) ppm. 
MS (EI = 70 eV): m/z (%) 200 [M]+ (78), 169 [M−31]+ (100), 141 [M−59]+ (51). 
The spectroscopic data are in agreement with those in the literature.[287] 
 
Methyl 6-carboxylate-2-methyl-1,4-naphthoquinone (172) 
To the solution of H5IO6 (299 mg, 1.31 mmol) and CrO3 (3.3 mg, 33.0 μmol) in acetonitrile 
(7 mL), the naphthalene 182 (66.0 mg, 330 μmol) in acetonitirile (7 mL) was added dropwise. 
After stirring at 0 ºC for 4 h, the reaction mixture was filtered over a short pad of 
normal-phase silica gel, and eluted quickly with CH2Cl2. After evaporation of the solvent in 
vacuo, the desired product was purified by column chromatography (PE/EtOAc = 97 : 3). 
 
Yellow powder. 
Yield: 30.0 mg (130 μmol, 40%). 
M.p. 149−152 °C (CH2Cl2). 
Lit.: 149−152 °C (MeOH).[288] 
IR (ATR): ν  = 2950 (w), 2929 (w), 2852 (w), 1716 (s), 1660 (s), 1603 (m), 1439 (m), 1356 
(w), 1259 (s), 1120 (m), 972 (m), 939 (m), 912 (m), 874 (m), 766 (m), 688 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.21 (s, 3H, CH3), 3.97 (s, 3H, CH3), 6.90 (s, 1H, Ar-H), 
8.15 (d, 3J = 8.0 Hz, 1H, Ar-H), 8.35 (d, 3J = 8.0 Hz, 1H, Ar-H), 8.68 (s, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 16.7 (Me), 52.9 (Me), 127.0 (CH), 127.7 (CH), 132.5 (C), 
134.4 (CH), 134.9 (C), 135.0 (C), 136.2 (CH), 148.7 (C), 165.6 (COO), 184.2 (CO), 185.1 
(CO) ppm. 
MS (EI = 70 eV): m/z (%) 230 [M]+ (100), 199 [M−31]+ (95), 171 [M−59]+ (47). 
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The spectroscopic data are in agreement with those in the literature.[288] 
 
Methyl 6-carboxylate-2-methyl-1,4-naphthoquinone-2,3-epoxide (177) 
67.0 μL (134 μmol) 2 N aqueous NaOH solution was added with stirring to the 
naphthoquinone 172 (62.0 mg, 269 μmol) in 1.0 mL H2O/MeOH (1/4 v/v) at 0 °C. After 10 
min, 41.1 μL 30% H2O2 solution was added to the reaction mixture and stirred for 4 h. The 
precipitation was filtered and and purified by column chromatography affording the product 
as a colorless solid. 
 
Colorless solid. 
Yield: 48.0 mg (193 μmol, 72%). 
M.p. 135 °C (MeOH/H2O). 
Lit.: 136 °C.[289] 
IR (ATR): ν  = 2954 (w), 2929 (w), 1716 (s), 1691 (s), 1606 (m), 1444 (m), 1400 (w), 1338 
(w), 1263 (s), 1184 (m), 1122 (m), 974 (w), 947 (m), 876 (w), 850 (w), 795 (w), 759 (m), 714 
(s), 640 (w) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.75 (s, 3H, CH3), 3.40 (s, 1H, CH), 3.97 (s, 3H, CH3), 8.07 
(d, 3J = 8.04 Hz, 1H, Ar-H), 8.36 (d, 3J = 8.04 Hz, 1H, Ar-H), 8.57 (s, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 14.8 (Me), 53.1 (Me), 61.7 (CH), 62.0 (C), 128.0 (CH), 
128.4 (CH), 132.3 (C), 135.2 (CH), 135.7 (C), 135.7 (C), 165.3 (COOH), 191.1 (CO), 191.7 
(CO) ppm. 
MS (EI = 70 eV): m/z (%) 246 [M]+ (36), 231 [M−15]+ (100), 218 [M−28]+ (87), 215 
[M−31]+ (35), 187 [M−59]+ (27). 
In the literature,[289] no spectroscopic data are described. 
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Methyl 6-carboxylate-3-hydroxy-2-methyl-1,4-naphthoquinone (173) 
To a solution of the epoxide 177 (23.0 mg, 93.0 μmol) in THF (1.0 mL), SiO2 (141 mg) 
and concentrated H2SO4 (115 μL) was added. THF was removed in vacuum (200 mbar) at 
60 °C for 20 min on a rotary evaporator. To the resultant red solid, H2O (20 mL) and CH2Cl2 
(20 mL) were added. The mixture was basified with 5% aqueous K2CO3 solution, acidified 
with 1 N aqueous HCl solution, and extracted with CH2Cl2 (20 mL × 3). The combined 
organic layers were dried over Na2SO4, concentrated in vacuo and purified by column 
chromatography. 
 
Yellow powder. 
Yield: 18.0 mg (73.0 μmol, 80%).  
M.p. 218 °C (CH2Cl2). 
Lit.: 213 °C (Benzene).[289] 
IR (ATR): ν  = 3367 (s), 2950 (w), 2921 (w), 1726 (s), 1641 (s), 1599 (m), 1427 (w), 1379 
(w), 1340 (m), 1288 (s), 1238 (s), 1190 (s), 1101 (s), 1072 (s), 937 (m), 881 (w), 802 (w), 727 
(s), 663 (s) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.13 (s, 3H, CH3), 3.99 (s, 3H, CH3), 8.20 (d, 3J = 8.0 Hz, 
1H, Ar-H), 8.38 (d, 3J = 8.0 Hz, 1H, Ar-H), 8.71 (s, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 9.0 (Me), 53.0 (Me), 121.5 (C), 127.3 (CH), 127.6 (CH), 
129.7 (C), 134.5 (C), 135.6 (CH), 135.8 (C), 153.8 (C), 165.5 (C), 180.6 (C), 184.5 (C) ppm. 
MS (EI = 70 eV): m/z (%) 246 [M]+ (100), 218 [M−28]+ (30), 215 [M−31]+ (30), 187 
[M−59]+ (38). 
The spectroscopic data are in agreement with those in the literature.[289]
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8  Synthesis of Triphoquinone (187a) 
4-Bromo-5,6-dimethoxy-2-methyl-4-naphthol (201) 
To a solution of 5,6-dimethoxy-2-methyl-4-naphthol (42) (1.17 g, 5.36 mmol) in 
CH2Cl2/MeOH (3/2 v/v) (50 mL), TBABr3 (2.71 g, 5.63 mmol) in CH2Cl2/MeOH(3/2 v/v) 
(50 mL) was slowly dropped under stirring at 0 °C over 2 h. The reaction mixture was stirred 
at room temperature overnight. After addition of H2O (100 mL), the organic solvents were 
removed on a rotary evaporator. The suspension was extracted with EtOEt (100 mL × 3). The 
combined organic layers were dried with Na2SO4 and concentrated in vacuo. The crude 
product was purified with flash column chromatography (PE/EtOAc = 95 : 5). 
 
Colorless solid. 
Yield: 1.09 g, (3.7 mmol, 69%). 
Lit.: 50%.[189] 
M.p. 103 °C (PE/EtOAc). 
Lit.: 103 °C (PE/EtOEt).[189]  
1H NMR (400 MHz, CDCl3): δ = 2.51 (s, 3H, CH3), 3.99 (s, 3H, CH3O), 4.07 (s, 3H, CH3O), 
6.77 (s, 1H, Ar-H), 7.31 (d, 3J = 8.0 Hz, 1H, Ar-H), 8.04 (d, 3J = 8.0 Hz, 1H, Ar-H) ppm. 
EIMS m/z (rel. int.): 298 [M]+ (100), 296 [M]+ (97), 283 [M−15]+ (46), 281 [M−15]+ (41). 
The spectroscopic data are in agreement with those in the literature.[189] 
 
1-Bromo-5,6-dimethoxy-4-methoxymethoxy-2-methylnaphthalene (205) 
A mixture of the bromide 201 (286.0 mg, 0.96 mmol) and sodium hydride (115.0 mg of a 
60% powder in oil, 2.89 mmol) in dry THF (10 mL) and DMF (1 mL) was stirred at 0 °C 
under an argon atmosphere for 1 h. Methoxymethyl chloride (364 μL, 4.80 mmol) in THF (8 
mL) was added dropwise to the above mixture over 15 min and the resulting suspension was 
stirred at 0 °C for 2 h followed by addition of H2O (30 mL). After removal of THF, the 
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suspension was extracted with EtOEt (30 mL × 4). The combined organic layers were 
extracted with H2O (50 mL), dried over Na2SO4, and concentrated to dryness affording the 
product after purification by flash column chromatography (PE/EtOAc = 19 : 1). 
 
Colorless solid. 
Yield: 310 mg, (0.91 mmol, 95%). 
M.p. 74 °C (CHCl3).  
IR (ATR): ν  = 2990 (w), 2937 (w), 2832(w), 1601 (w), 1498 (w), 1463 (w), 1442 (w), 1336 
(m), 1278 (m), 1241 (m), 1149 (m), 1133 (m), 1043 (s), 1005 (w), 945 (s), 918 (m), 783 (m), 
703 (m) cm−1.  
1H NMR (400 MHz, CDCl3): δ = 2.54 (s, 3H, CH3), 3.59 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 
3.97 (s, 3H, OCH3), 5.27 (s, 2H, CH2), 6.97 (s, 1H, Ar-H), 7.33 (d, 1H, 3J = 8.0 Hz, Ar-H), 
8.08 (d, 1H, 3J = 8.0 Hz, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 24.2 (CH3), 56.5 (CH3), 56.8 (CH3), 61.8 (CH3), 96.7 
(CH2), 115.8 (CH), 116.0 (CH), 117.4 (C), 121.8 (C), 124.1 (CH), 130.1 (C), 134.0 (C), 143.6 
(C), 150.0 (C), 151.9 (C) ppm. 
EIMS m/z (rel. int.): 342 [M]+ (100), 340 [M]+ (97), 297 [M−45]+ (24), 295 [M−45]+ (23). 
HRMS (ESI): calcd. for C15H17BrNaO4 [M+Na]+: 363.0201 and 365.0177; found 363.0202 
and 365.0178. 
 
1-Iodo-5,6-dimethoxy-4-methoxymethoxy-2-methylnaphthalene (212) 
To a solution of 205 (243 mg, 0.72 mmol) in THF (15 mL), n-BuLi (534 μL, 1.6 M in 
hexanes, 1.1 equiv.) was added dropwise at −78 °C and the mixture was stirred for 30 min. 
Iodine (217 mg, 0.86 mmol, 1.2 equiv.) in THF (10 mL ) was added dropwise at −78 °C and 
the reaction was stirred for another 30 min followed by addition of saturated aqueous 
Na2S2O3 solution (20 mL). The reaction mixture was warmed to room temperature and THF 
was removed under reduced pressure. The suspension was extracted with CH2Cl2 (100 mL × 
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3), and dried over anhydrous Na2SO4. The combined layers were concentrated in vacuo, and 
the residue was chromatographed on silica gel to afford pure iodide. 
 
Pale-yellow solid. 
Yield: 260 mg, (0.67 mmol, 94%). 
IR (ATR): ν  = 2968 (w), 2933 (w), 2830 (w), 1599 (m), 1553 (w), 1462 (m), 1441 (m), 
1330 (m), 1276 (s), 1239 (m), 1148 (s), 1131 (s), 1042 (s), 1001 (s), 941 (s), 918 (s), 804 (w), 
779 (m), 703 (m) cm−1.  
1H NMR (400 MHz, CDCl3): δ = 2.62 (s, 3H, CH3), 3.60 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 
3.97 (s, 3H, OCH3), 5.29 (s, 2H, CH2), 7.01 (s, 1H, Ar-H), 7.30 (d, 1H, 3J = 8.0 Hz, Ar-H), 
8.05 (d, 1H, 3J = 8.0 Hz, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 30.2 (CH3), 56.6 (CH3), 56.9 (CH3), 61.8 (CH3), 96.7 
(CH2), 97.7 (C), 115.1 (CH), 115.9 (CH), 121.0 (C), 129.5 (CH), 132.3 (C), 138.9 (C), 143.4 
(C), 150.0 (C), 153.0 (C) ppm. 
MS (EI = 70 eV): m/z 388 [M]+ (100), 344 [M−44]+ (54). 
 
2-(5,6-Dimethoxy-4-methoxymethoxy-2-methyl-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]di
oxaborolane (210) 
Compound 205 (143 mg, 419 μmol), potassium acetate (411 mg, 4.19 mmol), and 
bispinacolatodiboron (319 mg, 1.26 mmol) in DMF (10 mL) was degassed under argon for 10 
min. Pd(PPh3)4 (48.0 mg, 41.9 μmol) was added and the reaction mixture was degassed again 
and then heated at 120 °C overnight. The mixture was allowed to cool to room temperature, 
filtered on a short pad of Celite, and concentrated in vacuo. The residue was purified by flash 
column chromatography (PE/EtOAc = 9 : 1) affording the product as a colorless solid. 
 
Colorless solid. 
Yield: 130.1 mg, (335.0 μmol, 80%). 
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M.p. 50−53 °C (PE/EtOAc). 
IR (ATR): ν  = 2977 (w), 2938 (w), 1591 (m), 1567 (w), 1512 (m), 1468 (m), 1447 (m), 
1323 (m), 1294 (s), 1276 (m), 1236 (m), 1152 (m), 1134 (s), 1048 (s), 1022 (m), 968 (s), 861 
(m), 790 (m), 703 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.41 (s, 12H, Bpin-CH3), 2.52 (s, 3H, CH3), 3.55 (s, 3H, 
OCH3), 3.84 (s, 3H, OCH3), 3.91 (s, 3H, OCH3), 5.26 (s, 2H, CH2), 6.86 (s, 1H, Ar-H), 7.22 
(d, 1H, 3J = 8.0 Hz, Ar-H), 7.88 (d, 1H, 3J = 8.2 Hz, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3) (C-B is not observed): δ = 22.6 (CH3), 25.0 (Bpin-CH3), 56.4 
(CH3O), 57.0 (CH3O), 61.6 (CH3O), 83.8 (Bpin), 96.3 (CH2), 115.3 (CH), 120.3 (C), 124.5 
(CH), 135.6 (CH), 140.5 (CH), 143.9 (C), 149.2 (C), 153.8 (C), 162.6 (C) ppm. 
EIMS m/z (rel. int.): 388 [M]+ (100), 343 [M−45]+ (31), 149 [M−209]+ (99). 
HRMS (ESI): calcd. for C21H29NaO610B [M+23]+: 410.1986; found 410.1982. 
 
N,N-Diethyl-2-methoxy-benzamide (198) 
A mixture of thionyl chloride (11.7 g, 98.5 mmol, 7.00 mL) and 2-methoxy-benzoic acid 
(5.0 g, 32.9 mmol) in a 25 mL one-necked flask was refluxed at 80 °C overnight. The excess 
of thionyl chloride was removed by evaporation under reduced pressure to give 
2-methoxy-benzoyl chloride, to which a solution of diethylamine (7.18 g, 98.5 mmol, 10.2 
mL) in anhydrous THF (80 mL) was added carefully with stirring at 0 °C. The reaction was 
continued at room temperature overnight. The mixture was diluted with water, acidified with 
0.5 N aqueous HCl solution, and neutralized with saturated aqueous NaHCO3 solution. After 
removal of THF, the suspension was extracted with CH2Cl2 (100 mL × 3). The combined 
organic layers were dried with anhydrous Na2SO4, concentrated in vacuo, and subjected to 
column chromatography to afford the product. 
 
Dark brown liquid. 
Yield: 6.6 g, (32.9 mmol, 100%). 198 
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IR (ATR): ν  = 2972 (w), 2935 (w), 1625 (s), 1600 (s), 1492 (m), 1461 (m), 1427 (s), 1292 
(m), 1274 (m), 1243 (s), 1122 (m), 1087 (s), 1045 (m), 1022 (m), 943 (s), 877 (m), 753 (s), 
627 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 0.97 (t, 3J = 7.0 Hz, 3H, CH3), 1.22 (t, 3J = 7.0 Hz, 3H, 
CH3), 3.10 (q, 3J = 7.0 Hz, 2H, CH2), 3.54 (m, 2H, CH2), 3.78 (s, 3H, CH3O), 6.87 (d, 3J = 
8.4, 1H, Ar-H), 6.93 (dd, 3J = 8.4, 4J = 2.0 Hz, 1H, Ar-H), 7.15 (dd, 3J = 8.4, 4J = 2.0 Hz, 1H, 
Ar-H), 7.28 (dd, 3J = 8.4, 4J = 2.0 Hz, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 13.0 (CH3), 14.0 (CH3), 38.9 (CH2), 42.9 (CH2), 55.6 
(CH3O), 111.1 (CH), 120.8 (CH), 127.1 (C), 127.5 (CH), 130.0 (CH), 155.3 (C), 168.9 (CO) 
ppm. 
EIMS m/z (rel. int.): 207 [M]+ (12), 106 [M−1]+ (30), 135 [M−72]+ (100). 
The spectroscopic data are in agreement with those in the literature.[290] 
 
N,N-Diethyl-2-methoxy-(2-methyl-allyl)-benzamide (199) 
  To a solution of the benzamide 198 (6.2 g, 30.0 mmol) in THF (50 mL), s-BuLi (33.0 
mmol, 23.5 mL, 1.1 equiv.) and TMEDA (33.0 mmol, 4.9 mL, 1.1 equiv.) were added at 
−90 °C under argon by syringe injection and the mixture was stirred for 1.5 h. The solution of 
the resultant lithiated species was then warmed to −78 °C over 0.5 h and freshly prepared 
MgBr2▪2Et2O (60.0 mmol, 22.8 mL, 2 equiv.) was added. The above mixture was stirred for 
0.5 h, allowed to warm to room temperature, again cooled to −78 °C, and stirred for another 1 
h. Following addition of distilled 3-bromo-2-methylpropene (8.0 mL, 60.0 mmol), the 
reaction mixture was allowed to warm to room temperature, and stirred overnight. The 
mixture was treated with saturated aqueous NH4Cl solution (50 mL). After removal of THF 
on a rotary evaporator, the suspension was extracted with CH2Cl2 (50 mL × 3). The combined 
organic layers were dried with Na2SO4, concentrated to dryness followed by purification by 
column chromatography giving 199 as a yellowish liquid. 
 
Colorless liquid. 
Yield: 4.30 g, (16.1 mmol, 53%). 
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IR (ATR): ν  = 2969 (w), 2942 (w), 1617 (s), 1596 (m), 1579 (s), 1468 (s), 1429 (s), 1377 
(m), 1289 (s), 1253 (s), 1064 (s), 897 (s), 879 (m), 782 (s), 759 (s), 749 (s) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 0.99 (t, 3J = 7.0 Hz, 3H, CH3), 1.20 (t, 3J = 7.0 Hz, 3H, 
CH3), 1.65 (s, 3H, CH3), 3.04 (m, 2H, CH2) , 3.23 (m, 2H, CH2), 3.36 (m, 1H, CH2a), 3.71 
(m, 1H, CH2b), 3.72 (s, 3H, CH3O), 4.65 (s, 1H, CH2a), 4.80 (s, 1H, CH2b), 6.71 (s, 3J = 8.0 
Hz, 1H, Ar-H), 6.80 (s, 3J = 8.0 Hz, 1H, Ar-H), 7.19 (dd, 3J = 8.0, 3J = 8.0 Hz, 1H, Ar-H) 
ppm. 
13C NMR (100 MHz, CDCl3): δ = 12.8 (CH3), 13.4 (CH3), 22.4 (CH3), 38.3 (CH2), 40.8 
(CH2), 42.7 (CH2), 55.5 (CH3O), 108.5 (CH), 112.8 (CH2), 122.0 (CH), 126.9 (C), 129.0 
(CH), 137.5 (C), 143.9 (C), 155.5 (C), 168.0 (CO) ppm. 
EIMS m/z (rel. int.): 261 [M]+ (18), 189 [M−72]+ (100), 161 [M−100]+ (66). 
HRMS (ESI): calcd. for C16H23NNaO2 [M+23]+: 284.1621; found 284.1622. 
 
5-Methoxy-2-methyl-4-naphthol (200) 
To a solution of the ortho-allyl benzamide 199 (4.20 g, 16.1 mmol) in 30 mL THF, 2.2 
equiv. of MeLi were added with stirring at −78 °C. The reaction mixture was slowly warmed 
up to 0 °C over 3 h, followed by addition of saturated aqueous NH4Cl solution (50 mL). After 
removal of THF by evaporation under reduced pressure, the suspension was extracted with 
EtOAc (100 mL × 3). The combined organic layers were dried with Na2SO4, and 
concentrated to dryness. The crude product was purified by column chromatography to afford 
the naphthol 200 as a colorless solid. 
 
Colorless solid. 
Yield: 2.90 g, (15.4 mmol, 97%). 
M.p. 88 °C (PE/EtOAc). 
Lit.: 89 °C (PE/EtOEt).[189]  
IR (ATR): ν  = 3355 (m), 2972 (w), 2920 (w), 1639 (m), 1611 (m), 1578 (m), 1436 (m), 
1385 (m), 1370 (s), 1278 (s), 1234 (m), 1160 (m), 1090 (s), 1057 (m), 962 (m), 837 (s), 748 
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(s), 716 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.45 (s, 3H, CH3), 4.01 (s, 3H, OCH3), 6.69 (dd, 1H, 3J = 
8.2, 4J = 1.6 Hz, Ar-H), 6.78 (d, 1H, 4J = 1.6 Hz, Ar-H), 7.15 (d, 1H, 4J = 1.6 Hz, Ar-H), 7.27 
(dd, 1H, 3J = 8.0, 3J = 8.0 Hz, Ar-H), 7.34 (dd, 1H, 3J = 8.2, 4J = 1.6 Hz, Ar-H), 9.26 (s, 1H, 
OH) ppm. 
13C NMR (100 MHz, CDCl3): δ = 21.1 (CH3), 55.4 (CH3O), 103.2 (CH), 112.5 (CH), 113.2 
(C), 118.4 (CH), 121.4 (CH), 125.8 (CH), 137.0 (C), 138.0 (C), 154.3 (C), 156.3 (C) ppm. 
EIMS m/z (rel. int.): 188 [M]+ (100), 173 [M−15]+ (49), 145 [M−43]+ (36). 
The spectroscopic data are in agreement with those in the literature.[189] 
 
1-Bromo-5-methoxy-2-methyl-4-naphthol (202) 
To a solution of 200 (0.86 g 4.57 mmol) in CH2Cl2/MeOH (3/2 v/v) (30 mL), TBABr3 
(2.31 g, 4.80 mmol) in CH2Cl2/MeOH (3/2 v/v) (50 mL) was slowly dropped under stirring at 
0 °C over 3 h. The reaction mixture was stirred at room temperature for 2 h followed by 
addition of H2O (100 mL). The organic solvents were removed on a rotary evaporator. The 
suspension was extracted with EtOEt (100 mL × 3). The combined organic layers were dried 
with Na2SO4 and concentrated in vacuo. The crude product was purified by column 
chromatography (PE/EtOAc = 95 : 5). 
 
Colorless solid. 
Yield: 1.02 g, (3.8 mmol, 83%). 
M.p. 127 °C (PE/EtOAc). 
Lit.: 127 °C (PE/EtOEt).[189] 
IR (ATR): ν  = 3367 (s), 2938 (w), 2842 (w), 1631 (m), 1606 (m), 1562 (m), 1426 (m), 1353 
(m), 1291 (m), 1258 (m), 1238 (m), 1190 (m), 1090 (s), 1065 (m), 996 (m), 956 (m), 877 (m), 
795 (s), 751 (s), 740 (s) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.54 (s, 3H, CH3), 4.03 (s, 3H, OCH3), 6.76 (d, 1H, 3J = 8.2 
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Hz, Ar-H), 6.81 (s, 1H, Ar-H), 7.38 (dd, 1H, 3J = 8.0, 3J = 8.0 Hz, Ar-H), 7.89 (d, 1H, 3J = 8.2 
Hz, Ar-H), 9.37 (s, 1H, OH) ppm. 
13C NMR (100 MHz, CDCl3): δ = 23.7 (CH3), 55.8 (CH3O), 104.0 (CH), 112.9 (CH), 113.2 
(C), 114.4 (CH), 121.1 (CH), 127.1 (CH), 134.9 (C), 138.4 (C), 153.9 (C), 156.3 (C) ppm. 
EIMS m/z (rel. int.): 268 [M]+ (97), 266 [M]+ (100), 253 [M−15]+ (30), 253 [M−15]+ (31), 
225 [M−43]+ (33), 223 [M−43]+ (34). 
The spectroscopic data are in agreement with those in the literature.[189] 
 
1-Bromo-5-methoxy-4-methoxymethoxy-2-methylnaphthalene (206) 
A mixture of the bromide 202 (315 mg, 1.18 mmol) and sodium hydride (141 mg of a 60% 
powder in oil, 3.54 mmol) in dry THF (15 mL) and DMF (1 mL) was stirred at 0 °C under an 
argon atmosphere for 1 h. Methoxymethyl chloride (448 μL, 5.90 mmol) in THF (8 mL) was 
then added dropwise over 15 min and the resulting suspension was stirred at room 
temperature overnight followed by addition of H2O (30 mL). After removal of THF, the 
mixture was extracted with EtOEt (30 mL × 4). The combined organic layers were washed 
with H2O (50 mL × 2) and brine (50 mL × 2), and then dried over Na2SO4 and concentrated 
to dryness giving the crude product, which was purified by flash column chromatography 
(PE/EtOAc = 15 : 1). 
 
Yellowish solid. 
Yield: 300 mg, (0.95 mmol, 80%). 
M.p. 64 °C (PE/EtOAc). 
IR (ATR): ν  = 2958 (w), 2911 (w), 1598 (m), 1571 (m), 1460 (w), 1386 (s), 1349 (m), 1257 
(m), 1222 (w), 1145 (m), 1084 (m), 1049 (m), 950 (m), 915 (m), 795 (m), 738 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.59 (s, 3H, CH3), 3.62 (s, 3H, OCH3), 3.95 (s, 3H, OCH3), 
5.25 (s, 2H, CH2), 6.85 (d, 1H, 3J = 8.2 Hz, Ar-H), 7.00 (s, 1H, Ar-H), 7.44 (dd, 1H, 3J = 
8.0, 3J = 8.0 Hz, Ar-H), 7.95 (d, 1H, 3J = 8.2 Hz, Ar-H) ppm.  
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13C NMR (100 MHz, CDCl3): δ = 24.5 (CH3), 56.5 (CH3O), 56.6 (CH3O), 97.0 (CH2), 106.2 
(CH), 116.3 (CH), 117.7 (C), 118.3 (C), 120.1 (CH), 127.7 (CH), 135.6 (C), 136.9 (C), 153.2 
(C), 156.9 (C) ppm. 
EIMS m/z (rel. int.): 312 [M]+ (32), 310 [M]+ (32), 282 [M−30]+ (25), 280 [M−30]+ (25), 149 
[M−162]+ (100). 
HRMS (ESI): calcd. for C14H15BrNaO3 [M+23]+: 333.0097 and 335.0076; found 333.0097 
and 335.0076.  
 
1-Iodo-4-methoxymethoxy-2-methylnaphthalene (215) 
To a solution of 206 (209 mg, 0.67 mmol) in THF (15 mL), n-BuLi (504 μL, 1.6 M in 
hexanes, 1.2 equiv.) was added dropwise at −78 °C and the mixture was stirred for 30 min 
followed by careful addition of a solution of iodine (205 mg, 0.81 mmol, 1.2 equiv.) in THF 
(10 mL ). The reaction mixture was stirred for another 30 min followed by addition of 
saturated aqueous Na2S2O3 solution (20 mL). The mixture was warmed to room temperature. 
After removal of THF by evaporation under reduced pressure, the mixture was extracted with 
CH2Cl2 (100 mL × 3), and dried over anhydrous Na2SO4. The combined layers were 
concentrated in vacuo, and the residue was chromatographed on silica gel to afford the iodide. 
 
Yellowish solid. 
Yield: 222 mg, (0.62 mmol, 92%). 
IR (ATR): ν  = 2901 (w), 2831 (w), 1593 (m), 1567 (m), 1460 (m), 1383 (m), 1341 (m), 
1253 (m), 1147 (m), 1126 (m), 1084 (m), 1047 (s), 999 (m), 949 (m), 916 (m), 838 (m), 795 
(m), 740 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.54 (s, 3H, CH3), 3.51 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 
5.15 (s, 2H, CH2), 6.75 (d, 1H, 3J = 8.0 Hz, Ar-H), 6.92 (s, 1H, Ar-H), 7.31 (dd, 1H, 3J = 
8.0, 3J = 8.0 Hz, Ar-H), 7.80 (d, 1H, 3J = 8.0 Hz, Ar-H) ppm.  
13C NMR (100 MHz, CDCl3): δ = 30.7 (CH3), 56.6 (CH3), 56.7 (CH3), 96.9 (CH2), 98.1 (C), 
106.3 (CH), 115.6 (CH), 117.6 (C), 125.7 (CH), 127.9 (CH), 137.9 (C), 141.6 (C), 154.5 (C), 
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157.0 (C) ppm. 
MS (EI = 70 eV): m/z 358 [M]+ (80), 328 [M−30]+ (50). 
 
2-(5-Methoxy-4-methoxymethoxy-2-methyl-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxa
borolane (213) 
Compound 206 (38.0 mg, 122 μmol), potassium acetate (120 mg, 1.22 mmol), and 
bispinacolatodiboron (85 mg, 366 μmol) in a suspension of H2O (150 μL) and toluene (2 mL) 
was degassed under argon for 10 min. Pd(dppf)Cl2•DCM (10.0 mg, 12.2 μmol) was added 
and the reaction mixture was degassed again and then heated at 90 °C for 6 h. The mixture 
was allowed to cool to room temperature, diluted with H2O (20 mL), and extracted with 
CH2Cl2 (20 mL × 3). The combined organic layers were dried over Na2SO4 and concentrated 
in vacuo. The crude product was purified by flash column chromatography affording the 
product as a colorless solid. 
 
Colorless solid. 
Yield: 24.0 mg, (95 μmol, 55%). 
M.p. 62 °C (PE/EtOAc). 
IR (ATR): ν  = 2976 (w), 1611 (w), 1588 (m), 1461 (m), 1371 (m), 1307 (s), 1256 (s), 1140 
(m), 1119 (m), 1044 (m), 1030 (m), 964 (m), 945 (m), 920 (m), 856 (m), 754 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.46 (s, 12H, Bpin-CH3), 2.54 (s, 3H, CH3), 3.58 (s, 3H, 
OCH3), 3.93 (s, 3H, OCH3), 5.25 (s, 2H, CH2), 6.77 (d, 1H, 3J = 8.2 Hz, Ar-H), 6.87 (s, 1H, 
Ar-H), 7.32 (dd, 1H, 3J = 8.2, 3J = 8.2 Hz, Ar-H), 7.68 (d, 1H, 3J = 8.2 Hz, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3) (C-B is not observed): δ = 22.7 (CH3), 25.1 (Bpin-CH3), 56.4 
(CH3O), 56.5 (CH3O), 83.5 (Bpin), 83.9 (Bpin), 96.7 (CH2), 105.5 (CH), 115.7 (CH), 116.8 
(C), 120.8 (CH), 126.4 (CH), 141.0 (C), 142.5 (C), 155.0 (C), 157.0 (C) ppm. 
EIMS m/z (rel. int.): 358 [M]+ (25), 328 [M−30]+ (10), 167 [M−191]+ (41), 149 [M−209]+ 
(100). 
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HRMS (ESI): calcd. for C20H27NaO510B [M+23]+: 380.1880; found 381.1882. 
1-Bromo-4-isopropoxy-5,6-dimethoxy-2-methylnaphthalene (203) 
A mixture of the naphthol 201 (63.0 mg, 0.212 mmol) and Cs2CO3 (96.3 mg, 0.296 mmol) 
in dry acetone (3 mL) was stirred at room temperature under an argon atmosphere for 1 h. To 
the above solution, 2-iodopropane (92.0 μL, 0.848 mmol) was added and stirred in reflux 
overnight. After addition of H2O (3 mL) and removal of acetone, the reaction mixture was 
extracted with EtOAc (30 mL × 4). The combined organic extracts were washed with H2O (50 
mL) and brine (50 mL), dried over Na2SO4, and concentrated to dryness affording the crude 
product, which was purified by flash column chromatography. 
 
Colorless solid. 
Yield: 53.0 mg, (156 μmol, 49%). 
M.p. 60−62 °C (PE/EtOAc). 
IR (ATR): ν  = 2958 (w), 2928 (w), 2836 (w), 1595 (m), 1559 (m), 1463 (m), 1442 (m), 
1384 (m), 1349 (m), 1331 (m), 1277 (s), 1241 (s), 1114 (m), 1084 (m), 1060 (s), 1007 (m), 
824 (m), 805 (m), 782 (m), 782 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.42 (d, 3J = 6.0 Hz, 6H, CH3), 2.54 (s, 3H, CH3), 3.86 (s, 
3H, CH3O), 3.97 (s, 3H, CH3O), 4.61 (septet, 1H, CH), 6.75 (m, 1H, Ar-H), 7.32 (dd, 3J = 8.0 
Hz, 1H, Ar-H), 8.07 (d, 3J = 8.0 Hz, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 22.1 (2 × CH3), 24.4 (CH3), 57.1 (CH3O), 62.0 (CH3O), 
72.0 (CHO), 114.3 (CH), 115.7 (C), 115.9 (CH), 122.6 (C), 124.0 (CH), 130.3 (CH), 134.0 
(C), 144.2 (C), 150.1 (C), 152.8 (C) ppm. 
EIMS m/z (rel. int.): 340 [M]+ (43), 338 [M]+ (43), 298 [M−42]+ (57), 296 [M−42]+ (57), 283 
[M−57]+ (54), 281 [M−57]+ (54), 149 [M−191]+ (100). 
HRMS (ESI): calcd. for C16H19BrNaO3 [M+23]+: 361.0410 and 363.0391; found 361.0407 
and 363.0389. 
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1-Bromo-4-isopropoxy-2-methyl-5,6-naphthoquinone (207) 
To a solution of 203 (10.0 mg, 31 μmol) in CH3CN (1 mL), a solution of ammonium 
cerium (IV) nitrate (CAN) (42.4 mg, 77.0 μmol) in H2O (1 mL), was added at 0 °C and 
stirred for 15 min. After addition of cold H2O (10 mL), the reaction mixture was extracted 
with CH2Cl2 (20 mL × 3). The combined organic layers were dried with Na2SO4 and 
concentrated in vacuo affording the desired product in a quantitative yield. 
 
Red solid. 
Yield: 9.6 mg, (31 μmol, 100%). 
M.p. 88−90 °C (CH2Cl2). 
IR (ATR): ν  = 2971 (w), 2927 (w), 1686 (m), 1662 (s), 1570 (w), 1532 (w), 1450 (w), 1372 
(m), 1305 (m), 1245 (m), 1224 (m), 1177 (m), 1104 (s), 1021 (w), 946 (m), 911 (m), 827 (w), 
794 (m), 695 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 1.41 (d, 3J = 6.0 Hz, 6H, CH3), 2.49 (s, 3H, CH3), 4.67 
(septet, 1H, CH), 6.45 (d, 3J = 8.0 Hz, 1H, Ar-H), 6.98 (s, 1H, Ar-H), 8.09 (d, 3J = 8.0 Hz, 1H, 
Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 22.2 (2 × CH3), 25.7 (CH3), 72.8 (CH), 119.6 (C), 120.2 
(CH), 128.6 (CH), 131.1 (C), 135.3 (C), 144.6 (CH), 148.4 (C), 160.5 (C), 177.0 (C), 180.7 
(C) ppm. 
EIMS m/z (rel. int.): 282 [M−28]+ (75), 280 [M−28]+ (75), 212 [M−98]+ (50), 210 [M−98]+ 
(51), 131 [M−178]+ (100). 
HRMS (ESI): calcd. for C14H13BrNaO3 [M+23]+: 330.9940 and 332.9920; found 330.9942 
and 332.9922. 
 
1-Bromo-4-t-butyl-dimethyl-silane-5,6-dimethoxy-2-methylnaphthalene (204)  
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To a solution of the naphthol 201 (104.0 mg, 0.350 mmol) and imidazole (190.0 mg, 2.8 
mmol) in DMF (3 mL), TBDMSCl (527.0 mg, 3.5 mmol) was added at room temperature and 
the mixture was stirred at 60 °C for 16 h. The reaction mixture was quenched by addition of 
water (30 mL), and then extracted with EtOEt (30 mL × 3). The combined organic layers were 
washed with brine, dried over Na2SO4 and concentrated in vacuo affording a residue, which 
was purified by flash column chromatography on silica gel (PE/EtOAc = 98 : 2). 
 
Colorless solid. 
Yield: 135.0 mg, (328 μmol, 94%). 
M.p. 68−70 °C (PE/EtOAc). 
IR (ATR): ν  = 2927 (w), 2856 (w), 1594 (m), 1557 (m), 1469 (m), 1444 (m), 1348 (m), 
1277 (m), 1246 (s), 1085 (m), 1061 (m), 1005 (m), 903 (w), 833 (s), 803 (m), 777 (s), 673 (m) 
cm−1. 
1H NMR (400 MHz, CDCl3): δ = 0.23 (s, 6H, SiCH3), 1.04 (s, 9H, CH3), 2.52 (s, 3H, CH3), 
3.81 (s, 3H, OCH3), 3.98 (s, 3H, OCH3), 6.76 (s, 1H, Ar-H), 7.32 (d, 3J = 8.0 Hz, 1H, Ar-H), 
8.08 (d, 3J = 8.0 Hz, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = −4.0 (3 × SiCH3), 19.0 (SiC), 24.1 (CH3), 26.5 (3 × CH3), 
56.9 (CH3O), 62.1 (CH3O), 115.7 (CH), 116.1 (C), 119.4 (CH), 123.2 (C), 124.0 (CH), 130.3 
(CH), 134.1 (C), 144.1 (C), 149.5 (C), 150.5 (C) ppm. 
EIMS m/z (rel. int.): 410 [M]+ (8), 412 [M]+ (8), 338 [M−72]+ (100), 340 [M−72]+ (100), 323 
[M−87]+ (23), 325 [M−87]+ (23). 
HRMS (ESI): calcd. for C19H27BrNaO3Si [M+23]+: 433.0805 and 435.0789; found 433.0808 
and 435.0791. 
 
5,6-Dimethoxy-2-methyl-1,4-naphthoquinone (127) 
To a solution of 204 (57.0 mg, 138 μmol) in CH3CN (1.5 mL), a solution of ammonium 
cerium (IV) nitrate (CAN) (197.6 mg, 360 μmol) in H2O (1.5 mL) was added at 0 °C and 
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stirred for 15 min. The reaction mixture was added cold H2O (10 mL) and extracted with 
CH2Cl2 (20 mL × 3). The combined organic layers were dried with Na2SO4 and concentrated 
in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EtOAc 
= 8 : 2). 
 
Yellowish solid. 
Yield: 17.0 mg, (73.0 μmol, 53%). 
M.p. 182−185 °C (EtOAc). 
Lit.: 184−185 °C (MeOH).[99] 
1H NMR (250 MHz, CDCl3): δ = 2.13 (d, 4J = 1.5 Hz, 3H, CH3), 3.91 (s, 3H, OCH3), 3.96 (s, 
3H, OCH3), 6.71 (q, 4J = 1.5 Hz, 1H, Ar-H), 7.26 (d, 3J = 8.0 Hz, 1H, Ar-H), 7.93 (d, 3J = 8.0 
Hz, 1H, Ar-H) ppm. 
EIMS m/z (rel. int.): 232 [M]+ (100), 217 [M−15]+ (26), 203 [M−28]+ (12). 
The spectroscopic data are in agreement with those in the literature.[99] 
 
1-Bromo-4-methoxymethoxy-2-methyl-5,6-naphthoquinone (208) 
To a solution of the naphthalene 205 (29.0 mg, 87.0 μmol) in CH3CN (1.5 mL), a solution 
of ammonium cerium (IV) nitrate (CAN) (119.0 mg, 217 μmol) in H2O (1.5 mL) was added 
at 0 °C and stirred for 13 min. The reaction mixture was added cold H2O (20 mL) and 
extracted with CH2Cl2 (20 mL × 3). The combined organic layers were dried with Na2SO4 
and concentrated in vacuo affording the desired product in a quantitative yield. 
 
Red solid. 
Yield: 27.0 mg, (87 μmol, 100%). 
M.p. 152 °C (CH2Cl2). 
IR (ATR): ν  = 2924 (w), 1687 (w), 1657 (s), 1572 (w), 1540 (w), 1455 (w), 1365 (w), 1304 
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(m), 1249 (m), 1225 (m), 1181 (m), 1142 (m), 1093 (s), 1051 (s), 980 (w), 944 (s), 913 (s), 
797 (m), 689 (m) cm−1. 
1H NMR (400 MHz, CDCl3): δ = 2.48 (s, 3H, CH3), 3.52 (s, 3H, OCH3), 5.32 (s, 2H, CH2), 
6.48 (d, 3J = 8.0 Hz, 1H, Ar-H), 7.20 (s, 1H, Ar-H), 8.08 (d, 3J = 8.0 Hz, 1H, Ar-H) ppm. 
13C NMR (100 MHz, CDCl3): δ = 25.6 (CH3), 57.0 (CH3O), 95.0 (OCH2O), 121.1 (CH), 
121.2 (C), 128.6 (CH), 135.1 (C), 141.6 (C), 144.7 (CH), 148.8 (C), 159.2 (C), 177.1 (C), 
180.3 (C) ppm. 
EIMS m/z (rel. int.): 312 [M+2]+ (10), 314 [M+2]+ (100), 282 [M−28]+ (10), 284 [M−28]+ 
(31), 222 [M−88]+ (22), 224 [M−88]+ (22), 45 [M−266]+ (100). 
HRMS (ESI): calcd. for C13H11BrNaO4 [M+23]+: 332.9733 and 334.9723; found 332.9735 
and 334.9725. 
 
1-Bromo-4-hydroxy-2-methyl-5,6-naphthoquinone (209) 
130 μL concentrated HCl was added into the solution of 208 (13.0 mg, 42 μmol) in MeOH 
(1.5 mL) and stirred for 3 h at room temperature. After addition of H2O (20 mL), the reaction 
mixture was extracted with EtOAc (30 mL × 3). The combined organic layers were washed 
with water (20 mL) and brine (20 mL), dried over Na2SO4 and concentrated in vacuo giving 
the crude product, which was purified by flash column chromatography affording a red solid. 
 
Red solid. 
Yield: 5.0 mg, (19.0 μmol, 44%). 
M.p. 122 °C (PE/EtOAc). 
IR (ATR): ν  = 2922 (w), 2852 (w), 1671 (w), 1634 (w), 1457 (w), 1376 (w), 1335 (w), 1289 
(w), 1211 (w), 1181 (w), 1141 (w), 1031 (s), 951 (m), 874 (m), 801 (s), 768 (m), 696 (m), 683 
(m) cm−1. 
1H NMR (600 MHz, CDCl3): δ = 2.48 (s, 3H, CH3), 6.49 (d, 3J = 8.0 Hz, 1H, Ar-H), 7.00 (s, 
1H, Ar-H), 8.01 (d, 3J = 8.0 Hz, 1H, Ar-H), 12.25 (s, 1H, OH) ppm. 
209 
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13C NMR (150 MHz, CDCl3): δ = 25.5 (CH3), 114.8 (C), 120.5 (C), 123.4 (CH), 128.5 (CH), 
133.2 (C), 143.6 (CH), 151.8 (C), 165.4 (C), 180.1 (C), 180.8 (C) ppm.  
EIMS m/z (rel. int.): 240 [M−90]+ (75), 238 [M−100]+ (75), 212 [M−48]+ (29), 210 [M−48]+ 
(31). 
HRMS (ESI): calcd. for C11H7BrNaO3 [M+23]+: 288.9471 and 290.9447; found 288.9473 
and 290.9449.
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9  Cyclodysidins A−D 
Streptomyces strain RV15 was fermented in 16 2 L-Erlenmeyer flasks, each containing 1 L 
of ISP 2 medium at 30 °C for 10 d with shaking at 150 rpm. After 10 d of cultivation, 
sterilized XAD-16 resin (30 g L−1) was added. Resin was collected 6 h later by filtration and 
eluted with acetone. The acetone was removed under reduced pressure and the aqueous layer 
was extracted with ethyl acetate (500 mL × 3). The combined extracts were concentrated 
under reduced pressure and stored at 4 °C for chromatographic fractionation. After 
fractionation of crude extract (10 g) by silica gel chromatography, the fraction (935 mg) 
eluted with 40% chloroform in methanol was further chromatographed on Sephadex LH-20. 
The fraction (56 mg) eluted with 70% methanol in water, was enriched in cyclic peptides. 
Further purification was carried out by preparative HPLC using an acetonitrile (MeCN) and 
water solvent mixture complemented by 0.05% trifluoroacetic acid: (10% MeCN : H2O to 
100% MeCN over 20 min at a flow rate of 10 mL min−1), giving four pure compounds. This 
isolation work was performed by Dr. Usama Ramadan Abdelmohsen from Prof. Ute 
Hentschel’s research group. The structure elucidation of four new cyclopeptides 216−219 was 
done in our group. 
The eight partial fragments, two asparagine (Asn) units, one glutamine (Gln), two serine 
(Ser), one tyrosine (Tyr), one threonine (Thr) moiety, and a β-amino acid in each compound 
was identified by analysis of the COSY, HSQC, ROESY, and HMBC data. 
 
9.1  Cyclodysidin A (216) 
A white amorphous powder (2.0 mg, rention time = 7.3 min). 
M.p. 290−294 °C(CH3CN/H2O). 
[α] 20D  = −19 (c 0.55, MeOH). 
UV (MeOH) λmax (logε) = 220 (5.75), 235 (12.0) nm. 
1H and 13C NMR data, see Table 9. 
HRMS (ESI): calcd. for C45H71N11O15 [M+1]+: 1006.5209; found 1006.5207. 
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9.2  Cyclodysidin B (217) 
A white amorphous powder (1.5 mg, rention time = 7.7 min). 
M.p. 321−325 °C (CH3CN/H2O). 
[α] 20D  = −15.3 (c 0.55, MeOH). 
UV (MeOH) λmax (logε) = 223 (3.8), 238 (13.1) nm. 
1H and 13C NMR data, see Table 13. 
HRMS (ESI): calcd. for C46H73N11O15 [M+1]+: 1020.5366; found 1020.5364. 
8.3  Cyclodysidin C (218) 
A white amorphous powder (2.0 mg, rention time = 8.2 min). 
M.p. 332−336 °C(CH3CN/H2O). 
[α] 20D  = −22.5 (c 0.55, MeOH). 
UV (MeOH) λmax (logε) = 222 (4.3), 237 (14.2) nm. 
1H and 13C NMR data, see Table 14. 
HRMS (ESI): calcd. for C47H75N11O15 [M+1]+: 1034.5522; found 1034.5536. 
9.4  Cyclodysidin D (219) 
A white amorphous powder (1.7 mg, rention time = 8.5 min). 
M.p. 345−350 °C(CH3CN/H2O). 
[α] 20D  = −27.7 (c 0.55, MeOH). 
UV (MeOH) λmax (logε) = 224 (6.6), 238 (13.6) nm. 
1H and 13C NMR data, see Table 15. 
HRMS (ESI): calcd. for C49H79N11O1 5 [M+1]+: 1062.5835; found 1062.5832.
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Table 13. NMR-spectroscopic data of cyclodysidin B (217) in methanol-d4 (1H: 600 MHz; 13C: 150 
MHz) 
AA δC δH, mult COSY (J in Hz) HMBC ROESY 
Asn-1      
CO 173.7     
α 52.4 4.65, dd  β (7.5, 6.4) CO, β, γ, Tyr-CO Tyr-β 
β 37.1 2.76/2.72, m α CO, α, γ  
γ 174.9     
Asn-2      
CO 174.3     
α 52.3 4.51, dd  β (7.9, 5.7) CO, β, γ, Gln-CO  
β 37.4 2.52/2.44, m α CO, α, γ Gln-α 
γ 175.1     
Gln      
CO 174.1     
α 55.6 4.19, dd  β (8.3, 5.8) CO, β, γ, Ser2-CO Asn2-β 
β 27.1 2.17/2.10, m α, γ  CO, α, γ, δ   
γ 32.9 2.47, m β α, β, δ  
δ 176.6     
Ser-1      
CO 172.9     
α 57.4 4.37, t  β (5.6) CO, β, Asn1-CO Asn1-β 
β 62.4 3.84, m α CO, α Thr-β 
Ser-2      
CO 173.0     
α 57.2 4.31, t  Β (5.3) CO, β, β-AFA-CO β-AFA-2 
β 62.3 3.92, m α CO, α  
Thr      
CO 172.4     
α 60.0 4.28, d  β (2.6) CO, β, γ, Ser1-CO  
β 67.3 4.40, m α, γ CO, α, γ Ser1-β 
γ 20.4 1.16, d  β (6.5) α, β  
Tyr      
CO 174.4     
α 56.9 4.46, dd  β (9.2, 4.8) CO, β, Asn2-CO, 1  
β 36.4 3.14/2.85, dd  α (14.2,4.7) CO, α, 1, 2, 6 Asn1-α 
           
 
129.0     
            
 
131.3 7.06, d  Bz-m (8.5) Bz-I, Bz-m, Bz-p  
            
 
116.4 6.71, d  Bz-o (8.4) Bz-I, Bz-o, Bz-p  
            
 
157.3     
β-AFA      
CO 174.5     
2 42.1 2.43, m 3 CO, 3, 4 Ser2-α 
3 48.8 4.14, m 2, 4 CO, 2, 4, Thr-CO  
4 35.7 1.5, m 3, 5-12 2, 3  
5-12 23.6-33.1 1.25-1.31, m 4, 13 4, 13  
13 14.4 0.88, t  5-12 (7.1) 5-12  
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Table 14. NMR-spectroscopic data of cyclodysidin C (218) in methanol-d4 (1H: 600 MHz; 13C: 150 
MHz) 
AA δC δH, mult COSY (J in Hz) HMBC ROESY 
Asn-1      
CO 173.9     
α 52.5 4.67, dd  β (7.6, 6.5) CO, β, γ, 
 
Tyr-β 
β 37.3 2.77/2.73, m α CO, α, γ  
γ 174.8     
Asn-2      
CO 174.3     
α 52.4 4.54, dd  β (7.9, 5.8) CO, β, γ, 
 
 
β 37.6 2.53/2.44, m α CO, α, γ Gln-α 
γ 174.9     
Gln      
CO 174.2     
α 55.8 4.21, m β CO, β, γ, 
 
Asn2-β 
β 27.0 2.16/2.10, m α, γ  CO, α, γ, δ   
γ 32.9 2.46, m β α, β, δ  
δ 176.7     
Ser-1      
CO 172.9     
α 57.0 4.38, m β CO, β, 
 
Asn1-β 
β 62.7 3.85, m α CO, α Thr-β 
Ser-2      
CO 173.0     
α 57.6 4.34, t  β (5.4) CO, β, 
 
β-AFA-2 
β 62.6 3.93, m α CO, α  
Thr      
CO 172.3     
α 60.3 4.28, d  β (2.5) CO, β, γ, 
 
 
β 67.7 4.40, m α, γ CO, α, γ Ser1-β 
γ 20.6 1.17, d  β (6.6) α, β  
Tyr      
CO 174.5     
α 57.0 4.48, dd  β (9.4, 4.9) CO, β, 
  
 
β 36.7 3.14/2.85, dd  α (14.3,4.8) CO, α, 1, 2, 6 Asn1-α 
           
 
129.2     
            
 
131.5 7.06, d  Bz-m (8.6) Bz-I, Bz-m, 
 
 
            
 
116.5 6.72, d  Bz-o (8.5) Bz-I, Bz-o, 
 
 
            
 
157.5     
β-AFA      
CO 174.6     
2 42.3 2.43, m 3 CO, 3, 4 Ser2-α 
3 48.9 4.13, m 2, 4 CO, 2, 4, 
 
 
4 35.8 1.5, m 3, 5-11 2, 3  
5-14 23.9-33.2 1.25-1.31, m 4, 15 4, 15  
15 14.6 0.88, t  5-14 (6.5) 5-14  
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Table 15. NMR-spectroscopic data of cyclodysidin D (219) in methanol-d4 (1H: 600 MHz; 13C: 150 
MHz) 
AA δC δH, mult COSY (J in Hz) HMBC ROESY 
Asn-1      
CO 173.7     
α 52.4 4.65, dd  β (7.5, 6.5) CO, β, γ, Tyr-CO Tyr-β 
β 37.2 2.77/2.71, m α CO, α, γ  
γ 175.0     
Asn-2      
CO 174.3     
α 52.3 4.53, m β CO, β, γ, Gln-CO  
β 37.3 2.52/2.44, m α CO, α, γ Gln-α 
γ 175.2     
Gln      
CO 174.1     
α 55.9 4.21, dd  Β (8.4, 5.9) CO, β, γ, Ser2-CO Asn2-β 
β 27.4 2.18/2.10, m α, γ  CO, α, γ, δ   
γ 32.8 2.48, m β α, β, δ  
δ 176.7     
Ser-1      
CO 172.9     
α 57.4 4.37, m β CO, β, Asn1-CO Asn1-β 
β 62.5 3.84, m α CO, α Thr-β 
Ser-2      
CO 173.1     
α 57.3 4.33, m β CO, β, β-AFA-CO β-AFA-2 
β 62.3 3.92, m α CO, α  
Thr      
CO 172.3     
α 60.1 4.28, d  β (2.5) CO, β, γ, Ser1-CO  
β 67.4 4.40, m α, γ CO, α, γ Ser1-β 
γ 20.5 1.16, d  β (6.4) α, β  
Tyr      
CO 174.5     
α 57.0 4.47, dd  β (9.3, 4.9) CO, β, Asn2-CO, 
 
 
β 36.6 3.14/2.85, dd 
 
α CO, α, 1, 2, 6 Asn1-α 
1 129.2     
2,6 131.1 7.06, d  Bz-m (8.5) Bz-I, Bz-m, Bz-p  
3,5 116.4 6.72, d  Bz-o (8.4) Bz-I, Bz-o, Bz-p  
4 157.5     
β-AFA      
CO 174.6     
2 42.2 2.43, m 3 CO, 3, 4 Ser2-α 
3 48.6 4.14, m 2, 4 CO, 2, 4, Thr-CO 
 
 
 
 
4 35.6 1.5, m 3, 5-11 2, 3  
5-16 23.6-33.3 1.26-1.32, m 4, 17 4, 17  
17 14.4 0.88, t  5-16 (7.2) 5-16  
 
Literature  228 
  
Literature 
[1] H. Itokawa, S. L. Morris-Natschke, T. Akiyama, K. H. Lee; Plant-derived natural product research aimed at 
new drug discovery; J. Nat. Med. 2008, 62, 263-280. 
[2] B. Patwardhan, D. Warude, P. Pushpangadan, N. Bhatt; Ayurveda and traditional Chinese medicine: a 
comparative overview; Evid-based. Compl. Alt. 2005, 2, 465-473. 
[3] I. Veith; The Yellow Emperor's classic of internal medicine. Berkeley and Los Angeles: University of 
California Press, 2002, 1-230. 
[4] M. S. Rao; The history of medicine in India and Burma; Med. Hist. 1968, 12, 52-61. 
[5] L. Manniche; An ancient Egyptian herbal. British Museum Press, 1st University of Texas Press ed edition, 
1989, 1-176. 
[6] F. Firenzuoli, L. Gori; European traditional medicine international congress introductory statement; 
Evid-based. Compl. Alt. 2007, 4, 3-4. 
[7] D. M. Eisenberg, R. B. Davis, S. L. Ettner, S. Appel, S. Wilkey, M. Van Rompay, R. C. Kessler; Trends in 
alternative medicine use in the United States, 1990-1997: results of a follow-up national survey; J. Am. Med. 
Assoc. 1998, 280, 1569-1575. 
[8] P. M. Barnes, E. Powell-Griner, K. McFann, R. L. Nahin; Complementary and alternative medicine use 
among adults: United States, 2002; Semin. Integr. Med. 2004, 2, 54-71. 
[9] A. Vickers, C. Zollman; Herbal medicine; Br. Med. J. 1999, 319, 1050-1053. 
[10] S. Grabley, R. Thiericke; Drug discovery from nature. Springer Verlag Berlin Heidelberg, 1999, 1-335. 
[11] T. T. Hien, N. P. J. Day, N. H. Phu, N. T. H. Mai, T. T. H. Chau, P. P. Loc, D. X. Sinh, L. V. Chuong, H. Vinh, 
D. Waller; A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria; N. 
Engl. J. Med. 1996, 335, 76-83. 
[12] M. S. Butler; The role of natural product chemistry in drug discovery; J. Nat. Prod. 2004, 67, 2141-2153. 
[13] F. E. Koehn, G. T. Carter; The evolving role of natural products in drug discovery; Nat. Rev. Drug Discov. 
2005, 4, 206-220. 
[14] F. Balkenhohl, C. von dem Bussche-Hünnefeld, A. Lansky, C. Zechel; Combinatorial synthesis of small 
organic molecules; Angew. Chem. Int. Ed. 1996, 35, 2288-2337; Angew. Chem. 1996, 108, 2436-2488. 
[15] G. M. Cragg, D. J. Newman, K. M. Snader; Natural products in drug discovery and development; J. Nat. 
Prod. 1997, 60, 52-60. 
[16] D. J. Newman, G. M. Cragg, K. M. Snader; Natural products as sources of new drugs over the period 
1981-2002; J. Nat. Prod. 2003, 66, 1022-1037. 
[17] D. J. Newman, G. M. Cragg; Natural products as sources of new drugs over the last 25 Years; J. Nat. Prod. 
2007, 70, 461-477. 
[18] C. Cordier, D. Morton, S. Murrison, A. Nelson, C. O'Leary-Steele; Natural products as an inspiration in the 
diversity-oriented synthesis of bioactive compound libraries; Nat. Prod. Rep. 2008, 25, 719-737. 
[19] K. H. Lee; Novel antitumor agents from higher plants; Med. Res. Rev. 1999, 19, 569-596. 
[20] J. Schlauer; "New" data relating to the evolution and phylogeny of some carnivorous plant families; Carniv. 
Pl. Newslett. 1997, 26, 34-38. 
[21] N. Ruangrungsi, V. Wongpanich, P. Tantivatana, H. J. Cowe, P. J. Cox, S. Funayama, G. A. Cordell; 
Traditional medicinal plants of Thailand, V. ancistrotectorine, a new naphthalene-isoquinoline alkaloid from 
Literature  229 
  
Ancistrocladus tectorius; J. Nat. Prod. 1985, 48, 529-535. 
[22] G. Bringmann, M. Rübenacker, J. R. Jansen, D. Scheutzow; On the structure of the Dioncophyllaceae 
alkaloids Dioncophylline A (''triphyophylline'') and ''O-methyl-triphyophylline''; Tetrahedron Lett. 1990, 31, 
639-642. 
[23] G. François, G. Bringmann, J. D. Phillipson, L. Aké Assi, C. Dochez, M. Rübenacker, C. Schneider, M. Wéry, 
D. C. Warhurst, G. C. Kirby; Activity of extracts and naphthylisoquinoline alkaloids from Triphyophyllum 
peltatum, Ancistrocladus abbreviatus and A. barteri against Plasmodium falciparum in vitro; 
Phytochemistry 1994, 35, 1461-1464. 
[24] G. Bringmann, F. Teltschik, M. Michel, S. Busemann, M. Rückert, R. Haller, S. Bär, S. A. Robertson, R. 
Kaminsky; Ancistrobertsonines B, C, and D as well as 1,2-didehydroancistrobertsonine D from 
Ancistrocladus robertsoniorum; Phytochemistry 1999, 52, 321-332. 
[25] G. Bringmann, M. Dreyer, J. H. Faber, P. W. Dalsgaard, D. Stærk, J. W. Jaroszewski, H. Ndangalasi, F. 
Mbago, R. Brun, M. Reichert, K. Maksimenka, S. B. Christensen; Ancistrotanzanine A, the first 5,3'-coupled 
naphthylisoquinoline alkaloid, and two further, 5,8'-linked related compounds from the newly described 
species Ancistrocladus tanzaniensis; J. Nat. Prod. 2003, 66, 1159-1165. 
[26] G. Bringmann, J. Holenz, R. Weirich, M. Rübenacker, C. Funke, M. R. Boyd, R. J. Gulakowski, G. François; 
First synthesis of the antimalarial naphthylisoquinoline alkaloid dioncophylline C, and its unnatural 
anti-HIV dimer, jozimine C; Tetrahedron 1998, 54, 497-512. 
[27] M. Xu, T. Bruhn, B. Hertlein, R. Brun, A. Stich, J. Wu, G. Bringmann; Shuangancistrotectorines A-E, 
dimeric naphthylisoquinoline alkaloids with three chiral biaryl axes from the Chinese plant Ancistrocladus 
tectorius; Chem. Eur. J. 2010, 16, 4206-4216. 
[28] G. Bringmann, K. Messer, B. Schwöbel, R. Brun, L. Aké Assi; Habropetaline A, an antimalarial 
naphthylisoquinoline alkaloid from Triphyophyllum peltatum; Phytochemistry 2003, 62, 345-349. 
[29] G. Bringmann, K. Messer, K. Wolf, J. Mühlbacher, M. Grüne, R. Brun, A. M. Louis; Dioncophylline E from 
Dioncophyllum thollonii, the first 7,3'-coupled dioncophyllaceous naphthylisoquinoline alkaloid; 
Phytochemistry 2002, 60, 389-397. 
[30] G. François, G. Bringmann, C. Dochez, C. Schneider, G. Timperman, L. Aké Assi; Activities of extracts and 
naphthylisoquinoline alkaloids from Triphyophyllum peltatum, Ancistrocladus abbreviatus and 
Ancistrocladus barteri against Plasmodium berghei (Anka strain) in vitro; J. Ethnopharmacol. 1995, 46, 
115-120. 
[31] G. François, G. Timperman, J. Holenz, L. Aké Assi, T. Geuder, L. Maes, J. Dubois, M. Hanocq, G. 
Bringmann; Naphthylisoquinoline alkaloids exhibit strong growth-inhibiting activities against Plasmodium 
falciparum and P. berghei in vitro: structure-activity relationships of dioncophylline C; Ann. Trop. Med. 
Parasitol. 1996, 90, 115-123. 
[32] G. François, G. Timperman, T. Steenackers, L. Aké Assi, J. Holenz, G. Bringmann; In vitro inhibition of liver 
forms of the rodent malaria parasite Plasmodium berghei by naphthylisoquinoline alkaloids - 
structure-activity relationships of dioncophyllines A and C and ancistrocladine; Parasitol. Res. 1997, 83, 
673-679. 
[33] G. François, G. Timperman, W. Eling, L. Aké Assi, J. Holenz, G. Bringmann; Naphthylisoquinoline alkaloids 
against malaria: evaluation of the curative potentials of dioncophylline C and dioncopeltine A against 
Plasmodium berghei in vivo; Antimicrob. Agents Chemother. 1997, 41, 2533-2539. 
[34] G. Bringmann, K. Messer, R. Brun, V. Mudogo; Ancistrocongolines A-D, new naphthylisoquinoline 
alkaloids from Ancistrocladus congolensis; J. Nat. Prod. 2002, 65, 1096-1101. 
[35] G. Bringmann, A. Hamm, C. Günther, M. Michel, R. Brun, V. Mudogo; Ancistroealaines A and B, two new 
bioactive naphthylisoquinolines, and related naphthoic acids from Ancistrocladus ealaensis; J. Nat. Prod. 
Literature  230 
  
2000, 63, 1465-1470. 
[36] A. Ponte-Sucre, T. Gulder, A. Wegehaupt, C. Albert, C. Rikanović, L. Schaeflein, A. Frank, M. Schultheis, 
M. Unger, U. Holzgrabe, G. Bringmann, H. Moll; Structure-activity relationship and studies on the 
molecular mechanism of leishmanicidal N,C-coupled arylisoquinolinium salts; J. Med. Chem. 2008, 52, 
626-636. 
[37] A. Ponte-Sucre, J. H. Faber, T. Gulder, I. Kajahn, S. E. H. Pedersen, M. Schultheis, G. Bringmann, H. Moll; 
Activities of naphthylisoquinoline alkaloids and synthetic analogs against Leishmania major; Antimicrob. 
Agents Chemother. 2007, 51, 188-194. 
[38] G. Bringmann, V. Hoerr, U. Holzgrabe, A. Stich; Antitrypanosomal naphthylisoquinoline alkaloids and 
related compounds; Pharmazie 2003, 58, 343-346. 
[39] G. Bringmann, B. Hertlein-Amslinger, I. Kajahn, M. Dreyer, R. Brun, H. Moll, A. Stich, K. N. Ioset, W. 
Schmitz, L. H. Ngoc; Phenolic analogs of the N,C-coupled naphthylisoquinoline alkaloid ancistrocladinium 
A, from Ancistrocladus cochinchinensis (Ancistrocladaceae), with improved antiprotozoal activities; 
Phytochemistry 2011, 72, 89-93. 
[40] G. Bringmann, I. Kajahn, M. Reichert, S. E. H. Pedersen, J. H. Faber, T. Gulder, R. Brun, S. B. Christensen, 
A. Ponte-Sucre, H. Moll, G. Heubl, V. Mudogo; Ancistrocladinium A and B, the first N,C-coupled 
naphthyldihydroisoquinoline alkaloids, from a Congolese Ancistrocladus species; J. Org. Chem. 2006, 71, 
9348-9356. 
[41] M. R. Boyd, Y. F. Hallock, J. H. Cardellina II, K. P. Manfredi, J. W. Blunt, J. B. McMahon, R. W. Buckheit 
Jr, G. Bringmann, M. Schäffer, G. M. Cragg, D. W. Thomas, J. G. Jato; Anti-HIV michellamines from 
Ancistrocladus korupensis; J. Med. Chem. 1994, 37, 1740-1745. 
[42] J. B. McMahon, M. J. Currens, R. J. Gulakowski, R. W. Buckheit Jr, C. Lackman-Smith, Y. F. Hallock, M. R. 
Boyd; Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing 
by at least two distinct mechanisms; Antimicrob. Agents Chemother. 1995, 39, 484-488. 
[43] K. P. Manfredi, J. W. Blunt, J. H. Cardellina II, J. B. McMahon, L. L. Pannell, G. M. Cragg, M. R. Boyd; 
Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2; J. 
Med. Chem. 1991, 34, 3402-3405. 
[44] Y. F. Hallock, K. P. Manfredi, J. R. Dai, J. H. Cardellina II, R. J. Gulakowski, J. B. McMahon, M. Schäffer, 
M. Stahl, K. P. Gulden, G. Bringmann, G. François, M. R. Boyd; Michellamines D-F, new HIV-inhibitory 
dimeric naphthylisoquinoline alkaloids, and korupensamine E, a new antimalarial monomer, from 
Ancistrocladus korupensis; J. Nat. Prod. 1997, 60, 677-683. 
[45] G. Bringmann, J. Holenz, L. Aké Assi, C. Zhao, K. Hostettmann; Molluscicidal activity of 
naphthylisoquinoline alkaloids from Triphyophyllum and Ancistrocladus species; Planta Med. 1996, 62, 
556-557. 
[46] G. Bringmann, J. Holenz, L. Aké Assi, K. Hostettmann; Molluscicidal activity (Biomphalaria glabrata) of 
dioncophylline A: structure-activity investigations; Planta Med. 1998, 64, 485-486. 
[47] G. Bringmann, G. François, L. Aké Assi, J. Schlauer; The alkaloids of Triphyophyllum peltatum 
(Dioncophyllaceae); Chimia 1998, 1, 18-28. 
[48] G. François, M. Van Looveren, G. Timperman, B. Chimanuka, L. Aké Assi, J. Holenz, G. Bringmann; 
Larvicidal activity of the naphthylisoquinoline alkaloid dioncophylline A against the malaria vector 
Anopheles stephensi; J. Ethnopharmacol. 1996, 54, 125-130. 
[49] G. Bringmann, D. Feineis; Stress-related polyketide metabolism of Dioncophyllaceae and Ancistrocladaceae; 
J. Exp. Bot. 2001, 52, 2015-2022. 
[50] G. Bringmann, M. Wohlfarth, H. Rischer, M. Grüne, J. Schlauer; A new biosynthetic pathway to alkaloids in 
Literature  231 
  
plants: acetogenic isoquinolines; Angew. Chem. Int. Ed. 2000, 39, 1464-1466; Angew. Chem. 2000, 112, 
1523-1525. 
[51] G. Bringmann, J. Mutanyatta, M. Greb, S. Rüdenauer, T. F. Noll, A. Irmer; Biosynthesis of 
naphthylisoquinoline alkaloids: synthesis and incorporation of an advanced 13C2-labeled isoquinoline 
precursor; Tetrahedron 2007, 63, 1755-1761. 
[52] G. Bringmann, H. Rischer, M. Wohlfarth, J. Schlauer, L. Aké Assi; Droserone from cell cultures of 
Triphyophyllum peltatum (Dioncophyllaceae) and its biosynthetic origin; Phytochemistry 2000, 53, 339-343. 
[53] G. Bringmann, M. Wohlfarth, H. Rischer, M. Rückert, J. Schlauer; The polyketide folding mode in the 
biogenesis of isoshinanolone and plumbagin from Ancistrocladus heyneanus (Ancistrocladaceae); 
Tetrahedron Lett. 1998, 39, 8445-8448. 
[54] G. Bringmann, S. Rüdenauer, A. Irmer, T. Bruhn, R. Brun, T. Heimberger, T. Stühmer, R. Bargou, M. 
Chatterjee; Antitumoral and antileishmanial dioncoquinones and ancistroquinones from cell cultures of 
Triphyophyllum peltatum (Dioncophyllaceae) and Ancistrocladus abbreviatus (Ancistrocladaceae); 
Phytochemistry 2008, 69, 2501-2509. 
[55] G. Bringmann, S. Rüdenauer, A. Irmer, R. Brun, M. Chatterjee, R. Bargou; Dioncochinone, Ancistrochinone 
und davon abgeleitete Verbindungen, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren 
Verwendung; German Patent Application (DE 10 2008 007 898.0), filed 06.02.2008. 
[56] S. H. Kaufmann, D. Peereboom, C. A. Buckwalter, P. A. Svingen, L. B. Grochow, R. C. Donehower, E. K. 
Rowinsky; Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell 
lines; J. Natl. Cancer Inst. 1996, 88, 734-741. 
[57] D. Collins; Problems monitoring response in multiple myeloma; Cancer Imag. 2005, 5, 119-126. 
[58] G. M. Dores, O. Landgren, K. A. Mcglynn, R. E. Curtis, M. S. Linet, S. S. Devesa; Plasmacytoma of bone, 
extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 
1992-2004; Brit. J. Haematol. 2009, 144, 86-94. 
[59] H. J. Cohen, J. Crawford, M. K. Rao, C. F. Pieper, M. S. Currie; Racial differences in the prevalence of 
monoclonal gammopathy in a community-based sample of the elderly; Am. J. Med. 1998, 104, 439-444. 
[60] G. Bringmann, F. Pokorny; The Naphthylisoquinoline Alkaloids; in The Alkaloids, vol. 46, (Ed.: G.A. 
Cordell), Academic Press, New York, 1995, 127-271. 
[61] S. Knop, C. Gerecke, P. Liebisch, M. S. Topp, U. Platzbecker, O. Sezer, C. Vollmuth, K. Falk, A. 
Glasmacher, U. Maeder, H. Einsele, R. Bargou; Lenalidomide, adriamycin, and dexamethasone (RAD) in 
patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group 
DSMM (Deutsche Studiengruppe Multiples Myelom); Blood 2009, 113, 4137-4143. 
[62] G. M. Durie; Treatment of myeloma - are we making progress?; New Engl. J. Med. 2008, 359, 964-966. 
[63] M. Von Lilienfeld-Toal, C. Hahn-Ast, K. Furkert, F. Hoffmann, R. Naumann, R. Bargou, G. Cook, A. 
Glasmacher; A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in 
patients with relapsed or refractory multiple myeloma; Eur. J. Haematol. 2008, 81, 247-252. 
[64] R. A. Kyle, S. V. Rajkumar; Multiple myeloma; Blood 2008, 111, 2962-2972. 
[65] S. Singhal, J. Mehta, R. Desikan, D. Ayers, P. Roberson, P. Eddlemon, N. Munshi, E. Anaissie, C. Wilson, M. 
Dhodapkar; Antitumor activity of thalidomide in refractory multiple myeloma; New Engl. J. Med. 1999, 341, 
1565-1571. 
[66] M. Weber, C. Chen, R. Niesvizky, M. Wang, A. Belch, E. A. Stadtmauer, D. Siegel, I. Borrello, S. V. 
Rajkumar, A. A. Chanan-Khan; Lenalidomide plus dexamethasone for relapsed multiple myeloma in North 
America; New Engl. J. Med. 2007, 357, 2133-2142. 
Literature  232 
  
[67] M. Dimopoulos, A. Spencer, M. Attal, H. M. Prince, J. L. Harousseau, A. Dmoszynska, J. S. Miguel, A. 
Hellmann, T. Facon, R. Foa; Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma; 
New Engl. J. Med. 2007, 357, 2123-2132. 
[68] A. Ciechanover; The ubiquitin-proteasome proteolytic pathway; Cell 1994, 79, 13-21. 
[69] M. G. Peter; Chemical modifications of biopolymers by quinones and quinone methides; Angew. Chem. Int. 
Ed. 1989, 28, 555-570; Angew. Chem. 1989, 28, 555-570. 
[70] J. L. Bolton, M. A. Trush, T. M. Penning, G. Dryhurst, T. J. Monks; Role of quinones in toxicology; Chem. 
Res. Toxicol. 2000, 13, 135-160. 
[71] Y. Misono, Y. Ishikawa, Y. Yamamoto, M. Hayashi, K. Komiyama, M. Ishibashi; Dihydrolindbladiones, 
three new naphthoquinone pigments from a myxomycete Lindbladia tubulina; J. Nat. Prod. 2003, 66, 
999-1001. 
[72] J. H. Su, A. F. Ahmed, P. J. Sung, Y. C. Wu, J. H. Sheu; Meroditerpenoids from a Formosan soft coral 
Nephthea chabrolii; J. Nat. Prod. 2005, 68, 1651-1655. 
[73] J. H. Sheu, J. H. Su, P. J. Sung, G. H. Wang, C. F. Dai; Novel meroditerpenoid-related metabolites from the 
Formosan soft coral Nephthea chabrolii; J. Nat. Prod. 2004, 67, 2048-2052. 
[74] H. Hardt, P. R. Jensenand William; Neomarinone, and new cytotoxic marinone derivatives, produced by a 
marine filamentous bacterium (actinomycetales); Tetrahedron Lett. 2000, 41, 2073-2076. 
[75] T. S. Wu, H. C. Hsu, P. L. Wu, C. M. Teng, Y. C. Wu; Rhinacanthin-Q, a naphthoquinone from Rhinacanthus 
nasutus and its biological activity; Phytochemistry 1998, 49, 2001-2003. 
[76] M. Higa, N. Noha, H. Yokaryo, K. Ogihara, S. Yogi; Three new naphthoquinone derivatives from Diospyros 
maritima BLUME; Chem. Pharm. Bull. 2002, 50, 590-593. 
[77] B. A. Adeniyi, H. H. S. Fong, J. M. Pezzuto, L. Luyengi, H. A. Odelola; Antibacterial activity of diospyrin, 
isodiospyrin and bisisodiospyrin from the root of Diospyros piscatoria (Gurke)(Ebenaceae); Phytother. Res. 
2000, 14, 112-117. 
[78] B. Hazra, R. Ghosh, A. Banerjee, G. C. Kirby, D. C. Warhurst, J. D. Phillipson; In vitro antiplasmodial 
effects of diospyrin, a plant-derived naphthoquinoid, and a novel series of derivatives; Phytother. Res. 1995, 
9, 72-74. 
[79] S. Ganapaty, P. Steve Thomas, G. Karagianis, P. G. Waterman, R. Brun; Antiprotozoal and cytotoxic 
naphthalene derivatives from Diospyros assimilis; Phytochemistry 2006, 67, 1950-1956. 
[80] S. Ganapaty, P. Steve Thomas, S. Fotso, H. Laatsch; Antitermitic quinones from Diospyros sylvatica; 
Phytochemistry 2004, 65, 1265-1271. 
[81] K. O. Eyong, G. N. Folefoc, V. Kuete, V. P. Beng, K. Krohn, H. Hussain, A. E. Nkengfack, M. Saeftel, S. R. 
Sarite, A. Hoerauf; Newbouldiaquinone A: a naphthoquinone-anthraquinone ether coupled pigment, as a 
potential antimicrobial and antimalarial agent from Newbouldia laevis; Phytochemistry 2006, 67, 605-609. 
[82] B. Onegi, C. Kraft, I. Köhler, M. Freund, K. Jenett-Siems, K. Siems, G. Beyer, M. F. Melzig, U. Bienzle, E. 
Eich; Antiplasmodial activity of naphthoquinones and one anthraquinone from Stereospermum kunthianum; 
Phytochemistry 2002, 60, 39-44. 
[83] P. Kittakoop, J. Punya, P. Kongsaeree, Y. Lertwerawat, A. Jintasirikul, M. Tanticharoen, Y. Thebtaranonth; 
Bioactive naphthoquinones from Cordyceps unilateralis; Phytochemistry 1999, 52, 453-457. 
[84] B. Bieber, J. NüSke, M. Ritzau, U. Gräfe; Alnumycin a new naphthoquinone antibiotic produced by an 
Endophytic streptomyces sp; J. Antibiot. 1998, 51, 381-382. 
[85] H. P. Fiedler, A. Kulik, T. C. Schüz, C. Volkmann, A. Zeeck; Biosynthetic capacities of actinomycetes. 
Juglomycin Z, a new naphthoquinone antibiotic from Streptomyces tendae; J. Antibiot. 1994, 47, 1116-1122. 
Literature  233 
  
[86] J. R. Ioset, A. Marston, M. P. Gupta, K. Hostettmann; Antifungal and larvicidal cordiaquinones from the 
roots of Cordia curassavica; Phytochemistry 2000, 53, 613-617. 
[87] J. Galván, N. Mir-Rashed, M. Jessulat, M. Atanya, A. Golshani, T. Durst, P. Petit, V. T. Amiguet, T. 
Boekhout, R. Summerbell; Antifungal and antioxidant activities of the phytomedicine pipsissewa, 
Chimaphila umbellata; Phytochemistry 2008, 69, 738-746. 
[88] A. Hasan, S. Begum, T. Furumoto, H. Fukui; A new chlorinated red naphthoquinone from roots of Sesamum 
indicum; Biosci. Biotech. Bioch. 2000, 64, 873-874. 
[89] F. M. Feroj Hasan, T. Furumoto, S. Begum, H. Fukui; Hydroxysesamone and 2,3-epoxysesamone from roots 
of Sesamum indicum; Phytochemistry 2001, 58, 1225-1228. 
[90] C. Wu, C. F. Peng, I. L. Tsai, E. R. Abd, H. Mohamed, H. S. Huang, I. S. Chen; Secondary metabolites from 
the roots of Engelhardia roxburghiana and their antitubercular activities; Phytochemistry 2007, 68, 
1338-1343. 
[91] O. Veshkurova, Z. Golubenko, E. Pshenichnov, I. Arzanova, V. Uzbekov, E. Sultanova, S. Salikhov, H. J. 
Williams, J. H. Reibenspies, L. S. Puckhaber; Malvone A, a phytoalexin found in Malva sylvestris (family 
Malvaceae); Phytochemistry 2006, 67, 2376-2379. 
[92] A. Bohle, A. Schubert, Y. Sun, W. R. Thiel; A new metal-free access to vitamin K3; Adv. Synth. Catal. 2006, 
348, 1011-1015. 
[93] A. Couladouros, A. T. Strongilos; Product class 3: naphtho-1,4-quinones; Science of synth. 2006, 28, 
217-322. 
[94] R. G. F. Giles, I. R. Green, N. van Eeden; The synthesis of ventiloquinone F and isoventiloquinone F as 
racemates; Eur. J. Org. Chem. 2004, 2004, 4416-4423. 
[95] L. Boger, P. Turnbull; Synthesis and evaluation of a carbocyclic analogue of the CC-1065 and duocarmycin 
alkylation subunits: role of the vinylogous amide and implications on DNA alkylation catalysis; J. Org. 
Chem. 1998, 63, 8004-8011. 
[96] M. A. Rizzacasa, M. V. Sargent; The Wittig reaction of 
2-t-butoxycarbonyl-1-methoxycarbonylethylidenetriphenylphosphorane: a surrogate for the Stobbe reaction; 
Aust. J. Chem. 1987, 40, 1737-1743. 
[97] J. Sauer, R. Sustmann; Mechanistic aspects of Diels-Alder reactions: a critical survey; Angew. Chem. Int. Ed. 
1980, 19, 779-807; Angew. Chem. 1980, 92, 773-801. 
[98] K. C. Nicolaou, S. A. Snyder, T. Montagnon, G. Vassilikogiannakis; The Diels-Alder reaction in total 
synthesis; Angew. Chem. Int. Ed. 2002, 41, 1668-1698; Angew. Chem. 2002, 114, 1742-1773. 
[99] M. Watanabe, S. Hisamatsu, H. Hotokezaka, S. Furukawa; Reaction of lithiated senecioamide and related 
compounds with benzynes: efficient syntheses of naphthols and naphthoquinones; Chem. Pharm. Bull. 1986, 
34, 2810-2820. 
[100] V. Snieckus; Directed ortho metalation. tertiary amide and O-carbamate directors in synthetic strategies for 
polysubstituted aromatics; Chem. Rev. 1990, 90, 879-933. 
[101] M. P. Sibi, M. A. J. Miah, V. Snieckus; Ortho-lithiated tertiary benzamides. magnesium transmetalation and 
synthesis of phthalides and isocoumarins including mellein and kigelin; J. Org. Chem. 1984, 49, 737-742. 
[102] M. P. Sibi, J. W. Dankwardt, V. Snieckus; Anionic aromatic ring annelation of o-allyl benzamides. 
Regiospecific synthesis of naphthols and naphthoquinones; J. Org. Chem. 1986, 51, 271-273. 
[103] M. Pohmakotr, K. H. Geiss, D. Seebach; Anwendungen der Magnesiumderivate von 
Thioacrolein-Dianionen zur synthese schwefelfreier Verbindungen (Vinyl- und Divinylepoxide, 
Acylcyclopentene); Chem. Ber. 1979, 112, 1420-1439. 
Literature  234 
  
[104] M. Hauser, R. P. Rhee; New synthetic methods for the regioselective annelation of aromatic rings: 
1-hydroxy-2,3-disubstituted naphthalenes and 1,4-dihydroxy-2,3-disubstituted naphthalenes; J. Org. Chem. 
1978, 43, 178-180. 
[105] A. Kraus, H. Sugimoto; An annelation route to quionones; Tetrahedron Lett. 1978, 19, 2263-2266. 
[106] G. Myers, N. J. Tom, M. E. Fraley, S. B. Cohen, D. J. Madar; A convergent synthetic route to (+)-dynemicin 
A and analogs of wide structural variability; J. Am. Chem. Soc. 1997, 119, 6072-6094. 
[107] J. Dessolin, C. Biot, E. Davioud-Charvet; Bromination studies of the 2,3-dimethylnaphthazarin core 
allowing easy access to naphthazarin derivatives; J. Org. Chem. 2001, 66, 5616-5619. 
[108] L. S. Liebeskind, S. L. Baysdon, V. Goedken, R. Chidambaram; Phthaloylcobalt complexes in synthesis. 
Ligand modifications leading to a practical naphthoquinone synthesis; Organometallics 1986, 5, 1086-1092. 
[109] L. S. Liebeskind; Cyclobutenediones as precursors to quinones and cyclopentenones; Tetrahedron 1989, 45, 
3053-3060. 
[110] R. Solorio-Alvarado, E. Pena-Cabrera, J. Garcia-Soto, J. Lopez-Godinez, F. J. Gonzalez, A. 
Alvarez-Hernandez; 2-Hydroxynaphthoquinones. synthesis, electrochemical study, and biological essays of 
activity; Arkivoc 2009, 2, 239-257. 
[111] E. Pena-Cabrera, L. S. Liebeskind; Squaric acid ester-based total synthesis of echinochrome A; J. Org. 
Chem. 2002, 67, 1689-1691. 
[112] K. H. Dötz, P. Tomuschat; Annulation reactions of chromium carbene complexes: scope, selectivity and 
recent developments; Chem. Soc. Rev. 1999, 28, 187-198. 
[113] M. W. Davies, C. N. Johnson, J. P. A. Harrity; Synthesis of novel quinone boronic ester derivatives via a 
highly regioselective Cr-mediated benzannulation reaction and their application in Pd-catalyzed coupling 
processes; J. Org. Chem. 2001, 66, 3525-3532. 
[114] A. Voskobojnik; Dioncochinon B. Isolierung, Synthese und Wirkoptimierung eines neuen Wirkstoffes gegen 
das Multiple Myelom; Diploma Dissertation, Universität Würzburg, 2008. 
[115] G. Bringmann, G. Zhang, A. Hager, M. Moos, A. Irmer, R. Bargou, M. Chatterjee; Anti-tumoral activities of 
dioncoquinones B and C and related naphthoquinones gained from total synthesis or isolation from plants; 
Eur. J. Med. Chem. 2011, 46, 5778-5789. 
[116] M. Said, I. B. Ahmad, M. D. Yahya, A. M. Marini; Biological activity studies of Ancistrocladus tectorius; 
Pharm. Biol. 2001, 39, 357-363. 
[117] Z. Chen, B. Wang, K. W. Quin, B. E. Zhang, Q. L. Su, Q. C. Lin; Isolation and identification of alkaloids 
from Ancistrocladus tectorius; Acta Pharm. Sinica 1981, 16, 519-523. 
[118] G. Bringmann, L. Kinzinger; (+)-Ancistrocline, a naphthylisoquinoline alkaloid from Ancistrocladus 
tectorius; Phytochemistry 1992, 31, 3297-3299. 
[119] K. P. Manfredi, M. Britton, V. Vissieche, L. K. Pannell; Three new naphthyldihydroisoquinoline alkaloids 
from Ancistrocladus tectorius; J. Nat. Prod. 1996, 59, 854-859. 
[120] A. Montagnac, A. H. A. Hadi, F. Remy, M. Païs; Isoquinoline alkaloids from Ancistrocladus tectorius; 
Phytochemistry 1995, 39, 701-704. 
[121] P. Tang, Y. P. Yang, Y. Zhong, Q. X. Zhong, H. M. Wu, Y. Ye; Four new naphthylisoquinoline alkaloids from 
Ancistrocladus tectorius; J. Nat. Prod. 2000, 63, 1384-1387. 
[122] P. Tang, Z. Q. Xin, X. Q. Li, Y. Ye; Two new naphthylisoquinoline alkaloids from stems and leaves of 
Ancistrocladus tectorius; Nat. Prod. Res. 2010, 24, 989-994. 
[123] H. Meimberg, H. Rischer, F. G. Turini, V. Chamchumroon, M. Dreyer, M. Sommaro, G. Bringmann, G. 
Literature  235 
  
Heubl; Evidence for species differentiation within the Ancistrocladus tectorius complex (Ancistrocladaceae) 
in Southeast Asia: a molecular approach; Plant Syst. Evol. 2010, 284, 77-98. 
[124] G. Bringmann, J. Spuziak, J. H. Faber, T. Gulder, I. Kajahn, M. Dreyer, G. Heubl, R. Brun, V. Mudogo; Six 
naphthylisoquinoline alkaloids and a related benzopyranone from a Congolese Ancistrocladus species 
related to Ancistrocladus congolensis; Phytochemistry 2008, 69, 1065-1075. 
[125] G. Bringmann, T. Geuder, M. Rübenacker, R. Zagst; A facile degradation procedure for determination of 
absolute configuration in 1,3-dimethyltetra- and dihydroisoquinolines; Phytochemistry 1991, 30, 2067-2070. 
[126] G. Bringmann, H. Reuscher; Aryl-coupling via "Axially Prostereogenic" lactones: first total Synthesis of 
(+)-ancistrocladisine and (optionally) its atropisomer; Tetrahedron Lett. 1989, 30, 5249-5252. 
[127] N. H. Anh, A. Porzel, H. Ripperger, G. Bringmann, M. Schäffer, R. God, T. Van Sung, G. Adam; 
Naphthylisoquinoline alkaloids from Ancistrocladus cochinchinensis; Phytochemistry 1997, 45, 1287-1291. 
[128] G. Bringmann, R. God, M. Schäffer; An improved degradation procedure for determination of the absolute 
configuration in chiral isoquinoline and ß-carboline derivatives; Phytochemistry 1996, 43, 1393-1403. 
[129] G. Bringmann, L. Kinzinger, H. Brusse, C. Zhao; Isolation, structure elucidation and total synthesis of 
ancistrocline, an alkaloid of Ancistrocladus tectorius; Planta Med. 1992, 58, 704. 
[130] T. R. Govindachari, P. C. Parthasarathy; Ancistrocladine, a novel isoquinoline alkaloid from Ancistrocladus 
heyneanus Wall.; Indian J. Chem. 1970, 8, 567-569. 
[131] G. Bringmann, F. Teltschik, M. Schäffer, R. Haller, S. Bär, S. A. Robertson, M. A. Isahakia; 
Ancistrobertsonine A and related naphthylisoquinoline alkaloids from Ancistrocladus robertsoniorum; 
Phytochemistry 1998, 47, 31-35. 
[132] T. R. Govindachari, P. C. Parthasarathy, T. G. Rajagopalan; Hamatine, a new isoquinoline alkaloid from 
Ancistrocladus hamatus (Vahl) Gilg; Indian. J. Chem. 1975, 13, 641-643. 
[133] T. R. Govindachari, K. Nagarajan, P. C. Parthasarathy, T. G. Rajagopalan, H. K. Desai, G. Kartha, S. L. Chen, 
K. Nakanishi; Absolute stereochemistry of ancistrocladine and ancistrocladinine; J. Chem. Soc. 1974, Perkin 
Trans. 1, 1413-1417. 
[134] G. Bringmann, D. Koppler, B. Wiesen, A. S. Sankara Narayanan, M. R. Almeida, H. Schneider, U. 
Zimmermann; Ancistroheynine A, the first 7,8'-coupled naphthylisoquinoline alkaloid from Ancistrocladus 
heyneanus; Phytochemistry 1996, 43, 1405-1410. 
[135] G. Bringmann, M. Wohlfarth, H. Rischer, J. Schlauer, R. Brun; Extract screening by HPLC coupled to 
MS-MS, NMR, and CD: a dimeric and three monomeric naphthylisoquinoline alkaloids from 
Ancistrocladus griffithii; Phytochemistry 2002, 61, 195-204. 
[136] G. Bringmann, W. Saeb, M. Rückert, J. Mies, M. Michel, V. Mudogo, R. Brun; Ancistrolikokine D, a 
5,8'-coupled naphthylisoquinoline alkaloid, and related natural products from Ancistrocladus likoko; 
Phytochemistry 2003, 62, 631-636. 
[137] G. Bringmann, C. Günther, M. Ochse, O. Schupp, S. Tasler; Biaryls in nature: a multi-facetted class of 
stereochemically, biosynthetically, and pharmacologically intriguing secondary metabolites. In: Herz, W., 
Falk, H., Kirby, G.W., Moore, R.E., Tamm, C. (Eds.), Progress in the Chemistry of Organic Natural Products, 
vol. 82. Springer, Wien, New York, 2001, 1-249. 
[138] Y. F. Hallock, J. H. Cardellina II, M. Schäffer, G. Bringmann, G. François, M. R. Boyd; Korundamine A, a 
novel HIV-inhibitory and antimalarial "hybrid" naphthylisoquinoline alkaloid heterodimer from 
Ancistrocladus korupensis; Bioorg. Med. Chem. Lett. 1998, 8, 1729-1734. 
[139] J. Bruneton, A. Bouquet, A. Fournet, A. Cavé; La triphyophylline, nouvel alcaloïde isolé du Triphyophyllum 
peltatum; Phytochemistry 1976, 15, 817-818. 
Literature  236 
  
[140] G. Bringmann, J. R. Jansen, H. Reuscher, M. Rübenacker, K. Peters, H. G. von Schnering; First total 
synthesis of (-)-dioncophylline A ("Triphyophylline") and of selected stereoisomers: complete (revised) 
stereostructure; Tetrahedron Lett. 1990, 31, 643-646. 
[141] G. Bringmann, J. R. Jansen, H. P. Rink; Regioselective and atropoisomeric-selective aryl coupling to give 
naphthylisoquinoline alkaloids: the first total synthesis of (-)-ancistrocladine; Angew. Chem. Int. Ed. 1986, 
25, 913-915; Angew. Chem. 1986, 98, 917-919. 
[142] G. Bringmann, F. Pokorny, M. Stäblein, M. Schäffer, L. Aké Assi; Ancistrobrevine C from Ancistrocladus 
abbreviatus: the first mixed 'Ancistrocladaceae/Dioncophyllaceae-type' naphthylisoquinoline alkaloid; 
Phytochemistry 1993, 33, 1511-1515. 
[143] G. Bringmann, M. Rückert, J. Schlauer, M. Herderich; Separation and identification of dimeric 
naphthylisoquinoline alkaloids by liquid chromatography coupled to electrospray ionization mass 
spectrometry; J. Chromatogr. 1998, 810, 231-236. 
[144] G. Bringmann, W. Saeb, M. Wohlfarth, K. Messer, R. Brun; Jozipeltine A, a novel, unnatural dimer of the 
highly hydroxylated naphthylisoquinoline alkaloid dioncopeltine A; Tetrahedron 2000, 56, 5871-5875. 
[145] G. Bringmann, W. Saeb, D. Koppler Guido, G. François; Jozimine A ('dimeric' dioncophylline A), a 
non-natural michellamine analog with high antimalarial activity; Tetrahedron 1996, 52, 13409-13418. 
[146] G. Bringmann, R. Zagst, H. Reuscher, L. Aké Assi; Ancistrobrevine B, the first naphthylisoquinoline 
alkaloid with a 5,8'-coupling site, and related compounds from Ancistrocladus abbreviatus; Phytochemistry 
1992, 31, 4011-4014. 
[147] G. Bringmann, F. Pokorny, M. Stäblein, L. Aké Assi; Ancistrobrevine C: A "Mixed" 
Ancistrocladaceae/Dioncophyllaceae-type naphthylisoquinoline alkaloid from Ancistrocladus abbreviatus; 
Planta Med. 1991, 57, 97-98. 
[148] G. Bringmann, C. Schneider, L. Aké Assi; Ancistrobarterine A: a new "mixed" 
Ancistrocladaceae/Dioncophyllaceae-type alkaloid from Ancistrocladus barteri; Planta Med. 1993, 59, 620. 
[149] S. Nwaka, B. Ramirez, R. Brun, L. Maes, F. Douglas, R. Ridley; Advancing drug innovation for neglected 
diseases - criteria for lead progression; Plos Negl. Trop. Dis. 2009, 3, e440. 
[150] P. D. Leeson, B. Springthorpe; The influence of drug-like concepts on decision-making in medicinal 
chemistry; Nat. Rev. Drug Discov. 2007, 6, 881-890. 
[151] M. M. Hann; Molecular obesity, potency and other addictions in drug discovery; Med. Chem. Commun. 
2011, 2, 349-355. 
[152] G. Bringmann, W. Saeb, J. Kraus, R. Brun, G. François; Jozimine B, a constitutionally unsymmetric, 
antiplasmodial 'dimer' of the naphthylisoquinoline alkaloid ancistrocladine; Tetrahedron 2000, 56, 
3523-3531. 
[153] G. Bringmann, S. Harmsen, J. Holenz, T. Geuder, R. Götz, P. A. Keller, R. Walter, Y. F. Hallock, J. H. 
Cardellina II, M. R. Boyd; ‘Biomimetic’oxidative dimerization of korupensamine A: Completion of the first 
total synthesis of michellamines A, B, and C; Tetrahedron 1994, 50, 9643-9648. 
[154] G. Bringmann, W. Saeb, J. Mies, K. Messer, M. Wohlfarth, R. Brun; One-step oxidative dimerization of 
genuine, unprotected naphthylisoquinolines alkaloids to give michellamines and other bioactive quateraryls; 
Synthesis 2000, 1843-1847. 
[155] T. R. Hoye, M. Chen, B. Hoang, L. Mi, O. P. Priest; Total synthesis of michellamines A-C, korupensamines 
A-D, and ancistrobrevine B; J. Org. Chem. 1999, 64, 7184-7201. 
[156] G. Bringmann, M. Wenzel, M. Rückert, K. Wolf, S. Busemann, M. Schäffer, L. Aké Assi; Dioncophyllinol D, 
the first 4-hydroxylated naphthylisoquinoline alkaloid, from the leaves of Triphyophyllum peltatum; 
Heterocycles 1998, 47, 985-990. 
Literature  237 
  
[157] G. Bringmann, W. Saeb, M. Rübenacker; Directed joint total synthesis of the three naphthylisoquinoline 
alkaloids dioncolactone A, dioncopeltine A, and 5'-O-demethyldioncophylline A; Tetrahedron 1999, 55, 
423-432. 
[158] G. Bringmann, S. Tasler; Oxidative aryl coupling reactions: a biomimetic approach to configurationally 
unstable or axially chiral biaryl natural products and related bioactive compounds; Tetrahedron 2001, 57, 
331-343. 
[159] G. Bringmann, R. Götz, S. Harmsen, J. Holenz, R. Walter; Biomimetic total synthesis of michellamines A–C; 
Liebigs Ann. 1996, 2045-2058. 
[160] G. Bringmann, R. Götz; Synthesis of pindikamine A, a michellamine-related dimer of a non-natural, 'skew' 
naphthylisoquinoline; Tetrahedron 1996, 52, 13419-13426. 
[161] G. Bringmann, G. Zhang, T. Büttner, G. Bauckmann, T. Kupfer, R. Brun, V. Mudogo; 2012, unpublished 
paper. 
[162] J. Cannon, V. Lojanapiwatna, C. Raston, W. Sinchai, A. H. White; The quinones of Nepenthes rafflesiana. 
the crystal structure of 2,5-dihydroxy-3,8-dimethoxy-7-methylnaphtho-1,4-quinone (nepenthone-E) and a 
synthesis of 2,5-dihydroxy-3-methoxy-7-methylnaphtho-1,4-quinone (nepenthone-C); Aust. J. Chem. 1980, 
33, 1073-1093. 
[163] J. Budzianowski; Naphthoquinone glucosides of Drosera gigantea from in vitro cultures; Planta Med. 2000, 
66, 667-669. 
[164] G. Bringmann, M. Rübenacker, P. Vogt, H. Busse, L. Aké Assi, K. Peters, H. G. von Schnering; 
Dioncopeltine A and dioncolactone A: alkaloids from Triphyophyllum peltatum; Phytochemistry 1991, 30, 
1691-1696. 
[165] G. Bringmann, M. Rübenacker, T. Geuder, L. Aké Assi; Dioncophylline B, a naphthylisoquinoline alkaloid 
with a new coupling type from Triphyophyllum peltatum; Phytochemistry 1991, 30, 3845-3847. 
[166] G. Bringmann, T. Ortmann, R. Zagst, B. Schöner, L. Aké Assi, C. Burschka; (±)-Dioncophyllacine A, a 
naphthylisoquinoline alkaloid with a 4-methoxy substituent from the leaves of Triphyophyllum peltatum; 
Phytochemistry 1992, 31, 4015-4018. 
[167] G. Bringmann, M. Rübenacker, R. Weirich, L. Aké Assi; Dioncophylline C from the roots of Triphyophyllum 
peltatum, the first 5,1'-coupled Dioncophyllaceae alkaloid; Phytochemistry 1992, 31, 4019-4024. 
[168] G. Bringmann, W. Koch, D. Koppler, M. Rübenacker, L. Aké Assi; A new atropisomeric dioncophylline A 
derivative from Triphylophyllum peltatum; Planta Med. 1993, 59 (Suppl. 1), 621-622. 
[169] G. Bringmann, M. Rübenacker, W. Koch, D. Koppler, T. Ortmann, M. Schäffer, L. Aké Assi; 
5'-O-demethyl-8-O-methyl-7-epi-dioncophylline A and its 'regularly' configurated atropisomer from 
Triphyophyllum peltatum; Phytochemistry 1994, 36, 1057-1061. 
[170] G. Bringmann, W. Saeb, L. Aké Assi, G. Francois, A. S. Sankara Narayanan, K. Peters, E. M. Peters; 
Betulinic acid: isolation from Triphyophyllum peltatum and Ancistrocladus heyneanus, antimalarial activity 
and crystal structure of the benzyl ester; Planta Med. 1997, 63, 255-257. 
[171] G. Bringmann, M. Wenzel, M. Rübenacker, M. Schäffer, M. Rückert, L. Aké Assi; Dioncophylline D and 
8-O-methyldioncophylline D, 7,8'-coupled naphthylisoquinoline alkaloids from Triphyophyllum peltatum; 
Phytochemistry 1998, 49, 1151-1155. 
[172] G. Bringmann, C. Günther, W. Saeb, J. Mies, R. Brun, L. Aké Assi; 8-O-Methyldioncophyllinol B and 
revised structures of other 7,6'-coupled naphthylisoquinoline alkaloids from Triphyophyllum peltatum 
(Dioncophyllaceae); Phytochemistry 2000, 54, 337-346. 
[173] K. Rembold, S. Poppinga, O. Kriesten, A. Irmer, H. Rischer, G. Bringmann; Triphyophyllum peltatum 
(Dioncophyllaceae) in the botanical gardens of Bonn and Würzburg: generation of carnivorous glandular 
Literature  238 
  
leaves and in-vitro progeny; Carniv. Pl. Newslett. 2010, 39, 71-77. 
[174] G. Bringmann, J. Schlauer, K. Wolf, H. Rischer, U. Buschbom, A. Kreiner, F. Thiele, M. Duschek, L. Aké 
Assi; Cultivation of Triphyophyllum peltatum (Dioncophyllaceae), the part-time carnivorous 
plant; Carniv. Pl. Newslett. 1999, 28, 7-13. 
[175] G. Bringmann, H. Rischer; In vitro propagation of the alkaloid-producing rare African liana, Triphyophyllum 
peltatum (Dioncophyllaceae); Plant Cell Rep. 2001, 20, 591-595. 
[176] G. Bringmann, H. Rischer, J. Schäluer, K. Wolf, A. Kreiner, M. Duschek, L. Aké Assi; The tropical liana 
Triphyophyllum peltatum (Dioncophyllaceae): formation of carnivorous organs is only a facultative 
prerequisite for shoot elongation; Carniv. Pl. Newslett. 2002, 31, 44-52. 
[177] D. Jacquemin, J. Preat, V. Wathelet, E. A. Perpète; Time-dependent density functional theory determination 
of the absorption spectra of naphthoquinones; Chem. phys. 2006, 328, 324-332. 
[178] S. M. Colegate, P. R. Dorling, C. R. Huxtable, B. W. Skelton, A. H. White; Stypandrol, a toxic 
binaphthalenetetrol isolated from Stypandra imbricata; Aust. J. Chem. 1985, 38, 1233-1241. 
[179] K. Yoshihira, S. Natori, P. Kanchanapee; The structure of diospyrol, the principle from the fruit of Diospyros 
mollis; Tetrahedron Lett. 1967, 48, 4857-4860. 
[180] E. Okuyama, M. Homma, Y. Satoh, H. Fujimoto, M. Ishibashi, M. Yamazaki, M. Satake, A. B. A. Ghazali; 
Monoamine oxidase inhibitory naphthoquinone and/or naphthalene dimers from Lemuni Hitam (Diospyros 
sp.), a Malaysian herbal medicine; Chem. Pharm. Bull. 1999, 47, 1473-1476. 
[181] F. Bohn, W. Federle; Insect aquaplaning: Nepenthes pitcher plants capture prey with the peristome, a fully 
wettable water-lubricated anisotropic surface; Proc. Natl. Acad. Sci. 2004, 101, 14138-14143. 
[182] L. Gaume, S. Gorb, N. Rowe; Function of epidermal surfaces in the trapping efficiency of Nepenthes alata 
pitchers; New Phytol. 2002, 156, 479-489. 
[183] A. Andrej Pavlovič, E. Masarovičová, J. Hudák; Carnivorous syndrome in Asian pitcher plants of the genus 
Nepenthes; Ann. Bot. (Lond.). 2007, 100, 527-536. 
[184] K. Likhitwitayawuid, R. Kaewamatawong, N. Ruangrungsi, J. Krungkrai; Antimalarial naphthoquinones 
from Nepenthes thorelii; Planta Med. 1998, 64, 237-241. 
[185] H. Rischer, A. Hamm, G. Bringmann; Nepenthes insignis uses a C2-portion of the carbon skeleton of 
L-alanine acquired via its carnivorous organs, to build up the allelochemical plumbagin; Phytochemistry 
2002, 59, 603-609. 
[186] S. Min, S. Y. Lee, J. H. Kim, J. K. Lee, T. J. Kim, D. H. Kim, Y. H. Kim, H. Joung, H. K. Lee, N. Nakamura; 
Anti-complement activity of constituents from the stem-bark of Juglans mandshurica; Biol. Pharm. Bull. 
2003, 26, 1042-1044. 
[187] L. Hörhammer, H. Wagner, H. G. Arndt, R. Dirscherl, L. Farkas; Über die Synthese von 
Quercetin-3-Glykosiden, I. Synthese und Strukturbeweis von Isoquercitrin, Hyperosid und Quercitrin; Chem. 
Ber. 1968, 101, 450-453. 
[188] S. Marquina, J. Bonilla-Barbosa, L. Alvarez; Comparative phytochemical analysis of four Mexican 
Nymphaea species; Phytochemistry 2005, 66, 921-927. 
[189] M. Moos; Synthese Mono- und Dimerer Naphthalin-wirkstoffe; Diploma Dissertation, Universität Würzburg, 
2010. 
[190] B. de Koning, A. L. Rousseau, W. A. L. van Otterlo; Modern methods for the synthesis of substituted 
naphthalenes; Tetrahedron 2003, 59, 7-36. 
[191] S. Chandrasekhar, N. R. Reddy, Y. S. Rao; Synthetic studies on ecteinascidin-743: synthesis of building 
blocks through Sharpless asymmetric dihydroxylation and aza-Michael reactions; Tetrahedron 2006, 62, 
Literature  239 
  
12098-12107. 
[192] J. D. White, P. Hrnciar, F. Stappenbeck; Asymmetric synthesis of (+)-morphine. the phenanthrene route 
revisited; J. Org. Chem. 1997, 62, 5250-5251. 
[193] A. Piettre, E. Chevenier, C. Massardier, Y. Gimbert, A. E. Greene; Synthetic approach to hypoxyxylerone, 
novel inhibitor of topoisomerase I; Org. Lett. 2002, 4, 3139-3142. 
[194] M. Rizzacasa, M. Sargent; The synthesis of stypandrol, a toxic binaphthalenetetrol isolated from Stypandra 
imbricata: new syntheses of dianellidin and stypandrone; Aust. J. Chem. 1988, 41, 1087-1097. 
[195] L. F. Tietze, C. Güntner, K. M. Gericke, I. Schuberth, G. Bunkoczi; A Diels-Alder reaction for the total 
synthesis of the novel antibiotic antitumor agent mensacarcin; Eur. J. Org. Chem. 2005, 2459-2467. 
[196] G. Fioroni, F. Fringuelli, F. Pizzo, L. Vaccaro; Epoxidation of α,β-unsaturated ketones in water. an 
environmentally benign protocol; Green Chem. 2003, 5, 425-428. 
[197] A. Henderson, P. N. Collier, G. Pavé, P. Rzepa, A. J. P. White, J. N. Burrows, A. G. M. Barrett; Studies on the 
total synthesis of lactonamycin: construction of model ABCD ring systems; J. Org. Chem. 2006, 71, 
2434-2444. 
[198] R. Zhu, L. Xing, X. Wang, C. Cheng, B. Liu, Y. Hu; Practical preparation of diosphenols by ring opening of 
α,β-epoxyketones catalyzed by silica gel supported acids; Synlett 2007, 14, 2267-2271. 
[199] P. Beak, V. Snieckus; Directed lithiation of aromatic tertiary amides: an evolving synthetic methodology for 
polysubstituted aromatics; Accounts Chem. Res. 1982, 15, 306-312. 
[200] S. Kamila, C. Mukherjee, S. S. Mondal, A. De; Application of directed metallation in synthesis. Part 3: 
studies in the synthesis of (±)-semivioxanthin and its analogues; Tetrahedron 2003, 59, 1339-1348. 
[201] M. Khaldi, F. Chrétien, Y. Chapleur; Dramatic effect of substituents and TMEDA additive on the 
regioselectivity of directed orthometalation of tetrasubstituted aromatics; Tetrahedron Lett. 1994, 35, 
401-404. 
[202] R. Ohlan, S. Ohlan, V. Judge, R. Narang, M. Ahuja, B. Narasimhan; 
2-(2,4-Difluorophenyl)-1,3-bis-(1,2,4-triazol-1-yl)-propan-2-ol derivatives: synthesis, antifungal evaluation 
and QSAR studies by Hansch analysis; Arkivoc 2007, 14, 172-184. 
[203] H. Li, C. Wang, T. Sanchez, Y. Tan, C. Jiang, N. Neamati, G. Zhao; Amide-containing diketoacids as HIV-1 
integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity; Bioorg. Med. 
Chem. 2009, 17, 2913-2919. 
[204] J. H. P. Utley, G. G. Rozenberg; Electroorganic reactions. Part 56: anodic oxidation of 2-methyl-and 
2-benzylnaphthalenes: factors influencing competing pathways; Tetrahedron 2002, 58, 5251-5265. 
[205] M. Berglund, M. F. Dalence-Guzmán, S. Skogvall, O. Sterner; SAR studies of capsazepinoid 
bronchodilators 3: the thiourea part (coupling region) and the 2-(4-chlorophenyl) ethyl moiety (C-region); 
Bioorg. Med. Chem. 2008, 16, 2529-2540. 
[206] S. Yamazaki; Chromium (VI) oxide-catalyzed oxidation of arenes with periodic acid; Tetrahedron Lett. 2001, 
42, 3355-3357. 
[207] V. V. Dhekne, B. V. Bhide; Synthesis of 7-methoxy-3-methyl-1-tetralone and its oxidation with selenium 
dioxide; J. Indian Chem. Soc. 1951, 28, 504-506. 
[208] T. Ohgiya, S. Nishiyama; A simple deprotection of triflate esters of phenol derivatives; Tetrahedron Lett. 
2004, 45, 6317-6320. 
[209] G. Wurm, B. Goeßler; Untersuchung an 1,4-Naphthochinonen, 18. Mitt.: 6-Methyl- und 
3,6-Dimethylplumbagin; Arch. d. Pharm. 1989, 322, 489-491. 
Literature  240 
  
[210] H. Taguchi, S. Kita, M. Kobayashi, Y. Tani; Selective oxidation of 2-methylnaphthalene to 
2-methyl-1-naphthol by Rhodococus sp. M192; Biosci. Biotech. Bioch. 1996, 60, 769-772. 
[211] G. Giri, S. M. S. Chauhan; Oxidation of polycyclic aromatic hydrocarbons with hydrogen peroxide 
catalyzed by Iron (III) porphyrins; Catal. Commun. 2009, 10, 383-387. 
[212] H. Wang, Y. Mao, A. Y. Chen, N. Zhou, E. J. LaVoie, L. F. Liu; Stimulation of topoisomerase II-mediated 
DNA damage via a mechanism involving protein thiolation; Biochemistry 2001, 40, 3316-3323. 
[213] R. T. Arnold, R. Larson; Quinones by the peroxide oxidation of aromatic compounds; J. Org. Chem. 1940, 5, 
250-252. 
[214] W. Adam, P. A. Ganeshpure; Oxidation of arenes to para-quinones with hydrogen peroxide catalyzed by 
hexafluoroacetone hydrate; Synthesis 1993, 1993, 280-282. 
[215] Y. Asakawa, R. Matsuda, M. Tori, M. Sono; Efficient preparation of some biologically active substances 
from natural and nonnatural aromatic compounds by m-chloroperbenzoic acid oxidation; J. Org. Chem. 
1988, 53, 5453-5457. 
[216] W. A. Herrmann, J. J. Haider, R. W. Fischer; Rhenium-catalyzed oxidation of arenes-an improved synthesis 
of vitamin K3; J. Mol. Catal. A. Chem. 1999, 138, 115-121. 
[217] R. Song, A. Sorokin, J. Bernadou, B. Meunier; Metalloporphyrin-catalyzed oxidation of 
2-methylnaphthalene to vitamin K3 and 6-methyl-1,4-naphthoquinone by potassium monopersulfate in 
aqueous solution; J. Org. Chem. 1997, 62, 673-678. 
[218] S. V. Barkanova, V. M. Derkacheva, O. V. Dolotova, V. D. Li, V. M. Negrimovsky, O. L. Kaliya, E. A. 
Luk'yanets; Homogeneous oxidation of aromatics in nucleus with peracetic acid catalyzed by iron and 
manganese phthalocyanine complexes; Tetrahedron Lett. 1996, 37, 1637-1640. 
[219] S. Hirashima, A. Itoh; Synthesis of benzoic acids by aerobic photooxidation with hydrobromic acid; 
Synthesis 2006, 1757-1759. 
[220] H. T. Clarke, E. R. Taylor; Org. Synth. Coll. Vol. 2, J. Wiley & Sons, New York, 1943, S. 135-136. 
[221] W. Singer, S. M. McElvain; Org. Synth. Coll. Vol. 3, J. Wiley & Sons, New York, 1955, S. 740-741. 
[222] G. Bringmann, A. J. Price Mortimer, P. A. Keller, M. J. Gresser, J. Garner, M. Breuning; Atroposelective 
synthesis of axially chiral biaryl compounds; Angew. Chem. Int. Ed. 2005, 44, 5384-5427; Angew. Chem. 
2005, 117, 5518-5563. 
[223] G. Bringmann, T. Gulder, T. A. M. Gulder, M. Breuning; Atroposelective total synthesis of axially chiral 
biaryl natural products; Chem. Rev. 2011, 111, 563-639. 
[224] J. M. Wilson, D. J. Cram; Studies in stereochemistry. 47. Asymmetric induction by leaving group in 
nucleophilic aromatic substitution; J. Org. Chem. 1984, 49, 4930-4943. 
[225] J. M. Wilson, D. J. Cram; Chiral leaving groups induce asymmetry in syntheses of binaphthyls in 
nucleophilic aromatic substitution reactions; J. Am. Chem. Soc. 1982, 104, 881-884. 
[226] A. Meyers, K. A. Lutomski; Enantioselective synthesis of binaphthyls via nucleophilic aromatic substitution 
on chiral oxazolines; J. Am. Chem. Soc. 1982, 104, 879-881. 
[227] T. Hayashi, K. Hayashizaki, T. Kiyoi, Y. Ito; Asymmetric synthesis catalyzed by chiral 
ferrocenylphosphine-transition-metal complexes. 6. practical asymmetric synthesis of 1,1'-binaphthyls via 
asymmetric cross-coupling with a chiral [(alkoxyalkyl) ferrocenyl] monophosphine/nickel catalyst; J. Am. 
Chem. Soc. 1988, 110, 8153-8156. 
[228] N. Miyaura, A. Suzuki; Palladium-catalyzed cross-coupling reactions of organoboron compounds; Chem. 
Rev. 1995, 95, 2457-2483. 
Literature  241 
  
[229] K. Nicolaou, P. G. Bulger, D. Sarlah; Palladium-catalyzed cross-coupling reactions in total synthesis; Angew. 
Chem. Int. Ed. 2005, 44, 4442-4489; Angew. Chem. 2005, 117, 4516-4563. 
[230] O. Baudoin; The asymmetric Suzuki coupling route to axially chiral biaryls; Eur. J. Org. Chem. 2005, 
4223-4229. 
[231] N. Cammidge, K. V. L. Crépy; The first asymmetric Suzuki cross-coupling reaction; Chem. Commun. 2000, 
1723-1724. 
[232] N. Cammidge, K. V. L. Crépy; Synthesis of chiral binaphthalenes using the asymmetric Suzuki reaction; 
Tetrahedron 2004, 60, 4377-4386. 
[233] J. F. Jensen, M. Johannsen; New air-stable planar chiral ferrocenyl monophosphine ligands: Suzuki 
cross-coupling of aryl chlorides and bromides; Org. Lett. 2003, 5, 3025-3028. 
[234] M. Genov, A. Almorín, P. Espinet; Efficient synthesis of chiral 1,1'-binaphthalenes by the asymmetric 
Suzuki-Miyaura reaction: dramatic synthetic improvement by simple purification of naphthylboronic acids; 
Chem. Eur. J. 2006, 12, 9346-9352. 
[235] Y. Uozumi, Y. Matsuura, T. Arakawa, Y. Yamada; Asymmetric Suzuki-Miyaura coupling in water with a 
chiral palladium catalyst supported on an amphiphilic resin; Angew. Chem. Int. Ed. 2009, 121, 2746-2748; 
Angew. Chem. 2009, 121, 2746-2748. 
[236] S. D. Walker, T. E. Barder, J. R. Martinelli, S. L. Buchwald; A rationally designed universal catalyst for 
Suzuki-Miyaura coupling processes; Angew. Chem. Int. Ed. 2004, 43, 1871-1876; Angew. Chem. 2004, 116, 
1907-1912. 
[237] T. E. Barder, S. D. Walker, J. R. Martinelli, S. L. Buchwald; Catalysts for Suzuki-Miyaura coupling 
processes: scope and studies of the effect of ligand structure; J. Am. Chem. Soc. 2005, 127, 4685-4696. 
[238] J. P. Wolfe, S. L. Buchwald; A highly active catalyst for the room-temperature amination and Suzuki 
coupling of aryl chlorides; Angew. Chem. Int. Ed. 1999, 38, 2413-2416; Angew. Chem. 1999, 111, 
2570-2573. 
[239] J. H. Kirchhoff, C. Dai, G. C. Fu; A Method for palladium-catalyzed cross-couplings of simple alkyl 
chlorides: Suzuki reactions catalyzed by [Pd2(dba)3]/PCy3; Angew. Chem. Int. Ed. 2002, 114, 2025-2027; 
Angew. Chem. 2002, 114, 2025-2027. 
[240] F. Littke, C. Dai, G. C. Fu; Versatile catalysts for the Suzuki cross-coupling of arylboronic acids with aryl 
and vinyl halides and triflates under mild conditions; J. Am. Chem. Soc. 2000, 122, 4020-4028. 
[241] G. Bringmann, S. Rüdenauer, T. Bruhn, L. Benson, R. Brun; Total synthesis of the antimalarial 
naphthylisoquinoline alkaloid 5-epi-4'-O-demethylancistrobertsonine C by asymmetric Suzuki 
cross-coupling; Tetrahedron 2008, 64, 5563-5568. 
[242] S. Kamisuki, S. Takahashi, Y. Mizushina, S. Hanashima, K. Kuramochi, S. Kobayashi, K. Sakaguchi, T. 
Nakata, F. Sugawara; Total synthesis of dehydroaltenusin; Tetrahedron 2004, 60, 5695-5700. 
[243] S. Kajigaeshi, T. Kakinami, T. Okamoto, H. Nakamura, M. Fujikawa; Halogenation using quaternary 
ammonium polyhalides. IV: selective bromination of phenols by use of tetraalkylammonium tribromides; 
Bull. Chem. Soc. Jpn. 1987, 60, 4187-4189. 
[244] M. A. Brimble, M. Y. H. Lai; Suzuki-Miyaura homocoupling of naphthyl triflates using bis (pinacolato) 
diboron: approaches to the biaryl skeleton of crisamicin A; Org. Biomol. Chem. 2003, 1, 2084-2095. 
[245] P. Jacob III, P. S. Callery, A. T. Shulgin, N. Castagnoli Jr; A convenient synthesis of quinones from 
hydroquinone dimethyl ethers. oxidative demethylation with ceric ammonium nitrate; J. Org. Chem. 1976, 
41, 3627-3629. 
[246] M. C. Carreno, J. L. Garcia Ruano, A. Urbano; Asymmetric Diels-Alder reactions of 
Literature  242 
  
(S)-2-(p-tolylsulfinyl)-1,4-naphthoquinones; J. Org. Chem. 1992, 57, 6870-6876. 
[247] H. Godbole, A. Ranade, A. Joseph, M. Paradkar; Novel synthesis of linear furonaphthoquinones; Synth. 
Commun. 2000, 30, 2951-2960. 
[248] T. Nguyen Van, B. Kesteleyn, N. De Kimpe; Synthesis of 1,3-disubstituted naphtho [2,3-c] 
pyran-5,10-diones; Tetrahedron 2001, 57, 4213-4219. 
[249] F. Rothenfluh, A. M. Oliver, M. N. Paddon-Row; Synthesis, electrochemistry and ab initio molecular orbital 
calculations on some norbornane-and bicyclo [2.2.2] octane-fused 5,12-bis (dicyanomethylidene) 
naphthalene systems; J. Chem. Soc., Perkin Trans. 2 1996, 639-648. 
[250] G. Bringmann, M. Ochse, R. Götz; First atropo-divergent total synthesis of the antimalarial korupensamines 
A and B by the "lactone method"; J. Org. Chem. 2000, 65, 2069-2077. 
[251] A. James, V. Snieckus; Combined directed metalation-cross coupling strategies. total synthesis of the 
aglycones of gilvocarcin V, M and E; Tetrahedron Lett. 1997, 38, 8149-8152. 
[252] G. F. Giles, I. R. Green, L. S. Knight, V. R. L. Son, S. C. Yorkea; The stereoselective formation of naphtho 
[1,2-c] pyrans, angular analogues of the aphin-derived glucoside B, by an intramolecular version of the 
Mukaiyama reaction of 4-naphthyldioxolanes; J. Chem. Soc., Perkin Trans. 1 1994, 865-873. 
[253] E. Corey, A. Venkateswarlu; Protection of hydroxyl groups as tert-butyldimethylsilyl derivatives; J. Am. 
Chem. Soc. 1972, 94, 6190-6191. 
[254] B. Hatano, S. Toyota, F. Toda; Efficient solvent-free O-silylation of alcohols with R3SiCl; Green Chem. 
2001, 3, 140-142. 
[255] H. Firouzabadi, S. Etemadi, B. Karimi, A. A. Jarrahpour; Efficient and chemoselective protection of 
alcohols and phenols with tert-butyldimethylchlorosilane (TBDMCS) under solvent-free conditions; 
Phosphorus, Sulfur Silicon Relat. Elem. 1998, 143, 45-51. 
[256] G. Gibbons; Total synthesis of (±)-pleuromutilin; J. Am. Chem. Soc. 1982, 104, 1767-1769. 
[257] F. Teplý, I. G. Starý, I. Starý, A. Kollárovič, D. Luštinec, Z. Krausová, D. Šaman, P. Fiedler; A convenient 
route to 2-hydroxy- and 2,15-dihydroxyhexahelicene; Eur. J. Org. Chem. 2007, 4244-4250. 
[258] C. Olano, C. Méndez, J. A. Salas; Antitumor compounds from marine actinomycetes; Mar. Drugs 2009, 7, 
210-248. 
[259] M. Pimentel-Elardo, S. Kozytska, T. S. Bugni, C. M. Ireland, H. Moll, U. Hentschel; Anti-parasitic 
compounds from Streptomyces sp. strains isolated from mediterranean sponges; Mar. Drugs 2010, 8, 
373-380. 
[260] K. Engelhardt, K. F. Degnes, M. Kemmler, H. Bredholt, E. Fjærvik, G. Klinkenberg, H. Sletta, T. E. 
Ellingsen, S. B. Zotchev; Production of a new thiopeptide antibiotic, TP-1161, by a marine Nocardiopsis 
species; Appl. Environ. Microbiol. 2010, 76, 4969-4976. 
[261] M. Ongena, P. Jacques; Bacillus lipopeptides: versatile weapons for plant disease biocontrol; Trends 
Microbiol. 2008, 16, 115-125. 
[262] Y. Seto, K. Takahashi, H. Matsuura, Y. Kogami, H. Yada, T. Yoshihara, K. Nabeta; Novel cyclic peptide, 
epichlicin, from the endophytic fungus, Epichloe typhina; Biosci. Biotech. Bioch. 2007, 71, 1470-1475. 
[263] L. Zhang, H. M. Hua, Y. H. Pei, X. S. Yao; Three new cytotoxic cyclic acylpeptides from marine Bacillus sp; 
Chem. Pharm. Bull. 2004, 52, 1029-1030. 
[264] H. Nielsen, J. Sorensen; Production of cyclic lipopeptides by Pseudomonas fluorescens strains in bulk soil 
and in the sugar beet rhizosphere; Appl. Environ. Microbiol. 2003, 69, 861-868. 
[265] S. Lee, H. J. Shin, K. H. Jang, T. S. Kim, K. B. Oh, J. Shin; Cyclic peptides of the nocardamine class from a 
Literature  243 
  
marine-derived bacterium of the genus Streptomyces; J. Nat. Prod. 2005, 68, 623-625. 
[266] A. Romano, D. Vitullo, A. Di Pietro, G. Lima, V. Lanzotti; Antifungal lipopeptides from Bacillus 
amyloliquefaciens Strain BO7; J. Nat. Prod. 2011, 74, 145-151. 
[267] K. Kanoh, Y. Matsuo, K. Adachi, H. Imagawa, M. Nishizawa, Y. Shizuri; Mechercharmycins A and B, 
cytotoxic substances from marine-derived Thermoactinomyces sp. YM3-251; J. Antibiot. (Tokyo) 2005, 58, 
289-292. 
[268] R. Abdelmohsen, S. M. Pimentel-Elardo, A. Hanora, M. Radwan, S. H. Abou-El-Ela, S. Ahmed, U. 
Hentschel; Isolation, phylogenetic analysis and anti-infective activity screening of marine sponge-associated 
actinomycetes; Mar. Drugs 2010, 8, 399-412. 
[269] R. Abdelmohsen, G. Zhang, A. Philippe, W. Schmitz, S. M. Pimentel-Elardo, B. Hertlein-Amslinger, U. 
Hentschel, G. Bringmann; Cyclodysidins A-D, cyclic lipopeptides from the marine sponge-derived 
Streptomyces strain RV15; Tetrahedron Lett. 2012, 53, 23-29. 
[270] I. Lee, M. Narayan, J. S. Barrett; Analysis and comparison of active constituents in commercial standardized 
silymarin extracts by liquid chromatography-electrospray ionization mass spectrometry; J Chromatogr. B 
2007, 845, 95-103. 
[271] M. Sheldrick; A short history of SHELX; Acta. Cryst. 2008, 64, 112-122. 
[272] T. Murashige, F. Skoog; A revised medium for rapid growth and bioassays with tobacco tissue cultures; 
Physiol. Plantarum 1962, 15, 473-497. 
[273] J. H. Faber; Naphthylisoquinoline alkaloids: structural elucidation, metabolism, and functional analysis of 
their bioactivities; Doctoral Dissertation, Universität Würzburg, 2007. 
[274] A. Nguyen, H. Ripperger, A. Porzel, T. Van Sung, G. Adam; Tetralones from Ancistrocladus cochinchinensis; 
Phytochemistry 1997, 44, 549-551. 
[275] T. R. Govindachari, P. C. Parthasarathy, T. G. Rajagopalan, H. K. Desai, K. S. Ramachandran, E. Lee; 
Absolute configuration of ancistrocladisine and ancistrocladidine; J. Chem. Soc., Perkin Trans. 1 1975, 
2134-2136. 
[276] G. Bringmann, M. Dreyer, J. H. Faber, P. W. Dalsgaard, D. Stærk, J. W. Jaroszewski, H. Ndangalasi, F. 
Mbago, R. Brun, S. B. Christensen; Ancistrotanzanine C and related 5,1'-and 7,3'-coupled 
naphthylisoquinoline alkaloids from Ancistrocladus tanzaniensis; J. Nat. Prod. 2004, 67, 743-748. 
[277] G. Bringmann, M. Dreyer, M. Michel, F. S. K. Tayman, R. Brun; Ancistroheynine B and two further 
7,3'-coupled naphthylisoquinoline alkaloids from Ancistrocladus heyneanus Wall.; Phytochemistry 2004, 65, 
2903-2907. 
[278] B. Kreher, A. Neszmélyi, H. Wagner; Naphthoquinones from Dionaea muscipula; Phytochemistry 1990, 29, 
605-606. 
[279] A. McDonald, T. J. Simpson, A. F. Sierakowski; 13C NMR spectral studies of some naturally occurring 
quinones and related compounds; Aust. J. Chem. 1977, 30, 1727-1734. 
[280] Y. Kashiwada, A. Aoshima, Y. Ikeshiro, Y. P. Chen, H. Furukawa, M. Itoigawa, T. Fujioka, K. Mihashi, L. M. 
Cosentino, S. L. Morris-Natschke; Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of 
Nelumbo nucifera, and structure-activity correlations with related alkaloids; Bioorg. Med. Chem. 2005, 13, 
443-448. 
[281] D. A. Frost, G. A. Morrison; Naturally occurring compounds related to phenalenone. Part VI. Synthesis of 
atrovenetin (8,9-dihydro-3,4,5,6-tetrahydroxy-1,8,8,9-tetra-methylphenaleno [1,2-b] furan-7-one) and 
related compounds; J. Chem. Soc., Perkin I 1973, 2388-2396. 
[282] D. B. Haydock, T. P. C. Mulholland, B. Telford, J. M. Thorp, J. S. Wain; Analogues of clofibrate and 
Literature  244 
  
clobuzarit containing fluorine in the side chains; Eur. J. Med. Chem. 1984, 19, 205-214. 
[283] M. Bollini, J. J. Casal, A. M. Bruno; Design, synthesis, and antitumor activity of new 
bis-aminomethylnaphthalenes; Bioorg. Med. Chem. 2008, 16, 8003-8010. 
[284] H. Pluim, H. Wynberg; Catalytic asymmetric induction in oxidation reactions. synthesis of optically active 
epoxynaphthoquinones; J. Org. Chem. 1980, 45, 2498-2502. 
[285] F. Fieser, A. M. Seligman; A study of the addition reactions of certain alkylated naphthoquinones; J. Am. 
Chem. Soc. 1934, 56, 2690-2696. 
[286] K. Hagiya, S. Mitsui, H. Taguchi; A facile and selective synthetic method for the preparation of aromatic 
dialdehydes from diesters via the amine-modified SMEAH reduction system; Synthesis 2003, 823-828. 
[287] R. D. Haworth, B. M. Letsky, C. R. Mavin; Syntheses of alkylphenanthrenes. Part II. pimanthrene, 
1,4,7-trimethylphenanthrene, retene, and 1,4-dimethyl-7-isopropylphen-anthrene; J. Am. Chem. Soc. 1932, 
54, 1784-1792. 
[288] U. Akpuaka, R. L. Beddoes, J. M. Bruce, S. Fitzjohn, O. S. Mills; Methoxycarbonyl shifts in Diels-Alder 
adducts of methoxycarbonyl-1,4-benzoquinones; J. Chem. Soc. 1982, 686-688. 
[289] J. Smith, R. H. Thomson; Diquinones. I. the oosporein-tomichaedin degradation; Tetrahedron 1960, 10, 
148-152. 
[290] P. Beak, R. A. Brown; The tertiary amide as an effective director of ortho lithiation; J. Org. Chem. 1982, 47, 
34-46. 
 
 
Acknowledgements 245 
  
Acknowledgements 
I would like to take this opportunity to express my sincerest thanks to all the people who 
have helped me during my stay in Würzburg for the completion of this thesis. 
I owe my deepest gratitude to Prof. Dr. Dr. h.c. G. Bringmann. He accommodated me to do 
my research work in his working group in the Organic Chemistry Department in University of 
Würzburg. He has constantly inspired, encouraged, and supported me for honing my skills. I 
am so blessed to have met him and admire him for his knowledge, preciseness and willpower. 
I could have never succeeded in this thesis without him. 
I am highly grateful to Prof. Dr. U. Holzgrabe and Prof. Dr. med. R. Bargou for 
co-supervision of my work on behalf of the Graduate School of Life Sciences (GSLS). I am 
also heartfully indebted to GSLS for all the activities, from which I benefited a lot induring 
the course of my study. 
I would like to gratefully acknowledge Ms. A. Zillenbiller and Dr. D. Feineis for their 
assistance. 
The naphthoquinone project would not have been possible without the support from Dr. M. 
Chatterjee working in the University Hospital of Würzburg. I am very grateful to him for the 
antitumor assay and sharing his knowledge with me. 
I am very thankful to our biological partners, Prof. R. Brun, Prof. A. Stich, Dr. T. 
Ölschläger, for their invaluable scientific contribution to my thesis in biotesting experiments 
on infective pathogens. 
The project on naphthylisoquinoline alkaloids would not have been initiated without the 
precious plant material or the crude extract, which were kindly provided by Prof. J. Wu, Dr. 
M. Xu, and Prof. V. Mudogo. I would also like to thank them for their generosity and 
kindness. 
I am highly obliged to A. Irmer and C. Steinert for helping me adapt to Bringmann’s 
working group when I first joined into our team, and for sharing their wide knowledge with 
me in the field of natural products. A lot of assistance from them makes my lab work more 
Acknowledgements 246 
  
efficient and my life in Würzburg more enjoyable. 
I am extremely appreciatory to M. Mikyna and T. Büttner for much assistance in organic 
synthesis experiments, and the translation work of the English summary part in this thesis into 
German, and A. Gehrold for careful corrections. 
Many thanks and appreciations also go to Dr. U. Abdelmohsen, A. Philippe, and Prof. U. 
Hentschel in the joint project of the phytochemical investigation on the marine 
sponge-derived strain, Dr. T. Kupfer for contribution in X-ray crystallography, Y. Hemberger 
in quantum chemical circular dichroism calculations, M. Michel in oxidative degradation 
experiments, B. Wanner and J. Köller in synthesis of some naphthoquinones, Dr. M. Grüne 
and E. Ruckdeschel in NMR measurements, and Dr. M. Büchner and F. Dadrich in MS 
experiments. 
I would also like to thank my former and current colleagues in Bringmann’s group, who 
created a very warm research atmosphere in the laboratory and also made my life in 
Würzburg highly joyous and delighted. It has been my great pleasure to work with them, Dr. 
D. Götz, Dr. M. Narasimhulu, Dr. T. Bruhn, A. Schaumlöffel, B. Amslinger, B. K. Lombe, C. 
Grimmer, C. Albert, D. T. Tshitenge, E. Paulsen, F. Witterauf, G. Bauckmann, L. Kötzner, M. 
Diegel, M. Knauer, M. K. S. Jean-Pierre, M. Moos, M. Pfletscher, M. Schraut, P. Altenberger, 
S. Bischof, and S. Schmitt. 
I am grateful to all my friends who made my study in Würzburg very enjoyable. 
Finally, I would like to avail myself of this very opportunity to extend my deepest gratitude 
and love to my beloved parents and my wife for their continuous support, concern and 
understanding!
 
 
Publications 247 
  
Publications 
1. Gerhard Bringmann, Guoliang Zhang, Anastasia Hager, Michael Moos, Andreas Irmer, Ralf 
Bargou, Manik Chatterjee. Antitumoral activities of dioncoquinones B and C and related 
naphthoquinones gained from total synthesis or isolation from plants. Eur. J. Med. 
Chem. 2011, 46, 5778-5789. 
2. Usama Ramadan Abdelmohsen, Guoliang Zhang,∗ Allan Philippe, Werner Schmitz, Sheila 
Marie Pimentel-Elardo, Barbara Hertlein-Amslinger, Ute Hentschel, Gerhard Bringmann. 
Cyclodysidins A−D, cyclic lipopeptides from the new marine sponge-derived 
Streptomyces strain RV152. Tetrahedron Lett. 2012, 53, 23-29. 
3. Gerhard Bringmann, Guoliang Zhang, Tobias Ölschläger, August Stich, Jun Wu, Reto 
Brun. Highly selectiveantiplasmodial naphthylisoquinoline alkaloids from Ancistrocladus 
tectorius. Phytochemistry (in press). 
4. Gerhard Bringmann, Guoliang Zhang, Tobias Büttner, Gabi Bauckmann, Thomas Kupfer, 
Reto Brun, Virima Mudogo. Jozimine A2, the first dimeric Dioncophyllaceae-type 
naphthylisoquinoline alkaloid, with three chiral axes and high antiplasmodial activity. 
Chem. Eur. J. (manuscript in preparation). 
5. Gerhard Bringmann, Guoliang Zhang, Yasmin Hemberger, Reto Brun. One-step synthesis 
of dioncotetralones A and B from dioncophylline A. Org. Biomol. Chem. (manuscript in 
preparation). 
6. Gerhard Bringmann, Guoliang Zhang, Reto Brun. Jozimine A3, a novel unnatural 
symmetric highly antiplasmodial dimeric naphthylisoquinoline alkaloid. Tetrahedron Lett. 
(manuscript in preparation). 
 
 
Posters and Oral Presentations at Congresses and Symposia 248 
  
Posters and Oral Presentations at Congresses and Symposia 
1. 43th Natural Products Meeting: Chemistry, Biology and Ecology in Halle, Germany (27. 
04. 2012); Participant. 
2. 42th Natural Products Meeting: Chemistry, Biology and Ecology in Bayreuth, Germany 
(14. 10. 2011); Oral Presentation: “Cyclodysidins A−D, New Cyclic Lipopeptides from 
the Marine Sponge-derived Streptomyces Strain RV15”. 
3. GSLS Annual Retreat (29. 07. 2011 − 31. 07. 2011) in Nürnberg, Germany; Poster 
Presentation: “Jozimine A2, the First Natural Dioncophyllaceae-type 
Naphthylisoquinoline Alkaloid Dimer with Three Chiral Axes and High Antimalarial 
Activity”. 
4. 6th. Joint Ph.D. Student Meeting: “New Trends in Infectious Disease Research” in 
Ellwangen, Germany (22. 11. 2010 − 24. 11. 2010); Poster Presentation: “Isolation and 
Synthesis of Compounds from Cell and Root Cultures of Triphyophyllum peltatum”. 
5. 39th Natural Products Meeting: Chemistry, Biology and Ecology in Jena, Germany (16. 
04. 2010); Oral Presentation: “Dioncoquinones A and B from Plant Cell Cultures, as 
Promising Agents against Incurable Multiple Myeloma”. 
6. SFB 630 “New Trends in Infectious Disease Research” in Heidelberg (19. 11. 2009 − 21. 
11. 2009); Participant.  
7. 38th Natural Products Meeting: Chemistry, Biology and Ecology in Halle, Germany (16. 
10. 2009); Participant. 
8. SFB 630 “Novel Agents against Infectious Diseases - an Interdisciplinary Approach” in 
Würzburg (7. 10. 2009 − 10. 10. 2009); Participant.  
9. 37th Natural Products Meeting: Chemistry, Biology and Ecology in Bayreuth, Germany 
(15. 05. 2009); Participant. 
10. 36th Natural Products Meeting: Chemistry, Biology and Ecology (10. 10. 2008) in 
Würzburg; Participant.  
    
Workshops 249 
  
Workshops 
1. Becoming a Better Academic Writer (01. 07. 2011 − 02. 07. 2011), Graduate School of 
Life Sciences, Würzburg, Germany. 
2. Giving Academic Talks (11. 03. 2010 − 12. 03. 2010), Graduate School of Life Sciences, 
Würzburg, Germany.  
3. Spoken and Written English (15. 03. 2010 and 01. 03. 2010), Graduate School of Life 
Sciences, Würzburg, Germany. 
4. Poster Design and Presentation (23. 02. 2010), Graduate School of Life Sciences, 
Würzburg, Germany. 
 
 
Curriculum Vitae 250 
  
Curriculum Vitae 
Name: Guoliang Zhang 
Date of Birth: 08. 06. 1982 
Place of Birth:  Jingmen, Hubei Province, P. R. China 
  
Education and Work Experience: 
08. 2008 – Present 
 
Ph. D. dissertation: “Phytochemical Research on Two Ancistrocladus 
Species, Semi-Synthesis of Dimeric Naphthylisoquinoline Alkaloids, 
and Structure Optimization of Antitumoral Naphthoquinones” 
Julius-Maximilians-Universität Würzburg, Germany 
Main Supervisor: Prof. Dr. Dr. h.c. G. Bringmann 
03. 2008 – 06. 2008 Sales Engineer in Tegent Technology LTD, Shanghai, China 
08. 2007 – 02. 2008 Researcher in Analytical Chemistry Laboratory, 
Wuxi PharmaTech Inc. Shanghai, China 
09. 2004 – 07. 2007 Master of Science 
Master dissertation: “Bioactive Lignans from Peperomia heyneana” 
Shanghai Institute of Materia Medica, Chinese Academy of 
Sciences, China 
Supervisor: Prof. Dr. Na Li 
09. 2000 – 07. 2004 Bachelor of Agriculture 
Bachelor dissertation: “Expression and Purification of a 
transcriptional factor” 
Southwest University, Chongqing, China 
Supervisor: Dr. Minghui Li 
  
 
Affidavit 251 
  
Affidavit 
I hereby declare that my thesis entitled: “Phytochemical Research on Two Ancistrocladus 
Species, Semi-Synthesis of Dimeric Naphthylisoquinoline Alkaloids, and Structure 
Optimization of Antitumoral Naphthoquinones” is the result of my own work. I did not 
receive any help or support from commercial consultants. All sources and / or materials 
applied are listed and specified in the thesis. 
 
Furthermore, I verify that this thesis has not yet been submitted as part of another examination 
process neither in identical nor in similar form. 
 
 
Würzburg  
Date Signature 
 Guoliang Zhang 
 
 
